Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific nTPM"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific nTPM"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific nTPM"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific nTPM"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific nTPM"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific nTPM"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific nTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific nTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Blood expression cluster"	"Tissue expression cluster"	"Cell line expression cluster"	"Single cell expression cluster"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [nTPM]"	"Tissue RNA - adrenal gland [nTPM]"	"Tissue RNA - amygdala [nTPM]"	"Tissue RNA - appendix [nTPM]"	"Tissue RNA - basal ganglia [nTPM]"	"Tissue RNA - bone marrow [nTPM]"	"Tissue RNA - breast [nTPM]"	"Tissue RNA - cerebellum [nTPM]"	"Tissue RNA - cerebral cortex [nTPM]"	"Tissue RNA - cervix [nTPM]"	"Tissue RNA - choroid plexus [nTPM]"	"Tissue RNA - colon [nTPM]"	"Tissue RNA - duodenum [nTPM]"	"Tissue RNA - endometrium 1 [nTPM]"	"Tissue RNA - epididymis [nTPM]"	"Tissue RNA - esophagus [nTPM]"	"Tissue RNA - fallopian tube [nTPM]"	"Tissue RNA - gallbladder [nTPM]"	"Tissue RNA - heart muscle [nTPM]"	"Tissue RNA - hippocampal formation [nTPM]"	"Tissue RNA - hypothalamus [nTPM]"	"Tissue RNA - kidney [nTPM]"	"Tissue RNA - liver [nTPM]"	"Tissue RNA - lung [nTPM]"	"Tissue RNA - lymph node [nTPM]"	"Tissue RNA - medulla oblongata [nTPM]"	"Tissue RNA - midbrain [nTPM]"	"Tissue RNA - ovary [nTPM]"	"Tissue RNA - pancreas [nTPM]"	"Tissue RNA - parathyroid gland [nTPM]"	"Tissue RNA - pituitary gland [nTPM]"	"Tissue RNA - placenta [nTPM]"	"Tissue RNA - pons [nTPM]"	"Tissue RNA - prostate [nTPM]"	"Tissue RNA - rectum [nTPM]"	"Tissue RNA - retina [nTPM]"	"Tissue RNA - salivary gland [nTPM]"	"Tissue RNA - seminal vesicle [nTPM]"	"Tissue RNA - skeletal muscle [nTPM]"	"Tissue RNA - skin 1 [nTPM]"	"Tissue RNA - small intestine [nTPM]"	"Tissue RNA - smooth muscle [nTPM]"	"Tissue RNA - spinal cord [nTPM]"	"Tissue RNA - spleen [nTPM]"	"Tissue RNA - stomach 1 [nTPM]"	"Tissue RNA - testis [nTPM]"	"Tissue RNA - thalamus [nTPM]"	"Tissue RNA - thymus [nTPM]"	"Tissue RNA - thyroid gland [nTPM]"	"Tissue RNA - tongue [nTPM]"	"Tissue RNA - tonsil [nTPM]"	"Tissue RNA - urinary bladder [nTPM]"	"Tissue RNA - vagina [nTPM]"	"Tissue RNA - white matter [nTPM]"	"Cell RNA - A-431 [nTPM]"	"Cell RNA - A549 [nTPM]"	"Cell RNA - AF22 [nTPM]"	"Cell RNA - AN3-CA [nTPM]"	"Cell RNA - ASC diff [nTPM]"	"Cell RNA - ASC TERT1 [nTPM]"	"Cell RNA - BEWO [nTPM]"	"Cell RNA - BJ [nTPM]"	"Cell RNA - BJ hTERT+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [nTPM]"	"Cell RNA - CACO-2 [nTPM]"	"Cell RNA - CAPAN-2 [nTPM]"	"Cell RNA - Daudi [nTPM]"	"Cell RNA - EFO-21 [nTPM]"	"Cell RNA - fHDF/TERT166 [nTPM]"	"Cell RNA - GAMG [nTPM]"	"Cell RNA - HaCaT [nTPM]"	"Cell RNA - HAP1 [nTPM]"	"Cell RNA - HBEC3-KT [nTPM]"	"Cell RNA - HBF TERT88 [nTPM]"	"Cell RNA - HDLM-2 [nTPM]"	"Cell RNA - HEK 293 [nTPM]"	"Cell RNA - HEL [nTPM]"	"Cell RNA - HeLa [nTPM]"	"Cell RNA - Hep G2 [nTPM]"	"Cell RNA - HHSteC [nTPM]"	"Cell RNA - HL-60 [nTPM]"	"Cell RNA - HMC-1 [nTPM]"	"Cell RNA - HSkMC [nTPM]"	"Cell RNA - hTCEpi [nTPM]"	"Cell RNA - hTEC/SVTERT24-B [nTPM]"	"Cell RNA - hTERT-HME1 [nTPM]"	"Cell RNA - hTERT-RPE1 [nTPM]"	"Cell RNA - HUVEC TERT2 [nTPM]"	"Cell RNA - JURKAT [nTPM]"	"Cell RNA - K-562 [nTPM]"	"Cell RNA - Karpas-707 [nTPM]"	"Cell RNA - LHCN-M2 [nTPM]"	"Cell RNA - MCF7 [nTPM]"	"Cell RNA - MOLT-4 [nTPM]"	"Cell RNA - NB-4 [nTPM]"	"Cell RNA - NTERA-2 [nTPM]"	"Cell RNA - OE19 [nTPM]"	"Cell RNA - PC-3 [nTPM]"	"Cell RNA - REH [nTPM]"	"Cell RNA - RH-30 [nTPM]"	"Cell RNA - RPMI-8226 [nTPM]"	"Cell RNA - RPTEC TERT1 [nTPM]"	"Cell RNA - RT4 [nTPM]"	"Cell RNA - SCLC-21H [nTPM]"	"Cell RNA - SH-SY5Y [nTPM]"	"Cell RNA - SiHa [nTPM]"	"Cell RNA - SK-BR-3 [nTPM]"	"Cell RNA - SK-MEL-30 [nTPM]"	"Cell RNA - SuSa [nTPM]"	"Cell RNA - T-47d [nTPM]"	"Cell RNA - THP-1 [nTPM]"	"Cell RNA - TIME [nTPM]"	"Cell RNA - U-138 MG [nTPM]"	"Cell RNA - U-2 OS [nTPM]"	"Cell RNA - U-2197 [nTPM]"	"Cell RNA - U-251 MG [nTPM]"	"Cell RNA - U-266/70 [nTPM]"	"Cell RNA - U-266/84 [nTPM]"	"Cell RNA - U-698 [nTPM]"	"Cell RNA - U-87 MG [nTPM]"	"Cell RNA - U-937 [nTPM]"	"Cell RNA - WM-115 [nTPM]"	"Blood RNA - basophil [nTPM]"	"Blood RNA - classical monocyte [nTPM]"	"Blood RNA - eosinophil [nTPM]"	"Blood RNA - gdT-cell [nTPM]"	"Blood RNA - intermediate monocyte [nTPM]"	"Blood RNA - MAIT T-cell [nTPM]"	"Blood RNA - memory B-cell [nTPM]"	"Blood RNA - memory CD4 T-cell [nTPM]"	"Blood RNA - memory CD8 T-cell [nTPM]"	"Blood RNA - myeloid DC [nTPM]"	"Blood RNA - naive B-cell [nTPM]"	"Blood RNA - naive CD4 T-cell [nTPM]"	"Blood RNA - naive CD8 T-cell [nTPM]"	"Blood RNA - neutrophil [nTPM]"	"Blood RNA - NK-cell [nTPM]"	"Blood RNA - non-classical monocyte [nTPM]"	"Blood RNA - plasmacytoid DC [nTPM]"	"Blood RNA - T-reg [nTPM]"	"Blood RNA - total PBMC [nTPM]"	"Brain RNA - amygdala [nTPM]"	"Brain RNA - basal ganglia [nTPM]"	"Brain RNA - cerebellum [nTPM]"	"Brain RNA - cerebral cortex [nTPM]"	"Brain RNA - hippocampal formation [nTPM]"	"Brain RNA - hypothalamus [nTPM]"	"Brain RNA - medulla oblongata [nTPM]"	"Brain RNA - midbrain [nTPM]"	"Brain RNA - pons [nTPM]"	"Brain RNA - spinal cord [nTPM]"	"Brain RNA - thalamus [nTPM]"	"Brain RNA - white matter [nTPM]"	"Single Cell Type RNA - Adipocytes [nTPM]"	"Single Cell Type RNA - Alveolar cells type 1 [nTPM]"	"Single Cell Type RNA - Alveolar cells type 2 [nTPM]"	"Single Cell Type RNA - Astrocytes [nTPM]"	"Single Cell Type RNA - B-cells [nTPM]"	"Single Cell Type RNA - Basal keratinocytes [nTPM]"	"Single Cell Type RNA - Basal prostatic cells [nTPM]"	"Single Cell Type RNA - Basal respiratory cells [nTPM]"	"Single Cell Type RNA - Basal squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Bipolar cells [nTPM]"	"Single Cell Type RNA - Breast glandular cells [nTPM]"	"Single Cell Type RNA - Breast myoepithelial cells [nTPM]"	"Single Cell Type RNA - Cardiomyocytes [nTPM]"	"Single Cell Type RNA - Cholangiocytes [nTPM]"	"Single Cell Type RNA - Club cells [nTPM]"	"Single Cell Type RNA - Collecting duct cells [nTPM]"	"Single Cell Type RNA - Cone photoreceptor cells [nTPM]"	"Single Cell Type RNA - Cytotrophoblasts [nTPM]"	"Single Cell Type RNA - dendritic cells [nTPM]"	"Single Cell Type RNA - Distal enterocytes [nTPM]"	"Single Cell Type RNA - Distal tubular cells [nTPM]"	"Single Cell Type RNA - Ductal cells [nTPM]"	"Single Cell Type RNA - Early spermatids [nTPM]"	"Single Cell Type RNA - Endometrial ciliated cells [nTPM]"	"Single Cell Type RNA - Endometrial stromal cells [nTPM]"	"Single Cell Type RNA - Endothelial cells [nTPM]"	"Single Cell Type RNA - Enteroendocrine cells [nTPM]"	"Single Cell Type RNA - Erythroid cells [nTPM]"	"Single Cell Type RNA - Excitatory neurons [nTPM]"	"Single Cell Type RNA - Exocrine glandular cells [nTPM]"	"Single Cell Type RNA - Extravillous trophoblasts [nTPM]"	"Single Cell Type RNA - Fibroblasts [nTPM]"	"Single Cell Type RNA - Gastric mucus-secreting cells [nTPM]"	"Single Cell Type RNA - Glandular and luminal cells [nTPM]"	"Single Cell Type RNA - granulocytes [nTPM]"	"Single Cell Type RNA - Granulosa cells [nTPM]"	"Single Cell Type RNA - Hepatic stellate cells [nTPM]"	"Single Cell Type RNA - Hepatocytes [nTPM]"	"Single Cell Type RNA - Hofbauer cells [nTPM]"	"Single Cell Type RNA - Horizontal cells [nTPM]"	"Single Cell Type RNA - Inhibitory neurons [nTPM]"	"Single Cell Type RNA - Intestinal goblet cells [nTPM]"	"Single Cell Type RNA - Ionocytes [nTPM]"	"Single Cell Type RNA - Kupffer cells [nTPM]"	"Single Cell Type RNA - Langerhans cells [nTPM]"	"Single Cell Type RNA - Late spermatids [nTPM]"	"Single Cell Type RNA - Leydig cells [nTPM]"	"Single Cell Type RNA - Macrophages [nTPM]"	"Single Cell Type RNA - Melanocytes [nTPM]"	"Single Cell Type RNA - Microglial cells [nTPM]"	"Single Cell Type RNA - monocytes [nTPM]"	"Single Cell Type RNA - Muller glia cells [nTPM]"	"Single Cell Type RNA - NK-cells [nTPM]"	"Single Cell Type RNA - Oligodendrocyte precursor cells [nTPM]"	"Single Cell Type RNA - Oligodendrocytes [nTPM]"	"Single Cell Type RNA - Pancreatic endocrine cells [nTPM]"	"Single Cell Type RNA - Paneth cells [nTPM]"	"Single Cell Type RNA - Peritubular cells [nTPM]"	"Single Cell Type RNA - Plasma cells [nTPM]"	"Single Cell Type RNA - Prostatic glandular cells [nTPM]"	"Single Cell Type RNA - Proximal enterocytes [nTPM]"	"Single Cell Type RNA - Proximal tubular cells [nTPM]"	"Single Cell Type RNA - Respiratory ciliated cells [nTPM]"	"Single Cell Type RNA - Rod photoreceptor cells [nTPM]"	"Single Cell Type RNA - Sertoli cells [nTPM]"	"Single Cell Type RNA - Skeletal myocytes [nTPM]"	"Single Cell Type RNA - Smooth muscle cells [nTPM]"	"Single Cell Type RNA - Spermatocytes [nTPM]"	"Single Cell Type RNA - Spermatogonia [nTPM]"	"Single Cell Type RNA - Squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Suprabasal keratinocytes [nTPM]"	"Single Cell Type RNA - Syncytiotrophoblasts [nTPM]"	"Single Cell Type RNA - T-cells [nTPM]"	"Single Cell Type RNA - Theca cells [nTPM]"	"Single Cell Type RNA - Undifferentiated cells [nTPM]"	"Single Cell Type RNA - Urothelial cells [nTPM]"
AASS	"LKRSDH, LORSDH"	ENSG00000008311	"Aminoadipate-semialdehyde synthase"	Q9UDR5	7	122064583-122144308	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Multifunctional enzyme, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 44.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 145.9;Hepatocytes: 113.9;Oligodendrocyte precursor cells: 106.1;Oligodendrocytes: 132.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 41.5;NTERA-2: 55.3;SuSa: 37.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020637, HPA020728, HPA020734"	Enhanced		Approved	Nucleoplasm,Vesicles,Mitochondria		Yes	No		19000		"Cluster 15: Liver - Metabolism"	"Cluster 12: NES - Nervous system development"	"Cluster 64: Astrocytes - Nervous system maintenance"	Mitochondria	"Nucleoplasm, Vesicles"	"HPA020637: AB_1844415, HPA020728: AB_1844416, HPA020734: AB_1844417"	"unprognostic (4.84e-2)"	"unprognostic (2.29e-1)"	"unprognostic (7.91e-4)"	"unprognostic (6.08e-2)"	"unprognostic (1.49e-2)"	"unprognostic (8.00e-2)"	"prognostic favorable (9.81e-4)"	"unprognostic (4.48e-3)"	"unprognostic (2.38e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.99e-1)"	"unprognostic (7.76e-3)"	"unprognostic (8.56e-3)"	"unprognostic (1.55e-1)"	"unprognostic (6.50e-2)"	"unprognostic (2.67e-1)"	9.7	5.9	10.0	1.8	12.2	0.2	8.4	10.3	14.4	8.2	15.5	5.2	0.9	9.5	7.5	3.2	11.7	2.1	9.2	9.4	10.6	13.9	44.3	6.3	1.4	11.6	11.0	25.2	4.8	7.1	3.5	3.2	11.4	5.4	1.4	3.7	3.5	4.8	8.6	2.8	3.6	4.4	10.1	2.9	5.5	2.2	11.0	1.5	4.7	6.2	1.4	6.9	6.2	11.8	0.1	0.0	21.9	41.5	27.3	13.5	9.4	5.4	8.0	7.3	9.1	12.6	0.1	0.0	0.2	6.6	8.3	4.1	33.5	16.8	9.6	0.0	12.2	9.4	4.3	12.5	22.0	0.0	2.9	12.2	0.5	9.2	7.1	18.9	19.8	12.1	2.7	15.5	5.1	0.1	0.9	0.0	55.3	0.1	1.7	11.8	16.3	0.3	5.3	2.4	2.7	0.7	1.5	0.0	5.3	37.8	0.5	0.0	8.1	13.6	3.4	7.0	8.3	3.5	3.0	0.0	4.9	0.8	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	10.0	12.2	10.3	14.4	9.4	10.6	11.6	11.0	11.4	10.1	11.0	11.8	16.0	9.6	37.8	145.9	2.1	6.2	9.0	2.8	14.8	7.0	8.7	6.3	9.7	14.3	5.6	14.7	16.7	11.6	1.5	0.6	0.0	2.7	12.2	4.1	24.0	11.7	3.0	5.2	5.0	1.8	3.3	14.4	5.6	7.7	3.8	18.1	24.7	113.9	1.5	11.8	4.4	2.6	2.0	2.2	2.5	7.4	19.0	1.4	12.4	35.6	0.0	8.9	0.0	106.1	132.5	2.3	2.5	24.5	1.6	4.7	5.4	8.6	0.9	3.3	19.7	38.9	15.8	12.4	2.4	7.8	4.7	5.1	2.1	8.0	1.9	4.8
ABRAXAS2	"ABRO1, Em:AC068896.4, FAM175B, KIAA0157"	ENSG00000165660	"Abraxas 2, BRISC complex subunit"	Q15018	10	124801819-124836667	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 25.6;Collecting duct cells: 23.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037591, HPA037592, HPA074089"	Approved		Supported	Cytosol		Yes	No			"Cluster 41: Basophils - Cellular respiration"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 7: Non-specific - Mitochondria"	Cytosol		"HPA037591: AB_10671877, HPA037592: AB_2675566, HPA074089: AB_2686659"	"unprognostic (2.78e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.66e-1)"	"unprognostic (6.47e-2)"	"unprognostic (1.08e-1)"	"unprognostic (3.51e-2)"	"unprognostic (5.52e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.99e-1)"	"unprognostic (6.81e-2)"	"unprognostic (3.72e-2)"	"unprognostic (2.09e-2)"	"unprognostic (1.80e-3)"	"unprognostic (3.09e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.66e-1)"	9.1	10.5	8.0	10.3	8.3	12.3	12.2	8.0	9.9	8.8	6.6	9.9	10.2	9.4	9.3	9.8	9.0	8.2	10.0	8.4	8.6	12.3	13.7	9.3	12.5	7.8	8.4	10.4	8.3	12.7	3.9	10.3	8.5	9.5	10.3	5.3	8.5	8.8	19.0	11.6	10.8	10.5	7.7	10.0	9.5	6.7	8.2	12.9	12.7	16.2	13.3	9.7	6.8	7.9	22.2	14.9	15.7	21.6	19.9	19.6	13.5	22.4	35.1	26.2	24.1	12.1	20.9	24.7	18.6	24.4	14.2	24.4	25.0	21.0	27.5	21.6	17.2	18.8	11.8	15.0	25.4	32.6	18.9	21.6	25.1	25.8	46.4	28.3	20.1	21.7	20.0	16.6	21.6	14.5	25.1	29.1	13.5	20.0	13.8	20.0	16.6	15.1	19.5	11.1	10.8	19.8	17.9	17.0	24.4	15.8	14.0	22.2	17.4	14.0	11.2	16.5	27.1	17.2	17.1	23.6	18.3	15.9	10.1	22.8	10.5	9.8	7.6	14.5	10.5	10.5	8.8	10.6	12.9	11.6	9.3	10.3	4.1	7.7	11.8	8.7	11.4	7.0	8.0	8.3	8.0	9.9	8.4	8.6	7.8	8.4	8.5	7.7	8.2	7.9	15.1	25.6	14.3	0.0	3.5	0.0	0.0	0.0	0.0	0.0	9.4	10.3	0.0	0.0	6.2	23.9	0.0	16.9	7.0	0.0	17.6	13.7	0.0	11.1	15.6	6.3	0.0	0.0	0.0	12.5	13.0	5.5	0.0	12.3	12.6	12.4	0.0	0.0	16.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	0.0	0.0	20.7	0.0	0.0	0.0	0.0	10.2	0.0	0.0	1.6	0.0	0.0	18.6	12.4	0.0	0.0	0.0	6.8	0.0	0.0	0.0	0.0	16.0	4.3	13.5	0.0	0.0
AC087721.2		ENSG00000285920	"Novel protein"		15	41284007-41380996	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"Alveolar cells type 1: 6.4;Alveolar cells type 2: 5.3;Club cells: 5.6;granulocytes: 3.8;Respiratory ciliated cells: 2.9"					"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"											"HPA042904, HPA074847"	Uncertain		Approved	"Nucleoplasm,Nucleoli,Nucleoli fibrillar center"		Yes	Yes			"Cluster 12: Non-specific - Basic cellular processes"		"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 11: Alveolar cells - Smell perception"	"Nucleoplasm, Nucleoli, Nucleoli fibrillar center"		"HPA042904: AB_2678220, HPA074847: AB_2732269"																		0.8	1.5	0.3	1.8	0.2	2.9	1.3	2.1	1.0	1.0	0.1	1.8	1.7	0.9	0.3	1.6	0.7	1.1	0.8	0.1	0.3	1.1	1.7	1.0	2.4	0.4	0.6	1.5	0.6	0.9		1.3	0.5	0.7	1.9	1.8	0.6	1.1	3.1	1.0	1.4	1.1	0.2	1.6	1.2	2.9	0.6	2.6	0.7	1.9	2.5	1.5		0.4	3.7	1.2	6.6	5.5	2.5	3.7	3.4	3.8	2.9	4.8	4.7	2.0	4.1	2.8	4.0	2.2	4.4	8.7	10.1	5.3	4.1	7.2	3.6	9.4	3.8	3.6	2.0	14.2	8.2	2.1	3.3	3.3	8.8	1.9	4.7	10.6	8.7	11.0	4.3	1.8	5.5	4.5	6.9	9.2	5.5	7.6	5.0	4.3	4.6	4.0	6.6	6.0	6.6	3.9	2.6	7.0	6.6	8.5	4.3	2.8	5.5	3.2	5.8	5.6	10.7	9.4	2.4	8.7	5.6	0.1	0.4	1.0	0.2	0.4	0.3	0.4	0.5	0.4	0.6	0.3	0.2	0.2	0.1	0.3	0.5	0.9	0.9	0.5	0.3	0.2	2.1	1.0	0.1	0.3	0.4	0.6	0.5	0.2	0.6	0.4	0.0	6.4	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0
ACBD4	FLJ13322	ENSG00000181513	"Acyl-CoA binding domain containing 4"	Q8NC06	17	45132600-45144181	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 93.0"	"Cell type enhanced"	"Detected in all"		"Proximal enterocytes: 56.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051772	Approved		Approved	Nucleoplasm,Vesicles		Yes	No			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 85: Liver - Metabolism"	"Cluster 6: T47d - Mammary gland"	"Cluster 45: Enterocytes - Digestion"	"Nucleoplasm, Vesicles"		"HPA051772: AB_2681603"	"unprognostic (1.57e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.59e-2)"	"unprognostic (1.54e-1)"	"unprognostic (5.33e-3)"	"unprognostic (1.60e-2)"	"prognostic favorable (4.76e-4)"	"unprognostic (2.27e-2)"	"unprognostic (9.06e-2)"	"unprognostic (4.86e-2)"	"prognostic favorable (4.64e-4)"	"unprognostic (8.24e-2)"	"unprognostic (2.04e-3)"	"unprognostic (1.97e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.27e-1)"	"prognostic favorable (6.53e-4)"	11.1	17.2	14.4	6.3	14.1	4.1	12.9	13.9	16.6	19.1	13.1	21.2	29.9	14.4	4.0	7.1	22.3	6.6	11.8	13.4	13.9	24.6	93.0	9.6	9.9	14.2	14.0	19.3	20.0	14.5	15.8	4.3	13.4	21.6	5.7	10.3	14.1	12.2	6.8	9.0	25.9	5.7	14.5	16.2	14.7	4.2	14.2	5.4	21.1	5.1	6.4	15.7	13.6	13.2	7.9	15.4	1.9	4.2	3.5	6.4	5.1	2.9	6.1	4.7	9.2	6.0	10.8	8.4	7.4	4.3	2.8	7.3	2.6	4.8	1.9	12.2	5.9	4.2	11.3	12.0	7.5	1.6	11.1	6.4	4.6	1.7	2.4	16.1	4.6	7.7	2.7	13.1	2.3	5.3	6.0	2.1	0.3	8.3	4.2	4.8	0.5	18.8	11.8	5.1	3.1	1.4	2.1	3.1	8.9	1.0	20.1	3.0	1.7	1.2	3.6	1.8	1.8	20.4	5.9	2.6	6.8	2.1	2.0	4.4	2.3	3.5	2.9	2.6	3.2	3.7	3.4	3.2	2.0	5.0	3.7	4.3	0.5	4.0	1.7	1.3	4.3	3.2	14.4	14.1	13.9	16.6	13.4	13.9	14.2	14.0	13.4	14.5	14.2	13.2	5.7	3.2	3.0	12.4	7.8	1.9	5.9	3.9	2.8	16.6	7.4	6.9	9.7	14.3	2.6	3.7	22.9	6.3	5.9	9.6	7.9	7.3	1.4	2.0	2.7	5.3	6.0	2.1	7.2	7.1	1.3	7.3	4.6	3.6	8.2	7.4	5.0	21.8	5.3	11.8	8.5	7.8	6.1	1.9	2.6	5.0	6.8	3.1	3.6	2.8	4.5	14.7	5.2	4.5	1.9	5.6	12.5	7.5	5.2	3.1	56.8	25.6	2.6	16.8	6.6	8.7	7.7	2.5	5.2	3.1	1.8	6.3	6.4	4.4	9.1	2.8
ALDH7A1	"ATQ1, EPD, PDE"	ENSG00000164904	"Aldehyde dehydrogenase 7 family member A1"	P49419	5	126531200-126595362	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 162.2"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 414.1;Proximal tubular cells: 302.1;Syncytiotrophoblasts: 222.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"plasmacytoid DC: 6.4"	"Lineage enriched"	"Detected in many"	5	"dendritic cells: 6.4"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 256.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023296, HPA053675"	Enhanced		Supported	Mitochondria,Cytosol		Yes	No		430000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 15: Liver - Metabolism"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	Mitochondria	Cytosol	"HPA023296: AB_1844738, HPA053675: "	"unprognostic (1.37e-1)"	"unprognostic (9.67e-2)"	"unprognostic (2.07e-2)"	"unprognostic (2.20e-2)"	"unprognostic (4.15e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.58e-3)"	"unprognostic (9.49e-3)"	"unprognostic (7.61e-2)"	"unprognostic (7.08e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.33e-1)"	"prognostic favorable (3.08e-4)"	"unprognostic (1.51e-1)"	"unprognostic (3.70e-1)"	"unprognostic (3.10e-3)"	"unprognostic (4.93e-2)"	23.7	38.3	46.6	9.1	47.6	1.8	47.1	43.7	45.8	32.7	40.7	29.5	23.7	25.1	8.8	35.9	28.8	19.1	27.9	44.7	43.2	115.1	162.2	15.7	8.6	43.1	43.5	65.3	27.0	34.0	8.8	44.9	42.6	42.0	27.4	19.7	40.6	27.9	12.2	29.4	21.0	23.6	44.8	7.0	23.6	12.3	44.0	18.3	47.6	26.5	17.1	18.1	20.9	45.2	64.9	41.9	116.6	193.4	95.5	56.4	147.8	76.1	93.4	86.5	110.5	118.6	60.7	0.0	75.5	60.0	36.1	47.1	36.5	256.2	78.8	0.1	44.6	12.3	63.1	102.1	46.3	0.2	0.0	69.0	59.2	67.3	47.7	64.2	70.0	0.0	0.0	0.1	77.1	42.1	2.6	0.3	79.4	47.5	35.2	38.9	131.8	0.0	81.2	48.4	39.4	47.2	0.0	41.1	44.7	89.0	75.2	2.7	86.1	24.8	75.6	28.8	53.1	0.1	0.1	0.4	13.4	0.2	40.6	0.7	0.2	0.1	0.1	0.0	0.2	0.8	0.2	0.1	1.8	0.6	1.2	0.6	0.1	0.1	0.0	6.4	0.0	0.4	46.6	47.6	43.7	45.8	44.7	43.2	43.1	43.5	42.6	44.8	44.0	45.2	17.6	16.0	29.3	99.3	5.0	25.9	59.5	110.0	87.0	23.6	40.6	91.1	39.9	27.1	43.5	42.3	22.9	414.1	3.7	15.2	76.3	43.5	31.4	18.7	44.3	19.1	21.7	5.2	16.0	13.8	107.8	34.0	27.0	21.4	7.0	50.4	18.9	74.6	51.1	25.2	21.5	25.9	20.3	9.4	7.6	41.7	25.4	9.1	55.2	12.2	7.5	102.1	0.0	41.7	30.0	12.6	15.6	37.2	2.0	27.5	23.4	302.1	23.4	13.6	19.7	19.4	25.8	1.0	5.1	59.2	16.1	222.3	4.6	39.3	46.4	50.4
ALDOC		ENSG00000109107	"Aldolase, fructose-bisphosphate C"	P09972	17	28573115-28576948	"Cancer-related genes, Candidate cardiovascular disease genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	Glycolysis	Lyase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 1384.6;choroid plexus: 589.6;retina: 1183.1"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 112.5;Horizontal cells: 274.2;Muller glia cells: 127.1;Proximal enterocytes: 120.0;Rod photoreceptor cells: 348.5"	"Cancer enriched"	"Detected in all"	6	"glioma: 128.9"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 250.9;U-266/70: 161.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003282, CAB020828, HPA067442"	Enhanced	Supported	Approved	"Nucleoplasm,Nucleoli fibrillar center,Vesicles,Cytosol"		Yes	No		150000000	"Cluster 20: T-cells - T-cell receptor"	"Cluster 77: Retina - Visual perception"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Nucleoplasm, Nucleoli fibrillar center"	"Vesicles, Cytosol"	"CAB020828: , HPA003282: AB_1078130, HPA067442: "	"unprognostic (2.90e-1)"	"unprognostic (4.45e-3)"	"unprognostic (5.69e-3)"	"unprognostic (1.43e-1)"	"unprognostic (3.56e-1)"	"prognostic unfavorable (9.80e-4)"	"unprognostic (1.03e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.30e-1)"	"unprognostic (6.03e-3)"	"unprognostic (3.90e-1)"	"unprognostic (3.24e-2)"	"prognostic unfavorable (1.29e-7)"	"unprognostic (1.28e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.74e-2)"	"unprognostic (1.23e-1)"	87.0	24.3	953.6	12.7	909.7	23.6	42.5	1238.3	1162.3	39.3	589.6	18.5	18.7	17.9	10.9	40.8	14.3	10.9	285.5	955.7	958.0	16.8	98.3	13.7	19.3	1297.5	962.6	39.1	4.9	12.1	30.6	4.1	1384.6	18.9	14.7	1183.1	19.9	15.8	4.8	74.5	43.9	12.4	926.9	24.4	23.3	14.2	1090.2	9.6	7.4	8.1	30.5	19.0	47.0	886.1	29.9	2.1	13.7	55.7	29.9	32.9	2.9	16.7	37.7	12.9	76.0	17.9	3.0	14.9	17.3	15.5	3.3	36.9	10.3	102.3	23.4	12.4	8.9	28.3	11.6	30.4	25.8	10.0	29.2	27.8	13.9	1.5	24.0	1.7	5.3	29.7	19.3	71.9	10.7	15.1	11.9	32.0	20.8	6.7	15.3	9.5	1.6	250.9	1.9	4.3	36.2	61.9	9.1	67.3	0.5	20.8	36.6	21.2	3.5	1.2	5.3	2.1	2.4	161.0	51.4	10.9	105.2	28.0	1.9	0.5	7.4	3.0	21.6	8.7	30.6	24.0	29.5	17.8	9.4	25.1	37.7	28.4	18.0	29.4	5.3	4.6	40.9	19.0	953.6	909.7	1238.3	1162.3	955.7	958.0	1297.5	962.6	1384.6	926.9	1090.2	886.1	4.2	0.0	15.8	97.6	9.8	7.5	20.3	80.5	8.6	112.5	9.0	11.0	22.1	11.5	29.3	7.3	106.3	1.1	9.5	31.7	3.9	21.9	0.9	1.0	3.0	11.3	21.6	3.2	19.2	10.2	6.5	5.8	6.6	1.2	13.3	4.9	14.3	93.1	5.4	274.2	41.3	12.9	28.5	4.4	5.3	1.3	9.3	3.1	24.9	21.5	34.1	127.1	12.3	26.7	16.8	12.4	12.4	10.1	2.6	6.1	120.0	2.1	11.8	348.5	13.1	6.4	10.1	0.3	3.2	7.9	10.9	1.5	17.0	11.7	5.1	7.8
ANAPC11	"APC11, Apc11p, HSPC214, MGC882"	ENSG00000141552	"Anaphase promoting complex subunit 11"	Q9NYG5	17	81890790-81900991	"Metabolic proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 1161.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA021989, HPA027838"	Approved		Enhanced	Nucleoplasm,Nucleoli		Yes	No			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm	Nucleoli	"HPA021989: AB_1844915, HPA027838: AB_10600978"	"unprognostic (9.00e-3)"	"unprognostic (1.24e-2)"	"unprognostic (3.76e-1)"	"unprognostic (4.93e-2)"	"unprognostic (8.76e-2)"	"unprognostic (1.67e-1)"	"unprognostic (5.13e-2)"	"unprognostic (8.20e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.17e-3)"	"unprognostic (2.22e-2)"	"unprognostic (1.08e-1)"	"unprognostic (4.76e-2)"	"unprognostic (8.07e-2)"	"unprognostic (9.08e-2)"	"unprognostic (2.51e-2)"	"unprognostic (3.16e-1)"	112.1	120.5	104.8	52.1	108.6	109.3	103.4	110.9	149.5	85.9	100.7	126.0	61.0	86.4	39.0	125.8	80.3	58.0	231.3	106.4	106.8	127.3	185.7	89.3	73.0	110.0	105.1	76.4	108.1	59.0	92.0	54.8	105.0	105.7	27.3	19.3	117.6	42.0	272.8	99.7	83.4	36.5	110.4	86.7	117.9	189.7	113.0	50.1	90.6	126.5	34.0	95.9	94.7	118.1	262.4	605.0	139.0	209.7	118.7	132.8	164.3	123.4	100.6	111.4	127.1	248.6	226.9	82.1	133.3	114.4	121.8	148.9	58.1	166.4	40.5	122.5	437.1	126.8	257.9	379.0	131.3	95.3	103.6	145.6	151.8	120.4	98.2	73.4	184.9	111.9	173.7	233.8	120.8	474.1	225.5	150.6	131.2	259.2	448.7	92.3	136.2	168.0	104.9	229.3	175.8	282.6	133.5	205.7	253.8	96.7	254.1	222.7	108.4	215.0	169.5	229.4	234.1	110.5	52.1	107.0	228.7	144.5	177.7	495.1	419.8	418.8	229.7	359.9	218.7	309.0	232.0	252.9	348.0	296.2	223.0	212.3	212.1	258.5	345.4	581.1	297.9	506.0	104.8	108.6	110.9	149.5	106.4	106.8	110.0	105.1	105.0	110.4	113.0	118.1	137.2	128.2	157.2	11.4	110.5	148.6	215.0	406.1	145.7	59.5	272.5	332.7	360.2	201.6	272.3	198.6	20.9	467.8	119.5	239.6	522.3	260.6	451.9	157.0	151.3	152.9	190.3	201.6	9.8	337.7	524.6	182.9	124.4	169.5	108.3	158.3	159.2	496.4	448.2	33.7	10.2	272.6	319.4	174.6	194.3	1161.0	181.7	170.1	261.5	13.1	251.4	227.7	176.1	7.1	17.0	324.3	274.0	164.7	226.8	334.2	290.7	548.0	199.8	78.9	105.2	115.9	245.0	435.8	252.5	257.4	186.7	508.7	117.3	156.0	271.4	307.0
ANG	"RAA1, RNASE5"	ENSG00000214274	Angiogenin	P03950	14	20684177-20698971	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Angiogenesis, Differentiation, Stress response"	"Developmental protein, DNA-binding, Endonuclease, Hydrolase, Nuclease, Protein synthesis inhibitor"	"Amyotrophic lateral sclerosis, Cancer-related genes, Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	52	"liver: 3018.1"	"Cell type enriched"	"Detected in many"	24	"Hepatocytes: 4816.3"	"Cancer enriched"	"Detected in all"	17	"liver cancer: 279.2"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"classical monocyte: 24.5;myeloid DC: 14.5"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"Hep G2: 152.2;OE19: 116.1"	"Low region specificity"	"Detected in all"							HPA055896			Approved	"Nucleoli,Nucleoli rim,Mitotic chromosome,Actin filaments"	"Secreted to blood"	Yes	No	308000000	410000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	"Nucleoli, Nucleoli rim, Mitotic chromosome"	"Actin filaments"	"HPA055896: "	"unprognostic (2.50e-2)"	"unprognostic (1.82e-1)"	"unprognostic (9.77e-2)"	"prognostic favorable (6.85e-4)"	"unprognostic (5.71e-3)"	"unprognostic (6.99e-2)"	"prognostic favorable (7.83e-5)"	"unprognostic (1.16e-1)"	"unprognostic (3.20e-3)"	"unprognostic (9.19e-3)"	"unprognostic (1.31e-1)"	"unprognostic (3.69e-1)"	"unprognostic (6.65e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.39e-1)"	"unprognostic (2.00e-1)"	"unprognostic (3.09e-1)"	37.6	3.0	3.6	6.0	3.5	1.0	37.8	3.5	4.9	38.2	5.6	32.6	23.2	23.4	17.9	9.8	30.5	28.5	16.9	3.6	4.9	18.4	3018.1	18.5	3.5	4.5	4.2	58.1	30.8	5.3	5.0	3.8	4.3	32.7	45.7	2.2	52.6	13.3	6.2	27.4	27.1	10.4	4.5	7.4	58.2	10.2	3.7	1.5	8.8	10.5	4.1	24.8	31.4	4.8	3.7	9.9	2.3	0.0	23.9	27.8	0.3	4.8	8.8	1.1	4.0	5.9	5.1	0.4	1.5	12.0	8.0	3.8	2.8	3.1	1.3	18.4	3.8	0.9	5.1	152.2	5.0	4.0	0.5	22.2	2.5	1.5	5.1	11.8	5.7	4.2	0.2	27.0	3.5	0.7	0.9	1.2	0.7	116.1	10.7	0.7	3.9	11.3	2.3	2.9	0.0	0.4	4.6	1.7	6.5	5.1	4.0	0.7	6.0	1.9	2.8	1.7	0.7	5.9	4.8	0.5	3.2	2.0	5.0	0.0	24.5	0.0	0.6	2.9	0.4	5.8	1.2	1.1	14.5	4.9	0.3	0.2	0.4	0.0	0.1	2.3	0.8	7.1	3.6	3.5	3.5	4.9	3.6	4.9	4.5	4.2	4.3	4.5	3.7	4.8	9.7	28.9	17.7	0.0	9.7	27.1	43.3	39.2	14.2	0.1	33.8	24.8	0.8	194.5	24.6	11.0	0.0	1.6	0.7	32.5	11.7	40.0	1.0	6.2	9.7	11.0	71.0	27.8	0.0	31.6	5.3	48.8	56.1	24.9	0.0	10.7	62.4	4816.3	15.9	0.0	0.0	171.9	12.2	95.9	18.7	2.9	71.1	13.8	23.2	0.0	4.9	10.1	0.0	0.0	0.0	21.6	33.3	24.0	11.7	43.7	91.3	61.2	76.5	0.6	13.1	29.7	17.7	1.0	1.3	9.4	52.4	9.3	5.6	0.5	51.6	39.2
ANLN	"ANILLIN, scra, Scraps"	ENSG00000011426	"Anillin actin binding protein"	Q9NQW6	7	36389821-36453791	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	Actin-binding	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"brain: 266.0"	"Group enriched"	"Detected in many"	5	"Early spermatids: 156.4;Oligodendrocytes: 441.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in all"		"HBF TERT88: 655.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005680, CAB033902, HPA050556, CAB062547, CAB068175"	Enhanced		Enhanced	Nucleoplasm,Midbody		Yes	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 70: Brain - Nervous system development"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm	Midbody	"CAB033902: AB_2058302, CAB062547: AB_2665622, CAB068175: AB_2665623, HPA005680: AB_2667388, HPA050556: AB_2681175"	"unprognostic (4.23e-2)"	"unprognostic (1.59e-3)"	"unprognostic (1.49e-1)"	"prognostic unfavorable (1.73e-4)"	"unprognostic (1.67e-2)"	"unprognostic (3.44e-2)"	"prognostic unfavorable (5.97e-7)"	"prognostic unfavorable (6.99e-5)"	"unprognostic (2.69e-2)"	"unprognostic (3.66e-2)"	"prognostic unfavorable (2.00e-6)"	"unprognostic (3.13e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (5.29e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.94e-2)"	"unprognostic (4.04e-3)"	1.2	0.7	59.8	5.2	134.5	36.4	2.0	125.1	72.7	1.8	18.4	6.0	4.4	1.8	0.2	10.4	0.9	2.1	0.8	59.3	83.6	0.4	1.2	1.4	6.7	162.3	106.5	0.9	0.6	0.2	0.2	8.9	160.2	0.9	8.0	0.3	1.7	0.4	0.3	13.6	4.3	14.9	99.2	1.2	4.8	12.4	102.3	16.0	0.8	0.3	9.5	3.2	3.2	266.0	476.1	96.5	79.3	61.0	10.7	26.9	85.6	292.5	169.3	344.4	256.0	66.4	142.7	23.9	82.1	148.6	182.8	237.0	63.4	170.7	655.4	16.1	46.0	32.7	104.8	55.8	1.7	47.3	36.7	6.0	7.7	225.3	147.2	40.8	109.3	31.2	69.6	48.8	284.4	71.0	40.0	54.8	88.5	71.9	102.3	29.1	238.2	15.9	76.5	76.5	33.5	39.5	154.1	175.8	26.1	109.6	119.0	53.6	104.5	214.2	239.0	127.6	346.6	20.1	34.2	43.2	72.9	74.9	460.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.3	0.3	59.8	134.5	125.1	72.7	59.3	83.6	162.3	106.5	160.2	99.2	102.3	266.0	0.4	0.0	1.1	2.3	1.0	14.1	1.9	8.3	7.4	0.0	1.9	2.0	0.6	0.0	3.2	0.0	0.0	13.8	1.1	2.8	0.0	0.7	156.4	18.9	3.2	1.9	0.0	35.3	3.4	0.2	23.2	6.9	10.2	12.8	0.0	15.4	1.1	0.5	9.8	0.0	5.7	3.4	6.1	1.6	5.9	53.3	1.2	2.7	0.0	0.0	0.0	0.0	0.0	1.5	441.3	0.6	0.1	0.0	8.8	1.6	0.8	0.3	10.4	0.0	0.0	0.4	5.2	20.0	17.7	27.1	9.2	2.9	2.6	1.7	6.0	3.3
ARHGAP36	FLJ30058	ENSG00000147256	"Rho GTPase activating protein 36"	Q6ZRI8	X	131058346-131089885	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	22	"adrenal gland: 105.4;brain: 144.3;pituitary gland: 176.9"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 1.0;Breast glandular cells: 2.7;Oligodendrocyte precursor cells: 1.0;Skeletal myocytes: 1.5"	"Cancer enriched"	"Detected in some"	21	"thyroid cancer: 62.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	161	"SH-SY5Y: 176.9"	"Region enhanced"	"Detected in many"		"hypothalamus: 89.4"	"Low region specificity"	"Detected in many"			"HPA002064, HPA076209"	Enhanced		Approved	"Nucleoplasm,Vesicles,Plasma membrane"		Yes	NA				"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 37: Myocytes - Muscle contraction"	Nucleoplasm	"Vesicles, Plasma membrane"	"HPA002064: AB_1078891, HPA076209: "	"unprognostic (2.92e-2)"			"unprognostic (7.71e-9)"	"unprognostic (2.19e-1)"	"unprognostic (8.15e-2)"				"unprognostic (1.67e-1)"	"unprognostic (1.78e-1)"	"unprognostic (2.73e-1)"		"unprognostic (1.40e-2)"	"unprognostic (1.34e-2)"	"unprognostic (2.31e-1)"		0.2	105.4	20.1	0.0	3.7	0.0	1.4	0.8	3.2	1.6	0.8	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.1	13.5	132.5	0.0	0.0	0.0	0.0	35.0	46.1	0.0	0.0	0.0	176.9	0.1	144.3	0.2	0.1	0.0	0.2	0.0	6.6	0.1	0.0	0.0	4.7	0.0	0.1	0.8	52.1	0.4	0.1	1.1	0.0	0.0	0.1	10.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	176.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.1	3.7	0.8	3.2	13.5	132.5	35.0	46.1	144.3	4.7	52.1	10.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.2	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0
ARMCX2	"ALEX2, GASP9, KIAA0512"	ENSG00000184867	"Armadillo repeat containing X-linked 2"	Q7L311	X	101655281-101659850	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 154.8"	"Cell type enhanced"	"Detected in many"		"Sertoli cells: 59.2"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 47.7"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"LHCN-M2: 164.1;NTERA-2: 117.2;SuSa: 90.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005761	Enhanced		Approved	Nucleoplasm,Mitochondria		Yes	No			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 68: Epididymis - Unknown function"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 48: Smooth muscle cells - ECM organization"	Mitochondria	Nucleoplasm	"HPA005761: AB_10600782"	"unprognostic (1.33e-1)"	"unprognostic (2.26e-2)"	"unprognostic (4.25e-2)"	"unprognostic (1.48e-1)"	"unprognostic (9.59e-2)"	"unprognostic (6.96e-2)"	"unprognostic (5.00e-2)"	"unprognostic (1.87e-1)"	"unprognostic (7.17e-2)"	"unprognostic (3.41e-2)"	"prognostic favorable (3.45e-5)"	"unprognostic (9.06e-2)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (2.69e-4)"	"unprognostic (1.12e-1)"	"unprognostic (6.73e-2)"	"unprognostic (1.25e-1)"	17.0	46.2	28.7	11.5	29.1	0.5	17.6	22.8	29.7	36.9	26.5	25.4	5.4	30.6	154.8	9.2	28.8	20.6	33.2	29.1	31.6	28.3	3.2	16.8	8.5	25.9	26.2	47.8	18.9	71.2	78.3	26.3	27.5	28.3	7.9	15.3	44.5	67.9	6.2	6.5	13.0	32.3	23.4	21.3	16.3	5.8	28.1	7.7	59.7	7.5	6.5	26.9	20.1	25.4	0.0	0.0	50.8	0.4	43.6	39.4	0.4	56.0	70.4	1.4	1.4	0.0	21.8	0.0	0.0	74.6	0.0	1.5	0.0	1.3	0.6	0.0	2.0	0.2	60.9	0.0	46.4	0.4	0.1	63.7	17.6	43.5	0.4	68.3	59.7	0.0	0.2	0.3	164.1	0.0	0.0	0.6	117.2	3.4	0.3	14.5	88.9	0.3	2.8	0.0	20.4	36.6	0.0	0.2	1.7	90.3	25.9	0.1	13.0	61.9	65.1	38.8	0.4	0.0	0.0	0.2	55.7	0.1	1.2	0.0	0.4	0.0	1.0	0.9	0.4	2.8	0.9	0.9	0.7	4.0	2.4	2.5	0.0	2.8	0.6	0.9	0.7	1.1	28.7	29.1	22.8	29.7	29.1	31.6	25.9	26.2	27.5	23.4	28.1	25.4	10.4	16.0	6.4	8.5	8.2	4.2	16.4	5.8	21.1	12.5	18.0	20.8	28.7	5.7	11.4	33.1	8.4	1.2	2.4	0.1	3.9	9.6	0.2	11.2	23.4	13.3	9.1	3.2	15.4	2.0	0.7	28.4	4.6	15.2	2.5	18.1	19.2	0.7	3.8	1.7	14.3	3.0	2.0	2.4	6.5	1.3	24.2	7.4	5.4	11.2	7.1	9.3	0.0	16.1	14.0	2.2	0.1	24.5	2.8	16.5	0.3	4.3	4.9	11.3	59.2	31.8	23.9	1.4	1.9	3.8	3.0	5.1	2.5	4.6	1.6	7.2
ASH2L	"ASH2, ASH2L1, ASH2L2, Bre2"	ENSG00000129691	"ASH2 like, histone lysine methyltransferase complex subunit"	Q9UBL3	8	38105493-38144076	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 69.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEL: 200.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042289	Approved		Supported	"Nucleoplasm,Plasma membrane"		Yes	No			"Cluster 2: Granulocytes - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 36: HEL - Hemostasis"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	"Plasma membrane"	"HPA042289: AB_10795608"	"unprognostic (9.39e-2)"	"unprognostic (5.58e-3)"	"unprognostic (2.67e-3)"	"unprognostic (5.40e-3)"	"unprognostic (2.87e-1)"	"unprognostic (2.66e-2)"	"unprognostic (4.04e-1)"	"unprognostic (9.15e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.12e-1)"	"unprognostic (5.10e-2)"	"unprognostic (9.73e-3)"	"prognostic favorable (4.25e-4)"	"unprognostic (9.95e-2)"	"unprognostic (1.27e-1)"	"unprognostic (7.69e-3)"	"unprognostic (2.54e-1)"	28.9	18.9	19.7	17.9	20.3	31.6	21.4	19.2	21.5	19.9	14.7	22.5	18.2	22.0	17.1	23.8	20.1	17.4	21.3	20.2	17.4	23.3	23.6	18.5	27.9	16.7	16.1	26.2	17.7	24.8	12.0	22.1	16.7	19.9	22.3	21.7	20.6	21.0	32.4	20.4	18.3	24.2	16.5	18.9	22.1	41.3	19.0	33.6	21.1	27.7	28.3	18.5	16.1	18.1	45.6	23.3	39.8	39.8	26.3	34.0	49.8	44.1	45.7	53.5	47.0	24.9	21.1	51.4	38.2	37.1	27.2	27.5	49.0	24.8	50.4	20.3	22.4	200.3	22.9	51.7	39.4	32.0	41.3	28.6	22.9	25.0	27.7	28.1	43.9	48.0	138.2	40.0	53.7	26.1	91.9	40.7	51.7	39.3	15.6	38.2	42.9	23.4	28.9	33.1	18.3	32.4	33.5	22.5	38.4	37.1	27.4	40.4	33.5	35.3	35.0	50.4	37.6	37.8	48.7	44.9	35.2	44.7	49.7	39.9	23.0	55.9	16.8	26.8	18.1	19.6	18.8	20.0	27.7	19.2	19.3	18.4	19.2	26.1	25.8	15.8	21.3	21.6	19.7	20.3	19.2	21.5	20.2	17.4	16.7	16.1	16.7	16.5	19.0	18.1	11.1	12.8	15.8	18.3	14.3	6.9	9.3	13.3	10.8	12.9	9.6	8.0	18.1	8.6	15.9	12.9	10.4	37.0	15.9	11.5	7.9	21.2	10.8	12.7	13.2	14.0	10.8	62.1	19.7	28.7	37.2	17.3	8.6	10.8	19.6	38.2	12.8	11.9	24.2	6.7	21.4	11.6	12.2	17.2	5.7	13.0	23.3	17.0	23.2	15.9	29.2	17.8	19.6	17.6	16.5	21.3	8.9	20.7	8.4	6.2	12.8	17.1	18.0	15.5	13.1	14.6	20.7	69.6	33.9	11.6	6.8	30.9	11.9	37.3	10.9	7.4
ATAD2	"ANCCA, CT137, DKFZp667N1320, MGC29843, MGC5254, PRO2000"	ENSG00000156802	"ATPase family AAA domain containing 2"	Q6PL18	8	123319850-123416350	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 28.3"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 79.1;Spermatocytes: 106.0;Spermatogonia: 82.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 294.4"					"Low region specificity"	"Detected in all"			"HPA029424, CAB056158"	Enhanced		Enhanced	Nucleoplasm		Yes	Yes			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"CAB056158: AB_2665580, HPA029424: AB_10611680"	"unprognostic (1.56e-1)"	"unprognostic (4.55e-2)"	"unprognostic (2.07e-1)"	"prognostic unfavorable (2.04e-4)"	"unprognostic (2.08e-1)"	"unprognostic (4.44e-2)"	"unprognostic (2.98e-2)"	"unprognostic (2.74e-3)"	"unprognostic (2.02e-3)"	"unprognostic (5.62e-2)"	"unprognostic (1.19e-2)"	"unprognostic (4.98e-2)"	"prognostic unfavorable (8.33e-15)"	"unprognostic (1.15e-2)"	"unprognostic (1.82e-1)"	"unprognostic (4.84e-2)"	"unprognostic (6.17e-2)"	2.9	3.4	3.8	7.7	3.6	26.5	6.8	2.6	3.9	12.8	2.0	5.3	5.0	4.3	3.8	6.8	3.4	3.2	5.8	3.2	4.5	1.4	9.9	4.1	14.4	2.9	3.8	7.0	3.3	1.9	3.9	4.8	2.6	10.3	6.9	1.4	4.3	4.7	9.3	6.8	5.2	4.1	2.8	4.9	4.7	18.9	5.1	28.3	3.9	3.2	12.8	4.8	3.9	2.8	103.7	39.6	55.0	19.0	9.7	12.3	24.3	79.2	27.2	66.8	73.9	30.1	43.8	67.2	23.6	25.2	26.5	48.3	74.2	25.6	106.1	94.3	39.0	121.2	41.0	61.4	3.8	44.6	57.4	4.1	3.8	63.6	21.0	14.3	20.7	38.6	57.7	66.4	50.4	107.1	129.5	32.8	10.0	77.8	38.4	66.5	65.6	36.4	23.8	46.7	70.2	30.5	114.4	294.4	20.8	22.1	60.2	41.2	13.0	50.4	69.3	40.2	96.6	21.2	40.7	60.8	32.9	72.9	40.4	5.3	0.8	3.3	1.6	0.8	2.2	2.6	2.3	2.7	1.4	1.5	1.5	1.7	0.2	2.5	1.9	0.1	4.6	1.0	3.8	3.6	2.6	3.9	3.2	4.5	2.9	3.8	2.6	2.8	5.1	2.8	4.8	6.4	11.0	9.4	18.5	15.8	27.9	9.1	14.2	2.8	17.3	21.2	27.3	2.8	10.2	3.7	4.2	14.9	15.3	9.0	1.9	3.5	54.9	7.9	17.3	9.6	1.2	79.1	25.6	2.2	26.2	17.1	13.3	17.5	14.5	37.9	7.1	16.3	11.2	1.7	16.4	13.1	4.1	8.2	6.9	24.4	7.5	11.7	1.8	14.0	6.3	6.3	17.5	11.6	2.8	3.5	4.3	13.9	34.0	20.7	3.1	1.0	5.4	1.9	0.0	9.5	17.5	106.0	82.4	23.7	12.1	13.5	22.8	3.7	14.6	24.5
ATF3		ENSG00000162772	"Activating transcription factor 3"	P18847	1	212565334-212620777	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 1462.0;Endometrial ciliated cells: 1049.4;Glandular and luminal cells: 1429.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"basophil: 6.4;intermediate monocyte: 4.0;myeloid DC: 1.6;non-classical monocyte: 6.3"	"Group enriched"	"Detected in many"	15	"dendritic cells: 1.6;granulocytes: 6.4;monocytes: 6.3"	"Cell line enhanced"	"Detected in many"		"BEWO: 131.5;HDLM-2: 100.4;SuSa: 155.0"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"spinal cord: 9.3"	HPA001562	Approved		Supported	Nucleoplasm,Nucleoli		Yes	Yes			"Cluster 7: Monocytes - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 12: NES - Nervous system development"	"Cluster 7: Non-specific - Mitochondria"	"Nucleoplasm, Nucleoli"		"HPA001562: AB_1078233"	"unprognostic (2.66e-2)"	"unprognostic (1.52e-2)"	"unprognostic (2.80e-1)"	"unprognostic (4.27e-3)"	"unprognostic (3.29e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.73e-1)"	"unprognostic (9.31e-2)"	"unprognostic (8.65e-3)"	"unprognostic (8.75e-2)"	"unprognostic (1.52e-1)"	"unprognostic (6.97e-2)"	"unprognostic (3.31e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.04e-2)"	"unprognostic (2.08e-2)"	176.1	82.8	14.2	63.3	17.7	45.3	97.6	16.5	18.7	106.2	17.1	66.6	21.0	108.6	9.3	128.4	122.6	135.0	113.7	14.4	20.2	98.1	139.9	116.0	20.8	21.1	16.7	40.2	67.2	48.8	45.0	66.3	17.2	116.3	60.0	16.2	33.1	24.1	30.7	154.9	45.6	313.0	15.4	24.4	104.8	3.9	18.8	84.5	181.1	30.0	3.1	281.2	55.2	25.0	21.1	1.2	40.7	8.7	3.9	10.4	131.5	14.7	11.9	12.5	29.8	27.7	15.5	0.4	6.5	0.9	68.0	11.6	24.6	4.0	20.5	100.4	24.6	1.6	11.6	10.0	72.9	9.0	22.7	18.3	65.3	34.9	80.4	2.4	2.6	23.9	10.0	77.0	1.9	2.8	27.5	5.9	29.2	11.5	9.2	8.1	27.1	18.4	1.8	3.0	18.3	18.4	19.1	34.2	59.0	155.0	19.9	6.5	2.4	3.6	19.5	12.3	6.7	60.4	27.9	7.4	11.9	4.8	10.8	6.4	0.7	0.0	0.3	4.0	0.3	0.0	0.0	0.0	1.6	0.2	0.0	0.0	0.2	0.0	6.3	0.8	0.0	0.7	14.2	17.7	16.5	18.7	14.4	20.2	21.1	16.7	17.2	15.4	18.8	25.0	568.2	423.1	146.5	1.6	55.3	202.8	866.2	236.1	1462.0	4.4	753.9	510.9	689.3	92.9	136.0	55.2	0.0	178.9	100.3	611.7	1.9	186.2	3.7	1049.4	318.2	176.2	889.6	2.7	2.6	122.7	330.8	452.6	966.9	1429.3	78.6	5.6	30.7	25.8	103.7	1.7	2.4	758.4	114.0	29.8	282.8	2.8	17.4	351.8	174.3	3.7	32.3	39.9	0.0	1.5	10.8	185.7	484.8	1.2	161.0	457.5	421.3	3.3	133.2	5.3	98.6	279.4	573.7	2.2	3.1	474.6	202.7	420.6	97.1	5.8	349.6	263.6
ATP6V1D	"ATP6M, VATD, VMA8"	ENSG00000100554	"ATPase H+ transporting V1 subunit D"	Q9Y5K8	14	67294371-67360265	"Metabolic proteins, Predicted intracellular proteins"	"Cilium biogenesis/degradation, Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 365.9;Proximal tubular cells: 365.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031515, HPA057316"	Enhanced		Approved	Nucleoplasm		Yes	No		19000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"HPA031515: AB_10600785, HPA057316: AB_2683409"	"unprognostic (1.10e-1)"	"unprognostic (7.35e-2)"	"unprognostic (1.59e-1)"	"unprognostic (7.10e-3)"	"unprognostic (1.52e-1)"	"unprognostic (7.64e-2)"	"unprognostic (7.78e-3)"	"unprognostic (1.19e-1)"	"unprognostic (2.32e-1)"	"unprognostic (3.05e-2)"	"unprognostic (1.13e-2)"	"unprognostic (3.08e-2)"	"prognostic favorable (7.60e-13)"	"unprognostic (2.78e-1)"	"unprognostic (3.18e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.44e-2)"	43.4	116.2	98.0	32.2	103.2	28.8	43.8	91.8	119.7	40.3	101.8	52.9	40.4	34.3	72.5	96.7	48.1	38.7	136.6	107.2	103.5	129.8	51.7	37.5	33.3	96.1	98.4	26.1	36.2	88.8	65.8	43.4	106.7	55.7	57.5	78.0	45.1	49.8	78.5	40.4	41.7	46.4	95.1	24.3	43.8	42.5	99.7	52.4	89.5	108.5	46.3	54.5	54.1	99.6	242.5	64.7	96.2	62.4	80.2	82.8	73.5	199.1	109.4	145.8	109.1	76.2	85.2	24.8	73.9	155.1	105.3	89.2	72.6	117.9	195.7	82.5	50.8	23.4	74.5	51.0	144.0	24.9	64.8	65.1	77.7	105.4	73.1	131.4	97.6	58.6	50.2	55.3	206.6	78.5	66.5	46.2	60.7	104.6	83.3	48.8	84.2	32.8	171.2	104.3	120.2	49.8	122.9	65.4	145.6	96.2	98.3	53.4	123.8	162.4	121.6	77.6	120.1	55.8	46.1	33.4	150.2	44.1	96.1	106.7	77.5	92.8	48.5	78.8	40.8	39.9	53.2	52.7	83.4	42.0	41.6	41.7	94.0	48.9	83.5	73.9	78.8	65.0	98.0	103.2	91.8	119.7	107.2	103.5	96.1	98.4	106.7	95.1	99.7	99.6	31.3	54.5	63.0	13.4	27.6	96.2	66.6	112.3	26.2	60.0	44.8	41.8	160.8	55.8	85.0	82.8	54.2	92.3	51.4	91.6	365.9	125.9	190.3	120.8	44.1	40.7	54.4	78.1	22.7	48.9	85.5	51.5	42.3	71.8	41.2	39.8	27.5	45.8	132.0	87.5	21.0	49.4	175.0	44.6	61.0	97.9	32.9	62.2	80.0	6.5	58.5	89.4	47.4	9.5	22.1	121.5	78.7	50.8	21.3	65.9	80.9	365.5	184.1	94.2	13.1	44.5	64.1	100.1	61.5	78.4	138.4	205.9	40.8	71.6	40.6	113.8
AURKA	"AIK, ARK1, AurA, BTAK, PPP1R47, STK15, STK6, STK7"	ENSG00000087586	"Aurora kinase A"	O14965	20	56369389-56392337	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Cilium biogenesis/degradation, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 22.1;testis: 30.8"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 81.6;Extravillous trophoblasts: 67.1;granulocytes: 54.1;Spermatocytes: 168.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB001454, HPA002636"	Enhanced		Approved	"Nucleoplasm,Mitotic spindle,Centrosome,Cytosol"		Yes	Yes			"Cluster 7: Monocytes - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Centrosome"	"Mitotic spindle, Cytosol"	"CAB001454: AB_563420, HPA002636: AB_1845217"	"unprognostic (7.73e-2)"	"unprognostic (2.46e-2)"	"unprognostic (2.76e-2)"	"prognostic unfavorable (9.40e-5)"	"unprognostic (1.92e-1)"	"unprognostic (2.11e-2)"	"prognostic unfavorable (1.49e-4)"	"unprognostic (4.69e-3)"	"unprognostic (2.42e-1)"	"unprognostic (6.88e-2)"	"prognostic unfavorable (6.13e-4)"	"unprognostic (1.40e-1)"	"prognostic unfavorable (1.47e-8)"	"unprognostic (1.67e-1)"	"unprognostic (6.83e-2)"	"unprognostic (9.00e-2)"	"unprognostic (5.14e-2)"	1.3	2.3	1.3	10.4	1.6	15.3	2.2	2.4	1.4	1.4	0.6	10.8	11.7	1.5	0.8	7.5	1.2	2.0	5.3	0.8	1.0	2.3	5.0	2.2	20.9	1.7	1.2	8.4	2.0	1.8	0.6	8.1	1.4	1.1	12.9	3.0	1.9	1.3	8.7	3.5	9.3	4.9	1.3	5.2	4.9	30.8	1.6	20.2	1.4	8.2	22.1	2.9	2.6	1.3	179.9	127.2	84.5	61.2	4.9	10.8	106.3	145.2	66.8	339.7	142.9	361.4	124.8	58.4	96.2	59.2	176.2	142.2	152.4	96.4	360.0	52.4	57.5	102.6	128.9	229.8	2.8	140.4	140.4	5.1	10.1	117.3	104.5	26.7	80.7	93.2	121.8	45.3	146.9	182.1	85.3	108.9	78.3	145.6	129.8	62.9	163.4	65.9	56.0	46.8	73.9	39.6	200.5	228.8	94.2	77.3	137.9	86.1	47.1	149.7	145.3	83.0	208.6	62.3	78.9	100.5	80.5	80.9	127.0	0.2	3.5	4.3	1.2	5.9	1.8	2.5	2.0	1.1	3.7	0.8	0.9	0.9	2.3	1.4	3.4	0.8	4.7	1.7	1.3	1.6	2.4	1.4	0.8	1.0	1.7	1.2	1.4	1.3	1.6	1.3	2.5	0.0	2.8	0.3	7.4	1.1	1.2	5.6	0.6	1.0	4.3	6.2	5.6	1.5	2.3	3.7	2.1	34.5	8.3	8.3	1.9	4.0	33.9	2.0	2.3	3.1	6.0	81.6	1.1	4.9	67.1	7.0	13.7	3.4	54.1	12.3	3.6	2.6	17.5	1.7	1.5	10.8	2.0	3.5	7.6	16.3	1.5	11.7	0.0	1.0	12.0	3.7	3.1	1.0	2.0	5.2	2.8	0.4	10.1	2.0	5.1	4.2	1.5	2.7	6.6	2.2	7.7	168.2	30.8	8.3	1.1	8.2	8.0	8.7	15.5	1.5
AURKB	"Aik2, AIM-1, ARK2, AurB, IPL1, PPP1R48, STK12, STK5"	ENSG00000178999	"Aurora kinase B"	Q96GD4	17	8204733-8210600	"Cancer-related genes, Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 44.1;lymphoid tissue: 60.1"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 40.5;Erythroid cells: 59.3;Extravillous trophoblasts: 89.1;Granulosa cells: 24.7;Hofbauer cells: 29.4"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"T-reg: 7.9"	"Group enriched"	"Detected in many"	6	"B-cells: 2.5;T-cells: 7.9"	"Low cell line specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"basal ganglia: 1.3;white matter: 4.0"	"Low region specificity"	"Detected in all"			"CAB005862, HPA037708"	Enhanced		Enhanced	Nucleoplasm,Midbody		Yes	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	Midbody	"CAB005862: AB_449204, HPA037708: AB_2675623"	"unprognostic (4.76e-2)"	"unprognostic (3.61e-3)"	"unprognostic (2.25e-1)"	"unprognostic (3.14e-2)"	"unprognostic (2.27e-1)"	"unprognostic (6.05e-2)"	"prognostic unfavorable (1.24e-4)"	"unprognostic (1.99e-3)"	"unprognostic (9.41e-3)"	"unprognostic (3.47e-2)"	"unprognostic (4.61e-3)"	"unprognostic (1.01e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (7.77e-2)"	"unprognostic (2.93e-1)"	"unprognostic (6.76e-2)"	"unprognostic (3.77e-1)"	1.1	1.2	0.1	14.2	0.2	44.1	1.7	0.2	0.2	3.0	0.1	11.1	12.1	1.6	0.4	18.6	0.6	1.5	0.7	0.1	0.2	0.9	2.0	2.5	36.7	0.1	0.3	0.5	0.6	0.3	0.2	8.2	0.3	0.8	11.0	0.0	2.7	0.3	5.5	9.3	11.6	3.2	0.0	12.0	4.6	1.2	0.4	60.1	0.6	0.0	36.6	3.5	5.9	0.2	196.5	130.9	191.1	93.0	4.2	6.5	73.4	91.7	49.5	186.2	170.6	171.5	57.4	193.3	46.2	37.0	77.0	139.8	140.1	62.6	153.7	84.9	231.3	115.7	78.3	146.1	0.7	62.2	109.2	3.5	2.9	109.4	67.7	18.5	86.5	123.6	73.3	73.4	82.9	92.9	225.1	87.4	119.6	63.9	57.6	149.8	176.1	80.5	41.2	38.2	41.2	59.1	81.7	36.5	61.2	56.5	63.5	41.4	33.9	74.3	75.6	67.6	243.3	53.2	37.7	147.9	35.7	92.9	153.4	0.0	0.4	0.6	0.5	0.3	0.1	1.1	1.3	2.1	0.5	2.5	0.1	0.7	0.9	0.3	0.2	0.2	7.9	0.9	0.1	0.2	0.2	0.2	0.1	0.2	0.1	0.3	0.3	0.0	0.4	0.2	0.3	0.0	0.5	0.0	7.6	4.5	1.8	6.1	0.6	0.0	1.8	2.2	1.4	0.0	2.6	0.0	0.0	40.5	1.8	13.2	0.0	0.4	0.1	0.5	1.6	3.1	0.0	59.3	0.0	0.0	89.1	5.7	6.1	2.1	4.5	24.7	6.1	0.7	29.4	0.0	0.0	10.8	0.0	5.7	7.3	0.2	0.6	5.1	1.8	0.0	0.9	0.0	3.1	0.0	0.1	0.3	2.8	0.0	15.4	1.2	1.5	0.1	0.2	0.0	0.0	0.1	4.8	1.6	7.2	11.8	2.4	9.0	4.3	1.0	22.0	2.8
BCKDHB		ENSG00000083123	"Branched chain keto acid dehydrogenase E1 subunit beta"	P21953	6	80106647-80346270	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease variant, Maple syrup urine disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 78.4"	"Cell type enhanced"	"Detected in all"		"Astrocytes: 296.5;Early spermatids: 110.9;Inhibitory neurons: 94.9;Oligodendrocyte precursor cells: 98.5;Oligodendrocytes: 101.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031580, HPA031956"	Approved		Supported	Nucleoplasm,Nucleoli,Mitochondria	"Intracellular and membrane"	Yes	No			"Cluster 15: NK-cells - Transcription"	"Cluster 85: Liver - Metabolism"	"Cluster 32: U-937 - Innate immune response"	"Cluster 64: Astrocytes - Nervous system maintenance"	Mitochondria	"Nucleoplasm, Nucleoli"	"HPA031580: AB_10696054, HPA031956: "	"unprognostic (4.23e-1)"	"unprognostic (1.61e-1)"	"unprognostic (9.50e-3)"	"unprognostic (9.37e-3)"	"unprognostic (1.66e-1)"	"unprognostic (6.03e-2)"	"unprognostic (6.84e-3)"	"unprognostic (2.30e-2)"	"unprognostic (1.94e-1)"	"unprognostic (7.32e-3)"	"unprognostic (2.67e-1)"	"unprognostic (4.65e-2)"	"prognostic favorable (5.54e-9)"	"unprognostic (2.67e-1)"	"unprognostic (1.12e-1)"	"unprognostic (8.02e-2)"	"unprognostic (1.49e-2)"	19.7	10.7	7.3	7.6	8.3	8.2	22.3	11.5	7.8	11.7	11.6	22.5	11.5	9.2	7.1	10.3	11.5	7.8	18.8	8.8	7.0	31.8	78.4	7.3	8.8	10.7	9.2	14.6	12.9	19.7	7.2	4.8	13.1	15.9	20.7	7.9	26.6	11.3	10.9	8.5	12.4	9.4	11.8	6.3	17.6	13.1	8.7	9.1	15.5	15.3	9.1	11.2	7.6	16.0	13.8	5.1	18.8	25.3	18.6	16.1	14.9	9.7	19.8	15.4	21.0	8.3	18.5	38.9	10.1	23.1	18.0	13.6	10.6	12.7	21.5	48.8	15.6	19.4	12.6	11.3	20.7	27.7	8.3	15.6	12.8	10.7	13.3	13.8	18.6	29.8	16.6	33.8	35.0	7.6	10.3	16.3	14.0	30.1	6.5	25.5	58.3	33.8	43.2	20.7	12.6	17.8	16.2	13.4	9.9	20.6	17.3	21.1	8.0	9.2	6.3	8.5	13.0	24.0	25.2	12.9	11.3	20.4	14.2	3.4	4.2	1.0	10.1	5.1	13.3	10.6	8.3	8.5	8.3	12.7	11.0	11.6	0.8	17.4	5.9	12.9	20.3	6.1	7.3	8.3	11.5	7.8	8.8	7.0	10.7	9.2	13.1	11.8	8.7	16.0	8.4	9.6	21.0	296.5	11.5	8.5	12.5	21.1	15.9	7.8	19.6	14.7	29.3	8.6	18.0	5.5	2.1	17.0	9.1	17.5	27.4	8.2	110.9	8.3	10.3	8.0	12.0	10.3	72.0	10.4	8.3	13.7	15.3	17.6	16.5	19.2	11.0	66.5	12.2	3.3	94.9	31.3	10.2	9.1	9.0	13.7	8.7	5.4	16.0	59.0	7.3	15.5	10.3	98.5	101.7	5.4	10.4	8.6	8.4	6.2	11.5	33.1	13.5	8.7	6.6	11.1	9.4	15.2	5.6	20.1	12.4	10.4	9.9	15.5	17.4	10.9
BEND7	"C10orf30, FLJ40283"	ENSG00000165626	"BEN domain containing 7"	Q8N7W2	10	13438484-13528974	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Early spermatids: 167.3;Late spermatids: 268.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 17.5;hTERT-RPE1: 17.3"									HPA037835	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center,Vesicles"		Yes	No			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 34: Spermatids - Unknown function"	"Nucleoplasm, Nucleoli fibrillar center, Vesicles"		"HPA037835: AB_10669722"	"unprognostic (6.22e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.18e-2)"	"unprognostic (4.62e-3)"	"unprognostic (3.24e-3)"	"unprognostic (3.52e-2)"	"unprognostic (1.26e-1)"	"unprognostic (5.02e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.19e-3)"	"unprognostic (1.57e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.58e-1)"	"unprognostic (5.20e-3)"	8.0	6.0	4.7	2.4	4.9	0.7	9.4	6.5	4.7	7.4	4.9	11.2	16.5	7.3	13.6	2.2	12.4	6.5	7.4	5.0	4.9	18.5	9.0	9.1	1.1	5.1	5.9	8.3	12.1	14.8	10.3	4.3	5.9	5.7	6.6	15.4	15.1	6.5	16.4	3.2	19.3	6.1	4.7	3.0	11.2	16.3	5.6	0.5	23.5	13.3	1.0	6.8	4.4	4.4	9.9	5.9	6.0	2.2	0.1	0.0	8.7	3.8	0.1	9.3	5.6	2.4	17.5	0.0	5.1	7.3	5.2	0.4	9.8	2.1	8.3	0.0	8.7	0.0	0.0	11.4	3.9	0.0	0.0	0.2	5.7	1.2	0.0	17.3	10.3	1.4	4.3	0.0	9.3	4.0	0.1	0.0	1.8	0.0	1.0	0.0	4.4	0.0	8.0	1.3	0.4	4.7	10.7	0.0	0.1	9.1	0.1	4.7	9.2	1.1	13.8	11.6	4.8	0.0	0.0	0.0	3.2	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	4.7	4.9	6.5	4.7	5.0	4.9	5.1	5.9	5.9	4.7	5.6	4.4	33.6	22.4	11.6	23.5	1.9	3.4	23.6	1.1	1.8	14.4	15.4	11.4	11.0	22.8	9.8	20.2	8.4	3.0	2.6	13.2	3.9	13.0	167.3	25.0	5.8	16.7	7.8	0.0	7.5	16.5	2.9	8.0	9.7	36.2	6.3	14.7	22.5	9.6	3.0	1.7	10.2	8.5	6.1	9.4	1.9	268.7	5.0	2.5	3.6	24.4	4.5	20.3	12.3	47.7	0.7	21.8	9.5	6.0	0.5	23.9	45.2	52.0	9.7	32.2	0.0	14.1	8.4	21.5	20.0	3.3	1.8	2.5	3.5	3.4	10.3	36.1
BRCA2	"BRCC2, FACD, FAD, FAD1, FANCD, FANCD1, XRCC11"	ENSG00000139618	"BRCA2 DNA repair associated"	P51587	13	32315086-32400268	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA recombination, DNA repair"	DNA-binding	"Cancer-related genes, Disease variant, Fanconi anemia, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 5.8;lymphoid tissue: 3.1;testis: 2.7"	"Cell type enhanced"	"Detected in many"		"Spermatocytes: 115.4;Spermatogonia: 85.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"							HPA026815	Uncertain		Supported	Nucleoplasm,Cytosol		Yes	No			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	Cytosol	"HPA026815: AB_10602692"	"unprognostic (9.36e-2)"	"unprognostic (2.50e-1)"	"unprognostic (4.50e-3)"	"unprognostic (1.06e-2)"	"unprognostic (5.40e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.60e-2)"	"unprognostic (2.01e-1)"	"unprognostic (6.97e-3)"	"unprognostic (4.06e-2)"	"unprognostic (3.07e-9)"	"unprognostic (2.36e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.32e-1)"	0.2	0.1	0.0	1.3	0.0	5.8	0.5	0.0	0.0	0.2	0.2	0.7	0.5	0.3	0.0	0.5	0.1	0.3	0.0	0.0	0.0	0.1	0.3	0.3	2.1	0.1	0.1	0.1	0.1	0.0	0.0	1.0	0.1	0.1	0.8	0.0	0.2	0.0	0.0	0.7	0.5	0.3	0.1	0.9	0.6	2.7	0.2	3.1	0.2	0.0	2.0	0.5	0.2	0.1	4.7	4.0	6.0	5.0	0.6	1.4	7.0	4.8	3.1	5.5	5.0	10.6	6.0	15.9	3.2	2.1	7.6	6.1	5.5	2.9	10.5	10.5	3.1	10.3	2.5	3.5	0.1	15.4	4.9	0.2	0.0	10.3	6.9	0.4	4.5	8.1	7.0	5.5	6.4	5.1	11.8	8.3	8.3	4.9	2.3	11.4	17.3	3.0	1.4	5.4	2.4	4.6	5.9	2.4	2.2	2.2	2.9	7.3	1.3	6.3	6.8	7.0	6.7	2.0	3.3	8.0	2.7	5.7	5.8	0.0	0.3	1.5	0.5	0.7	0.1	1.7	0.4	0.4	0.3	2.2	0.5	0.4	0.8	0.5	0.8	3.0	1.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.2	0.1	4.4	9.6	2.6	0.0	12.4	2.5	3.3	2.5	2.2	0.0	4.3	3.3	1.9	0.0	1.8	0.0	0.0	14.1	10.5	4.8	0.0	2.5	5.2	4.4	6.3	5.5	1.2	29.5	0.7	1.6	12.7	5.8	10.7	4.6	3.8	26.9	1.4	0.8	9.5	0.0	0.5	4.4	0.0	7.5	11.0	4.4	2.1	14.4	3.6	4.7	20.1	0.3	0.0	0.0	0.6	1.2	1.8	1.2	27.8	1.2	1.0	0.6	2.9	0.0	13.1	8.3	5.3	115.4	85.6	8.0	1.3	5.5	7.9	4.2	7.8	2.3
BRF1	"BRF, GTF3B, hBRF, TAF3B2, TAF3C, TFIIIB90"	ENSG00000185024	"BRF1 RNA polymerase III transcription initiation factor subunit"	Q92994	14	105209286-105315589	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator	"Disease variant, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051918, HPA074990"	Approved		Approved	"Nucleoplasm,Nuclear bodies"		Yes	No			"Cluster 40: NK-cells - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Nucleoplasm	"Nuclear bodies"	"HPA051918: AB_2681663, HPA074990: "	"unprognostic (1.98e-1)"	"unprognostic (4.45e-2)"	"unprognostic (1.46e-2)"	"unprognostic (2.51e-2)"	"unprognostic (1.07e-1)"	"unprognostic (7.52e-2)"	"unprognostic (1.52e-4)"	"unprognostic (2.67e-2)"	"unprognostic (3.25e-1)"	"unprognostic (2.26e-1)"	"prognostic favorable (7.25e-6)"	"unprognostic (8.83e-2)"	"prognostic favorable (1.13e-4)"	"unprognostic (1.85e-1)"	"unprognostic (2.70e-1)"	"unprognostic (5.39e-2)"	"unprognostic (2.52e-1)"	10.5	11.4	19.7	5.5	22.2	6.5	10.5	23.1	23.6	12.5	12.9	11.1	7.6	12.1	4.2	10.4	12.8	6.0	12.2	17.1	19.2	11.6	13.1	8.4	8.1	31.8	24.9	13.0	15.1	10.3	20.4	6.0	29.7	12.0	4.2	7.5	10.1	6.3	17.7	11.2	10.3	4.6	18.7	12.6	11.2	14.6	25.4	7.3	10.5	9.6	5.8	11.5	9.9	37.4	12.6	28.0	11.8	25.3	10.3	11.4	11.9	17.4	11.2	15.4	12.2	20.2	18.8	9.4	16.9	12.0	7.5	24.2	14.4	11.7	8.4	25.2	14.2	11.5	15.1	9.9	11.5	13.7	24.3	11.3	10.1	9.3	11.5	7.8	11.3	19.7	13.1	7.5	7.6	40.9	16.2	17.1	8.6	20.7	27.7	28.2	8.1	9.6	7.6	29.9	37.5	27.8	18.4	14.0	16.0	5.4	33.4	18.9	16.8	12.1	9.6	22.7	14.2	13.8	11.5	8.9	14.5	11.3	16.9	0.4	1.2	2.0	1.6	1.0	1.1	1.5	1.1	1.6	1.2	1.4	1.4	1.3	0.5	2.5	4.0	3.1	1.6	1.6	19.7	22.2	23.1	23.6	17.1	19.2	31.8	24.9	29.7	18.7	25.4	37.4	11.5	3.2	5.9	17.6	11.4	7.5	7.1	4.5	8.6	18.8	10.7	9.0	8.5	2.8	6.3	3.7	16.7	11.4	15.5	16.2	3.9	5.8	2.3	26.5	10.9	9.5	9.6	6.3	18.3	7.1	8.9	7.7	14.8	16.5	2.5	16.0	8.9	11.3	7.2	30.3	20.8	11.7	4.1	6.7	10.3	1.4	6.5	7.8	8.8	10.3	5.3	7.1	4.1	15.1	34.2	4.8	6.5	4.5	13.4	7.7	8.9	6.1	12.4	20.0	0.0	9.6	8.2	9.2	12.7	7.7	8.8	9.3	11.6	13.2	12.5	5.1
BUB1B	"Bub1A, BUBR1, MAD3L, SSK1"	ENSG00000156970	"BUB1 mitotic checkpoint serine/threonine kinase B"	O60566	15	40161023-40221123	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Cell cycle, Cell division, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease variant, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 17.8;lymphoid tissue: 35.7;testis: 22.2"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 23.5;Spermatocytes: 79.2;Spermatogonia: 26.8"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"naive B-cell: 1.1"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"							HPA008419			Supported	Cytosol		Yes	Yes			"Cluster 24: B-cells - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Cytosol		"HPA008419: AB_1078308"	"unprognostic (4.40e-2)"	"unprognostic (2.23e-1)"	"unprognostic (4.65e-2)"	"unprognostic (2.44e-3)"	"unprognostic (9.66e-2)"	"unprognostic (3.52e-2)"	"prognostic unfavorable (7.43e-6)"	"prognostic unfavorable (3.56e-4)"	"unprognostic (3.69e-3)"	"unprognostic (2.32e-1)"	"prognostic unfavorable (1.79e-4)"	"unprognostic (1.76e-2)"	"unprognostic (0.00e+0)"	"unprognostic (3.75e-2)"	"unprognostic (4.66e-2)"	"unprognostic (2.20e-1)"	"unprognostic (3.94e-2)"	0.4	0.5	0.1	6.7	0.1	17.8	1.6	0.3	0.2	1.0	7.7	4.6	4.7	1.2	0.3	5.2	0.6	0.6	0.3	0.3	0.1	0.3	0.4	1.0	12.6	0.0	0.1	0.2	0.2	0.2	0.1	3.4	0.1	0.4	6.0	0.1	0.9	0.2	0.0	3.5	4.1	2.1	0.0	3.1	2.4	22.2	0.2	35.7	0.5	0.0	15.0	1.5	1.7	0.0	66.5	32.8	103.0	41.5	2.5	7.1	33.2	60.9	34.2	64.6	55.7	48.1	25.0	59.7	33.5	22.7	59.0	72.6	98.8	33.2	70.5	51.8	52.1	86.4	83.6	45.5	0.2	79.0	45.7	1.6	2.0	39.2	37.1	12.9	47.7	66.5	76.4	61.7	65.6	22.5	62.5	48.9	70.2	55.6	36.8	66.5	83.7	45.2	19.9	33.1	67.1	40.8	38.0	35.9	13.3	45.1	41.9	40.9	27.6	49.3	51.8	49.2	55.5	32.1	58.2	95.6	26.3	87.8	65.4	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.1	0.2	1.1	0.0	0.1	0.0	0.1	0.0	0.8	0.0	0.1	0.1	0.1	0.3	0.2	0.3	0.1	0.0	0.1	0.1	0.0	0.2	0.0	0.1	3.2	1.1	0.3	1.8	0.8	0.3	1.0	1.8	0.7	0.9	2.0	0.8	0.0	1.9	0.0	0.0	5.4	0.6	1.8	0.0	0.4	3.0	0.9	1.4	1.0	0.0	23.5	0.7	0.0	6.7	2.4	5.6	2.1	0.0	12.9	1.1	0.3	5.2	0.0	0.7	2.5	0.0	1.9	1.7	3.3	1.5	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	1.5	0.4	12.6	0.3	0.3	0.1	0.2	0.2	6.6	0.2	1.7	79.2	26.8	6.9	0.3	0.8	1.8	0.8	5.4	0.6
BUD23	"MERM1, MGC19709, MGC2022, MGC5140, PP3381, WBMT, WBSCR22"	ENSG00000071462	"BUD23 rRNA methyltransferase and ribosome maturation factor"	O43709	7	73683025-73705161	"Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing, Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Transferase"	"Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Ductal cells: 119.9;Endometrial ciliated cells: 133.6;Exocrine glandular cells: 140.8;Pancreatic endocrine cells: 126.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RPMI-8226: 712.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052185	Approved		Supported	Nucleoplasm,Nucleoli		Yes	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 7: Non-specific - Mitochondria"	"Nucleoplasm, Nucleoli"		"HPA052185: AB_2681753"	"unprognostic (2.49e-1)"	"unprognostic (1.87e-1)"	"unprognostic (2.67e-2)"	"unprognostic (4.79e-2)"	"unprognostic (3.62e-3)"	"unprognostic (8.54e-2)"	"prognostic unfavorable (9.92e-4)"	"unprognostic (1.17e-1)"	"unprognostic (9.16e-2)"	"unprognostic (9.20e-2)"	"unprognostic (6.71e-2)"	"unprognostic (4.20e-2)"	"prognostic unfavorable (1.46e-4)"	"unprognostic (5.15e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.13e-3)"	39.8	49.2	34.5	40.0	36.7	58.7	43.4	36.4	39.8	36.3	41.0	48.6	47.0	38.6	72.3	41.7	58.9	34.5	87.9	36.1	39.0	53.3	47.2	38.5	52.6	37.0	36.1	37.8	70.8	49.2	45.1	30.7	36.3	37.8	47.7	20.3	55.9	42.2	128.0	43.8	40.3	41.4	36.4	42.1	44.9	130.0	36.6	44.7	56.5	78.4	51.7	51.9	32.8	38.5	142.1	151.8	53.6	429.2	72.0	64.2	91.1	95.1	83.3	118.5	96.1	211.4	182.6	163.6	48.9	99.5	204.0	97.0	124.8	91.0	108.4	116.6	147.1	72.0	174.8	86.7	91.2	200.3	98.8	57.3	102.2	103.2	93.9	59.7	77.4	130.3	285.4	288.9	103.7	219.6	128.0	277.8	130.2	317.8	172.2	110.5	106.8	712.0	132.5	100.2	163.4	124.4	126.3	329.2	146.5	53.0	207.9	159.0	85.2	101.8	130.3	130.0	208.3	99.5	192.6	275.5	232.3	155.6	218.0	54.8	64.9	60.6	112.0	74.2	124.9	175.3	127.1	122.5	122.9	153.5	132.8	121.5	11.9	125.4	68.0	190.9	150.6	132.6	34.5	36.7	36.4	39.8	36.1	39.0	37.0	36.1	36.3	36.4	36.6	38.5	67.0	44.8	64.5	0.0	26.5	0.0	0.0	0.0	0.0	0.0	75.4	85.7	0.0	0.0	42.7	46.0	0.0	75.7	64.1	0.0	97.8	119.9	0.0	133.6	51.2	28.6	0.0	0.0	0.0	140.8	82.7	24.5	0.0	79.6	46.7	49.2	0.0	0.0	70.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.8	0.0	0.0	21.2	0.0	0.0	0.0	0.0	126.0	0.0	0.0	16.5	0.0	0.0	103.5	78.7	0.0	0.0	0.0	26.4	0.0	0.0	0.0	0.0	106.7	28.1	73.0	0.0	0.0
BVES	"HBVES, POP1, POPDC1"	ENSG00000112276	"Blood vessel epicardial substance"	Q8NE79	6	105096822-105137157	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Cell adhesion"	"Developmental protein"	"Limb-girdle muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 27.8;skeletal muscle: 43.9;tongue: 29.3"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 34.2;Early spermatids: 36.1;Late spermatids: 55.3;Oligodendrocytes: 17.8;Spermatocytes: 24.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"RH-30: 29.7;WM-115: 30.2"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA014788, HPA018176"	Enhanced		Supported	"Plasma membrane,Cell Junctions"		Yes	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 25: Spermatids - Spermatogenesis"	"Plasma membrane, Cell Junctions"		"HPA014788: AB_1845504, HPA018176: AB_1845503"	"unprognostic (2.91e-1)"	"unprognostic (2.45e-1)"	"unprognostic (2.79e-2)"	"unprognostic (1.73e-2)"	"unprognostic (5.46e-2)"	"unprognostic (3.66e-2)"	"unprognostic (5.21e-2)"	"unprognostic (2.22e-2)"	"unprognostic (8.37e-2)"	"unprognostic (4.49e-2)"	"unprognostic (2.29e-2)"	"unprognostic (8.92e-2)"	"unprognostic (5.84e-3)"	"unprognostic (3.77e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.02e-2)"	"unprognostic (3.24e-4)"	2.9	0.7	2.6	2.3	7.1	0.2	1.5	5.8	3.6	2.5	4.6	14.9	1.4	5.8	1.7	5.3	2.8	1.8	27.8	2.7	4.3	1.6	0.3	1.9	0.6	7.3	5.6	1.0	0.6	0.7	2.4	3.5	7.4	5.2	3.3	0.2	1.4	10.0	43.9	0.7	3.0	17.7	5.2	0.3	6.9	11.5	5.2	0.2	1.3	29.3	0.4	9.3	2.2	10.8	1.3	2.0	7.6	1.3	10.9	14.9	3.3	5.8	4.1	8.8	11.6	0.5	0.0	0.0	0.0	10.9	14.7	0.1	3.3	2.0	8.1	0.0	2.8	0.0	1.0	0.3	2.4	0.0	0.6	8.7	6.9	13.6	1.1	6.6	4.0	3.3	0.1	19.3	19.7	0.1	0.2	1.0	1.6	0.0	0.0	5.7	29.7	0.0	0.0	0.0	9.9	17.1	3.7	0.1	7.7	5.5	0.0	20.0	8.9	14.0	0.0	0.0	15.3	1.8	0.8	0.0	8.3	0.0	30.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	2.6	7.1	5.8	3.6	2.7	4.3	7.3	5.6	7.4	5.2	5.2	10.8	2.1	0.0	0.0	1.6	0.0	0.3	0.4	0.1	0.6	0.0	0.4	1.0	34.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	36.1	1.9	4.4	3.1	0.0	0.0	3.3	0.0	0.2	2.6	0.0	6.0	0.0	0.9	2.2	0.1	2.3	0.0	0.6	0.0	0.0	0.0	1.9	55.3	1.2	0.5	0.0	3.7	1.0	0.0	0.0	5.0	17.8	0.1	0.0	3.4	0.0	0.5	0.1	0.1	0.1	0.0	13.1	11.8	4.4	24.4	5.4	0.1	0.9	0.1	0.2	1.3	0.0	0.3
C10orf82	"Em:AC016825.4, MGC33547"	ENSG00000165863	"Chromosome 10 open reading frame 82"	Q8WW14	10	116663696-116670264	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	23	"testis: 84.5"	"Group enriched"	"Detected in some"	113	"Early spermatids: 1053.9;Late spermatids: 1926.7"	"Cancer enhanced"	"Detected in many"		"breast cancer: 2.4"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	103	"basophil: 10.2"	"Lineage enriched"	"Detected in single"	103	"granulocytes: 10.2"	"Cell line enhanced"	"Detected in some"		"BEWO: 1.2;Hep G2: 2.8;NTERA-2: 1.4;SuSa: 2.5;T-47d: 3.5"	"Not detected"	"Not detected"							HPA043022			Approved	Mitochondria		Yes	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 6: T47d - Mammary gland"	"Cluster 34: Spermatids - Unknown function"	Mitochondria		"HPA043022: "	"unprognostic (9.98e-2)"	"unprognostic (2.09e-2)"	"unprognostic (8.41e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.63e-2)"	"unprognostic (9.52e-2)"		"unprognostic (3.46e-3)"	"unprognostic (3.48e-1)"	"unprognostic (6.15e-2)"	"unprognostic (1.50e-2)"	"unprognostic (8.00e-2)"	"unprognostic (1.47e-3)"	"unprognostic (2.61e-2)"	"unprognostic (1.94e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.07e-1)"	0.3	1.7	0.3	0.2	0.2	0.0	0.9	0.1	0.4	0.4	0.0	0.9	0.1	0.0	0.2	0.3	0.2	0.1	0.4	0.2	0.8	1.2	0.0	0.0	0.0	0.3	0.5	3.6	1.1	0.0	1.0	0.0	0.4	0.9	0.2	0.1	0.2	0.7	0.0	0.2	0.4	0.0	0.2	0.1	0.4	84.5	0.9	0.0	1.6	0.1	0.0	0.3	0.6	0.2	0.0	0.1	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.5	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.1	0.4	0.2	0.8	0.3	0.5	0.4	0.2	0.9	0.2	0.0	0.0	0.0	0.3	0.0	0.1	0.4	0.0	0.0	0.0	1.1	1.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	1053.9	0.3	0.2	0.5	1.2	0.0	0.5	0.2	0.1	0.1	0.0	0.7	0.0	5.6	0.0	0.0	0.1	0.0	1.8	1.1	0.0	0.0	0.0	1926.7	9.0	0.6	1.8	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	5.3	0.0	0.7	0.1	0.1	0.0	0.0	13.1	0.4	0.2	10.5	8.0	0.0	0.0	0.0	0.1	8.0	1.2	0.3
C14orf39	SIX6OS1	ENSG00000179008	"Chromosome 14 open reading frame 39"	Q8N1H7	14	60396469-60515543	"Plasma proteins, Predicted intracellular proteins"	"DNA recombination, Meiosis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"pituitary gland: 4.8;salivary gland: 4.6;testis: 10.8"	"Cell type enriched"	"Detected in some"	4	"Spermatocytes: 92.5"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.5"	"Group enriched"	"Detected in some"	16	"hypothalamus: 2.9;thalamus: 2.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEL: 6.2;JURKAT: 28.3;MOLT-4: 23.9;RH-30: 6.2;U-2 OS: 12.7"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA059518	Uncertain		Approved	Nucleoplasm,Nucleoli		Yes	No				"Cluster 77: Retina - Visual perception"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Nucleoplasm, Nucleoli"		"HPA059518: AB_2684049"	"unprognostic (6.17e-2)"	"unprognostic (1.73e-3)"		"unprognostic (3.00e-6)"	"unprognostic (2.78e-1)"	"unprognostic (6.97e-2)"		"unprognostic (7.55e-4)"	"unprognostic (2.12e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.78e-1)"		"unprognostic (7.46e-2)"	"unprognostic (4.35e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.09e-1)"	0.3	1.8	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.2	0.8	0.4	0.2	0.5	0.0	0.1	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.1	0.0	0.1	0.1	1.2	0.0	0.5	4.8	0.0	0.0	1.1	0.0	2.7	4.6	0.1	3.0	0.0	0.1	0.1	0.0	0.0	0.3	10.8	2.4	0.1	0.2	3.7	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.8	6.2	0.0	0.0	0.0	0.0	0.3	4.5	0.0	0.7	0.0	0.1	0.0	28.3	0.0	0.0	2.0	0.0	23.9	0.3	3.0	0.0	1.4	0.0	6.2	0.0	0.4	1.7	0.1	2.6	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	12.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	2.9	0.1	0.1	0.0	0.0	2.4	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.6	0.5	0.0	0.9	0.0	0.1	0.7	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.0	0.0	0.0	0.2	0.0	0.0	2.8	0.0	0.0	0.3	0.0	0.0	1.3	0.0	0.0	0.0	0.0	3.3	0.9	0.0	0.0	0.0	0.0	6.8	0.3	0.0	0.0	1.0	0.0	12.3	0.0	1.0	0.7	0.0	0.0	0.7	0.0	0.8	0.0	0.0	1.2	1.1	0.0	10.0	0.2	92.5	19.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2
C17orf50		ENSG00000270806	"Chromosome 17 open reading frame 50"	Q8WW18	17	35760887-35765079	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	82	"testis: 105.6"	"Group enriched"	"Detected in some"	45	"Early spermatids: 769.0;Late spermatids: 1197.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"HaCaT: 3.7;MOLT-4: 1.0"	"Not detected"	"Not detected"							"HPA043184, HPA063464"			Supported	Nucleoplasm		Yes	NA			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 74: Testis - Spermatogenesis"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA043184: AB_2678358, HPA063464: "	"unprognostic (2.21e-1)"	"unprognostic (1.07e-1)"	"unprognostic (4.36e-2)"	"unprognostic (4.01e-2)"	"unprognostic (5.84e-2)"	"unprognostic (5.12e-3)"		"unprognostic (2.04e-2)"		"unprognostic (1.97e-2)"	"unprognostic (7.94e-2)"	"unprognostic (5.36e-2)"	"unprognostic (1.14e-2)"	"unprognostic (2.71e-1)"	"unprognostic (6.68e-2)"	"unprognostic (4.67e-2)"	"unprognostic (1.54e-2)"	0.1	0.1	1.2	0.0	0.9	0.0	0.1	0.0	1.0	0.0	0.0	0.2	0.0	0.0	0.3	0.1	0.3	0.0	0.0	0.8	0.7	0.1	0.0	0.1	0.0	0.4	0.7	0.0	0.2	0.0	0.3	0.0	0.1	0.1	0.0	0.3	0.0	0.1	0.1	0.2	0.2	0.0	0.0	0.1	0.1	105.6	0.6	0.1	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.4	1.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.3	0.7	0.8	0.7	0.4	0.0	0.7	1.2	1.4	0.0	0.1	0.0	1.4	0.0	0.2	1.2	0.9	0.0	1.0	0.8	0.7	0.4	0.7	0.1	0.0	0.6	0.0	0.0	0.0	0.0	1.3	0.1	0.0	0.0	0.2	0.0	0.4	0.5	0.6	0.3	0.0	0.1	9.2	0.0	0.0	0.2	0.4	0.0	0.0	769.0	1.8	0.0	0.5	1.2	0.0	0.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.4	2.0	0.0	0.0	1197.7	8.4	0.4	0.0	0.0	0.1	1.2	0.0	0.0	0.0	0.0	0.2	5.7	0.0	0.1	0.4	1.0	1.5	0.2	6.6	0.0	0.2	21.8	7.2	0.0	0.0	0.0	0.1	0.1	0.5	0.1
CALD1	"CDM, H-CAD, L-CAD"	ENSG00000122786	"Caldesmon 1"	Q05682	7	134744252-134970729	"Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding, Muscle protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 916.1"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 1190.3;Leydig cells: 1745.0;Peritubular cells: 2005.6;Sertoli cells: 2294.3;Smooth muscle cells: 2549.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	8	"neutrophil: 1.9"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 1.9"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 736.3;fHDF/TERT166: 1202.8;U-138 MG: 733.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000006, HPA008066, HPA017330"	Enhanced		Enhanced	"Plasma membrane,Actin filaments"		Yes	No		39000000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	"Plasma membrane, Actin filaments"		"CAB000006: AB_2065456, HPA008066: AB_1078378, HPA017330: AB_1845917"	"unprognostic (2.16e-2)"	"unprognostic (1.19e-2)"	"unprognostic (2.80e-3)"	"unprognostic (3.05e-2)"	"unprognostic (4.51e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.22e-2)"	"prognostic unfavorable (3.73e-4)"	"unprognostic (2.07e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.14e-1)"	"prognostic unfavorable (1.84e-5)"	"unprognostic (6.52e-3)"	"unprognostic (1.14e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.18e-3)"	225.8	119.2	27.3	164.9	35.0	1.3	161.1	28.1	47.6	241.6	37.2	916.1	80.3	523.3	150.7	275.6	304.4	203.2	115.0	26.9	29.1	134.7	224.4	155.5	75.4	32.3	30.4	326.2	52.5	32.7	53.3	430.0	30.9	348.9	149.8	13.1	70.3	781.7	46.5	76.0	233.1	688.4	27.9	129.2	324.2	52.7	33.4	28.5	114.1	75.2	34.4	505.3	208.0	28.8	115.9	75.3	163.3	146.1	572.7	464.8	161.6	661.6	736.3	227.2	246.6	138.3	3.5	0.7	153.3	1202.8	148.1	26.9	106.0	202.3	308.4	1.5	38.9	4.0	87.8	94.7	375.6	1.5	0.8	360.9	153.6	252.8	147.4	343.6	193.0	0.0	0.6	1.6	338.7	0.3	0.6	3.2	197.7	0.1	25.6	1.4	146.6	2.3	46.9	32.2	29.0	72.1	235.3	31.7	90.0	491.0	7.2	1.4	508.5	733.2	130.0	143.8	230.3	0.9	1.1	1.3	259.0	0.8	573.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	1.9	0.2	0.0	0.0	0.0	2.9	27.3	35.0	28.1	47.6	26.9	29.1	32.3	30.4	30.9	27.9	33.4	28.8	400.6	22.4	17.6	43.1	7.3	420.4	379.6	218.8	164.4	172.0	115.5	466.1	456.5	228.8	33.5	44.1	6.2	202.7	5.0	0.3	23.5	392.6	61.0	89.4	1190.3	432.9	3.6	16.0	95.4	23.6	903.9	886.9	16.3	206.2	5.1	251.0	422.0	638.4	43.5	92.5	58.3	1.2	28.5	21.0	112.8	83.6	1745.0	38.8	336.2	94.6	8.4	140.6	6.2	98.5	158.8	146.0	0.2	2005.6	4.2	456.9	0.1	332.1	11.3	21.2	2294.3	326.1	2549.3	12.1	12.2	70.1	171.8	276.6	27.5	414.1	0.8	36.7
CALML4	"MGC4809, NY-BR-20"	ENSG00000129007	"Calmodulin like 4"	Q96GE6	15	68190705-68206079	"Predicted intracellular proteins, RAS pathway related proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 91.9"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 49.2;Gastric mucus-secreting cells: 31.6;Paneth cells: 39.3;Proximal enterocytes: 36.2;Respiratory ciliated cells: 107.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"intermediate monocyte: 184.3;non-classical monocyte: 216.9"	"Lineage enriched"	"Detected in many"	7	"monocytes: 216.9"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA051109	Enhanced		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		Yes	No			"Cluster 51: Monocytes - Innate immune response"	"Cluster 9: Intestine - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 49: Ciliated cells - Cilium organization"	"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA051109: AB_2681346"	"unprognostic (1.69e-2)"	"unprognostic (1.78e-1)"	"unprognostic (4.97e-2)"	"unprognostic (8.50e-2)"	"unprognostic (1.63e-1)"	"unprognostic (3.71e-2)"	"unprognostic (4.05e-2)"	"unprognostic (6.53e-2)"	"unprognostic (6.77e-2)"	"unprognostic (2.10e-1)"	"unprognostic (4.19e-3)"	"unprognostic (6.24e-2)"	"unprognostic (3.85e-2)"	"unprognostic (7.92e-3)"	"unprognostic (2.46e-1)"	"unprognostic (7.49e-2)"	"unprognostic (1.32e-1)"	5.2	5.1	2.9	14.5	2.9	4.5	3.1	3.9	3.8	9.2	12.6	70.1	91.9	3.3	1.4	2.1	19.3	18.7	1.2	3.1	2.7	29.1	15.0	5.1	3.9	2.8	2.7	1.7	7.0	0.9	3.5	5.4	2.9	6.2	64.7	4.3	2.2	4.4	3.4	4.8	76.0	7.3	2.4	5.9	15.6	3.3	3.0	4.5	1.6	0.7	4.0	3.5	2.3	3.3	3.4	11.6	7.9	4.8	1.6	1.7	5.7	2.2	2.3	4.8	3.0	22.1	29.8	3.7	3.0	1.9	3.7	15.1	18.2	2.8	2.0	3.3	16.9	6.7	21.6	7.9	3.5	5.8	14.7	1.6	4.4	1.8	3.4	3.0	5.9	10.8	6.2	3.9	0.7	10.2	14.5	12.6	8.5	24.1	3.4	30.1	8.1	8.2	1.3	6.0	4.4	4.3	3.5	3.2	9.9	3.1	2.8	12.6	3.5	5.0	4.5	9.2	8.7	14.4	9.4	10.0	3.3	14.9	2.2	0.1	43.7	0.2	0.1	184.3	0.6	0.6	0.6	0.2	29.1	0.1	0.5	0.3	21.3	0.0	216.9	1.4	0.4	18.3	2.9	2.9	3.9	3.8	3.1	2.7	2.8	2.7	2.9	2.4	3.0	3.3	1.3	0.0	1.5	3.3	0.7	1.5	0.8	2.8	1.8	11.1	0.4	0.1	0.3	12.8	15.8	3.7	0.0	0.5	0.3	49.2	0.0	2.5	6.5	9.4	0.6	6.4	7.7	1.3	3.8	4.3	0.5	3.2	31.6	0.4	0.0	0.4	5.0	8.1	3.9	8.4	4.0	17.1	0.0	11.7	1.5	0.5	3.7	8.1	0.0	4.7	3.9	2.0	2.1	3.0	3.4	3.0	39.3	6.8	2.4	1.1	36.2	25.4	107.8	3.1	0.0	1.1	0.7	0.0	0.4	1.3	2.0	0.1	1.2	0.1	21.1	1.1
CAPG	"AFCP, MCP"	ENSG00000042493	"Capping actin protein, gelsolin like"	P40121	2	85394753-85418432	"Plasma proteins, Predicted intracellular proteins"		"Actin capping, Actin-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"granulocytes: 548.8;Hofbauer cells: 1107.4;Macrophages: 432.1;monocytes: 432.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"basophil: 1136.5;classical monocyte: 1139.3;eosinophil: 712.7;intermediate monocyte: 431.6;memory B-cell: 575.6;myeloid DC: 1363.2;naive B-cell: 516.8;NK-cell: 605.5;plasmacytoid DC: 959.7"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 563.6;HMC-1: 972.7;SK-MEL-30: 722.2;THP-1: 513.5;U-937: 569.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018843, HPA019080, HPA019092"	Enhanced		Enhanced	Nucleoplasm		Yes	No		5400000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"	Nucleoplasm		"HPA018843: AB_2669948, HPA019080: AB_1845979, HPA019092: AB_1845980"	"unprognostic (2.82e-2)"	"unprognostic (1.37e-1)"	"unprognostic (8.80e-2)"	"unprognostic (1.28e-2)"	"unprognostic (4.37e-2)"	"unprognostic (7.52e-2)"	"prognostic unfavorable (3.22e-5)"	"unprognostic (8.83e-2)"	"unprognostic (3.22e-2)"	"unprognostic (1.54e-1)"	"unprognostic (5.70e-3)"	"unprognostic (1.75e-1)"	"prognostic favorable (2.96e-4)"	"unprognostic (1.45e-1)"	"unprognostic (7.68e-2)"	"unprognostic (5.30e-3)"	"unprognostic (7.89e-3)"	92.4	26.3	42.8	82.4	44.2	159.3	94.9	46.3	79.6	119.1	37.5	56.9	30.3	50.0	46.2	289.5	48.7	44.4	19.2	41.7	51.1	201.1	8.9	175.7	117.9	60.2	46.3	19.7	44.9	151.7	27.2	26.1	57.2	76.5	42.9	4.2	111.8	38.0	16.5	219.9	54.2	24.5	57.5	46.2	94.4	26.0	66.1	58.0	162.3	5.8	109.5	97.1	174.8	79.4	165.5	75.9	0.7	6.9	50.2	102.8	83.7	59.6	6.1	51.2	49.8	9.4	563.6	28.1	96.6	116.0	64.0	181.1	0.2	113.7	23.0	142.0	4.4	74.3	128.0	29.3	40.6	44.8	972.7	93.8	80.5	53.8	70.3	3.6	37.5	143.8	8.2	60.1	38.1	150.1	101.3	414.8	23.2	166.5	112.8	87.3	13.3	11.8	220.6	77.7	0.8	1.4	86.9	128.4	722.2	44.2	40.0	513.5	148.7	111.6	26.8	4.6	2.4	1.4	6.2	10.3	259.5	569.5	1.5	1136.5	1139.3	712.7	12.2	431.6	39.2	575.6	107.8	41.1	1363.2	516.8	30.5	13.9	162.9	605.5	131.3	959.7	122.1	977.9	42.8	44.2	46.3	79.6	41.7	51.1	60.2	46.3	57.2	57.5	66.1	79.4	6.6	19.2	24.5	3.3	84.7	121.2	167.5	265.0	60.9	0.8	86.8	70.4	1.3	51.5	119.6	316.3	0.0	34.3	91.5	211.0	211.3	113.8	4.1	33.0	10.3	16.2	28.8	16.0	0.2	91.5	324.0	34.7	124.9	63.9	548.8	1.2	3.6	1.1	1107.4	1.7	0.2	55.9	50.8	141.6	337.2	15.2	46.9	432.1	147.7	1.0	432.4	43.6	11.3	0.5	0.1	405.8	205.4	22.6	17.2	106.0	74.1	168.5	48.8	1.7	13.1	2.0	54.0	9.6	33.1	167.4	169.5	35.7	101.9	0.9	83.9	253.1
CASD1	"C7orf12, FLJ21213, FLJ21879"	ENSG00000127995	"CAS1 domain containing 1"	Q96PB1	7	94509219-94557019	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 93.7;Inhibitory neurons: 108.5;Oligodendrocyte precursor cells: 122.6;Oligodendrocytes: 170.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044404	Uncertain		Approved	Nucleoplasm		Yes	No			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm		"HPA044404: AB_10964353"	"unprognostic (4.02e-2)"	"unprognostic (4.16e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.82e-1)"	"unprognostic (7.04e-2)"	"unprognostic (7.90e-2)"	"unprognostic (3.66e-2)"	"unprognostic (2.18e-2)"	"unprognostic (9.83e-2)"	"unprognostic (4.74e-2)"	"unprognostic (4.95e-3)"	"unprognostic (2.16e-2)"	"unprognostic (5.24e-2)"	"unprognostic (4.01e-3)"	"unprognostic (1.93e-1)"	"unprognostic (7.07e-2)"	"unprognostic (2.59e-3)"	11.1	25.3	11.4	9.6	14.0	6.0	15.7	11.1	12.9	11.3	4.8	16.5	6.5	14.1	14.6	6.3	11.0	10.0	17.1	14.9	17.4	12.4	9.0	11.3	12.5	8.8	10.7	16.4	9.8	13.8	8.7	12.3	12.9	13.9	19.3	22.1	20.3	9.4	14.1	3.8	6.1	11.0	11.3	10.6	7.3	13.1	14.6	11.2	16.0	19.6	10.8	9.1	4.3	14.0	5.5	10.4	34.7	12.9	10.4	12.3	5.9	7.2	12.8	7.9	10.2	6.5	13.2	13.9	18.5	9.8	14.1	3.0	8.8	2.5	15.4	22.2	7.1	12.3	8.5	11.9	8.8	20.5	0.0	11.4	9.2	7.2	10.3	15.4	12.6	16.0	6.7	29.3	19.6	8.0	28.5	11.6	17.7	7.7	8.2	19.3	28.0	10.8	15.9	14.9	13.1	44.5	11.4	20.7	7.4	24.9	5.4	12.8	6.7	19.6	15.5	16.2	10.6	28.0	28.1	28.5	10.7	4.7	12.9	0.0	0.2	0.0	0.6	0.2	1.6	0.6	0.9	0.8	0.4	0.5	0.9	0.7	0.0	0.6	0.2	0.3	0.6	0.2	11.4	14.0	11.1	12.9	14.9	17.4	8.8	10.7	12.9	11.3	14.6	14.0	26.2	28.9	26.3	76.0	15.4	4.6	5.8	5.8	4.0	56.4	14.4	12.8	21.1	17.2	12.8	20.2	18.8	14.2	14.6	29.7	3.9	5.1	3.4	18.0	13.1	16.4	7.2	4.6	93.7	5.6	5.7	14.6	5.1	9.9	10.2	23.7	16.1	13.3	8.8	67.3	108.5	30.2	2.0	9.8	5.5	7.0	11.5	10.8	24.9	61.8	7.1	23.3	10.3	122.6	170.3	6.8	11.8	9.8	9.2	10.0	0.6	10.8	18.1	31.4	19.7	41.2	12.2	9.6	12.8	4.7	4.5	16.8	12.2	25.8	19.5	4.5
CBR3	SDR21C2	ENSG00000159231	"Carbonyl reductase 3"	O75828	21	36135079-36146562	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 56.3;salivary gland: 41.4"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 102.5;Basal squamous epithelial cells: 107.0;Peritubular cells: 75.6;Squamous epithelial cells: 230.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	9	"B-cells: 23.9;NK-cells: 11.5;T-cells: 33.7"	"Cell line enhanced"	"Detected in many"		"RPMI-8226: 64.9"	"Region enhanced"	"Detected in all"		"basal ganglia: 48.6"	"Low region specificity"	"Detected in many"			HPA018434	Uncertain		Supported	Nucleoplasm,Cytosol		Yes	NA		2800000	"Cluster 30: Non-specific - Translation"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Nucleoplasm, Cytosol"		"HPA018434: AB_1846110"	"unprognostic (3.64e-3)"	"unprognostic (2.32e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.18e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.22e-2)"	"unprognostic (6.12e-2)"	"unprognostic (2.98e-2)"	"unprognostic (3.75e-1)"	"unprognostic (9.10e-2)"	"prognostic unfavorable (5.95e-6)"	"unprognostic (3.13e-1)"	"unprognostic (1.80e-1)"	"unprognostic (3.99e-3)"	"unprognostic (1.94e-1)"	17.3	2.3	12.8	4.0	14.7	1.4	15.3	13.9	19.8	12.4	11.2	7.8	3.0	7.5	11.0	56.3	8.8	6.5	6.1	13.2	12.4	2.7	0.8	4.6	2.9	12.8	12.1	11.2	1.6	0.6	2.4	2.9	12.3	9.9	3.6	0.6	41.4	5.1	3.1	21.6	5.4	6.1	12.0	3.1	5.2	3.1	12.2	2.0	4.6	7.8	7.6	11.6	16.8	12.4	33.5	9.5	4.0	8.2	31.0	47.8	5.9	35.4	42.4	40.6	32.1	0.4	6.9	0.0	10.2	37.2	13.7	15.0	5.5	7.2	16.2	45.3	17.2	1.4	10.0	0.3	2.6	0.1	0.1	6.8	0.8	28.1	3.6	19.1	24.9	3.7	0.0	0.3	12.1	25.4	3.1	14.7	3.2	10.3	41.5	6.7	7.6	64.9	13.7	14.2	2.1	2.9	27.3	32.6	53.3	2.2	9.8	3.9	17.1	25.7	2.2	28.8	35.0	1.5	0.6	0.0	26.9	0.9	47.3	0.0	0.6	0.1	2.2	0.5	3.0	23.6	25.1	7.7	2.4	23.9	33.7	23.5	0.9	11.5	1.0	0.7	10.9	11.5	12.8	14.7	13.9	19.8	13.2	12.4	12.8	12.1	12.3	12.0	12.2	12.4	41.7	0.0	3.2	6.8	5.2	71.0	22.1	102.5	107.0	0.8	23.1	38.6	0.2	2.8	23.0	0.0	0.0	1.2	2.9	1.9	9.8	4.7	0.7	13.1	7.5	26.5	0.0	1.7	3.9	0.7	0.3	53.4	7.7	14.7	5.7	1.1	14.3	0.3	8.4	0.0	5.5	12.6	69.2	3.8	41.3	4.0	67.7	5.8	65.8	2.8	20.9	1.9	0.0	1.5	0.5	2.6	1.7	75.6	1.4	43.4	1.3	0.2	13.1	0.6	0.0	21.4	19.7	0.4	0.2	230.4	46.7	0.3	7.0	1.0	8.1	21.1
CCDC171	"bA536D16.1, bA778P13.1, C9orf93, Em:AL513423.1, FLJ39267, FLJ46740"	ENSG00000164989	"Coiled-coil domain containing 171"	Q6TFL3	9	15553043-16061663	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 11.3"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 194.5;Excitatory neurons: 92.4;Inhibitory neurons: 70.6;Late spermatids: 172.4;Spermatocytes: 148.2"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"basophil: 2.4"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"Daudi: 7.5;HEL: 11.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA019803, HPA019806, HPA024133"	Uncertain		Approved	Nucleoplasm,Nucleoli		Yes	No			"Cluster 41: Basophils - Cellular respiration"	"Cluster 21: Non-specific - Transcription"	"Cluster 36: HEL - Hemostasis"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	Nucleoli	"HPA019803: AB_1845846, HPA019806: AB_1845847, HPA024133: AB_1845848"	"unprognostic (1.35e-2)"	"unprognostic (2.03e-4)"	"unprognostic (7.22e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.51e-2)"	"unprognostic (2.05e-2)"	"unprognostic (2.18e-1)"	"unprognostic (6.76e-3)"	"unprognostic (5.37e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.92e-3)"	"unprognostic (7.80e-2)"	"unprognostic (4.90e-2)"	"unprognostic (1.15e-1)"	"unprognostic (6.91e-3)"	0.8	1.1	2.3	0.7	2.8	2.1	1.6	3.7	3.2	1.4	0.0	0.9	0.8	5.8	1.1	1.0	2.0	1.5	1.0	2.5	0.3	1.2	0.4	1.1	1.1	1.5	0.3	2.9	1.3	1.4	1.1	0.9	2.0	1.1	1.1	5.5	0.8	1.2	0.8	2.4	1.0	3.3	0.2	0.6	1.4	11.3	0.5	4.8	2.0	1.1	1.0	0.8	0.9	3.3	1.4	0.7	1.6	1.6	0.9	1.9	1.0	1.0	0.8	1.0	1.1	0.4	0.6	7.5	0.5	0.6	1.9	0.3	0.7	1.0	1.1	1.6	0.7	11.7	1.2	1.0	1.3	1.6	1.4	1.1	1.9	0.8	1.5	0.8	0.5	4.1	0.3	2.0	1.2	0.5	3.3	1.5	1.3	0.6	1.6	3.8	1.2	0.2	0.7	1.1	2.3	1.1	2.1	0.7	2.8	1.3	0.9	1.1	0.8	2.1	1.2	0.6	0.7	1.1	1.4	4.8	0.9	1.0	1.5	2.4	0.2	0.0	0.2	0.2	0.6	0.2	0.2	0.2	0.2	0.6	0.1	0.2	0.1	0.1	0.1	0.2	0.2	0.0	2.3	2.8	3.7	3.2	2.5	0.3	1.5	0.3	2.0	0.2	0.5	3.3	4.4	0.0	7.5	56.8	2.6	2.8	5.8	1.8	7.4	27.7	5.0	8.0	8.5	0.0	5.9	3.7	16.7	6.7	1.4	3.6	5.9	2.9	194.5	24.3	7.8	3.8	1.2	3.8	92.4	3.5	4.1	5.7	8.2	12.9	1.3	7.6	3.3	0.8	1.9	10.1	70.6	3.5	6.1	1.0	1.1	172.4	5.9	2.1	0.0	16.9	1.6	12.5	5.2	54.8	63.1	2.5	1.0	6.0	1.9	0.8	2.8	2.1	12.0	44.0	13.1	11.6	5.7	148.2	40.6	5.4	3.3	5.6	3.6	10.7	4.9	3.7
CCNA2	"CCN1, CCNA"	ENSG00000145386	"Cyclin A2"	P20248	4	121816444-121823883	"Cancer-related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Host-virus interaction, Mitosis"	Cyclin	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 38.6;lymphoid tissue: 46.9;retina: 31.7"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 47.9;Erythroid cells: 102.1;Extravillous trophoblasts: 92.8;Plasma cells: 35.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"T-reg: 3.1"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"basal ganglia: 3.4;white matter: 7.6"					"CAB000114, HPA020626"	Enhanced		Enhanced	Nucleoplasm,Cytosol		Yes	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Cytosol"		"CAB000114: AB_563675, HPA020626: AB_1847376"	"unprognostic (4.02e-2)"	"unprognostic (1.93e-1)"	"unprognostic (7.66e-3)"	"prognostic unfavorable (8.78e-4)"	"unprognostic (1.25e-1)"	"unprognostic (1.67e-2)"	"prognostic unfavorable (9.17e-5)"	"prognostic unfavorable (4.27e-4)"	"unprognostic (3.92e-3)"	"unprognostic (2.65e-2)"	"prognostic unfavorable (4.43e-6)"	"unprognostic (8.38e-3)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (1.65e-1)"	"unprognostic (1.82e-1)"	"unprognostic (6.07e-2)"	"unprognostic (1.59e-1)"	1.5	1.2	2.5	11.4	2.5	38.6	2.5	3.5	4.7	4.3	2.5	9.8	10.1	2.5	0.6	8.4	2.2	1.8	1.3	2.3	2.4	1.5	1.6	1.8	25.0	2.8	2.7	3.8	0.8	0.6	2.7	10.5	2.6	1.9	11.5	31.7	1.8	0.8	0.7	6.7	9.9	4.0	2.6	4.6	4.4	6.2	2.6	46.9	1.2	0.5	24.4	2.9	3.9	3.5	177.1	45.3	120.5	51.8	6.4	16.3	98.8	119.7	52.8	156.7	115.6	99.4	106.5	161.2	31.7	63.8	55.0	58.0	154.2	71.1	128.0	77.8	70.8	129.7	56.0	96.9	1.5	197.0	88.0	4.2	5.3	65.1	38.7	24.7	95.4	84.3	187.9	156.9	126.1	63.8	251.8	113.1	95.5	109.9	49.8	114.1	233.5	78.2	44.8	34.6	51.0	53.8	63.1	76.0	32.4	89.8	63.7	81.9	56.5	72.7	109.3	77.4	115.9	98.0	112.3	181.9	41.5	197.6	82.4	0.0	0.1	0.3	0.1	0.0	0.0	0.1	0.9	0.6	0.4	0.0	0.0	0.2	0.1	0.8	0.1	0.0	3.1	0.9	2.5	2.5	3.5	4.7	2.3	2.4	2.8	2.7	2.6	2.6	2.6	3.5	0.8	0.0	1.1	1.6	5.7	2.8	1.5	5.5	1.8	2.9	1.9	1.8	0.8	0.0	1.6	0.0	12.5	47.9	1.9	4.9	0.0	0.7	9.6	0.6	2.7	3.3	1.2	102.1	3.3	0.2	92.8	6.3	9.2	2.1	0.0	18.1	4.2	0.9	25.3	0.0	4.1	7.7	8.2	6.9	3.6	2.1	0.9	3.6	1.8	2.8	0.2	1.2	0.0	4.5	5.2	0.5	3.1	1.2	35.5	3.3	1.8	0.2	2.5	14.2	0.0	0.9	6.0	10.3	17.7	24.0	1.3	8.5	6.3	1.4	19.9	2.1
CCNB1	CCNB	ENSG00000134057	"Cyclin B1"	P14635	5	69167135-69178245	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Cell cycle, Cell division, Mitosis"	Cyclin	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 52.9;lymphoid tissue: 76.2"	"Cell type enriched"	"Detected in many"	6	"Extravillous trophoblasts: 723.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"basal ganglia: 3.0;white matter: 8.3"	"Not detected"	"Not detected"			"CAB000115, CAB003804, HPA030741, HPA061448"	Enhanced		Enhanced	Cytosol		Yes	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Cytosol		"CAB000115: , CAB003804: AB_562272, HPA030741: AB_2673586, HPA061448: AB_2684522"	"unprognostic (4.12e-2)"	"unprognostic (2.75e-2)"	"unprognostic (1.91e-3)"	"unprognostic (4.08e-3)"	"unprognostic (2.78e-1)"	"unprognostic (1.39e-1)"	"prognostic unfavorable (1.54e-7)"	"prognostic unfavorable (3.38e-4)"	"unprognostic (1.43e-2)"	"unprognostic (1.63e-2)"	"unprognostic (2.49e-3)"	"unprognostic (1.40e-1)"	"prognostic unfavorable (1.11e-16)"	"unprognostic (2.44e-1)"	"unprognostic (3.73e-1)"	"unprognostic (1.44e-1)"	"unprognostic (5.15e-3)"	4.0	5.1	4.0	26.0	3.9	52.9	10.0	6.0	4.9	6.3	2.8	22.2	20.9	7.7	5.4	36.0	8.2	4.0	3.0	3.8	4.0	4.8	4.3	3.9	54.5	6.2	4.4	5.0	4.2	5.8	2.6	20.8	6.5	3.8	29.5	5.7	6.5	3.9	3.4	14.5	19.5	14.4	3.5	11.1	10.8	32.9	5.2	76.2	9.3	2.0	67.0	8.4	10.4	4.0	466.0	317.1	423.5	377.1	22.2	37.1	980.2	201.3	150.8	521.3	437.0	471.2	423.9	285.2	239.1	187.6	594.2	284.2	432.4	442.8	577.2	281.4	217.2	181.6	243.2	323.2	6.8	160.5	197.7	16.6	27.7	300.5	207.2	47.7	282.8	274.2	223.5	217.9	430.2	441.4	220.5	184.7	236.7	153.3	199.3	228.4	305.2	288.2	192.6	168.2	212.7	133.5	347.7	160.3	141.9	236.4	306.4	162.5	119.8	114.4	368.5	207.6	510.2	109.2	216.6	399.8	158.8	271.9	358.6	3.1	2.0	1.5	3.2	5.1	4.5	15.4	8.3	7.4	6.0	11.1	2.7	2.6	1.3	8.2	2.4	5.0	17.6	6.2	4.0	3.9	6.0	4.9	3.8	4.0	6.2	4.4	6.5	3.5	5.2	4.0	4.0	0.0	0.5	2.0	11.8	11.5	7.2	32.1	4.6	4.8	9.8	12.3	1.9	1.5	8.8	5.5	2.1	108.2	8.3	9.5	1.9	6.5	110.2	15.2	7.4	6.6	1.2	76.2	2.7	1.4	723.1	18.3	21.4	13.0	2.5	63.0	8.9	3.2	60.2	0.0	2.1	13.8	73.2	12.0	7.2	17.8	3.1	9.7	3.6	1.0	2.7	3.9	2.1	0.5	1.0	2.4	1.5	2.6	24.1	4.5	2.5	5.6	13.1	4.1	6.6	4.9	18.5	74.3	62.2	37.4	7.2	41.5	8.0	11.8	33.4	7.8
CCNB2	HsT17299	ENSG00000157456	"Cyclin B2"	O95067	15	59105126-59125045	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Cell cycle, Cell division, Mitosis"	Cyclin	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 74.6;lymphoid tissue: 73.1;testis: 69.4"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 67.9;Early spermatids: 228.5;Erythroid cells: 123.6;Extravillous trophoblasts: 128.3;Spermatocytes: 288.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in many"	5	"T-reg: 22.7"	"Lineage enriched"	"Detected in many"	6	"T-cells: 22.7"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"HPA008873, CAB009575"	Enhanced		Enhanced	"Golgi apparatus,Cytosol"		Yes	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Cytosol	"Golgi apparatus"	"CAB009575: AB_2072392, HPA008873: AB_1078604"	"unprognostic (2.69e-2)"	"unprognostic (2.25e-1)"	"unprognostic (4.43e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.77e-1)"	"unprognostic (4.65e-2)"	"prognostic unfavorable (2.83e-4)"	"prognostic unfavorable (4.63e-4)"	"prognostic unfavorable (3.21e-5)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (1.74e-5)"	"unprognostic (4.48e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (1.96e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.98e-2)"	"unprognostic (4.44e-1)"	1.0	1.1	0.4	12.2	1.1	74.6	2.9	0.7	0.7	2.9	1.1	14.3	14.1	2.6	0.3	16.1	1.1	1.9	0.7	0.6	0.7	1.1	1.4	2.2	33.0	1.3	1.0	0.8	0.7	0.2	0.3	11.4	1.0	1.6	16.8	0.3	2.8	0.4	0.7	9.4	12.0	6.4	0.7	7.1	5.6	69.4	1.1	73.1	1.0	0.4	43.7	3.6	5.6	2.2	132.5	112.1	188.6	47.1	8.5	16.6	97.5	104.8	69.9	165.2	135.6	187.8	81.1	122.1	75.4	71.8	97.2	160.1	181.4	92.6	157.8	124.1	92.4	153.1	127.3	108.1	2.5	118.1	98.6	6.3	12.6	71.4	91.9	32.7	114.1	147.0	163.1	194.5	128.2	96.5	137.9	177.2	138.6	58.5	65.2	157.5	260.0	124.4	53.3	91.9	115.2	75.9	148.9	80.2	97.3	147.9	139.4	120.4	58.5	81.6	134.4	90.5	210.5	84.2	133.2	213.8	53.6	267.1	117.9	0.0	0.1	0.7	0.1	0.0	0.3	2.1	4.6	5.0	3.0	1.7	0.0	0.1	0.8	3.6	0.1	0.1	22.7	2.1	0.4	1.1	0.7	0.7	0.6	0.7	1.3	1.0	1.0	0.7	1.1	2.2	0.3	0.0	0.6	0.0	6.8	4.8	2.8	11.5	1.8	0.2	2.5	3.3	0.5	0.0	3.2	0.0	0.0	67.9	1.6	4.1	0.0	0.7	228.5	5.3	3.1	3.9	3.0	123.6	0.7	0.2	128.3	7.2	7.1	5.9	0.0	29.9	6.1	1.1	29.9	0.0	0.8	10.1	20.3	10.6	3.3	53.5	4.4	7.9	0.0	0.0	2.4	0.2	1.0	0.0	1.4	0.4	1.9	1.9	18.7	2.3	2.1	0.0	1.8	0.3	0.0	1.0	5.7	288.7	32.1	20.3	6.1	16.3	4.4	4.1	23.4	5.0
CCND2		ENSG00000118971	"Cyclin D2"	P30279	12	4269771-4305353	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division"	Cyclin	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 354.3;Granulosa cells: 438.5;Langerhans cells: 255.3;Plasma cells: 371.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 152.4;HBEC3-KT: 136.6;HDLM-2: 238.8;Karpas-707: 287.9;RH-30: 202.7;RPMI-8226: 114.2"									"HPA049138, HPA054196"	Approved		Enhanced	Nucleoplasm		Yes	Yes			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm		"HPA049138: AB_2680650, HPA054196: AB_2682412"	"unprognostic (2.98e-3)"	"unprognostic (1.15e-1)"	"unprognostic (7.21e-2)"	"unprognostic (1.65e-2)"	"unprognostic (1.70e-2)"	"unprognostic (4.82e-2)"	"unprognostic (4.94e-2)"	"unprognostic (2.01e-3)"	"unprognostic (3.16e-2)"	"unprognostic (1.66e-2)"	"prognostic favorable (2.52e-4)"	"unprognostic (1.75e-1)"	"unprognostic (1.25e-1)"	"unprognostic (8.23e-2)"	"unprognostic (4.52e-1)"	"prognostic favorable (9.76e-5)"	"unprognostic (7.06e-2)"	20.0	52.6	5.4	8.7	12.9	20.3	13.0	0.0	13.5	26.9	0.0	40.8	17.4	26.1	7.5	12.2	22.1	2.7	51.9	14.4	1.1	9.7	1.9	17.2	5.3	9.6	0.2	14.2	24.5	9.9	23.5	12.9	2.7	20.7	10.4	0.7	10.8	9.1	1.8	12.6	25.9	9.8	7.8	19.7	12.7	4.0	0.0	3.2	20.3	0.0	5.1	26.5	19.9	4.5	0.0	0.0	152.4	0.0	10.1	0.4	0.0	0.0	0.0	0.0	0.0	62.8	0.0	0.0	0.4	0.0	0.0	16.2	0.1	136.6	0.0	238.8	2.5	0.7	0.0	0.0	0.0	57.0	12.6	23.8	2.4	0.0	97.0	0.0	0.0	0.8	17.0	287.9	6.8	0.0	0.0	52.8	50.8	0.0	0.0	0.0	202.7	114.2	0.0	8.1	0.0	0.0	0.0	0.0	0.0	89.6	0.0	0.0	4.2	0.0	39.3	0.0	0.0	1.4	60.7	0.0	0.0	32.3	0.0	6.6	0.4	4.7	11.1	0.0	17.1	3.1	16.3	13.8	0.4	1.7	10.4	12.1	1.1	9.4	0.0	1.1	13.6	6.8	5.4	12.9	0.0	13.5	14.4	1.1	9.6	0.2	2.7	7.8	0.0	4.5	23.9	60.9	46.6	10.1	82.9	106.8	23.9	73.4	174.2	7.6	3.4	41.8	354.3	2.8	37.4	12.9	0.0	4.0	128.7	37.5	0.0	3.1	0.8	3.3	110.8	35.7	64.8	37.2	54.1	68.3	2.7	123.6	4.6	3.6	55.8	438.5	19.6	2.2	13.0	3.3	55.2	147.7	12.2	11.9	255.3	3.3	52.5	39.3	39.2	19.7	9.8	170.0	89.6	55.3	4.0	20.7	49.4	124.1	371.2	35.8	34.4	1.4	10.3	6.5	26.3	21.4	112.6	0.8	5.1	50.9	39.6	6.3	122.6	41.5	159.7	8.4
CCNI2	FLJ16793	ENSG00000205089	"Cyclin I family member 2"	Q6ZMN8	5	132747426-132754403	"Predicted intracellular proteins"		Cyclin		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 4.3;intestine: 3.6"	"Cell type enhanced"	"Detected in some"		"Distal tubular cells: 3.9;Gastric mucus-secreting cells: 7.1;Intestinal goblet cells: 3.5;Muller glia cells: 4.9;Plasma cells: 4.8;Undifferentiated cells: 4.2"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 5.4"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"MOLT-4: 25.7"					"Low region specificity"	"Detected in all"			HPA056288	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		Yes	NA			"Cluster 13: T-cells - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"	"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA056288: AB_2683086"	"unprognostic (3.84e-2)"	"unprognostic (2.44e-3)"	"prognostic favorable (8.21e-4)"	"unprognostic (5.97e-2)"	"unprognostic (3.39e-1)"	"unprognostic (6.71e-3)"	"unprognostic (1.21e-1)"	"unprognostic (7.49e-2)"	"unprognostic (3.03e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.96e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.62e-1)"	"unprognostic (1.77e-1)"	"unprognostic (4.95e-1)"	"unprognostic (1.71e-7)"	"unprognostic (1.58e-1)"	0.2	0.3	1.2	0.9	1.9	0.1	0.2	1.3	1.5	0.5	0.0	2.6	3.6	0.1	0.3	0.1	0.3	0.4	0.3	0.9	0.8	3.1	0.0	0.5	0.8	2.2	1.3	0.2	1.2	0.0	0.6	0.1	1.6	0.9	2.7	1.1	2.6	1.3	0.3	0.3	2.1	0.1	0.9	0.4	2.4	0.7	1.5	1.5	0.4	0.0	0.9	0.9	0.2	4.3	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	3.6	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	5.7	0.0	0.4	0.0	0.6	25.7	0.1	0.4	1.6	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.3	0.0	0.0	1.3	1.0	0.3	0.3	0.0	0.0	0.0	0.0	1.7	4.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.5	0.5	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.8	0.1	1.2	1.9	1.3	1.5	0.9	0.8	2.2	1.3	1.6	0.9	1.5	4.3	0.2	0.0	0.5	0.0	0.9	0.1	0.4	0.8	0.0	0.1	0.4	0.1	0.6	0.0	0.4	0.0	0.0	0.4	0.1	3.4	3.9	0.4	2.2	0.4	0.0	0.1	1.2	0.0	0.6	1.5	0.2	0.3	7.1	0.5	1.3	0.0	0.0	0.0	0.1	1.7	0.5	3.5	0.0	0.0	0.0	2.1	0.3	0.4	0.0	0.0	0.0	4.9	0.0	1.0	2.4	1.5	2.3	0.0	4.8	0.6	1.8	0.3	1.0	0.2	0.0	0.1	0.2	0.2	0.7	0.0	0.1	0.0	1.9	0.1	4.2	0.6
CCNQ	"CycM, FAM58A"	ENSG00000262919	"Cyclin Q"	Q8N1B3	X	153587925-153600045	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		Cyclin		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 72.4;Extravillous trophoblasts: 98.6;Syncytiotrophoblasts: 120.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050137, HPA059843"	Uncertain		Approved	Nucleoplasm,Cytosol		Yes	No			"Cluster 37: B-cells - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 7: Non-specific - Mitochondria"	"Nucleoplasm, Cytosol"		"HPA050137: AB_2681029, HPA059843: AB_2684140"	"unprognostic (3.94e-1)"	"unprognostic (1.94e-2)"	"unprognostic (7.36e-2)"	"unprognostic (2.92e-1)"	"unprognostic (5.08e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.47e-3)"	"unprognostic (2.12e-1)"	"unprognostic (8.50e-3)"	"unprognostic (2.08e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.20e-1)"	"unprognostic (8.75e-2)"	"unprognostic (2.31e-1)"	"unprognostic (2.71e-2)"	"unprognostic (5.25e-2)"	11.8	12.8	19.9	8.2	21.3	7.3	11.7	19.6	24.9	11.9	15.6	16.2	8.9	12.9	12.7	13.1	11.1	4.0	33.9	20.8	20.5	13.5	13.2	10.6	12.5	23.2	21.6	10.5	15.0	10.3	23.6	9.2	23.4	13.6	8.0	6.4	12.9	8.8	34.3	12.1	13.6	6.1	20.0	17.2	13.3	6.2	21.2	9.0	11.1	13.6	12.2	14.0	11.7	24.9	43.7	31.2	12.1	43.5	20.9	11.2	18.7	25.0	21.8	23.5	23.6	33.3	14.3	34.9	44.6	25.1	35.3	26.7	38.4	22.6	22.2	20.3	39.2	7.8	19.4	23.5	19.0	28.2	18.9	14.1	20.1	15.7	16.1	10.0	19.0	16.1	10.6	15.6	19.1	50.5	19.7	38.0	15.1	44.4	52.4	22.6	20.0	17.8	17.0	17.6	16.0	21.1	12.0	19.3	34.4	11.9	7.3	25.0	14.6	20.5	29.3	46.7	38.5	21.8	23.1	43.4	18.5	45.4	15.7	0.0	1.6	4.9	2.7	1.4	1.0	6.1	2.3	1.9	1.3	4.1	2.5	1.7	0.9	0.7	0.8	1.2	3.4	1.1	19.9	21.3	19.6	24.9	20.8	20.5	23.2	21.6	23.4	20.0	21.2	24.9	21.0	3.2	13.0	0.0	13.5	0.0	0.0	0.0	0.0	0.0	24.1	31.0	0.0	0.0	3.1	7.3	0.0	40.7	20.4	0.0	72.4	23.3	0.0	11.9	17.3	7.8	0.0	0.0	0.0	37.1	98.6	8.4	0.0	8.7	2.5	16.3	0.0	0.0	41.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.1	0.0	0.0	22.7	0.0	0.0	0.0	0.0	34.0	0.0	0.0	5.9	0.0	0.0	41.6	2.2	0.0	0.0	0.0	10.3	0.0	0.0	0.0	0.0	120.9	10.0	18.4	0.0	0.0
CCNYL1	FLJ40432	ENSG00000163249	"Cyclin Y like 1"	Q8N7R7	2	207711540-207761839	"Predicted intracellular proteins"		Cyclin		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 62.7;Paneth cells: 121.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"BEWO: 83.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046825	Approved		Approved	"Plasma membrane"		Yes	No			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane"		"HPA046825: AB_10963934"	"unprognostic (2.59e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.03e-2)"	"unprognostic (1.20e-3)"	"unprognostic (1.78e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.31e-3)"	"unprognostic (5.48e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.41e-2)"	"unprognostic (7.12e-3)"	"unprognostic (7.99e-2)"	"unprognostic (3.92e-2)"	"unprognostic (8.08e-2)"	"unprognostic (7.91e-2)"	"unprognostic (2.37e-2)"	"unprognostic (1.96e-3)"	12.8	4.7	3.8	10.6	4.9	9.9	7.1	2.8	5.3	8.2	3.7	15.3	11.7	5.0	5.2	17.8	4.2	7.9	6.1	5.2	5.1	10.9	12.4	11.8	8.6	4.8	4.2	3.4	13.7	4.2	4.5	13.6	5.1	4.8	13.3	9.0	6.9	4.8	7.8	3.9	11.3	8.7	4.2	8.1	11.0	16.2	4.5	6.1	11.4	4.4	9.3	10.4	9.5	6.8	25.7	11.0	14.5	20.4	18.6	21.2	83.3	15.6	25.8	15.7	17.7	51.1	23.7	9.9	14.2	28.6	38.5	17.4	17.7	29.4	15.2	3.7	13.5	13.3	12.8	41.6	18.7	11.9	15.2	10.7	12.0	20.0	20.9	13.8	52.5	11.5	6.8	9.4	21.9	13.6	10.5	11.2	28.1	10.3	12.2	9.4	12.4	8.0	16.2	19.5	3.5	10.8	18.5	8.0	23.5	33.6	7.2	31.5	27.3	17.7	16.6	23.2	10.5	5.6	8.4	13.4	18.5	13.5	15.4	0.7	1.1	0.5	0.3	0.6	0.4	0.3	0.5	0.5	0.5	1.1	0.4	0.8	1.3	0.6	0.5	0.5	0.4	0.3	3.8	4.9	2.8	5.3	5.2	5.1	4.8	4.2	5.1	4.2	4.5	6.8	31.8	3.2	19.1	10.1	14.1	12.2	13.8	7.6	5.7	6.2	10.0	10.0	9.0	2.8	8.5	23.9	10.4	12.6	13.2	62.7	1.9	5.8	13.7	13.6	7.7	17.0	9.6	6.5	34.1	14.7	42.9	11.4	25.0	20.4	5.7	5.8	23.9	12.5	16.2	5.0	11.6	13.1	8.2	17.5	29.9	10.9	2.8	18.7	8.8	7.5	20.8	10.2	7.2	14.6	28.7	13.9	121.3	3.8	7.7	16.1	10.1	12.6	6.3	12.3	0.0	16.0	10.4	23.9	9.5	7.6	10.5	7.7	10.9	4.3	17.0	18.0
CD2BP2	"LIN1, PPP1R59, Snu40, U5-52K"	ENSG00000169217	"CD2 cytoplasmic tail binding protein 2"	O95400	16	30350773-30355308	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041508, HPA061309"	Enhanced		Enhanced	"Nuclear speckles,Cytosol"		Yes	No			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 35: Non-specific - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 1: Pancreatic cells - Digestion"	"Nuclear speckles"	Cytosol	"HPA041508: AB_2677523, HPA061309: AB_2684476"	"unprognostic (5.66e-2)"	"unprognostic (7.50e-3)"	"unprognostic (1.47e-1)"	"unprognostic (2.82e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.78e-1)"	"prognostic unfavorable (1.84e-5)"	"unprognostic (1.71e-2)"	"unprognostic (1.16e-1)"	"unprognostic (9.76e-2)"	"unprognostic (2.30e-2)"	"unprognostic (7.47e-2)"	"unprognostic (2.09e-3)"	"unprognostic (1.44e-1)"	"unprognostic (3.22e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.66e-1)"	31.1	49.3	38.9	34.0	39.7	23.9	32.9	38.0	41.5	39.6	34.0	39.3	29.9	45.0	24.9	35.3	41.0	22.0	35.2	39.9	41.2	42.8	27.3	32.8	38.8	41.4	39.8	36.9	40.7	42.5	42.7	24.4	39.1	38.3	23.7	16.2	30.0	35.5	46.9	33.6	35.2	31.6	39.0	46.4	36.9	24.0	41.6	35.7	42.5	26.6	43.7	37.0	30.1	42.0	55.4	65.7	54.4	49.4	44.3	41.9	46.0	60.0	71.5	66.8	71.3	50.6	64.9	84.6	72.3	65.5	61.4	59.4	57.0	70.3	53.6	50.6	66.6	35.9	67.7	60.3	63.6	51.3	63.4	45.2	58.7	74.2	47.3	45.6	70.3	62.1	41.4	63.2	67.7	132.1	71.6	43.6	73.8	42.9	38.5	104.2	45.3	64.3	54.2	54.7	44.7	85.1	40.2	69.9	42.0	44.7	66.4	41.1	50.6	76.3	53.3	38.9	53.1	105.0	82.3	78.5	52.5	47.2	64.0	107.4	61.7	116.6	71.3	76.3	56.8	87.5	57.3	66.7	55.8	97.3	47.6	58.9	121.9	74.5	102.7	67.1	94.4	79.6	38.9	39.7	38.0	41.5	39.9	41.2	41.4	39.8	39.1	39.0	41.6	42.0	38.1	32.1	29.0	7.2	39.5	28.8	49.6	58.4	31.9	29.8	33.2	29.6	26.5	45.8	41.2	36.8	20.9	61.0	57.0	50.5	60.7	83.6	19.9	41.7	30.7	42.8	33.0	22.3	6.7	97.5	58.1	36.4	28.1	45.2	47.6	33.4	28.2	13.9	69.7	11.8	7.1	32.7	36.7	38.3	23.6	14.2	35.4	34.0	39.2	8.4	84.1	47.6	97.9	3.5	10.7	87.8	64.9	35.7	52.7	40.7	60.3	81.5	46.3	29.0	39.5	30.5	44.6	38.5	40.1	27.4	30.4	88.7	41.9	38.9	31.6	50.7
CDC20	"CDC20A, p55CDC"	ENSG00000117399	"Cell division cycle 20"	Q12834	1	43358981-43363203	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Cell cycle, Cell division, Differentiation, Mitosis, Neurogenesis, Ubl conjugation pathway"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 53.9;lymphoid tissue: 52.6;testis: 49.1"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 65.0;Early spermatids: 135.0;Erythroid cells: 96.0;Extravillous trophoblasts: 146.2;Spermatocytes: 126.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	7	"memory B-cell: 4.2;memory CD4 T-cell: 3.2;memory CD8 T-cell: 3.5;NK-cell: 9.5;T-reg: 11.6"	"Group enriched"	"Detected in many"	9	"B-cells: 4.2;NK-cells: 9.5;T-cells: 11.6"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"CAB004525, HPA045842, HPA055288"	Enhanced		Enhanced	Nucleoplasm,Cytosol		Yes	Yes			"Cluster 15: NK-cells - Transcription"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Cytosol"		"CAB004525: AB_628089, HPA045842: AB_2679470, HPA055288: AB_2682773"	"unprognostic (1.66e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.73e-2)"	"unprognostic (2.14e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (4.00e-8)"	"unprognostic (9.06e-3)"	"unprognostic (1.17e-2)"	"unprognostic (1.23e-2)"	"prognostic unfavorable (1.32e-4)"	"unprognostic (8.55e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (2.84e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.29e-2)"	1.6	1.5	0.6	16.2	1.1	53.9	5.2	0.8	1.3	3.5	0.4	14.8	13.7	2.3	2.5	27.2	1.7	1.2	0.9	0.7	1.1	2.3	1.7	2.5	32.6	1.3	1.1	0.7	0.6	0.2	0.3	9.7	1.1	0.8	16.0	0.2	4.4	0.7	0.3	11.3	12.2	7.3	0.8	11.7	7.0	49.1	1.7	52.6	1.7	0.2	50.8	3.3	7.0	1.3	311.9	148.2	202.8	133.4	6.9	17.6	193.5	140.3	125.0	400.0	211.4	234.5	250.9	178.3	80.1	130.1	140.6	212.8	225.3	267.9	331.5	140.8	165.6	261.4	143.6	147.3	2.1	184.3	91.4	6.0	12.4	278.2	249.6	35.1	172.2	167.5	120.2	119.3	184.0	120.4	179.2	113.5	257.2	147.0	196.9	255.8	277.9	112.9	98.5	81.3	119.2	58.9	248.1	165.8	76.6	154.9	116.3	231.7	90.2	118.9	276.2	133.7	445.0	90.6	86.7	185.7	85.2	227.6	181.6	0.0	0.1	0.0	0.3	0.0	0.0	4.2	3.2	3.5	0.9	0.9	0.1	0.3	0.7	9.5	0.0	0.2	11.6	2.8	0.6	1.1	0.8	1.3	0.7	1.1	1.3	1.1	1.1	0.8	1.7	1.3	2.1	0.0	1.1	0.0	12.2	10.5	3.8	17.6	6.2	0.5	6.4	9.7	0.7	1.5	4.8	0.0	0.0	65.0	2.8	16.9	0.0	2.2	135.0	14.6	2.4	4.5	0.0	96.0	0.2	0.4	146.2	9.3	11.7	4.6	0.0	46.5	7.9	1.3	37.4	0.0	0.0	18.5	24.4	6.2	7.5	18.5	2.8	9.3	0.0	0.0	1.8	0.3	0.0	0.0	1.6	0.7	0.5	1.9	34.4	2.7	3.2	3.1	8.3	2.9	0.0	1.0	25.4	126.5	39.8	47.3	8.4	10.7	5.1	1.6	37.5	7.4
CDCA2	"PPP1R81, Repo-Man"	ENSG00000184661	"Cell division cycle associated 2"	Q69YH5	8	25459199-25507911	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"bone marrow: 6.5;lymphoid tissue: 11.4;testis: 19.4"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 23.3;Early spermatids: 49.9;Erythroid cells: 19.0;Late spermatids: 24.2;Spermatocytes: 66.6;Spermatogonia: 27.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"HPA026293, HPA030049"	Enhanced		Supported	Nucleoplasm		Yes	Yes			"Cluster 15: NK-cells - Transcription"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA026293: AB_1846384, HPA030049: AB_10600862"	"unprognostic (2.12e-1)"	"unprognostic (4.75e-3)"	"prognostic favorable (9.62e-4)"	"unprognostic (2.92e-2)"	"unprognostic (9.69e-2)"	"unprognostic (3.56e-2)"	"unprognostic (2.50e-5)"	"unprognostic (1.47e-3)"	"unprognostic (6.06e-2)"	"unprognostic (2.91e-3)"	"unprognostic (1.32e-3)"	"unprognostic (1.99e-1)"	"prognostic unfavorable (2.30e-14)"	"unprognostic (1.36e-2)"	"unprognostic (4.02e-1)"	"unprognostic (1.91e-1)"	"unprognostic (5.30e-2)"	0.2	0.0	0.0	2.6	0.0	6.5	0.6	0.1	0.0	0.2	0.1	1.9	1.6	0.3	0.0	1.4	0.1	0.3	0.3	0.0	0.1	0.0	0.1	0.2	5.3	0.2	0.2	0.0	0.0	0.0	0.0	1.2	0.2	0.1	2.2	0.1	0.2	0.0	0.0	1.1	1.8	0.8	0.0	0.8	0.9	19.4	0.3	11.4	0.1	0.1	6.7	0.6	0.3	0.1	36.5	30.2	29.4	24.2	2.3	4.5	20.2	37.7	22.6	32.9	32.4	25.7	15.8	42.6	16.0	16.2	34.6	31.6	42.9	20.0	48.5	16.2	12.0	43.2	22.4	15.2	0.6	18.4	19.4	2.5	1.0	23.5	15.8	3.3	24.5	24.5	33.6	45.8	30.6	13.9	54.5	8.7	31.0	24.1	14.5	26.3	33.4	15.2	9.2	18.7	12.0	13.3	33.3	16.1	14.3	14.7	17.4	9.4	16.6	23.9	39.3	44.7	35.6	7.1	16.5	44.4	17.7	24.3	40.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.4	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.2	0.2	0.0	0.3	0.1	0.2	0.0	1.1	0.0	2.7	1.1	0.5	1.7	0.0	0.7	0.9	0.8	23.3	0.0	0.2	0.0	0.0	7.2	0.5	1.8	0.0	0.2	49.9	0.8	1.2	1.1	0.0	19.0	0.2	0.0	13.4	2.5	4.1	1.4	0.0	8.8	1.1	0.1	4.1	0.0	0.1	1.3	0.0	2.9	0.6	24.2	1.2	2.1	0.0	0.0	0.6	0.1	2.1	0.5	0.6	0.2	0.1	0.0	15.8	0.5	0.5	1.2	0.9	0.5	13.1	0.1	2.1	66.6	27.8	10.7	0.9	1.6	2.9	1.3	3.6	0.5
CDCA5		ENSG00000146670	"Cell division cycle associated 5"	Q96FF9	11	65066300-65084164	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 53.4;lymphoid tissue: 27.6;testis: 37.8"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 56.5;Extravillous trophoblasts: 38.3;Late spermatids: 116.9;Spermatocytes: 50.4;Spermatogonia: 31.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"NK-cell: 2.8;T-reg: 2.0"	"Group enriched"	"Detected in many"	5	"NK-cells: 2.8;T-cells: 2.0"	"Low cell line specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"white matter: 1.4"	"Low region specificity"	"Detected in many"			"HPA023691, HPA076007"	Enhanced		Enhanced	Nucleoplasm		Yes	Yes			"Cluster 15: NK-cells - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA023691: AB_1846392, HPA076007: "	"unprognostic (3.14e-2)"	"unprognostic (4.20e-2)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (2.67e-4)"	"unprognostic (2.15e-1)"	"unprognostic (2.68e-1)"	"prognostic unfavorable (8.21e-6)"	"unprognostic (1.41e-3)"	"unprognostic (7.55e-3)"	"unprognostic (6.93e-2)"	"prognostic unfavorable (8.72e-6)"	"unprognostic (2.16e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (3.55e-3)"	"unprognostic (1.86e-1)"	"unprognostic (1.35e-1)"	"unprognostic (8.97e-2)"	1.4	1.2	1.3	10.5	1.3	53.4	2.0	0.8	1.8	1.9	0.9	6.8	5.8	1.3	0.3	9.3	0.9	0.9	0.9	1.5	0.9	0.9	1.3	1.9	17.0	1.6	1.3	0.6	0.7	0.4	0.5	6.5	1.6	0.8	7.7	0.5	1.4	0.5	0.6	4.2	5.8	3.1	0.8	6.6	3.1	37.8	1.8	27.6	0.6	0.4	16.2	2.2	2.8	1.3	131.7	74.9	67.2	57.3	4.5	7.3	57.8	92.7	37.4	103.6	81.5	77.7	75.4	121.3	52.3	29.4	120.8	87.9	110.3	49.5	98.6	122.0	52.2	107.7	54.4	64.1	0.4	116.8	81.8	2.5	4.5	96.3	44.0	10.8	32.6	138.4	126.6	206.6	63.5	109.2	164.7	116.9	107.8	63.0	92.4	140.4	76.8	111.9	21.2	49.6	89.1	68.4	59.3	80.7	62.8	41.6	104.7	54.7	19.9	92.7	97.2	99.5	101.7	106.9	187.8	195.4	37.2	69.5	97.4	0.0	0.1	0.2	0.4	0.0	0.0	0.3	0.5	0.3	0.4	0.5	0.0	0.3	0.0	2.8	0.3	0.3	2.0	0.7	1.3	1.3	0.8	1.8	1.5	0.9	1.6	1.3	1.6	0.8	1.8	1.3	0.9	0.0	0.5	0.0	4.6	3.8	1.2	1.3	0.6	0.6	2.3	4.4	1.0	0.0	0.8	0.0	2.1	19.7	2.2	4.6	1.9	0.8	56.5	1.1	1.5	2.3	0.0	21.8	1.1	0.8	38.3	3.5	3.1	1.5	3.8	14.5	1.1	0.0	11.7	1.7	0.6	4.7	2.0	2.8	1.5	116.9	2.8	1.7	0.0	1.0	2.1	0.9	2.1	0.0	0.6	0.6	0.1	1.5	16.2	1.1	1.1	0.6	0.4	0.2	0.0	0.5	2.7	50.4	31.1	7.1	1.0	3.7	4.2	1.9	9.4	1.6
CDCA8	"BOR, DasraB, FLJ12042, MESRGP"	ENSG00000134690	"Cell division cycle associated 8"	Q53HL2	1	37692481-37709719	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 33.5;lymphoid tissue: 38.8;testis: 22.5"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 34.1;Extravillous trophoblasts: 26.0;Spermatocytes: 76.8;Spermatogonia: 42.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA028120, HPA028258, HPA028783, CAB040294"	Enhanced		Supported	"Nucleoplasm,Nucleoli,Cytokinetic bridge"		Yes	Yes			"Cluster 27: Non-specific - Gene expression"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoli	"Nucleoplasm, Cytokinetic bridge"	"CAB040294: , HPA028120: AB_10670556, HPA028258: AB_10669864, HPA028783: AB_10671092"	"unprognostic (8.36e-2)"	"unprognostic (2.00e-1)"	"unprognostic (8.39e-2)"	"unprognostic (7.75e-3)"	"unprognostic (2.34e-1)"	"unprognostic (5.42e-2)"	"prognostic unfavorable (4.93e-10)"	"unprognostic (4.30e-3)"	"prognostic unfavorable (6.04e-4)"	"unprognostic (3.00e-1)"	"prognostic unfavorable (8.32e-4)"	"unprognostic (3.78e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (6.39e-3)"	"unprognostic (2.99e-1)"	"unprognostic (3.18e-1)"	"unprognostic (1.67e-1)"	1.0	1.1	0.7	7.9	1.0	33.5	2.0	0.2	0.9	1.7	0.0	9.4	8.3	1.3	1.8	9.2	1.0	1.1	0.6	0.5	0.4	0.8	1.3	1.5	19.5	0.6	0.4	0.6	0.8	0.5	0.6	4.4	0.5	0.7	11.3	1.9	1.8	0.5	0.3	6.3	7.3	2.8	0.3	4.9	4.9	22.5	0.6	38.8	0.6	0.5	22.7	2.0	2.9	0.7	108.5	45.5	84.4	62.1	3.6	7.0	57.2	79.6	39.5	137.2	96.6	71.9	78.8	130.2	31.5	50.5	54.5	59.4	97.8	52.4	141.9	86.8	44.9	116.8	49.2	57.3	0.8	113.8	58.4	2.8	3.8	77.1	67.3	15.3	60.9	91.1	100.7	135.6	99.1	47.7	106.1	68.9	98.8	61.7	62.8	102.2	115.6	74.4	31.0	43.8	75.4	33.3	87.5	40.6	52.4	71.7	60.1	42.4	37.3	67.8	70.6	39.2	126.0	91.4	128.1	176.3	31.6	104.7	79.6	0.0	0.7	1.3	1.5	1.6	2.8	1.7	3.6	2.2	0.7	1.4	1.1	2.3	3.0	4.1	3.9	1.2	5.9	1.7	0.7	1.0	0.2	0.9	0.5	0.4	0.6	0.4	0.5	0.3	0.6	0.7	0.8	0.0	0.5	1.3	4.8	3.3	0.8	2.4	1.8	1.3	1.9	1.5	0.7	2.8	0.4	0.0	0.0	17.1	1.9	12.4	0.0	1.2	1.0	1.7	1.6	1.9	3.6	34.1	1.2	0.6	26.0	2.9	6.6	2.5	0.0	12.0	3.6	1.0	11.6	1.7	0.9	8.2	2.0	3.5	1.9	2.8	1.5	3.7	1.8	0.0	1.6	0.1	2.1	0.5	0.9	2.4	4.0	1.2	15.8	1.3	1.9	0.6	4.7	1.0	19.7	0.2	6.3	76.8	42.0	17.1	2.7	2.9	5.5	1.2	13.2	1.2
CEBPB	"C/EBP-beta, CRP2, IL6DBP, LAP, NFIL6, TCF5"	ENSG00000172216	"CCAAT enhancer binding protein beta"	P17676	20	50190830-50192668	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Macrophages: 765.6;Suprabasal keratinocytes: 800.1;Syncytiotrophoblasts: 1409.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 16.7"	"Group enriched"	"Detected in many"	8	"granulocytes: 16.7;monocytes: 7.7"	"Cell line enhanced"	"Detected in all"		"SK-MEL-30: 169.6"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"CAB004213, HPA061355, HPA062267"	Supported		Enhanced	Nucleoplasm		Yes	No			"Cluster 52: Eosinophils - Transcription"	"Cluster 85: Liver - Metabolism"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm		"CAB004213: AB_626772, HPA061355: AB_2684487, HPA062267: AB_2684731"	"unprognostic (2.30e-2)"	"unprognostic (2.64e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.09e-2)"	"unprognostic (9.48e-2)"	"unprognostic (2.24e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.40e-3)"	"unprognostic (1.79e-2)"	"unprognostic (9.85e-3)"	"unprognostic (9.26e-3)"	"unprognostic (6.55e-2)"	"prognostic unfavorable (2.44e-12)"	"unprognostic (7.29e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.45e-2)"	"unprognostic (7.63e-2)"	160.7	125.5	26.6	63.9	29.4	43.2	86.5	24.4	29.8	95.5	36.7	60.0	13.1	72.4	5.8	43.2	94.9	27.6	59.3	29.7	32.4	39.3	228.7	139.5	11.2	34.8	36.4	89.6	35.6	10.8	28.4	37.8	29.2	60.3	7.1	4.6	49.1	12.3	202.2	99.1	43.4	15.5	35.7	93.1	57.7	9.0	33.3	6.3	57.5	44.3	7.3	64.9	67.2	31.5	26.4	11.8	1.3	13.9	63.7	24.9	112.7	34.9	54.6	23.5	20.7	12.0	23.9	17.1	64.5	14.5	115.4	35.3	3.7	34.2	15.9	12.5	8.3	5.2	15.0	17.8	78.3	8.7	32.9	26.7	88.5	29.9	52.9	49.0	3.3	17.4	25.4	31.0	15.0	9.9	4.1	19.0	7.3	24.8	33.6	12.3	3.4	20.1	7.9	6.3	6.7	4.4	28.9	70.7	169.6	7.4	18.8	48.1	4.5	48.6	37.2	42.1	34.0	64.6	29.5	15.9	88.7	19.6	21.6	8.6	3.5	12.5	0.5	6.8	0.1	0.6	0.4	0.6	1.5	0.3	0.4	0.2	16.7	0.5	7.7	0.0	0.3	0.8	26.6	29.4	24.4	29.8	29.7	32.4	34.8	36.4	29.2	35.7	33.3	31.5	83.3	35.3	67.6	16.3	64.2	724.2	371.8	48.3	241.9	3.9	244.6	244.5	48.7	130.1	35.6	46.0	0.0	185.0	208.1	83.4	31.3	32.9	9.9	305.3	417.4	74.9	66.7	33.9	18.4	13.2	681.2	605.1	102.4	410.5	51.4	10.8	94.9	402.7	345.7	3.3	8.6	102.5	24.4	500.4	438.5	10.6	129.5	765.6	217.1	37.5	159.0	87.6	61.8	0.5	1.8	19.2	60.9	96.3	102.7	346.5	61.9	74.2	29.8	5.6	157.8	466.2	356.7	1.1	13.3	162.1	800.1	1409.9	159.3	68.2	63.4	359.6
CENPF	hcp-1	ENSG00000117724	"Centromere protein F"	P49454	1	214603195-214664571	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Differentiation, DNA synthesis, Mitosis, Myogenesis"	"Developmental protein"	"Cancer-related genes, Ciliopathy, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 28.8;lymphoid tissue: 33.0"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 84.4;Erythroid cells: 268.7;Extravillous trophoblasts: 78.8;Granulosa cells: 165.8;Spermatocytes: 107.5;Spermatogonia: 107.1"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			"HPA052382, HPA064308, CAB070134"	Enhanced		Supported	Nucleoplasm		Yes	Yes				"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"CAB070134: AB_2229328, HPA052382: AB_2681808, HPA064308: AB_2732711"	"unprognostic (2.80e-1)"	"unprognostic (2.16e-1)"	"unprognostic (2.65e-1)"	"unprognostic (5.30e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.40e-2)"	"prognostic unfavorable (2.29e-5)"	"unprognostic (1.13e-2)"	"unprognostic (2.58e-3)"	"unprognostic (1.11e-1)"	"prognostic unfavorable (1.39e-4)"	"unprognostic (1.58e-1)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (3.92e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.89e-2)"	"unprognostic (4.12e-1)"	0.8	1.1	0.1	4.4	0.1	28.8	1.8	0.0	0.3	1.3	0.5	5.8	6.1	1.8	0.1	8.6	0.6	0.7	0.4	0.3	0.0	0.4	0.9	0.9	8.5	0.3	0.5	0.7	0.3	0.2	0.1	3.1	0.3	0.5	5.7	1.0	1.4	0.1	0.2	6.2	4.3	2.5	0.2	2.4	2.6	10.5	0.5	33.0	0.4	0.6	10.0	1.4	2.6	0.3	123.7	68.4	144.3	75.8	5.4	7.2	56.3	74.6	30.3	43.9	42.8	54.6	74.1	116.3	43.1	41.7	39.8	74.7	89.9	49.2	74.1	102.6	56.6	96.0	111.4	78.6	0.8	137.0	50.5	2.7	3.8	63.3	72.3	12.7	46.9	52.6	88.4	68.0	79.4	47.0	81.5	54.3	127.9	36.8	30.0	85.7	203.7	38.6	43.2	30.3	67.4	91.2	100.7	66.2	38.9	76.2	79.1	51.9	61.7	78.9	92.2	66.2	155.9	51.6	60.7	108.7	34.4	96.7	71.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.3	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.1	0.1	0.0	0.3	0.3	0.0	0.3	0.5	0.3	0.2	0.5	0.3	3.0	0.0	3.1	0.0	11.5	9.3	2.8	11.2	3.4	4.7	10.0	6.7	1.9	1.5	9.9	0.0	0.0	53.3	10.8	19.1	0.0	2.0	84.4	30.1	19.3	12.4	0.0	268.7	1.3	0.4	78.8	19.0	32.1	25.2	1.3	165.8	8.9	2.6	32.2	1.7	0.8	20.1	14.2	16.6	6.6	19.8	1.2	16.2	1.8	1.0	0.7	1.4	5.2	0.0	0.1	0.5	1.1	3.0	25.9	2.3	2.1	0.1	16.7	3.1	0.0	8.3	23.9	107.5	107.1	44.6	5.5	5.1	23.3	11.7	41.3	3.7
CENPV	"CENP-V, p30, PRR6"	ENSG00000166582	"Centromere protein V"	Q7Z7K6	17	16342534-16353656	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Proximal enterocytes: 100.4;Spermatogonia: 124.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"eosinophil: 1.3;memory B-cell: 1.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 106.4;JURKAT: 105.1;NTERA-2: 103.4"	"Low region specificity"	"Detected in all"							"HPA042529, HPA042616"	Enhanced		Approved	Nucleoplasm,Midbody,Cytosol		Yes	No			"Cluster 37: B-cells - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	"Midbody, Cytosol"	"HPA042529: AB_10793882, HPA042616: AB_10794050"	"unprognostic (7.64e-2)"	"unprognostic (4.41e-2)"	"unprognostic (5.92e-2)"	"unprognostic (9.66e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.24e-1)"	"unprognostic (6.47e-2)"	"unprognostic (1.21e-1)"	"unprognostic (4.00e-2)"	"unprognostic (7.73e-3)"	"unprognostic (7.93e-2)"	"unprognostic (4.09e-3)"	"unprognostic (2.58e-1)"	"unprognostic (1.89e-2)"	"unprognostic (2.54e-2)"	"unprognostic (3.60e-3)"	4.0	4.7	11.7	0.6	11.3	5.1	4.6	9.3	11.7	4.4	7.1	9.1	9.8	5.9	3.5	0.5	6.6	1.3	5.6	11.9	13.2	3.4	10.7	2.6	1.2	11.6	11.0	6.2	4.0	3.9	7.0	1.2	10.0	3.1	8.0	4.0	1.5	4.0	21.1	0.8	10.6	4.0	11.6	1.1	13.2	10.3	11.4	17.1	2.4	9.5	1.2	4.2	1.7	11.9	10.7	20.4	106.4	53.4	3.0	2.7	18.2	8.7	8.6	26.5	20.0	20.5	4.7	42.5	17.0	6.5	4.9	3.2	69.3	0.6	16.8	0.0	85.9	10.1	5.0	41.1	29.2	10.1	0.0	7.6	2.8	31.6	18.7	3.0	15.2	105.1	17.4	0.0	8.0	1.8	80.2	34.2	103.4	69.1	0.0	57.1	4.1	4.9	6.1	15.4	56.8	43.9	22.2	0.3	5.2	48.6	0.3	24.8	1.0	0.0	8.6	1.2	0.0	0.0	0.0	24.9	0.0	14.0	0.6	0.0	0.0	1.3	0.1	0.0	0.0	1.4	0.0	0.0	0.2	0.1	0.3	0.3	0.0	0.0	0.0	0.3	0.0	0.0	11.7	11.3	9.3	11.7	11.9	13.2	11.6	11.0	10.0	11.6	11.4	11.9	13.3	0.0	2.7	3.9	13.7	1.0	29.7	0.5	4.6	40.0	22.5	31.6	4.2	30.0	4.4	1.8	4.2	19.6	19.6	43.0	31.3	7.5	16.3	2.6	32.4	5.0	39.4	12.6	18.9	23.3	22.1	9.2	59.1	2.7	5.7	39.7	1.8	50.1	6.0	11.8	21.8	63.0	0.0	1.4	0.7	9.0	8.7	4.6	8.8	3.7	2.0	45.9	13.4	19.6	11.7	17.8	83.9	11.7	10.7	38.0	100.4	43.5	2.5	15.0	26.3	4.2	17.9	81.6	124.2	2.5	2.6	6.4	10.7	8.7	78.9	45.0
CEP192	"FLJ10352, KIAA1569, PPP1R62"	ENSG00000101639	"Centrosomal protein 192"	Q8TEP8	18	12991362-13125052	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 67.6;Excitatory neurons: 94.4;Inhibitory neurons: 91.3;Oligodendrocyte precursor cells: 76.9;Oligodendrocytes: 90.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039392, HPA040503"	Uncertain		Supported	Centrosome,Cytosol		Yes	No			"Cluster 14: Monocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 21: OE19 - Mitochondria"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Centrosome, Cytosol"		"HPA039392: AB_10697549, HPA040503: AB_10670919"	"unprognostic (6.94e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.23e-1)"	"unprognostic (5.89e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.13e-3)"	"unprognostic (6.87e-3)"	"unprognostic (5.83e-3)"	"unprognostic (2.20e-2)"	"unprognostic (9.00e-2)"	"unprognostic (6.61e-2)"	"unprognostic (1.28e-1)"	"unprognostic (7.89e-2)"	"unprognostic (2.39e-1)"	"unprognostic (4.54e-2)"	"unprognostic (1.66e-3)"	2.9	2.2	5.0	4.6	7.6	10.8	4.9	9.8	5.2	4.7	0.0	4.5	4.0	6.4	3.9	3.7	4.9	5.7	3.6	4.1	2.4	2.8	2.9	4.4	6.9	4.1	4.7	9.9	4.6	4.7	2.5	4.6	3.6	4.0	5.4	6.8	4.1	3.5	1.8	3.5	4.7	4.6	3.4	5.2	4.7	9.3	5.0	11.6	5.5	3.9	5.6	4.1	2.5	9.7	13.5	7.2	19.1	10.1	8.1	12.6	6.1	9.2	12.1	14.3	15.1	9.9	5.8	15.2	6.1	9.4	10.4	6.4	16.7	8.8	16.8	6.0	6.0	13.8	11.3	5.2	4.3	22.2	10.2	8.8	3.2	12.0	10.9	8.2	11.9	10.7	19.3	9.9	11.3	6.8	19.2	9.6	6.1	24.9	4.4	16.3	14.9	7.9	4.9	13.6	13.9	7.8	14.7	7.2	4.4	9.0	5.8	11.3	12.1	11.2	26.2	12.9	12.8	6.6	10.1	17.0	7.2	9.9	11.0	0.4	0.6	0.5	0.9	0.4	0.7	0.5	0.6	0.6	0.3	1.3	0.6	1.0	0.6	0.2	1.7	0.5	0.5	0.3	5.0	7.6	9.8	5.2	4.1	2.4	4.1	4.7	3.6	3.4	5.0	9.7	13.3	9.6	12.8	67.6	11.4	1.9	3.9	4.3	5.2	13.1	6.4	5.8	28.7	4.3	9.3	7.3	22.9	5.3	13.7	7.6	0.0	4.7	23.3	11.0	11.8	8.5	0.0	18.7	94.4	3.6	3.3	10.5	15.8	12.1	2.5	40.9	8.2	6.5	4.6	11.8	91.3	8.7	4.1	10.1	3.9	14.2	10.2	10.1	1.8	62.8	15.3	6.5	14.4	76.9	90.6	4.8	5.7	13.9	15.0	5.5	4.5	1.2	8.0	17.8	26.3	11.3	8.1	33.5	24.0	8.5	3.1	1.9	12.3	60.6	8.0	7.6
CLSPN		ENSG00000092853	Claspin	Q9HAW4	1	35720218-35769978	"Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA repair"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 11.3;lymphoid tissue: 7.9;retina: 6.8;testis: 5.7"	"Cell type enhanced"	"Detected in many"		"Rod photoreceptor cells: 101.0;Spermatocytes: 281.1;Spermatogonia: 263.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Region enriched"	"Detected in some"	6	"basal ganglia: 7.8"	"Low region specificity"	"Detected in many"			"HPA026305, HPA026312"			Enhanced	"Nucleoplasm,Golgi apparatus"		Yes	Yes			"Cluster 17: Basophils - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Nucleoplasm, Golgi apparatus"		"HPA026305: AB_2671833, HPA026312: AB_2671837"	"unprognostic (4.75e-2)"	"unprognostic (1.01e-1)"	"unprognostic (9.64e-3)"	"unprognostic (3.54e-2)"	"unprognostic (6.82e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.18e-6)"	"unprognostic (3.99e-3)"	"unprognostic (2.08e-3)"	"unprognostic (1.63e-2)"	"unprognostic (8.71e-6)"	"unprognostic (3.23e-2)"	"unprognostic (7.61e-6)"	"prognostic favorable (4.92e-4)"	"unprognostic (5.12e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.29e-1)"	0.5	0.2	0.7	3.2	0.6	11.3	0.5	0.6	1.4	0.2	0.4	1.4	1.0	0.4	0.7	0.9	0.2	0.3	0.1	1.3	0.3	0.2	0.5	0.4	4.9	0.4	0.4	0.1	0.1	0.2	0.0	1.5	0.6	0.2	2.0	6.8	0.2	0.1	0.6	1.2	1.0	0.9	0.2	1.3	0.9	5.7	0.6	7.9	0.2	0.0	5.2	0.6	0.4	0.9	22.0	17.5	37.8	19.9	2.6	4.8	14.1	43.6	12.0	31.0	41.3	27.9	19.6	45.7	13.9	11.8	22.7	21.4	37.1	14.9	48.1	31.6	16.8	64.5	38.1	12.6	0.1	54.0	36.8	1.0	0.6	53.8	3.7	3.7	16.9	27.1	44.2	30.8	30.3	14.1	56.9	13.1	36.0	14.9	12.2	36.0	57.0	13.8	6.4	35.3	14.0	16.2	37.7	11.6	7.4	25.6	10.0	21.1	12.5	44.6	33.8	27.6	49.3	11.1	29.1	47.1	14.1	37.4	37.0	1.1	0.3	0.3	0.3	0.2	0.1	0.1	0.2	0.2	0.2	0.3	0.1	0.2	1.0	0.5	0.2	0.2	0.3	0.3	0.7	0.6	0.6	1.4	1.3	0.3	0.4	0.4	0.6	0.2	0.6	0.9	2.6	0.0	0.5	0.3	6.5	5.6	5.7	4.4	1.2	9.4	2.9	3.8	1.4	2.8	2.7	0.0	12.5	19.7	4.6	12.8	0.0	1.6	7.9	1.0	3.6	3.6	1.2	55.6	1.6	0.6	41.1	5.2	4.6	3.3	1.3	12.0	2.2	0.4	16.9	1.7	1.5	9.4	2.0	3.0	8.2	6.1	2.5	5.8	3.6	0.0	9.1	9.4	4.1	0.0	0.6	1.4	9.5	0.4	32.5	1.8	0.4	0.2	0.0	101.0	6.6	5.3	8.7	281.1	263.3	5.8	2.0	10.4	7.2	1.2	12.0	3.9
CORIN	"ATC2, CRN, Lrp4, PRSC, TMPRSS10"	ENSG00000145244	"Corin, serine peptidase"	Q9Y5Q5	4	47593999-47838106	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"heart muscle: 56.9"	"Cell type enriched"	"Detected in some"	6	"Cardiomyocytes: 69.4"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"ASC TERT1: 44.0"	"Region enhanced"	"Detected in some"		"basal ganglia: 2.6"	"Low region specificity"	"Detected in some"			HPA070941			Approved	"Nuclear bodies,Plasma membrane,Actin filaments"	"Intracellular and membrane"	Yes	No				"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Plasma membrane"	"Nuclear bodies, Actin filaments"	"HPA070941: AB_2686324"	"unprognostic (1.05e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.10e-1)"	"unprognostic (3.18e-1)"	"unprognostic (3.58e-4)"	"unprognostic (3.19e-1)"	"unprognostic (3.67e-2)"	"unprognostic (8.22e-2)"	"unprognostic (9.78e-2)"	"unprognostic (6.53e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.86e-2)"	"unprognostic (5.18e-2)"	"unprognostic (7.22e-2)"	"unprognostic (1.33e-2)"	0.4	0.1	0.1	0.1	0.1	0.0	1.0	0.1	0.2	2.1	0.6	0.3	0.1	4.5	0.6	0.9	1.4	4.5	56.9	0.0	0.3	1.0	0.1	1.9	0.0	0.7	0.6	0.5	0.2	1.1	1.9	0.4	0.1	2.3	0.0	0.3	0.4	6.1	0.1	7.5	0.3	0.7	0.1	1.1	0.5	2.5	0.3	0.1	0.1	0.1	0.1	1.2	3.9	0.1	0.0	0.0	0.1	0.3	10.3	44.0	0.0	2.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.1	2.1	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.9	1.4	0.0	0.3	0.2	1.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.2	0.0	0.3	0.7	0.6	0.1	0.1	0.3	0.1	0.3	0.0	7.5	1.0	0.0	3.8	0.3	0.0	0.0	1.0	8.3	0.3	69.4	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.1	1.3	1.0	0.0	0.0	6.5	0.0	0.0	9.1	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.0	10.8	0.0	0.0	0.6	5.5	2.0	4.7	0.1	5.4	1.0	0.0	0.7	0.0	2.0	3.9	0.0	0.0	2.6	0.0	0.6	0.0	0.2	0.0	0.3	0.0	0.3	2.3	4.6	4.4	0.1	2.7	0.0	0.6	0.1	0.0	0.3
CPT2	"CPT1, CPTASE"	ENSG00000157184	"Carnitine palmitoyltransferase 2"	P23786	1	53196792-53214197	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism, Transport"	"Acyltransferase, Transferase"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 91.2"	"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 85.1;Hepatocytes: 88.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028201, HPA028202, HPA028214"	Enhanced		Approved	Nucleoplasm,Nucleoli,Mitochondria		Yes	No			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Nucleoplasm, Mitochondria"	Nucleoli	"HPA028201: AB_10599177, HPA028202: AB_10599942, HPA028214: AB_10601958"	"unprognostic (2.43e-1)"	"unprognostic (2.27e-1)"	"prognostic favorable (5.27e-4)"	"unprognostic (6.48e-2)"	"unprognostic (1.88e-1)"	"unprognostic (9.34e-2)"	"unprognostic (6.48e-2)"	"unprognostic (1.75e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.00e-2)"	"unprognostic (8.97e-2)"	"prognostic favorable (1.46e-12)"	"unprognostic (4.00e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.79e-2)"	"unprognostic (2.95e-2)"	12.9	14.3	6.6	9.4	8.2	5.4	13.6	7.9	7.3	10.3	16.8	35.4	32.4	6.8	10.5	14.2	10.5	9.5	19.5	6.1	7.1	35.1	91.2	11.5	10.6	8.1	7.5	10.2	21.7	27.3	6.7	18.0	8.0	12.2	32.8	7.1	14.6	11.7	17.3	6.7	24.9	11.4	7.7	8.7	18.4	12.9	9.0	10.2	12.5	33.1	13.2	11.1	4.5	8.9	16.0	8.3	17.2	17.8	14.6	11.3	17.5	9.8	13.2	17.5	17.5	8.6	14.5	28.9	14.6	9.2	20.1	19.1	35.1	25.1	15.1	17.0	16.0	21.8	9.9	6.4	25.9	15.9	19.5	23.0	23.2	13.8	11.1	18.6	15.4	26.5	20.9	9.9	13.1	12.8	10.7	13.0	29.8	38.4	20.0	13.2	16.2	34.4	22.9	22.0	25.3	14.4	22.1	30.3	39.7	36.6	32.3	32.2	8.7	8.4	6.1	16.5	8.5	26.3	19.8	16.2	11.6	20.6	12.4	5.6	14.1	14.6	7.2	20.0	8.1	5.3	6.3	8.4	17.9	7.4	10.5	7.2	5.3	6.9	20.5	8.9	9.9	10.3	6.6	8.2	7.9	7.3	6.1	7.1	8.1	7.5	8.0	7.7	9.0	8.9	5.0	12.8	24.1	4.2	7.8	1.8	5.2	20.5	5.2	6.0	7.5	7.0	18.1	15.7	11.4	11.0	14.6	85.1	4.5	49.3	25.4	12.9	1.1	10.9	8.1	5.9	14.5	9.4	1.5	10.5	20.3	7.2	18.3	10.3	2.5	12.7	8.9	88.8	26.3	15.2	2.0	26.6	16.2	15.1	7.2	2.8	6.8	10.5	7.2	1.9	20.2	11.6	6.2	2.5	4.5	10.5	25.6	5.3	9.1	4.9	38.6	41.0	7.6	11.0	6.6	7.5	8.4	49.9	31.3	13.8	2.6	54.6	6.9	25.6	29.5	5.7
CYLD	"CYLD1, KIAA0849, USPL2"	ENSG00000083799	"CYLD lysine 63 deubiquitinase"	Q9NQC7	16	50742050-50801935	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Immunity, Innate immunity, Ubl conjugation pathway, Wnt signaling pathway"	"Hydrolase, Protease, Thiol protease"	"Cancer-related genes, Disease variant, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 94.3"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 136.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011713, HPA050095"	Approved		Supported	"Nucleoplasm,Centriolar satellite"		Yes	No			"Cluster 10: Basophils - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Centriolar satellite"	Nucleoplasm	"CAB011713: AB_731794, HPA050095: AB_2681013"	"unprognostic (9.83e-2)"	"unprognostic (1.17e-2)"	"unprognostic (5.01e-2)"	"unprognostic (2.83e-2)"	"unprognostic (3.84e-1)"	"unprognostic (5.06e-2)"	"unprognostic (3.87e-2)"	"unprognostic (3.24e-2)"	"unprognostic (9.46e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.18e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.43e-2)"	"unprognostic (6.83e-2)"	"unprognostic (8.42e-2)"	14.3	22.0	23.9	38.8	23.5	94.3	13.6	17.9	18.2	13.0	22.3	16.3	16.1	15.1	12.1	23.3	11.0	20.5	20.1	17.3	23.3	14.2	21.0	21.5	53.4	21.3	27.8	15.4	15.2	23.0	15.4	15.4	23.6	16.3	19.3	22.0	18.9	16.0	34.3	15.2	16.2	16.8	21.6	39.0	19.9	38.3	32.7	35.6	24.9	20.5	48.4	24.1	12.9	24.2	26.9	8.3	9.4	10.6	14.3	21.0	8.7	39.1	56.7	39.9	23.4	6.9	12.5	30.7	13.7	38.3	43.4	10.3	11.3	23.7	58.7	136.6	16.6	15.5	15.3	5.8	29.1	15.4	69.5	23.0	18.6	48.1	50.1	37.7	16.3	21.3	6.6	26.1	56.4	4.0	14.4	22.3	10.1	8.5	13.3	13.4	18.8	29.4	12.9	9.1	12.0	9.2	33.1	11.2	9.8	14.3	11.0	18.9	18.6	67.2	15.4	23.4	15.9	68.0	68.4	33.2	49.3	16.7	14.7	64.6	15.2	38.3	18.1	17.7	21.8	17.2	27.1	24.5	18.3	11.1	24.4	19.4	32.3	25.7	18.8	11.0	37.3	19.5	23.9	23.5	17.9	18.2	17.3	23.3	21.3	27.8	23.6	21.6	32.7	24.2	28.8	44.8	31.8	31.6	87.7	120.1	59.5	32.2	40.9	89.2	35.5	26.0	34.4	21.5	32.9	18.4	93.8	6.8	84.1	28.3	5.9	20.0	48.2	22.5	24.9	36.0	31.1	26.1	51.9	19.1	4.4	37.3	22.4	47.1	80.5	21.4	27.8	25.5	21.5	67.3	54.7	10.7	30.5	40.0	127.6	31.3	25.4	66.4	74.7	57.1	63.7	23.3	70.0	51.8	119.2	18.0	22.4	21.1	79.7	66.4	15.4	13.9	23.3	48.3	6.6	54.2	30.5	59.2	15.2	64.3	155.6	4.1	119.5	21.3	14.8	66.7
DBF4	"ASK, chif, DBF4A, ZDBF1"	ENSG00000006634	"DBF4 zinc finger"	Q9UBU7	7	87876216-87909553	"Predicted intracellular proteins"	"Cell cycle, DNA replication"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	20	"testis: 15.1"	"Group enriched"	"Detected in all"	4	"Early spermatids: 468.6;Spermatocytes: 569.4"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.0"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA042923			Supported	"Nucleoplasm,Nuclear bodies"		Yes	Yes			"Cluster 10: Basophils - Unknown function"	"Cluster 74: Testis - Spermatogenesis"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Nuclear bodies"		"HPA042923: AB_2678222"	"unprognostic (2.48e-1)"	"unprognostic (8.32e-2)"	"unprognostic (1.15e-2)"	"unprognostic (4.86e-3)"	"unprognostic (2.81e-2)"	"unprognostic (3.63e-1)"	"prognostic unfavorable (4.45e-6)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (6.86e-4)"	"unprognostic (1.46e-3)"	"unprognostic (1.05e-3)"	"unprognostic (2.78e-3)"	"prognostic unfavorable (6.42e-7)"	"unprognostic (1.98e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.30e-1)"	0.1	0.2	0.2	0.2	0.4	0.6	0.2	0.7	0.4	0.2	0.1	0.2	0.2	0.2	0.3	0.1	0.1	0.4	0.1	0.2	0.1	0.2	0.2	0.1	0.5	0.2	0.2	0.2	0.1	0.1	0.0	0.1	0.2	0.2	0.2	0.2	0.1	0.1	0.1	0.2	0.3	0.0	0.1	0.3	0.2	15.1	0.2	0.6	0.3	0.0	0.5	0.1	0.1	0.3	0.9	0.8	2.0	2.5	0.4	0.4	0.5	1.0	0.2	1.0	2.1	1.4	0.6	2.1	0.6	0.6	1.7	0.9	2.2	0.5	1.0	1.6	1.3	1.3	1.0	0.4	0.1	1.7	1.0	0.4	0.6	1.2	1.0	0.3	0.9	1.9	1.2	4.2	1.4	1.7	2.8	2.0	2.0	2.1	1.9	0.7	3.1	2.5	0.8	0.1	3.0	1.8	1.2	2.2	1.0	1.6	0.9	1.6	0.1	1.2	1.4	3.1	2.0	2.3	5.2	2.1	0.8	3.1	2.5	1.0	0.1	0.1	0.3	0.0	0.1	0.2	0.2	0.1	0.0	0.2	0.2	0.3	0.2	0.2	0.0	0.2	0.4	0.1	0.2	0.4	0.7	0.4	0.2	0.1	0.2	0.2	0.2	0.1	0.2	0.3	13.3	3.2	12.6	5.5	38.4	15.6	16.4	10.7	12.0	6.6	13.0	16.8	3.7	2.8	7.7	9.2	12.5	19.6	59.2	9.7	3.9	8.3	468.6	12.1	23.6	11.1	14.9	40.8	14.7	14.7	36.4	12.4	14.3	17.7	31.0	19.4	6.4	6.5	16.1	3.3	9.1	20.6	16.2	9.1	15.5	116.0	15.5	20.8	12.4	2.8	11.0	2.1	24.7	6.0	6.7	14.1	8.5	9.4	48.9	18.4	4.2	5.8	10.2	16.6	13.1	9.7	11.4	569.4	74.6	20.5	12.6	9.6	44.4	13.5	22.3	11.7
DLGAP5	"DLG1, DLG7, HURP, KIAA0008"	ENSG00000126787	"DLG associated protein 5"	Q15398	14	55148112-55191608	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 29.7;lymphoid tissue: 42.0;testis: 17.4"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 92.6;Extravillous trophoblasts: 23.1;Plasma cells: 22.1;Spermatocytes: 68.1;Spermatogonia: 31.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"T-reg: 5.4"	"Lineage enriched"	"Detected in many"	5	"T-cells: 5.4"	"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA005546	Enhanced		Supported	"Centriolar satellite,Cytosol"		Yes	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Centriolar satellite, Cytosol"		"HPA005546: AB_1078677"	"unprognostic (2.24e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.19e-3)"	"prognostic unfavorable (4.59e-4)"	"unprognostic (1.42e-1)"	"unprognostic (1.66e-2)"	"prognostic unfavorable (1.52e-6)"	"prognostic unfavorable (7.85e-4)"	"unprognostic (6.15e-3)"	"unprognostic (3.55e-1)"	"prognostic unfavorable (9.94e-6)"	"unprognostic (4.69e-2)"	"unprognostic (0.00e+0)"	"unprognostic (1.06e-2)"	"unprognostic (3.64e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.93e-2)"	0.8	0.3	1.4	8.1	0.9	29.7	1.4	0.4	1.8	0.8	0.6	5.5	5.0	1.3	0.1	5.2	0.4	0.8	0.2	1.0	1.7	0.2	0.7	0.7	17.9	0.7	1.0	0.2	0.1	0.2	0.0	4.1	0.8	0.2	6.7	0.1	0.8	0.1	0.1	3.1	4.6	2.7	0.3	2.6	3.0	17.4	1.1	42.0	0.4	0.0	18.7	2.0	1.5	3.8	144.8	56.8	140.6	63.7	3.3	13.4	43.8	80.3	52.7	115.3	109.3	45.9	75.8	82.1	44.2	46.9	47.4	85.6	91.5	64.0	150.5	101.9	45.7	84.4	49.9	39.3	0.4	82.7	49.3	2.8	2.2	54.8	27.0	18.9	129.0	82.5	70.5	79.8	109.3	69.2	105.0	42.7	72.6	63.3	57.3	80.8	137.9	39.0	37.9	45.2	71.7	40.7	84.8	31.7	30.8	60.6	71.6	31.6	49.6	52.4	133.3	50.6	94.6	19.4	44.9	108.9	35.9	59.6	83.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.9	1.4	0.3	0.0	0.2	0.1	0.2	1.0	0.0	0.0	5.4	0.7	1.4	0.9	0.4	1.8	1.0	1.7	0.7	1.0	0.8	0.3	1.1	3.8	0.1	0.0	0.5	0.0	4.4	1.1	0.7	3.3	0.0	0.0	1.2	0.9	0.4	0.0	1.3	0.0	0.0	11.6	1.4	3.2	0.0	0.4	19.7	7.2	2.6	2.4	0.0	92.6	0.3	0.0	23.1	4.2	7.7	4.5	0.0	15.8	3.9	0.5	10.5	0.0	0.3	3.6	8.2	4.1	1.6	6.0	0.9	3.7	0.0	0.0	0.0	0.0	1.0	0.0	0.3	0.2	0.2	1.2	22.1	0.6	0.3	0.1	1.3	0.0	6.6	0.0	3.8	68.1	31.7	11.6	0.4	1.9	4.0	0.9	6.9	1.4
DNHD1	"C11orf47, CCDC35, DHCD1, DKFZp686J0796, DNHD1L, FLJ32752, FLJ35709, FLJ46184"	ENSG00000179532	"Dynein heavy chain domain 1"	Q96M86	11	6497260-6593758	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 69.5;Erythroid cells: 35.6;Excitatory neurons: 41.4;Inhibitory neurons: 32.8;Oligodendrocyte precursor cells: 36.2;Oligodendrocytes: 67.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA039698, HPA040267, HPA057639"	Uncertain		Approved	"Nucleoplasm,Cytokinetic bridge"		Yes	No			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 43: Testis - Unknown function"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 6: Erythroid cells - Oxygen transport"	"Nucleoplasm, Cytokinetic bridge"		"HPA039698: AB_10795111, HPA040267: AB_2676913, HPA057639: AB_2683486"	"unprognostic (1.01e-2)"	"unprognostic (2.31e-1)"	"unprognostic (5.87e-2)"	"unprognostic (2.18e-2)"	"unprognostic (9.96e-2)"	"unprognostic (2.00e-3)"	"unprognostic (1.43e-1)"	"unprognostic (3.11e-1)"	"unprognostic (5.38e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.96e-2)"	"unprognostic (9.25e-3)"	"unprognostic (5.45e-9)"	"unprognostic (2.33e-1)"	"unprognostic (2.50e-1)"	"unprognostic (4.56e-4)"	"unprognostic (8.15e-2)"	2.2	1.7	2.6	1.5	3.3	4.5	2.2	2.1	4.3	2.9	2.3	3.3	1.6	2.5	2.1	1.6	2.6	1.4	2.0	2.1	3.2	2.5	2.8	3.3	2.5	4.7	2.8	3.3	1.7	0.4	2.2	0.8	5.0	2.4	1.4	4.0	1.8	1.3	2.0	2.3	3.3	1.4	2.4	2.8	2.0	10.3	3.5	2.1	2.4	0.8	2.0	2.4	2.5	6.2	2.1	2.0	2.4	1.9	2.0	2.9	2.6	1.0	1.2	0.7	0.9	1.3	2.3	2.4	0.4	1.0	1.8	3.7	1.1	1.1	0.9	1.5	2.3	1.8	3.7	1.5	1.3	2.1	0.8	2.0	1.8	2.2	3.6	1.2	0.6	3.1	2.0	2.3	1.0	0.6	0.9	3.0	2.6	0.7	2.0	1.4	0.9	1.5	1.3	1.6	1.1	2.2	0.8	2.2	1.9	1.8	1.3	2.5	1.2	1.3	1.4	1.8	1.4	6.6	5.0	3.0	1.3	2.6	1.7	0.0	0.1	0.5	0.1	0.0	0.2	0.0	0.2	0.1	0.1	0.3	0.3	0.4	0.1	0.0	0.0	0.2	0.2	0.1	2.6	3.3	2.1	4.3	2.1	3.2	4.7	2.8	5.0	2.4	3.5	6.2	2.3	0.0	3.4	69.5	3.8	0.9	1.2	1.9	0.6	9.9	2.7	3.0	3.8	0.0	4.3	0.0	4.2	0.3	4.0	2.2	0.0	0.3	12.7	4.0	1.5	2.8	0.0	35.6	41.4	0.4	0.2	2.2	2.6	3.6	1.3	4.7	3.3	4.8	0.8	10.1	32.8	1.7	0.0	2.5	1.5	13.9	0.9	4.0	0.0	19.7	2.2	3.4	3.1	36.2	67.4	0.4	1.6	1.2	1.7	1.8	2.2	0.6	7.3	9.5	0.0	2.1	1.7	19.5	2.0	1.5	3.8	0.7	2.4	1.8	2.1	1.8
DOP1B	"C21orf5, DOPEY2, KIAA0933"	ENSG00000142197	"DOP1 leucine zipper like protein B"	Q9Y3R5	21	36156782-36294274	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 5.2;dendritic cells: 3.8;Extravillous trophoblasts: 11.4;Hofbauer cells: 16.7;Syncytiotrophoblasts: 8.1"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"cerebellum: 19.8"	"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA072065	Enhanced		Approved	Nucleoplasm,Mitochondria		Yes	No			"Cluster 19: B-cells - Humoral immune response"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	Mitochondria	"HPA072065: AB_2686486"	"prognostic unfavorable (7.08e-4)"	"unprognostic (7.68e-2)"	"unprognostic (2.50e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.38e-1)"	"unprognostic (1.36e-1)"	"unprognostic (3.13e-2)"	"unprognostic (4.35e-2)"	"unprognostic (3.01e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.85e-1)"	3.5	1.7	2.9	5.6	4.8	24.2	5.8	19.8	8.0	4.6	0.0	15.4	12.6	2.3	3.0	11.8	4.2	4.1	4.5	3.6	1.0	3.2	9.1	4.9	4.7	3.6	1.1	1.6	4.6	30.4	2.3	3.1	4.5	12.1	15.1	1.6	19.3	3.4	15.9	7.1	11.7	3.8	0.1	5.5	20.5	3.5	2.1	6.5	4.0	13.5	6.3	4.0	5.9	3.4	25.9	5.4	4.0	6.8	4.4	8.4	38.2	12.0	14.2	16.7	10.4	3.8	2.0	4.8	1.8	9.0	12.7	5.2	7.8	2.8	13.5	8.8	7.0	11.0	1.2	1.4	3.9	10.8	5.5	2.9	5.5	10.9	2.9	10.0	7.1	11.2	3.5	7.6	5.0	29.0	8.7	11.1	3.3	30.4	5.6	15.4	2.3	23.7	8.8	10.2	10.7	6.1	8.0	35.9	10.1	5.5	13.1	13.2	12.2	6.4	1.7	8.4	9.8	5.7	15.0	2.2	9.2	23.0	3.7	1.0	3.0	6.1	2.6	2.7	1.4	7.3	1.7	1.5	1.9	10.5	1.1	0.9	4.8	1.0	2.4	5.9	1.4	1.4	2.9	4.8	19.8	8.0	3.6	1.0	3.6	1.1	4.5	0.1	2.1	3.4	2.8	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	1.9	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	11.4	1.0	0.0	0.0	0.0	0.0	0.0	0.0	16.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	8.1	0.6	0.0	0.0	0.0
DPH2	DPH2L2	ENSG00000132768	"Diphthamide biosynthesis 2"	Q9BQC3	1	43970000-43973369	"Enzymes, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045796	Uncertain		Approved	Nucleoplasm		Yes	No			"Cluster 22: NK-cells - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 16: U-266 - Nucleosome"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"HPA045796: AB_2679456"	"unprognostic (2.41e-1)"	"unprognostic (1.15e-1)"	"unprognostic (4.20e-3)"	"unprognostic (9.13e-3)"	"unprognostic (3.83e-2)"	"unprognostic (1.30e-1)"	"prognostic unfavorable (1.17e-8)"	"unprognostic (1.38e-1)"	"unprognostic (1.81e-1)"	"unprognostic (3.72e-1)"	"unprognostic (2.49e-1)"	"unprognostic (3.42e-3)"	"unprognostic (2.60e-1)"	"prognostic favorable (1.37e-4)"	"unprognostic (1.38e-1)"	"unprognostic (2.41e-2)"	"unprognostic (6.37e-2)"	8.2	11.5	9.3	10.8	9.6	7.0	7.9	9.0	10.2	7.2	9.0	9.7	7.3	7.7	6.1	11.8	8.2	5.5	11.6	9.1	8.5	13.2	12.6	7.1	12.4	8.7	9.2	7.2	15.9	10.2	8.8	6.6	9.0	8.1	9.2	3.5	9.5	6.7	32.8	10.5	9.0	8.9	8.6	11.8	9.7	7.2	9.4	8.8	7.4	17.0	10.9	12.3	6.7	9.5	25.0	28.5	12.2	26.8	9.2	9.6	41.6	13.0	13.9	32.9	26.9	36.1	23.8	41.4	21.4	13.3	17.0	28.1	41.7	36.8	18.4	28.0	36.1	42.4	36.1	37.9	24.1	49.9	23.4	14.9	40.6	39.2	21.0	10.0	23.2	32.0	55.4	23.1	16.8	28.6	44.6	28.3	86.3	40.5	31.4	37.6	28.2	67.4	20.6	19.5	42.8	49.3	17.2	43.1	32.6	16.3	18.2	34.3	15.4	16.1	36.7	28.6	52.4	55.3	98.7	43.0	14.2	55.0	24.1	0.0	6.6	0.4	6.1	9.4	9.0	8.3	6.4	6.5	10.1	8.8	6.4	9.3	0.6	10.3	4.8	8.4	6.6	6.3	9.3	9.6	9.0	10.2	9.1	8.5	8.7	9.2	9.0	8.6	9.4	9.5	5.8	0.0	4.8	5.2	14.4	22.9	13.2	8.9	8.6	6.8	10.3	10.0	9.3	7.2	5.2	1.8	10.4	14.8	8.8	4.8	5.9	16.5	0.3	4.0	5.6	7.6	12.0	6.3	6.9	18.8	16.2	6.2	8.6	4.3	4.5	6.9	2.5	5.7	8.6	3.3	6.5	8.1	4.1	3.7	7.1	1.0	8.4	4.4	5.4	0.0	9.2	4.4	12.3	4.0	6.9	15.2	3.0	3.8	11.5	23.6	3.8	9.0	6.0	6.0	0.0	6.5	8.0	9.4	24.9	10.3	27.1	8.6	6.9	12.7	13.7	9.0
DTL	"CDT2, DCAF2, L2DTL, RAMP"	ENSG00000143476	"Denticleless E3 ubiquitin protein ligase homolog"	Q9NZJ0	1	212035553-212107400	"Predicted intracellular proteins"	"Biological rhythms, DNA damage, DNA replication, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 14.6;intestine: 4.7;lymphoid tissue: 14.2;placenta: 3.9;testis: 13.7"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 25.3;Erythroid cells: 36.2;Extravillous trophoblasts: 16.2;Spermatocytes: 53.2;Spermatogonia: 20.8"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"T-reg: 2.0"	"Lineage enriched"	"Detected in single"	8	"T-cells: 2.0"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA028016, HPA032023, HPA032031"	Supported		Supported	Nucleoplasm,Nucleoli,Cytosol		Yes	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Nucleoli, Cytosol"	"HPA028016: AB_10611958, HPA032023: AB_2674114, HPA032031: AB_2674119"	"unprognostic (7.61e-2)"	"unprognostic (1.01e-3)"	"unprognostic (2.14e-2)"	"unprognostic (3.05e-2)"	"unprognostic (2.19e-1)"	"unprognostic (5.31e-2)"	"prognostic unfavorable (4.41e-5)"	"unprognostic (8.96e-3)"	"unprognostic (2.45e-3)"	"unprognostic (8.83e-3)"	"unprognostic (2.52e-3)"	"unprognostic (2.83e-2)"	"prognostic unfavorable (1.71e-9)"	"unprognostic (5.93e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.96e-2)"	"unprognostic (2.82e-1)"	0.6	0.2	0.0	4.1	0.0	14.6	1.9	0.0	0.1	0.6	0.0	3.3	2.3	1.1	0.1	1.9	0.4	0.4	0.1	0.0	0.0	0.1	1.2	1.4	5.6	0.0	0.1	0.1	0.1	0.5	0.2	3.9	0.0	0.4	4.7	0.0	0.4	0.1	0.1	2.1	3.0	1.9	0.0	2.5	1.3	13.7	0.1	14.2	0.5	0.0	6.4	1.2	0.7	0.0	34.1	28.1	48.0	23.6	2.9	5.8	23.3	41.3	25.5	38.1	56.1	17.6	29.0	25.2	15.4	16.1	25.0	25.8	62.5	34.9	54.7	31.4	30.9	40.7	33.6	21.5	0.1	54.1	25.3	2.5	1.2	62.2	32.4	6.8	17.7	44.7	49.1	51.1	44.4	13.5	75.3	24.3	56.6	25.2	32.9	57.2	84.0	49.2	11.6	22.9	29.6	46.0	39.2	37.5	17.6	47.7	32.0	24.1	9.7	38.2	28.6	40.5	47.8	18.4	30.5	57.7	19.1	35.5	37.8	0.0	0.0	0.0	0.2	0.2	0.0	0.2	0.3	0.5	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	2.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	1.2	0.0	0.0	0.0	2.3	2.3	0.4	1.7	0.0	0.0	1.3	1.3	7.0	1.5	0.9	0.0	0.0	12.8	1.4	1.5	0.0	0.4	25.3	0.4	1.3	5.2	0.0	36.2	0.2	0.0	16.2	2.4	3.1	1.0	0.0	11.4	0.7	0.4	4.7	0.0	0.3	3.3	0.0	0.3	0.8	12.4	1.2	2.2	0.0	1.0	0.2	0.0	0.0	0.0	0.1	0.6	0.4	0.0	12.8	0.2	0.6	0.0	0.1	0.0	0.0	0.2	2.7	53.2	20.8	5.6	1.7	1.5	2.6	1.6	5.2	0.7
DUSP18	DUSP20	ENSG00000167065	"Dual specificity phosphatase 18"	Q8NEJ0	22	30652051-30667887	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 123.4;Late spermatids: 344.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034070, HPA051349"	Uncertain		Supported	Nucleoplasm		Yes	No			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm		"CAB034070: AB_2094867, HPA051349: AB_2681450"	"unprognostic (1.11e-1)"	"unprognostic (2.34e-2)"	"unprognostic (3.49e-3)"	"unprognostic (4.88e-3)"	"unprognostic (1.88e-1)"	"unprognostic (9.12e-2)"	"unprognostic (3.77e-4)"	"unprognostic (1.83e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.53e-2)"	"unprognostic (9.62e-2)"	"unprognostic (4.87e-2)"	"unprognostic (1.23e-3)"	"unprognostic (6.55e-2)"	"unprognostic (1.97e-1)"	"unprognostic (4.56e-2)"	"unprognostic (1.02e-1)"	3.3	1.9	3.4	4.5	3.6	3.3	2.8	2.9	5.3	2.4	9.1	5.4	5.0	2.9	4.9	4.1	10.9	4.2	2.0	3.7	4.0	2.2	1.0	5.5	4.7	5.4	7.6	2.4	2.9	3.3	4.2	2.1	4.9	2.1	6.8	5.2	2.5	2.4	1.3	4.8	4.6	3.8	4.8	4.3	4.8	13.9	4.5	4.0	3.3	1.6	3.9	3.3	2.6	6.0	5.4	5.4	2.5	5.8	6.2	11.9	2.3	4.9	5.3	4.7	5.1	3.1	5.3	3.6	3.3	6.0	6.2	3.8	1.3	3.8	5.3	9.8	6.1	1.5	2.2	2.2	2.6	7.4	5.3	3.1	5.4	7.8	3.0	5.3	15.0	4.1	1.7	2.8	5.2	4.8	4.2	1.8	0.8	6.4	3.3	2.8	1.7	1.2	5.6	3.7	6.2	3.7	4.8	1.7	3.5	3.2	4.5	2.2	11.1	9.9	5.4	2.7	2.8	2.1	2.6	1.7	11.4	1.3	5.0	31.4	15.3	29.9	8.6	19.3	6.6	9.7	9.6	7.7	17.2	8.7	6.6	7.5	31.8	7.4	21.4	9.7	13.2	8.4	3.4	3.6	2.9	5.3	3.7	4.0	5.4	7.6	4.9	4.8	4.5	6.0	7.2	19.2	5.4	11.4	7.1	21.4	13.3	6.5	2.2	2.9	4.9	3.4	2.0	10.0	9.6	5.5	45.9	1.2	12.0	10.0	3.9	10.1	123.4	34.5	5.0	10.1	35.5	2.1	8.0	9.4	3.9	6.8	8.6	5.0	7.0	4.4	13.9	1.1	8.1	1.7	4.4	15.4	6.1	15.6	28.5	344.2	8.4	13.2	8.8	13.1	13.9	10.1	9.2	1.5	14.3	9.3	15.4	6.8	3.9	8.8	24.2	4.1	64.6	16.8	6.6	8.6	6.6	63.0	17.2	5.7	21.3	1.0	9.7	3.5	19.0	8.7
DYSF	"FER1L1, LGMD2B"	ENSG00000135636	Dysferlin	O75923	2	71453722-71686768	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Disease variant, Limb-girdle muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 95.3"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 30.5;Endothelial cells: 43.7;Excitatory neurons: 34.7;Hepatic stellate cells: 32.2;Kupffer cells: 27.1;Oligodendrocytes: 62.7;Syncytiotrophoblasts: 66.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in some"	7	"neutrophil: 27.0"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 27.0"	"Group enriched"	"Detected in many"	5	"hTERT-RPE1: 31.9;HUVEC TERT2: 85.5;LHCN-M2: 75.3;RH-30: 78.5;TIME: 58.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB002510, HPA017071, HPA021945"	Enhanced		Supported	"Plasma membrane,Centriolar satellite"		Yes	No			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 59: Non-specific - Translation"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane, Centriolar satellite"		"CAB002510: AB_442097, HPA017071: AB_1847927, HPA021945: AB_1847928"	"unprognostic (1.04e-1)"	"unprognostic (7.66e-3)"	"unprognostic (5.43e-3)"	"unprognostic (1.66e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.42e-1)"	"unprognostic (4.43e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.70e-1)"	"unprognostic (3.21e-1)"	"unprognostic (2.93e-1)"	"unprognostic (6.43e-2)"	"unprognostic (4.88e-3)"	"unprognostic (1.22e-2)"	"unprognostic (3.18e-2)"	"unprognostic (1.36e-1)"	"unprognostic (5.97e-3)"	10.1	1.7	1.0	11.5	1.1	31.6	4.3	4.1	7.7	1.9	0.7	7.0	2.0	2.3	0.5	7.4	3.2	4.6	16.8	0.2	3.8	3.6	6.5	8.3	3.7	14.8	5.1	1.3	1.5	2.3	1.5	21.1	13.7	3.3	2.5	0.5	1.3	4.8	95.3	1.2	3.1	10.2	2.0	21.4	2.5	1.1	10.2	2.3	4.6	32.3	0.9	6.9	1.8	1.8	1.1	0.0	3.3	3.0	0.0	0.0	6.1	0.1	0.8	2.2	1.5	0.4	1.0	0.0	12.1	0.1	3.4	2.5	0.0	1.2	1.1	0.0	0.0	0.2	0.2	0.0	0.3	0.1	0.0	1.5	0.0	2.3	10.6	31.9	85.5	0.2	8.4	0.0	75.3	0.0	0.0	5.8	8.1	0.0	0.9	0.0	78.5	0.0	2.6	0.2	0.0	0.0	4.1	0.7	0.1	7.9	0.3	0.8	58.1	0.3	3.8	0.2	1.1	0.0	0.0	0.0	0.0	13.3	0.0	0.0	4.1	0.1	0.5	0.7	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	27.0	0.4	0.1	0.0	0.0	1.4	1.0	1.1	4.1	7.7	0.2	3.8	14.8	5.1	13.7	2.0	10.2	1.8	30.5	3.2	8.1	1.0	1.0	2.4	0.0	0.1	0.0	1.1	0.3	0.6	24.0	0.0	1.3	0.0	0.0	8.1	0.7	0.1	0.0	0.4	4.8	0.7	1.3	43.7	0.0	2.7	34.7	0.2	3.8	2.2	0.0	9.3	2.5	0.3	32.2	13.4	11.4	0.0	13.0	0.2	0.0	27.1	3.0	6.0	0.6	10.2	0.0	16.9	5.8	0.1	0.0	2.5	62.7	0.1	0.0	0.7	0.1	0.2	0.0	2.1	0.7	0.2	6.6	5.2	5.5	0.6	1.1	0.1	1.6	66.2	1.1	0.9	0.0	0.1
ECPAS	"ECM29, FLJ22036, KIAA0368"	ENSG00000136813	"Ecm29 proteasome adaptor and scaffold"	Q5VYK3	9	111360692-111484745	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 245.0"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 57.7;Alveolar cells type 2: 63.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021646, HPA059795"	Uncertain		Approved	Nucleoplasm		Yes	No		5400	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 16: U-266 - Nucleosome"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA021646: AB_2670788, HPA059795: AB_2684127"	"unprognostic (1.64e-1)"	"unprognostic (1.57e-1)"	"unprognostic (7.42e-2)"	"unprognostic (5.72e-2)"	"unprognostic (3.81e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.80e-2)"	"unprognostic (5.12e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.17e-1)"	"unprognostic (9.99e-2)"	"unprognostic (1.67e-1)"	"unprognostic (3.72e-3)"	"unprognostic (2.67e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.05e-1)"	41.6	34.1	33.8	23.5	43.7	28.6	31.8	33.9	52.9	31.6	31.6	34.0	32.1	28.4	23.6	28.7	26.5	19.9	44.4	52.7	30.6	31.0	28.2	31.0	21.6	32.0	31.9	33.0	38.4	40.6	32.7	24.0	33.7	34.3	29.6	28.3	32.0	25.6	245.0	32.4	29.6	28.5	26.1	22.4	31.2	35.6	31.4	16.2	32.4	97.1	21.2	31.6	30.9	40.1	58.9	53.1	35.0	37.7	81.6	81.1	57.5	70.8	60.4	57.0	39.1	49.7	35.6	59.3	32.5	62.6	46.5	83.7	45.1	47.4	52.7	65.4	28.3	36.6	64.5	72.0	60.4	68.9	38.2	74.2	48.8	57.3	84.4	64.6	58.8	14.7	85.4	81.1	47.1	49.5	0.3	39.9	68.6	74.7	44.1	33.4	107.2	35.7	48.9	52.2	66.7	31.7	60.5	64.1	46.2	37.6	50.5	36.4	64.7	38.1	43.6	57.5	65.5	71.2	144.9	71.3	55.7	27.8	36.0	2.7	5.8	1.9	4.6	6.0	5.3	3.9	4.7	5.3	8.1	4.2	2.8	4.9	1.7	4.8	4.5	3.6	4.1	2.9	33.8	43.7	33.9	52.9	52.7	30.6	32.0	31.9	33.7	26.1	31.4	40.1	24.6	57.7	63.9	0.0	5.3	0.0	0.0	0.0	0.0	0.0	19.0	14.7	0.0	0.0	32.8	12.9	0.0	17.3	11.6	0.0	9.8	21.0	0.0	19.3	32.0	12.1	0.0	0.0	0.0	21.7	11.4	12.5	0.0	26.2	24.0	30.6	0.0	0.0	14.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.1	0.0	0.0	10.9	0.0	0.0	0.0	0.0	25.7	0.0	0.0	4.9	0.0	0.0	14.4	24.0	0.0	0.0	0.0	9.8	0.0	0.0	0.0	0.0	20.2	6.5	29.2	0.0	0.0
ENKD1	"C16orf48, DKFZP434A1319, FBB11"	ENSG00000124074	"Enkurin domain containing 1"	Q9H0I2	16	67662945-67667265	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 34.2;Endometrial ciliated cells: 38.3;Respiratory ciliated cells: 42.5;Spermatocytes: 37.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"plasmacytoid DC: 1.3"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041163, HPA041478"	Approved		Approved	"Plasma membrane,Centrosome,Cytosol"		Yes	No			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 22: Non-specific - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 49: Ciliated cells - Cilium organization"	"Plasma membrane, Centrosome"	Cytosol	"HPA041163: AB_10794986, HPA041478: AB_10794668"	"unprognostic (6.02e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.59e-3)"	"prognostic favorable (1.68e-4)"	"unprognostic (4.41e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.78e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.25e-1)"	"unprognostic (5.69e-2)"	"unprognostic (6.58e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.44e-1)"	"unprognostic (3.31e-2)"	"unprognostic (2.23e-1)"	"unprognostic (9.60e-2)"	12.8	12.8	8.4	4.6	8.3	3.5	14.9	22.0	11.5	23.2	13.6	28.6	3.9	21.2	5.6	8.6	30.7	3.6	13.2	8.2	8.6	26.6	11.6	14.7	2.2	9.9	10.9	21.2	67.2	16.0	25.6	3.3	8.4	20.6	2.7	8.5	13.7	9.2	9.5	12.1	11.1	4.4	10.0	11.9	15.9	41.1	9.1	4.7	22.3	1.6	2.5	21.5	14.2	8.5	11.1	7.5	17.2	8.0	5.6	5.8	8.5	8.5	5.1	6.7	8.1	5.5	16.5	4.1	14.3	5.3	0.0	12.7	4.5	10.2	8.2	6.5	10.2	4.1	25.7	13.1	9.1	7.4	5.4	5.1	7.3	9.1	8.2	15.4	5.5	13.3	6.9	2.5	3.5	5.7	8.2	30.9	8.2	11.5	3.0	28.5	1.8	31.3	7.2	1.1	17.4	18.9	18.2	1.8	9.7	3.9	15.8	10.5	14.3	8.1	11.4	15.2	0.1	19.1	9.2	4.5	12.3	10.8	2.5	0.0	0.4	0.0	0.1	0.1	0.4	0.2	0.3	0.2	0.1	0.0	0.2	0.3	0.9	0.2	0.2	1.3	0.0	0.1	8.4	8.3	22.0	11.5	8.2	8.6	9.9	10.9	8.4	10.0	9.1	8.5	8.8	22.4	14.4	8.8	1.7	6.9	5.9	6.2	4.0	3.6	10.4	11.2	5.5	10.0	4.0	9.2	4.2	3.1	1.5	4.4	1.9	13.1	34.2	38.3	10.5	8.6	13.2	2.1	2.1	10.7	2.4	7.5	1.5	9.5	1.3	7.4	10.4	26.4	4.7	3.3	2.2	6.0	2.0	3.2	4.3	20.6	13.1	2.6	5.4	0.0	3.0	8.8	0.0	2.5	1.7	9.5	1.4	14.3	2.6	6.0	1.8	7.3	42.5	10.5	6.6	9.1	8.0	37.0	7.9	1.2	5.3	3.4	1.9	11.6	4.9	4.4
ENO3		ENSG00000108515	"Enolase 3"	P13929	17	4948092-4957131	"Candidate cardiovascular disease genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Glycolysis	Lyase	"Disease variant, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	26	"skeletal muscle: 14758.3;tongue: 10771.0"	"Group enriched"	"Detected in many"	5	"Cardiomyocytes: 582.2;Skeletal myocytes: 248.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 263.8;HeLa: 120.0;HMC-1: 115.1;RH-30: 170.2;RPMI-8226: 96.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000793, HPA068284, HPA068721"	Enhanced		Supported	"Plasma membrane,Cytosol"		Yes	No		86000000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 37: Myocytes - Muscle contraction"	"Plasma membrane, Cytosol"		"HPA000793: AB_1078742, HPA068284: , HPA068721: AB_2732119"	"unprognostic (7.35e-2)"	"unprognostic (5.25e-2)"	"prognostic unfavorable (7.33e-4)"	"unprognostic (1.57e-1)"	"unprognostic (1.29e-1)"	"unprognostic (5.86e-2)"	"unprognostic (5.68e-2)"	"unprognostic (2.08e-2)"	"unprognostic (8.12e-2)"	"unprognostic (1.42e-1)"	"unprognostic (6.04e-3)"	"unprognostic (2.21e-2)"	"unprognostic (4.63e-2)"	"unprognostic (5.34e-2)"	"unprognostic (3.48e-1)"	"unprognostic (2.15e-1)"	"unprognostic (4.50e-2)"	7.8	5.5	3.8	15.6	3.9	20.4	8.0	7.1	4.3	6.6	5.0	8.0	20.1	7.2	7.1	173.8	7.4	2.6	499.8	3.5	3.7	10.3	108.0	8.6	13.0	4.3	5.0	6.0	5.5	4.0	7.9	6.3	4.6	47.3	3.0	5.0	116.8	3.1	14758.3	8.3	15.6	2.8	4.1	16.9	10.1	9.3	4.3	5.8	10.3	10771.0	4.9	5.6	5.0	4.9	12.0	25.5	11.3	10.7	9.1	2.2	27.6	21.0	2.7	1.5	1.3	12.8	8.1	21.9	25.8	1.9	3.5	15.4	3.8	1.9	1.0	263.8	24.3	21.9	120.0	18.9	3.7	6.8	115.1	14.4	3.8	2.1	4.1	9.8	1.4	24.8	10.2	39.0	4.9	6.6	7.9	26.5	14.8	3.3	10.6	34.6	170.2	96.9	3.1	7.9	7.1	27.1	13.6	11.4	14.7	7.6	10.2	7.0	6.5	12.1	21.3	5.4	16.0	27.6	16.8	18.2	6.7	20.8	12.2	31.4	28.5	50.4	36.8	41.5	24.8	24.5	30.8	34.4	37.6	20.1	20.0	32.2	34.4	34.9	47.6	29.9	43.2	83.6	3.8	3.9	7.1	4.3	3.5	3.7	4.3	5.0	4.6	4.1	4.3	4.9	1.2	0.0	1.8	2.3	2.7	2.0	1.2	2.1	4.0	6.6	3.0	3.0	582.2	0.0	2.2	5.5	4.2	5.4	3.2	2.9	0.0	1.5	1.8	0.9	1.6	7.3	0.0	3.8	0.2	0.8	3.8	17.3	4.6	2.2	8.2	2.4	2.2	56.2	4.5	3.3	0.2	2.2	2.0	3.5	6.7	3.7	0.3	4.3	1.8	0.0	78.3	1.9	4.1	1.0	0.5	1.8	1.9	0.4	2.3	1.2	6.6	9.5	0.3	2.5	6.6	248.4	55.8	7.9	7.5	2.1	1.8	3.3	4.5	1.1	2.6	0.8
ERCC6	"ARMD5, CKN2, CSB, RAD26"	ENSG00000225830	"ERCC excision repair 6, chromatin remodeling factor"	"P0DP91, Q03468"	10	49454168-49539538	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Neurogenesis, Transcription, Transcription regulation"	"DNA-binding, Helicase, Hydrolase"	"Age-related macular degeneration, Cancer-related genes, Cataract, Cockayne syndrome, Deafness, Disease variant, Dwarfism, Mental retardation, Premature ovarian failure, Xeroderma pigmentosum"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 53.8;hTERT-RPE1: 123.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071297			Approved	"Nucleoplasm,Nuclear bodies"		Yes	No			"Cluster 6: Non-specific - Transcription"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	"Nuclear bodies"	"HPA071297: AB_2732177"	"unprognostic (1.92e-2)"	"unprognostic (1.85e-1)"	"unprognostic (9.79e-3)"	"unprognostic (7.26e-2)"	"unprognostic (5.45e-2)"	"unprognostic (2.95e-2)"	"unprognostic (3.03e-2)"	"unprognostic (2.99e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.80e-1)"	"unprognostic (4.57e-2)"	"unprognostic (1.04e-1)"	"unprognostic (8.61e-2)"	"unprognostic (4.75e-2)"	"unprognostic (1.73e-1)"	"unprognostic (7.05e-2)"	2.7	2.1	1.6	1.9	1.5	4.6	3.8	3.0	2.3	3.1	7.7	2.4	2.0	3.0	1.5	3.8	2.9	2.7	3.4	1.2	1.1	3.2	3.3	2.7	2.9	2.4	1.9	4.5	3.1	5.9	2.8	3.4	2.1	3.3	2.7	3.1	3.2	2.2	3.5	4.6	2.5	2.3	2.2	2.9	2.4	3.1	2.1	3.3	5.1	3.6	3.4	2.6	3.3	1.9	11.2	5.5	4.1	2.1	6.6	10.5	3.4	21.2	27.1	14.1	9.9	6.2	5.6	4.9	3.7	18.7	6.7	9.5	6.3	16.6	13.5	8.4	4.1	3.9	21.7	3.4	3.9	5.0	3.7	4.3	17.2	12.9	53.8	123.4	19.8	2.9	6.8	0.8	16.8	8.3	3.4	2.0	4.0	3.5	10.2	2.3	5.8	2.6	4.1	7.1	5.9	4.7	15.4	3.6	8.2	9.4	7.1	2.7	38.9	7.0	5.5	8.6	5.2	3.3	4.5	4.1	7.3	5.0	5.1	13.1	3.0	7.5	4.1	2.6	3.0	6.8	2.3	2.2	3.9	5.2	2.8	1.4	7.2	1.2	5.3	2.2	3.1	1.8	1.6	1.5	3.0	2.3	1.2	1.1	2.4	1.9	2.1	2.2	2.1	1.9	6.9	16.0	13.2	14.7	6.0	3.6	1.4	1.5	5.2	0.0	7.1	7.1	7.1	5.7	8.2	9.2	0.0	2.5	10.9	4.8	5.9	5.2	11.3	8.1	8.7	5.1	1.2	1.3	24.3	6.0	2.1	4.9	2.0	10.1	7.6	8.9	5.3	4.3	2.6	0.0	21.7	5.3	0.0	4.4	2.6	15.3	2.8	8.0	1.8	23.4	11.2	0.0	4.1	17.6	16.6	5.2	2.6	2.2	3.6	2.5	5.0	3.6	9.0	0.0	6.6	4.4	4.2	5.3	5.0	3.5	4.1	1.8	7.4	11.4	2.8	1.9
ESCO2	"EFO2, RBS"	ENSG00000171320	"Establishment of sister chromatid cohesion N-acetyltransferase 2"	Q56NI9	8	27771949-27812640	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Cell cycle"	"Acyltransferase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 6.0;intestine: 11.0;lymphoid tissue: 8.5;testis: 5.7"	"Group enriched"	"Detected in many"	4	"Erythroid cells: 44.6;Spermatocytes: 62.0;Spermatogonia: 80.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"T-reg: 1.3"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"HPA027243, HPA053679"			Supported	"Nucleoplasm,Golgi apparatus,Cell Junctions"		Yes	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Golgi apparatus"	"Cell Junctions"	"HPA027243: AB_2672175, HPA053679: AB_2682227"	"unprognostic (7.86e-2)"	"unprognostic (1.50e-2)"	"prognostic favorable (1.04e-4)"	"unprognostic (5.13e-3)"	"unprognostic (9.50e-2)"	"unprognostic (8.67e-3)"	"unprognostic (7.30e-4)"	"unprognostic (5.24e-3)"	"unprognostic (2.24e-2)"	"unprognostic (2.54e-2)"	"unprognostic (7.51e-4)"	"unprognostic (2.23e-1)"	"unprognostic (1.65e-14)"	"unprognostic (6.65e-3)"	"unprognostic (5.32e-1)"	"unprognostic (5.85e-2)"	"unprognostic (4.06e-1)"	0.5	0.4	0.0	2.7	0.2	6.0	1.2	0.4	0.2	0.5	0.0	3.7	11.0	0.6	0.0	2.4	0.2	0.6	0.2	0.0	0.0	0.1	0.7	0.4	4.6	0.0	0.0	0.1	1.0	0.3	0.0	1.1	0.1	0.3	4.3	0.5	0.3	0.1	0.0	1.1	7.9	0.7	0.0	0.8	2.5	5.7	0.0	8.5	0.3	0.2	5.7	0.8	0.5	0.2	54.6	39.9	17.9	22.0	2.3	3.9	10.2	31.6	12.9	27.8	32.5	14.2	10.7	21.0	16.6	8.3	24.7	29.2	22.0	8.5	43.6	15.8	9.2	24.4	16.2	15.3	0.3	12.5	21.4	0.7	0.9	17.0	4.2	3.0	11.6	15.2	20.0	30.0	17.7	10.5	49.8	5.9	12.2	29.9	13.4	21.7	53.0	14.8	9.6	31.9	8.0	11.7	15.5	19.6	7.9	6.5	13.2	14.1	5.2	17.9	37.0	36.2	25.7	4.0	11.1	25.2	10.2	20.5	25.2	0.0	0.2	0.1	0.0	0.4	0.0	0.4	0.2	0.2	0.6	0.0	0.1	0.1	0.2	0.3	0.1	0.0	1.3	0.3	0.0	0.2	0.4	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.3	0.0	4.7	0.0	2.4	2.3	0.6	2.1	1.8	1.2	1.5	1.7	1.2	0.0	3.3	0.0	4.2	4.6	1.3	8.2	0.0	0.4	5.4	1.3	2.6	1.0	1.2	44.6	0.3	0.0	6.6	3.2	5.6	3.1	1.3	11.4	1.4	1.5	5.4	0.0	0.4	4.4	2.0	2.5	3.5	0.8	1.8	3.2	0.0	1.0	0.5	0.1	4.1	1.0	0.9	0.1	1.5	0.0	11.5	0.6	15.1	0.1	1.6	2.0	6.6	0.8	2.3	62.0	80.0	6.8	0.6	1.0	3.1	1.8	8.0	1.4
ETNPPL	AGXT2L1	ENSG00000164089	"Ethanolamine-phosphate phospho-lyase"	Q8TBG4	4	108742048-108763054	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 155.6;liver: 191.1"	"Cell type enriched"	"Detected in some"	8	"Astrocytes: 219.4"	"Group enriched"	"Detected in some"	23	"glioma: 7.9;liver cancer: 21.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HeLa: 5.7;Hep G2: 2.3;NTERA-2: 1.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044546, HPA072938"	Supported		Approved	Nucleoplasm		Yes	NA				"Cluster 15: Liver - Metabolism"	"Cluster 20: HeLa - Mitochondria"	"Cluster 64: Astrocytes - Nervous system maintenance"	Nucleoplasm		"HPA044546: AB_10962867, HPA072938: AB_2686560"	"unprognostic (5.20e-3)"	"unprognostic (1.33e-1)"		"unprognostic (3.93e-1)"	"prognostic favorable (9.52e-5)"		"unprognostic (5.93e-3)"	"unprognostic (3.91e-2)"	"unprognostic (2.82e-1)"	"unprognostic (6.32e-2)"	"unprognostic (2.70e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.40e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.42e-2)"	"unprognostic (9.48e-2)"	0.3	5.5	155.6	0.1	155.6	0.0	0.1	98.4	144.3	0.1	47.4	0.0	0.2	0.3	0.0	0.1	0.0	0.2	10.6	124.4	145.8	9.1	191.1	0.1	0.0	100.7	118.1	0.1	0.0	2.9	1.9	0.0	110.3	0.0	0.0	1.7	34.4	0.1	2.4	0.0	0.0	0.0	101.2	0.7	18.3	0.5	119.8	0.1	1.1	1.5	0.0	0.0	0.0	101.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.5	0.0	5.7	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	155.6	155.6	98.4	144.3	124.4	145.8	100.7	118.1	110.3	101.2	119.8	101.3	0.0	0.0	0.0	219.4	0.2	0.0	0.0	0.0	0.0	0.0	1.2	0.0	14.2	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.2	0.4	0.0	0.0	0.4	0.0	0.0	0.5	1.5	0.4	0.0	0.0	0.7	26.8	0.0	0.0	0.6	0.0	0.0	1.6	0.0	1.7	0.0	0.0	0.0	7.5	0.0	8.5	0.0	1.5	0.7	0.0	0.0	0.0	0.1	0.0	0.0	7.9	0.0	0.2	0.0	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1
EYA3	DKFZp686C132	ENSG00000158161	"EYA transcriptional coactivator and phosphatase 3"	Q99504	1	27970344-28088637	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"	"Activator, Chromatin regulator, Developmental protein, Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 80.2;Oligodendrocytes: 80.5;Spermatocytes: 98.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052432, HPA062889"	Uncertain		Supported	Nucleoplasm		Yes	No			"Cluster 49: Eosinophils - Unknown function"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm		"HPA052432: AB_2681831, HPA062889: AB_2684895"	"unprognostic (3.57e-1)"	"unprognostic (2.61e-1)"	"unprognostic (2.85e-1)"	"unprognostic (8.74e-2)"	"unprognostic (1.39e-1)"	"prognostic favorable (5.11e-4)"	"unprognostic (1.39e-3)"	"unprognostic (2.21e-1)"	"unprognostic (4.81e-2)"	"unprognostic (1.00e-1)"	"unprognostic (9.13e-2)"	"unprognostic (8.98e-2)"	"prognostic favorable (3.15e-6)"	"unprognostic (5.17e-2)"	"unprognostic (2.79e-1)"	"unprognostic (7.60e-2)"	"unprognostic (6.11e-2)"	4.7	4.8	7.4	8.2	7.0	5.2	7.1	8.8	7.9	7.4	9.6	5.7	5.9	6.1	6.4	9.9	6.2	4.3	6.4	6.5	7.6	11.6	6.0	5.9	9.4	7.1	7.1	6.4	6.5	8.3	7.6	7.7	7.2	6.1	6.2	10.5	5.6	5.4	7.1	9.0	6.3	5.5	6.4	7.2	5.5	11.4	7.6	9.4	9.3	8.3	14.4	7.1	6.1	7.9	16.3	6.6	13.1	9.7	14.9	11.6	7.3	11.8	11.0	13.2	12.9	6.4	9.5	25.5	12.3	7.8	4.9	15.3	24.4	9.5	15.6	13.4	13.5	28.2	14.4	11.6	8.8	27.9	25.2	7.0	8.3	14.6	9.7	11.3	17.0	9.0	26.9	9.6	11.9	7.0	18.0	18.5	27.5	12.6	8.6	13.2	24.9	16.8	15.3	8.8	14.9	8.2	12.6	7.6	11.0	10.5	6.2	7.3	16.6	15.9	8.4	15.1	9.4	13.9	15.2	22.0	11.5	26.7	7.0	5.7	6.8	7.3	7.5	6.9	6.7	5.2	5.8	5.4	8.3	4.6	4.9	5.6	6.4	7.1	6.1	5.1	5.4	1.9	7.4	7.0	8.8	7.9	6.5	7.6	7.1	7.1	7.2	6.4	7.6	7.9	12.6	9.6	10.8	46.4	17.5	17.8	11.3	10.0	9.6	18.3	12.0	7.1	9.2	12.8	7.9	25.8	16.7	13.0	10.6	8.2	15.6	13.5	80.2	13.6	13.2	12.9	20.4	9.9	66.0	8.9	14.4	11.6	16.8	15.3	12.0	15.8	14.6	8.7	9.7	18.5	58.8	9.1	12.2	13.3	46.1	39.1	10.2	14.6	12.4	39.4	12.9	8.1	10.3	45.2	80.5	14.5	10.9	6.0	13.7	12.0	13.8	18.0	5.7	20.6	13.1	11.1	8.4	98.7	50.6	10.7	22.9	10.9	15.8	9.6	10.5	11.7
FAM117B	"ALS2CR13, FLJ38771"	ENSG00000138439	"Family with sequence similarity 117 member B"	Q6P1L5	2	202634969-202769757	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 45.8;Inhibitory neurons: 49.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003229, HPA028746"	Uncertain		Approved	Nucleoplasm,Centrosome		Yes	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm	Centrosome	"HPA003229: AB_2246696, HPA028746: AB_2672760"	"unprognostic (1.39e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.53e-2)"	"unprognostic (4.59e-2)"	"unprognostic (1.07e-2)"	"unprognostic (4.07e-3)"	"unprognostic (1.55e-2)"	"unprognostic (4.84e-2)"	"unprognostic (6.21e-2)"	"unprognostic (2.55e-2)"	"unprognostic (8.40e-3)"	"unprognostic (5.75e-1)"	"unprognostic (6.01e-2)"	"unprognostic (8.93e-2)"	"unprognostic (3.18e-1)"	"unprognostic (8.59e-2)"	"unprognostic (1.37e-3)"	3.1	7.5	5.1	4.5	5.4	2.9	3.3	7.0	7.1	2.7	0.7	4.9	4.3	2.9	2.9	5.4	3.8	3.0	1.8	5.0	6.3	4.9	1.9	2.9	7.2	3.1	3.8	5.1	4.6	7.3	3.5	6.9	3.6	5.1	4.7	2.6	3.3	3.0	1.5	5.0	3.7	2.0	3.3	5.4	4.1	5.8	6.4	9.6	2.8	1.8	7.4	3.8	3.2	4.1	2.0	2.4	10.5	7.2	3.5	1.9	10.2	0.6	0.9	0.6	1.1	3.1	4.2	8.2	6.5	1.2	1.6	1.9	9.0	4.6	1.7	0.2	7.2	6.9	4.3	11.6	2.8	5.9	3.0	2.6	6.3	1.3	1.9	4.7	2.8	10.8	10.1	1.6	0.6	3.9	16.1	12.1	10.7	5.8	4.5	12.5	2.1	9.8	5.5	5.2	17.7	15.4	8.0	5.3	3.9	8.7	2.2	8.1	1.7	1.2	2.4	1.9	1.1	5.9	3.6	10.8	2.4	4.5	1.3	0.4	3.9	1.5	1.3	8.2	3.4	8.1	3.0	2.7	4.5	7.7	8.2	5.7	2.2	4.4	9.1	1.5	1.2	3.1	5.1	5.4	7.0	7.1	5.0	6.3	3.1	3.8	3.6	3.3	6.4	4.1	9.7	3.2	7.5	13.1	21.5	17.2	2.9	3.0	12.0	4.9	8.1	4.3	4.9	12.8	2.6	18.4	4.2	8.4	8.8	11.7	0.0	10.2	2.2	8.6	6.5	4.9	25.8	3.0	45.8	6.4	6.3	6.1	7.1	10.1	5.7	15.3	8.2	2.2	2.8	6.7	49.7	11.8	2.0	27.4	13.9	1.4	13.1	17.1	3.6	23.4	17.1	1.7	3.1	29.1	29.4	5.8	9.7	23.7	5.2	6.7	4.9	5.9	3.0	2.7	6.6	2.0	4.1	5.0	16.3	29.2	19.9	2.7	10.1	11.1	13.8	6.0
FAM3A	"2-19, DXS560S, XAP-7"	ENSG00000071889	"FAM3 metabolism regulating signaling molecule A"	P98173	X	154506159-154516242	"Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal enterocytes: 116.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"EFO-21: 109.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025016, HPA035268, HPA056991"	Uncertain		Approved	"Nucleoplasm,Nucleoli rim,Mitotic chromosome"	"Secreted to blood"	Yes	No		15000	"Cluster 27: Non-specific - Gene expression"	"Cluster 35: Non-specific - Unknown function"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 45: Enterocytes - Digestion"	"Nucleoli rim"	"Nucleoplasm, Mitotic chromosome"	"CAB025016: , HPA035268: , HPA056991: AB_2683303"	"unprognostic (1.60e-1)"	"unprognostic (2.72e-2)"	"prognostic unfavorable (1.76e-4)"	"unprognostic (3.19e-2)"	"unprognostic (4.73e-2)"	"unprognostic (5.19e-2)"	"unprognostic (2.54e-2)"	"unprognostic (2.57e-2)"	"unprognostic (2.53e-1)"	"unprognostic (6.27e-2)"	"unprognostic (3.42e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.31e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.41e-1)"	"unprognostic (4.04e-1)"	"unprognostic (9.71e-2)"	28.4	37.3	43.5	11.3	49.1	11.3	27.6	50.8	51.3	44.6	38.8	35.3	28.0	36.0	7.7	41.3	38.9	8.4	58.7	40.6	45.8	38.6	63.1	26.8	9.4	52.2	47.6	51.5	52.0	14.8	40.9	10.1	47.8	39.1	6.8	6.1	28.5	12.7	36.8	31.1	33.8	7.4	46.9	28.2	36.1	10.0	46.4	12.1	39.9	13.7	5.5	35.8	35.3	58.1	44.4	41.1	10.3	34.5	30.3	15.4	28.8	22.3	15.1	14.8	17.6	19.1	26.2	28.5	109.2	36.8	29.0	31.6	16.2	19.3	3.6	23.4	21.7	11.2	36.9	13.8	47.2	7.6	17.6	19.0	17.5	30.7	21.4	17.7	10.5	18.1	21.6	20.5	17.3	46.3	14.2	32.7	4.6	47.8	52.4	17.3	10.4	79.6	16.6	18.0	20.4	15.6	10.3	24.4	37.3	7.4	18.7	11.8	12.0	19.9	12.0	54.7	30.6	77.6	46.5	36.0	36.4	19.6	20.8	23.4	10.8	15.2	13.4	12.7	13.2	6.1	8.6	9.6	11.0	8.7	10.0	12.0	5.8	10.6	11.3	14.6	9.1	10.1	43.5	49.1	50.8	51.3	40.6	45.8	52.2	47.6	47.8	46.9	46.4	58.1	23.5	12.8	16.7	13.1	16.9	16.3	23.4	29.2	22.8	25.4	21.9	24.9	21.9	22.8	16.3	22.0	14.6	47.0	19.3	60.2	27.4	27.6	1.0	13.4	18.3	18.3	17.5	29.9	7.1	42.5	50.0	28.4	50.0	15.0	5.7	34.8	23.6	30.3	29.8	21.9	9.4	58.9	18.3	16.4	15.3	2.8	33.5	18.0	33.8	6.5	17.6	28.9	24.7	11.1	14.3	28.2	57.5	29.3	32.5	28.7	116.2	33.1	12.7	20.4	6.6	26.7	24.5	5.2	10.1	32.1	21.2	71.3	19.3	23.7	39.7	22.9
FBXL6	FBL6	ENSG00000182325	"F-box and leucine rich repeat protein 6"	Q8N531	8	144355431-144359376	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Proximal enterocytes: 43.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"non-classical monocyte: 1.6"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008867			Approved	Nucleoplasm,Vesicles		Yes	No			"Cluster 14: Monocytes - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 45: Enterocytes - Digestion"	Nucleoplasm	Vesicles	"HPA008867: AB_2668161"	"unprognostic (2.97e-2)"	"unprognostic (3.30e-2)"	"unprognostic (1.13e-3)"	"unprognostic (3.13e-1)"	"unprognostic (9.88e-2)"	"unprognostic (1.68e-1)"	"unprognostic (6.29e-3)"	"unprognostic (2.62e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.43e-2)"	"unprognostic (9.04e-2)"	"unprognostic (9.73e-2)"	"prognostic unfavorable (4.49e-10)"	"unprognostic (3.93e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.53e-1)"	"unprognostic (2.00e-1)"	4.6	4.8	2.3	1.4	2.3	2.0	4.9	2.5	3.2	4.3	2.5	8.0	4.6	3.5	0.6	7.2	3.1	1.0	4.1	2.3	2.2	4.6	10.8	3.9	1.8	2.5	2.4	2.1	8.1	1.6	3.8	1.8	2.4	4.2	1.8	0.5	5.1	1.6	4.2	6.6	7.8	0.7	2.4	6.8	5.5	5.2	2.6	1.5	3.3	0.3	1.2	4.6	4.3	2.3	9.0	3.0	2.1	13.3	2.7	0.7	3.8	4.4	5.1	4.5	3.1	3.2	3.9	4.1	5.3	2.2	2.2	5.8	2.4	6.1	1.0	7.6	3.0	8.2	1.6	7.9	4.0	2.1	8.4	1.2	5.5	2.5	6.6	1.2	3.7	6.7	3.8	6.6	1.7	16.7	6.0	1.9	2.6	9.8	8.3	6.7	2.4	14.0	6.0	3.0	3.1	3.0	5.1	8.0	7.7	1.2	13.2	3.7	3.3	2.2	8.1	10.8	5.4	2.5	2.1	3.0	3.4	5.1	2.9	0.0	0.1	0.6	0.4	0.4	0.3	0.2	0.2	0.2	0.1	0.1	0.0	0.1	0.0	0.3	1.6	0.7	0.0	0.0	2.3	2.3	2.5	3.2	2.3	2.2	2.5	2.4	2.4	2.4	2.6	2.3	17.9	6.4	2.0	4.6	10.1	5.7	6.0	2.1	7.4	9.9	13.2	12.8	1.1	7.2	4.6	0.0	14.6	8.3	17.3	18.2	5.9	5.2	1.9	5.2	6.8	5.9	2.4	3.0	7.4	6.2	11.6	5.2	13.7	7.8	1.3	7.7	6.8	6.7	6.9	1.7	5.6	19.4	2.0	4.7	7.6	1.6	5.3	9.0	5.4	4.7	2.6	7.9	6.2	2.0	2.7	7.5	10.8	1.9	20.1	8.2	43.7	8.1	2.0	9.0	0.0	5.1	13.6	5.0	7.8	14.8	6.7	3.8	10.7	9.9	17.3	6.3
FCHSD2	"KIAA0769, SH3MD3"	ENSG00000137478	"FCH and double SH3 domains 2"	O94868	11	72836745-73142318	"Predicted intracellular proteins"	"Endocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Inhibitory neurons: 219.6;Microglial cells: 387.8;Oligodendrocyte precursor cells: 471.0;Oligodendrocytes: 198.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RPMI-8226: 164.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038545, HPA038546"	Uncertain		Approved	"Nuclear speckles,Plasma membrane,Actin filaments,Focal adhesion sites"		Yes	No			"Cluster 10: Basophils - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 68: Oligodendrocytes - Mixed function"	"Plasma membrane, Actin filaments"	"Nuclear speckles, Focal adhesion sites"	"HPA038545: AB_2676074, HPA038546: AB_10673013"	"unprognostic (1.80e-2)"	"unprognostic (1.50e-2)"	"prognostic favorable (1.71e-4)"	"unprognostic (1.63e-1)"	"unprognostic (3.14e-2)"	"unprognostic (2.62e-3)"	"unprognostic (1.41e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.27e-2)"	"unprognostic (2.56e-1)"	"unprognostic (3.69e-2)"	"unprognostic (6.16e-2)"	"unprognostic (2.89e-3)"	"unprognostic (2.02e-1)"	"unprognostic (4.70e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.23e-1)"	22.2	19.2	43.3	33.4	47.9	28.6	16.8	31.5	38.7	14.9	34.6	14.5	8.9	16.0	6.9	11.7	13.8	22.6	25.5	37.0	44.5	13.0	17.6	23.9	45.2	36.6	36.4	32.3	10.4	9.9	8.1	31.2	35.4	11.6	14.4	19.6	9.3	13.8	8.8	9.0	17.7	17.2	32.5	42.3	13.1	22.6	41.3	28.5	14.9	14.7	46.1	21.6	11.7	45.0	14.2	12.3	26.0	31.3	9.8	23.9	21.8	26.7	50.6	14.8	12.0	9.6	21.0	76.3	31.3	31.0	15.6	20.0	15.3	14.1	21.0	27.2	7.0	64.2	14.3	33.4	25.7	30.6	7.6	14.6	15.6	15.1	17.7	33.4	35.7	26.7	13.7	49.6	19.5	16.1	36.4	54.7	5.5	15.6	13.8	56.4	39.8	164.1	24.8	21.4	13.1	16.9	9.6	16.2	31.9	12.2	12.4	23.7	47.9	45.9	18.5	32.9	7.5	46.8	29.4	71.2	8.4	51.4	13.8	18.3	8.4	18.7	2.8	5.1	1.9	22.2	2.8	3.2	8.1	26.9	3.2	4.1	19.9	2.0	3.0	32.3	3.2	3.6	43.3	47.9	31.5	38.7	37.0	44.5	36.6	36.4	35.4	32.5	41.3	45.0	47.3	9.6	14.0	114.9	76.7	8.5	5.2	3.6	9.1	13.5	5.9	4.7	16.0	8.6	6.1	3.7	25.0	12.4	39.4	1.9	1.9	4.1	6.2	6.6	8.3	30.2	4.8	19.4	79.4	6.2	9.2	9.4	7.7	5.4	2.5	33.6	46.1	11.3	19.9	10.1	219.6	7.7	4.1	30.8	29.9	10.0	10.8	32.8	5.4	387.8	20.6	10.6	5.2	471.0	198.1	5.3	5.7	16.6	70.1	3.8	1.8	3.5	3.9	17.0	6.6	13.0	26.1	9.6	13.0	7.1	5.8	12.0	14.9	6.0	3.7	4.8
FLI1	"EWSR2, SIC-1"	ENSG00000151702	"Fli-1 proto-oncogene, ETS transcription factor"	Q01543	11	128686535-128813267	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Disease variant, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 35.8"	"Cell type enhanced"	"Detected in many"		"B-cells: 65.7;Endothelial cells: 84.2;Hepatic stellate cells: 64.6;Kupffer cells: 86.4;Microglial cells: 231.4;monocytes: 68.4;NK-cells: 93.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 113.9;HUVEC TERT2: 60.5;REH: 49.8;TIME: 63.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065030, HPA073099"	Approved		Supported	"Nucleoplasm,Nuclear bodies"		Yes	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 36: HEL - Hemostasis"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nucleoplasm, Nuclear bodies"		"HPA065030: , HPA073099: AB_2686572"	"unprognostic (1.38e-2)"	"unprognostic (7.46e-2)"	"unprognostic (6.16e-2)"	"unprognostic (3.74e-2)"	"unprognostic (6.22e-2)"	"unprognostic (4.26e-3)"	"unprognostic (1.33e-1)"	"unprognostic (8.32e-3)"	"unprognostic (2.97e-1)"	"unprognostic (9.91e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.42e-1)"	"prognostic unfavorable (4.60e-4)"	"unprognostic (4.79e-2)"	"unprognostic (2.07e-2)"	"unprognostic (2.62e-1)"	"unprognostic (4.79e-2)"	10.2	1.9	3.7	10.9	2.3	12.2	6.0	2.1	2.8	5.7	1.2	3.7	3.2	4.6	1.1	2.8	2.7	6.1	6.2	1.8	2.9	2.1	2.8	10.8	12.3	4.7	2.7	1.2	1.7	3.5	0.7	12.5	4.3	1.9	2.9	0.5	2.2	2.2	2.8	1.7	4.0	5.9	3.5	35.8	4.3	0.9	3.9	17.2	2.9	6.6	10.4	6.7	1.9	2.8	0.2	0.0	5.6	0.0	0.8	1.0	0.1	3.3	9.2	3.8	3.1	0.0	0.0	18.5	31.7	11.1	1.1	0.1	0.8	13.5	4.1	9.0	0.2	113.9	0.5	0.0	6.0	13.7	14.6	0.8	1.1	7.7	17.3	11.1	60.5	25.6	0.0	23.3	0.8	0.0	13.3	8.1	1.8	0.0	3.1	49.8	0.1	19.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	5.0	0.0	20.4	63.0	0.7	0.0	0.2	3.5	7.3	16.4	16.6	0.1	31.8	5.2	34.5	15.5	24.5	10.1	15.3	11.9	6.8	8.9	8.2	19.1	6.0	3.7	8.2	11.8	12.3	19.1	3.3	11.1	20.1	3.7	2.3	2.1	2.8	1.8	2.9	4.7	2.7	4.3	3.5	3.9	2.8	53.4	6.4	5.3	0.3	65.7	5.1	0.3	1.7	2.2	0.0	0.7	1.3	5.5	5.7	0.1	1.8	0.0	0.4	43.1	0.0	0.0	0.0	0.5	0.4	0.6	84.2	0.0	23.4	0.3	0.0	0.4	5.9	2.0	0.3	22.8	0.0	64.6	1.3	43.2	0.0	1.5	0.1	0.0	86.4	24.7	0.5	1.8	60.3	7.2	231.4	68.4	0.1	93.7	4.0	0.7	0.0	0.0	0.7	56.9	0.3	0.0	0.4	0.8	0.4	6.6	2.1	3.1	0.2	0.1	0.6	4.1	0.3	52.8	0.9	0.2	0.4
FOS	"AP-1, c-fos"	ENSG00000170345	"Fos proto-oncogene, AP-1 transcription factor subunit"	P01100	14	75278826-75282230	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"		DNA-binding	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	6	"neutrophil: 504.8"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 504.8"	"Cell line enhanced"	"Detected in many"		"hTCEpi: 453.1;OE19: 170.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"cerebellum: 80.9;spinal cord: 235.3"	HPA018531	Approved		Supported	Nucleoplasm		Yes	No			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm		"HPA018531: AB_1846576"	"unprognostic (1.18e-2)"	"unprognostic (8.70e-2)"	"unprognostic (1.61e-1)"	"unprognostic (3.80e-1)"	"unprognostic (3.08e-2)"	"unprognostic (4.82e-2)"	"unprognostic (2.09e-1)"	"unprognostic (3.30e-1)"	"unprognostic (9.55e-3)"	"unprognostic (4.20e-3)"	"unprognostic (1.04e-1)"	"prognostic favorable (7.81e-4)"	"unprognostic (3.20e-2)"	"unprognostic (1.52e-2)"	"unprognostic (3.22e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.66e-2)"	1136.1	735.7	62.9	576.0	87.2	2270.6	477.4	184.8	113.1	700.5	111.5	479.5	235.3	410.4	58.4	1250.8	1777.3	1160.0	513.1	58.9	190.7	266.1	308.8	486.9	449.9	145.1	84.0	1188.7	298.4	264.7	452.3	417.4	92.0	791.1	627.4	233.3	555.6	462.3	99.1	1645.4	584.5	964.3	100.6	178.0	525.6	87.2	104.4	424.2	1007.6	1014.2	26.8	946.5	346.6	121.7	2.2	1.4	7.1	10.4	59.9	18.3	42.1	6.4	2.4	4.5	3.2	4.4	12.6	0.6	1.8	43.5	42.6	3.0	3.6	74.7	1.1	1.2	1.1	1.0	21.9	1.9	27.6	2.6	42.8	44.3	453.1	3.9	27.4	6.2	2.7	9.2	2.0	19.7	1.2	26.1	0.9	12.9	7.4	170.9	2.5	2.0	1.4	23.8	18.8	20.4	52.4	3.6	9.8	85.9	39.8	21.8	1.4	9.2	6.3	0.4	5.7	3.7	2.0	52.4	61.2	9.6	2.9	8.0	5.7	38.3	81.0	89.5	0.3	20.1	0.4	0.3	0.2	0.7	69.6	0.2	0.2	0.1	504.8	4.6	2.5	1.5	0.4	27.7	62.9	87.2	184.8	113.1	58.9	190.7	145.1	84.0	92.0	100.6	104.4	121.7	3911.0	1102.6	1859.4	137.1	1015.9	859.7	1644.7	1577.5	4336.7	106.1	3184.1	2874.6	1027.6	1416.9	752.7	191.3	129.3	1506.7	1323.5	1648.6	17.6	690.9	17.4	1834.4	3720.3	1624.0	1628.0	290.5	4.9	528.1	2694.6	4146.8	2049.5	3656.5	1630.6	751.3	1317.2	207.2	1693.8	35.3	3.0	1967.2	793.5	2600.2	1540.4	53.5	943.8	2910.7	855.6	58.1	269.5	1119.5	10.3	6.0	1.8	383.5	1507.8	178.3	1256.1	1115.7	1675.1	20.0	354.4	406.9	1209.6	3390.9	2705.7	10.0	10.5	2438.0	1092.4	2283.3	1497.0	417.4	1366.2	298.4
FOXQ1	HFH1	ENSG00000164379	"Forkhead box Q1"	Q9C009	6	1312098-1314758	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"stomach 1: 107.2;urinary bladder: 53.5"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 60.4;Basal respiratory cells: 24.9;Collecting duct cells: 40.5;Gastric mucus-secreting cells: 67.2;Suprabasal keratinocytes: 45.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 39.0;HaCaT: 44.7;Hep G2: 93.8;OE19: 117.1;RT4: 38.2"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA059700			Supported	Nucleoplasm		Yes	NA				"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 61: Squamous epithelial cells - Keratinization"	Nucleoplasm		"HPA059700: AB_2684107"	"unprognostic (2.04e-3)"	"unprognostic (3.44e-1)"	"unprognostic (1.10e-1)"	"unprognostic (7.18e-2)"	"unprognostic (1.50e-3)"	"unprognostic (2.15e-1)"	"unprognostic (3.26e-2)"	"unprognostic (1.15e-3)"	"unprognostic (1.04e-2)"	"unprognostic (1.06e-1)"	"unprognostic (7.65e-3)"	"prognostic favorable (6.68e-4)"	"unprognostic (1.49e-2)"	"unprognostic (3.16e-3)"	"unprognostic (2.82e-1)"	"unprognostic (3.93e-2)"	"unprognostic (1.96e-2)"	0.3	0.0	6.9	0.2	5.2	0.0	1.4	7.1	7.1	6.7	3.8	0.8	10.4	0.9	0.3	11.3	3.9	5.4	0.0	4.7	5.1	9.8	6.4	4.0	0.0	5.6	6.0	0.0	6.5	0.1	2.5	1.1	6.0	8.9	0.4	0.1	30.4	1.1	0.2	25.7	0.6	0.0	5.3	0.0	107.2	0.2	7.5	0.6	3.6	0.6	8.0	53.5	16.9	4.7	16.0	1.4	0.0	0.0	0.0	0.0	0.0	0.7	13.5	0.1	0.1	39.0	22.6	0.0	0.7	0.0	0.1	44.7	0.0	1.7	0.0	0.0	1.1	0.0	8.2	93.8	0.0	0.0	2.4	0.0	16.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	117.1	0.8	0.0	0.0	0.0	0.4	38.2	0.3	0.0	3.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	15.5	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.9	5.2	7.1	7.1	4.7	5.1	5.6	6.0	6.0	5.3	7.5	4.7	0.3	16.0	10.6	0.0	0.0	60.4	3.2	24.9	6.8	0.0	5.3	5.1	0.8	0.0	16.8	40.5	0.0	0.0	0.0	0.0	1.9	3.0	0.0	5.2	3.0	0.4	0.0	0.0	1.2	13.4	0.0	1.4	67.2	14.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.1	0.0	2.9	0.0	0.0	0.7	1.8	15.9	0.0	0.0	0.0	0.0	0.5	11.8	0.0	0.0	0.2	0.6	0.0	6.2	5.0	0.0	0.0	0.0	1.6	0.0	0.0	22.2	45.5	0.0	0.3	0.0	0.0	3.9
GAS2		ENSG00000148935	"Growth arrest specific 2"	O43903	11	22625509-22813055	"Predicted intracellular proteins"	"Apoptosis, Cell cycle, Cell shape, Growth arrest"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"liver: 39.7"	"Group enriched"	"Detected in some"	4	"Astrocytes: 39.8;Excitatory neurons: 114.9;Inhibitory neurons: 141.9;Oligodendrocytes: 83.9"	"Cancer enhanced"	"Detected in many"		"liver cancer: 4.0"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"Hep G2: 43.2;JURKAT: 24.0;Karpas-707: 85.2;SCLC-21H: 24.8;U-266/84: 30.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058904	Enhanced		Approved	"Nucleoplasm,Nucleoli,Plasma membrane,Cytosol"		Yes	NA			"Cluster 30: Non-specific - Translation"	"Cluster 85: Liver - Metabolism"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane, Cytosol"	"Nucleoplasm, Nucleoli"	"HPA058904: AB_2683850"	"unprognostic (5.48e-3)"	"unprognostic (1.00e-1)"	"unprognostic (6.85e-2)"	"unprognostic (1.16e-2)"	"unprognostic (7.87e-2)"	"unprognostic (2.08e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.71e-2)"	"unprognostic (1.70e-2)"	"unprognostic (3.30e-5)"	"prognostic favorable (6.13e-4)"	"unprognostic (5.85e-2)"	"unprognostic (4.22e-2)"	"unprognostic (7.94e-2)"	"unprognostic (3.58e-2)"	0.4	0.8	2.1	0.3	1.9	0.1	0.8	4.5	5.4	0.9	0.0	0.7	1.8	0.8	0.0	0.7	1.2	1.6	3.5	0.7	2.2	5.4	39.7	1.0	1.0	6.2	7.5	2.0	9.6	0.1	2.5	0.4	6.3	1.0	0.4	2.2	1.5	0.6	4.6	0.8	1.6	0.3	3.3	1.3	2.6	0.8	6.1	8.2	0.8	1.8	0.7	1.0	0.7	6.1	0.0	0.1	1.7	0.0	0.4	0.1	0.2	0.0	0.0	0.0	0.0	0.8	0.0	0.8	0.0	0.0	0.0	0.0	1.0	0.0	0.1	1.7	0.4	0.2	0.0	43.2	0.5	0.1	0.3	0.1	0.1	0.0	0.2	0.3	0.0	24.0	1.6	85.2	0.0	0.4	0.3	0.1	0.3	2.4	0.0	0.9	0.5	4.4	0.0	1.1	24.8	1.3	0.0	0.0	0.5	0.2	0.1	0.0	1.8	0.0	0.4	1.1	0.0	1.1	30.7	0.0	0.4	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.1	1.9	4.5	5.4	0.7	2.2	6.2	7.5	6.3	3.3	6.1	6.1	0.1	0.0	0.0	39.8	0.4	0.1	0.4	0.1	0.6	1.9	0.4	0.1	12.7	10.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	1.4	2.3	1.3	0.1	0.4	0.0	0.0	114.9	3.3	0.0	1.0	3.1	0.7	0.0	0.2	0.7	22.9	0.0	0.0	141.9	0.6	0.0	0.0	0.0	5.4	0.6	0.0	0.0	9.4	0.2	0.2	0.0	18.6	83.9	1.6	1.4	0.0	0.5	0.1	0.1	3.2	4.0	1.2	0.0	0.3	0.8	0.4	1.1	0.6	0.0	0.0	0.4	0.1	0.9	0.3
GATA6		ENSG00000141448	"GATA binding protein 6"	Q92908	18	22169589-22202528	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Atrial septal defect, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 57.8;ovary: 73.0"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 97.6;Gastric mucus-secreting cells: 100.9;Granulosa cells: 52.9"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 26.0"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	23	"basophil: 4.0"	"Lineage enriched"	"Detected in single"	23	"granulocytes: 4.0"	"Cell line enhanced"	"Detected in many"		"BEWO: 54.8;CACO-2: 69.7;hTERT-RPE1: 25.5;OE19: 37.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB011581, HPA066629"	Approved		Supported	Nucleoplasm		Yes	No			"Cluster 34: Basophils - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"CAB011581: AB_732529, HPA066629: AB_2685695"	"unprognostic (1.90e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.11e-1)"	"unprognostic (4.48e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.72e-2)"	"unprognostic (2.16e-1)"	"unprognostic (9.43e-2)"	"unprognostic (4.36e-2)"	"unprognostic (3.47e-1)"	"unprognostic (2.61e-1)"	"unprognostic (8.45e-3)"	"prognostic unfavorable (1.92e-9)"	"unprognostic (8.75e-3)"	"unprognostic (2.07e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.12e-2)"	22.2	57.8	0.0	2.5	0.2	0.0	3.8	0.0	0.3	4.9	2.8	11.4	22.8	19.8	1.2	0.8	28.9	11.1	43.9	0.1	0.0	3.0	12.6	14.8	1.9	0.1	0.0	73.0	22.7	0.3	0.6	6.5	0.0	5.5	11.0	0.1	0.8	0.7	0.8	1.5	20.7	9.5	0.2	15.0	49.6	6.3	0.1	0.4	5.3	0.6	0.2	23.0	3.2	0.0	10.1	1.4	0.0	0.0	2.1	1.0	54.8	0.3	0.4	0.8	1.0	69.7	3.8	0.0	3.2	1.2	3.4	10.8	0.4	4.5	1.4	0.0	13.6	0.0	4.3	6.1	14.3	0.6	0.6	0.4	8.9	12.1	9.1	25.5	9.5	0.0	0.5	0.0	0.0	1.5	0.0	0.2	0.1	37.6	9.8	0.0	1.1	0.2	0.4	2.8	0.9	0.1	10.7	6.1	3.0	2.7	1.7	0.0	0.7	1.4	1.6	11.4	1.7	0.0	0.0	0.0	6.2	0.3	9.9	4.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.2	0.1	0.0	7.3	44.8	30.2	0.0	0.0	0.9	4.0	4.6	1.8	0.0	3.4	2.7	97.6	30.0	6.1	0.0	0.0	0.9	0.9	50.0	0.0	28.4	44.7	6.3	6.3	11.5	26.0	2.7	0.1	19.6	11.2	24.4	100.9	16.6	5.1	52.9	28.5	11.1	1.6	0.0	0.1	45.8	2.0	0.6	0.9	8.8	3.4	0.5	0.0	1.0	0.0	0.0	0.0	0.0	0.2	36.8	27.7	10.1	0.2	4.1	43.3	0.0	3.9	0.0	32.9	0.4	8.6	1.4	1.4	0.9	0.9	1.9	1.3	11.4	47.2	2.9
GATAD1	"FLJ22489, ODAG, RG083M05.2"	ENSG00000157259	"GATA zinc finger domain containing 1"	Q8WUU5	7	92447482-92460075	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"			"Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 234.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006105, HPA072785"			Enhanced	Nucleoplasm		Yes	No			"Cluster 17: Basophils - Unknown function"	"Cluster 50: Non-specific - Ribosome"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA006105: AB_1078956, HPA072785: AB_2686556"	"unprognostic (8.37e-2)"	"unprognostic (1.01e-1)"	"unprognostic (7.31e-3)"	"unprognostic (6.24e-2)"	"unprognostic (6.03e-2)"	"unprognostic (1.36e-1)"	"unprognostic (8.65e-3)"	"unprognostic (6.43e-2)"	"unprognostic (5.16e-2)"	"unprognostic (4.30e-2)"	"unprognostic (2.18e-1)"	"unprognostic (2.16e-1)"	"unprognostic (9.91e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.36e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.98e-3)"	22.7	22.1	9.5	7.3	12.8	6.2	22.2	10.1	10.9	26.8	9.7	22.3	11.2	21.4	18.3	14.6	26.5	11.8	16.2	9.6	10.5	21.4	20.1	20.1	8.7	12.1	11.5	33.6	29.4	15.5	23.1	12.4	12.4	23.9	11.3	13.2	18.4	12.4	10.8	14.0	18.6	11.7	10.4	20.2	21.6	10.2	12.0	6.7	26.0	5.7	7.3	22.0	20.2	16.0	12.3	7.5	15.3	16.1	19.7	22.4	12.1	11.9	17.8	12.4	16.9	8.5	18.5	9.1	15.9	8.9	28.9	14.3	10.7	8.1	13.0	15.8	11.3	11.6	8.0	11.6	27.4	14.1	30.0	16.8	19.3	9.5	27.4	22.3	14.2	6.6	24.2	19.0	13.8	17.7	5.5	20.2	20.8	19.9	14.4	7.2	18.1	12.1	13.6	13.4	13.4	21.4	15.7	16.5	23.7	19.0	9.2	18.8	13.0	19.7	14.9	30.0	15.5	15.2	5.5	10.0	16.6	9.0	27.6	2.9	1.1	1.2	0.7	0.7	0.7	0.9	0.5	0.5	0.6	1.4	0.6	0.9	1.0	0.9	0.8	1.2	0.6	0.4	9.5	12.8	10.1	10.9	9.6	10.5	12.1	11.5	12.4	10.4	12.0	16.0	59.0	48.1	64.6	98.9	26.5	13.3	37.8	14.6	26.7	79.0	33.3	35.1	16.3	24.3	26.6	47.8	70.9	25.7	28.8	30.2	3.9	22.4	3.8	46.7	48.3	34.7	16.8	24.6	77.8	22.0	23.4	38.1	30.5	51.6	53.2	115.1	37.1	21.7	24.6	62.2	70.4	33.3	2.0	30.8	23.7	5.0	45.4	40.2	21.4	54.4	25.8	65.3	32.0	108.6	234.9	27.0	30.7	35.0	13.6	45.9	33.2	18.2	36.1	114.1	19.7	54.3	36.7	14.1	10.4	23.6	17.8	20.7	24.7	56.0	31.9	35.7
GCAT	KBL	ENSG00000100116	"Glycine C-acetyltransferase"	O75600	22	37807905-37817176	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 140.2"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 80.3;Hepatocytes: 66.1;Proximal tubular cells: 163.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020460, HPA063924"	Approved		Supported	"Nucleoplasm,Nuclear speckles,Mitochondria"		Yes	No			"Cluster 20: T-cells - T-cell receptor"	"Cluster 22: Non-specific - Unknown function"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm	"Nuclear speckles, Mitochondria"	"HPA020460: AB_1849548, HPA063924: "	"unprognostic (1.61e-1)"	"unprognostic (1.80e-2)"	"unprognostic (8.38e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.10e-2)"	"unprognostic (4.17e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.37e-2)"	"unprognostic (3.56e-2)"	"unprognostic (2.76e-3)"	"unprognostic (1.12e-1)"	"unprognostic (2.51e-1)"	"unprognostic (1.36e-3)"	"unprognostic (8.00e-2)"	"unprognostic (1.97e-1)"	"unprognostic (4.73e-3)"	"unprognostic (3.99e-1)"	6.6	15.7	25.1	3.2	24.8	14.1	6.5	26.2	33.3	6.3	22.5	7.3	4.9	7.8	3.0	17.0	6.0	5.0	43.4	26.1	25.0	13.0	53.3	5.6	2.8	25.9	27.4	9.0	140.2	6.0	9.7	2.7	27.8	22.8	4.9	2.2	13.3	6.8	19.5	8.1	5.4	4.2	24.4	1.5	13.2	10.3	27.9	4.3	16.0	19.1	3.1	7.1	7.0	24.6	18.7	4.7	11.9	68.2	24.0	19.4	8.4	25.9	26.9	19.2	16.3	10.5	2.1	5.8	11.8	11.7	11.3	10.6	11.9	18.3	4.3	2.6	21.9	12.9	15.0	42.5	39.0	23.0	16.4	22.8	10.9	12.7	27.7	6.2	16.0	23.0	33.2	6.6	9.2	16.2	24.3	42.3	5.0	28.8	19.0	25.2	2.5	34.4	24.6	14.3	24.5	16.7	20.0	32.3	13.9	4.2	25.8	11.1	11.8	19.3	10.6	12.9	9.2	21.9	11.5	12.1	13.3	21.1	20.5	0.1	0.6	0.4	0.7	0.7	0.3	0.1	1.6	0.5	1.3	0.0	3.5	1.4	0.3	1.3	0.4	1.3	1.7	1.4	25.1	24.8	26.2	33.3	26.1	25.0	25.9	27.4	27.8	24.4	27.9	24.6	3.5	6.4	15.4	9.8	2.8	7.8	18.5	11.2	12.5	8.9	18.6	17.4	54.6	11.5	9.4	11.0	4.2	15.7	0.7	13.1	80.3	7.2	4.1	9.9	8.1	5.5	2.4	22.7	5.0	10.3	19.6	9.8	15.3	16.7	8.9	17.6	5.0	66.1	4.7	8.4	4.7	32.3	8.2	2.9	1.3	7.7	3.7	2.1	21.4	1.0	1.0	25.1	1.0	6.6	4.1	5.4	8.7	9.8	2.0	19.1	8.6	163.8	6.4	2.2	6.6	4.8	30.1	12.6	33.2	19.6	6.0	27.8	3.0	27.8	24.0	14.4
GDAP2	"dJ776P7.1, FLJ20142, MACROD3"	ENSG00000196505	"Ganglioside induced differentiation associated protein 2"	Q9NXN4	1	117863485-117929621	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046185	Approved		Approved	"Endoplasmic reticulum"		Yes	No			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 59: Non-specific - Transcription"	"Endoplasmic reticulum"		"HPA046185: AB_10960897"	"unprognostic (4.12e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.82e-2)"	"unprognostic (4.33e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.53e-3)"	"unprognostic (1.25e-1)"	"unprognostic (2.60e-1)"	"unprognostic (4.26e-3)"	"unprognostic (2.26e-3)"	"unprognostic (6.38e-2)"	"unprognostic (1.18e-1)"	"unprognostic (4.09e-2)"	"unprognostic (3.28e-2)"	"unprognostic (8.68e-2)"	"unprognostic (1.68e-1)"	3.0	2.4	2.3	3.2	2.1	8.0	3.2	3.6	2.7	3.4	3.4	3.8	4.0	2.8	4.0	3.1	2.4	3.2	2.5	2.0	2.3	4.8	5.1	3.4	3.6	2.1	2.6	2.4	4.5	4.9	2.3	4.1	2.4	3.4	4.4	2.9	3.0	3.3	1.8	2.9	4.7	3.0	2.4	4.2	4.4	4.8	2.7	4.1	4.6	2.1	4.4	4.5	3.1	2.9	9.2	5.1	6.1	5.1	6.5	3.1	9.0	5.2	6.8	10.3	9.9	5.4	6.2	3.6	6.2	7.1	7.8	5.3	8.1	6.8	12.6	7.2	4.7	5.4	6.7	5.9	7.7	6.8	6.6	2.5	8.5	12.9	9.9	4.7	6.9	8.1	5.7	7.6	8.6	9.6	6.0	5.5	10.6	6.9	8.8	3.2	16.7	5.3	5.8	9.1	4.6	5.1	6.3	10.7	8.2	18.3	3.7	6.8	4.3	7.3	8.5	8.5	7.1	7.9	6.1	5.1	9.4	4.8	9.1	11.4	6.7	12.6	2.4	7.2	3.8	2.3	2.7	2.9	6.5	2.2	2.4	2.3	6.5	4.1	7.6	1.5	3.6	3.2	2.3	2.1	3.6	2.7	2.0	2.3	2.1	2.6	2.4	2.4	2.7	2.9	9.2	9.6	8.6	27.7	13.5	13.5	6.5	8.1	8.6	13.1	8.1	5.5	7.8	8.6	10.8	3.7	18.8	12.4	11.6	13.4	7.9	10.6	21.2	12.8	9.0	7.6	4.2	13.9	36.7	6.2	11.4	7.7	18.3	11.5	0.0	10.4	6.4	9.0	13.8	15.2	39.1	14.0	14.2	17.2	15.8	5.7	5.9	20.0	10.6	34.7	16.2	9.2	8.2	31.7	35.8	10.7	7.5	7.2	21.0	9.8	17.8	10.2	10.5	13.7	0.0	8.6	10.2	28.4	14.5	14.3	13.8	21.1	13.8	6.7	8.3	9.6
GET4	"C7orf20, CEE, CGI-20, H_NH1244M04.5, TRC35"	ENSG00000239857	"Guided entry of tail-anchored proteins factor 4"	Q7L5D6	7	876554-896436	"Predicted intracellular proteins"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Gastric mucus-secreting cells: 36.7;Oligodendrocytes: 15.8;Plasma cells: 37.2;Squamous epithelial cells: 23.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019765	Uncertain		Enhanced	"Nucleoplasm,Nucleoli,Mitotic chromosome,Cytosol"		Yes	No			"Cluster 26: Non-specific - Mitochondria"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Cytosol"	"Nucleoli, Mitotic chromosome"	"HPA019765: AB_1845750"	"unprognostic (2.80e-2)"	"unprognostic (2.40e-2)"	"unprognostic (2.10e-2)"	"unprognostic (9.66e-4)"	"unprognostic (9.86e-2)"	"unprognostic (8.64e-2)"	"unprognostic (4.10e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.59e-1)"	"unprognostic (6.28e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.21e-1)"	"unprognostic (7.65e-2)"	"unprognostic (8.18e-2)"	"unprognostic (1.26e-1)"	"unprognostic (5.93e-2)"	"unprognostic (9.47e-2)"	25.0	98.0	28.9	12.5	33.7	31.6	26.8	29.7	37.0	28.1	19.1	33.5	20.8	25.5	21.1	43.7	32.1	11.4	33.1	28.8	31.1	68.8	98.4	25.5	15.8	36.1	33.4	34.3	46.1	13.7	70.7	20.5	36.0	37.8	8.8	16.4	28.8	12.3	56.3	46.9	33.6	7.7	29.1	37.5	41.5	79.0	34.0	14.4	34.3	21.9	10.4	31.3	28.9	45.6	78.8	38.1	25.8	38.4	13.2	9.1	81.7	21.2	14.9	26.5	26.6	103.4	95.1	28.5	21.7	12.4	73.7	48.7	29.3	23.3	11.5	11.6	50.9	15.8	31.5	59.5	29.1	27.1	28.1	13.8	27.6	23.4	15.1	19.9	21.1	32.5	103.6	25.7	15.2	59.7	20.8	65.2	93.3	46.1	56.0	43.0	4.5	30.8	23.8	45.4	46.7	50.5	19.5	71.2	32.2	31.5	54.2	47.8	21.4	19.6	43.6	45.7	29.5	38.5	25.9	37.5	20.1	46.2	50.3	22.3	28.5	32.4	23.9	27.6	23.3	24.3	26.4	24.1	29.4	24.5	25.2	27.0	21.9	27.7	35.3	33.3	26.9	24.8	28.9	33.7	29.7	37.0	28.8	31.1	36.1	33.4	36.0	29.1	34.0	45.6	0.3	0.0	3.1	14.7	10.6	1.0	0.3	0.2	14.8	0.8	1.1	0.9	0.6	0.0	2.2	0.0	4.2	1.1	0.7	2.3	0.0	0.9	4.0	2.0	1.1	1.5	0.0	9.2	9.1	0.7	0.7	3.8	36.7	2.8	1.3	1.2	0.0	0.4	0.6	8.4	9.1	2.8	0.0	0.6	0.8	2.7	0.0	6.1	0.0	4.7	0.5	0.2	0.0	10.1	15.8	0.8	1.0	0.0	37.2	0.4	3.6	1.1	2.1	1.4	0.0	0.8	1.8	0.6	1.1	23.5	1.0	1.6	9.9	0.8	1.7	0.8
GFUS	"FX, P35B, SDR4E1, TSTA3"	ENSG00000104522	"GDP-L-fucose synthase"	Q13630	8	143612618-143618048	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Isomerase, Multifunctional enzyme, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 32.1;Cytotrophoblasts: 82.1;Extravillous trophoblasts: 156.4;Hofbauer cells: 69.9;Syncytiotrophoblasts: 87.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023361	Approved		Approved	Nucleoplasm,Cytosol		Yes	No		850000	"Cluster 44: Non-specific - Transcription"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol	Nucleoplasm	"HPA023361: AB_1858420"	"unprognostic (1.37e-2)"	"unprognostic (5.35e-2)"	"unprognostic (8.62e-3)"	"unprognostic (3.55e-2)"	"unprognostic (2.90e-1)"	"unprognostic (5.82e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.98e-1)"	"unprognostic (8.62e-2)"	"prognostic favorable (2.41e-4)"	"unprognostic (6.62e-3)"	"unprognostic (6.89e-2)"	"prognostic unfavorable (1.59e-4)"	"unprognostic (4.23e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.87e-2)"	"unprognostic (3.27e-2)"	36.3	37.2	21.6	27.7	21.1	52.3	34.0	21.4	25.9	28.6	21.7	45.9	69.2	24.8	19.2	88.7	24.0	29.3	32.1	20.7	21.3	37.5	86.6	28.4	29.1	23.5	21.9	19.0	99.5	22.8	44.0	24.4	22.8	45.0	37.6	6.5	70.9	24.2	30.2	81.5	52.4	19.4	20.2	35.7	111.4	49.4	21.0	26.6	32.1	18.4	27.1	31.0	36.0	22.5	85.6	67.1	29.2	99.7	28.6	26.1	54.1	70.3	73.0	50.2	38.1	78.5	94.3	37.5	64.6	52.5	21.2	60.6	47.8	100.8	23.2	101.7	53.8	58.7	103.0	93.4	57.2	42.2	67.1	30.3	47.4	31.7	127.3	42.2	84.3	61.9	66.4	57.0	41.2	267.5	39.8	53.2	45.8	267.7	87.1	47.1	26.3	122.3	106.1	94.8	67.3	45.9	53.3	100.2	73.0	23.0	133.5	58.8	75.5	34.8	132.0	35.1	67.6	34.1	30.2	29.0	52.8	91.6	54.7	34.9	27.4	42.9	40.3	38.5	43.0	35.2	43.1	46.8	30.1	40.1	31.5	38.5	31.0	63.6	33.8	54.5	57.5	45.7	21.6	21.1	21.4	25.9	20.7	21.3	23.5	21.9	22.8	20.2	21.0	22.5	32.1	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.9	0.0	0.0	0.0	0.0	82.1	11.2	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	156.4	7.2	0.0	0.0	0.0	0.0	0.0	0.0	69.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	87.7	1.7	0.0	0.0	0.0
GMNN	Gem	ENSG00000112312	"Geminin DNA replication inhibitor"	O75496	6	24774931-24786099	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle"	"DNA replication inhibitor"	"Cancer-related genes, Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 231.4"	"Cell type enhanced"	"Detected in all"		"Glandular and luminal cells: 184.8;Paneth cells: 300.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011458, CAB047327, CAB047328, HPA049977, HPA054597"	Enhanced		Supported	Nucleoplasm,Cytosol		Yes	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 25: Pancreas - Digestion"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	Cytosol	"CAB011458: AB_2110946, CAB047327: , CAB047328: , HPA049977: AB_2680978, HPA054597: AB_2682538"	"unprognostic (1.37e-1)"	"unprognostic (3.43e-3)"	"unprognostic (3.91e-3)"	"unprognostic (1.52e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.37e-2)"	"unprognostic (2.90e-3)"	"unprognostic (8.29e-2)"	"unprognostic (1.23e-3)"	"prognostic favorable (4.13e-4)"	"prognostic unfavorable (9.77e-4)"	"unprognostic (1.33e-2)"	"prognostic unfavorable (7.82e-5)"	"unprognostic (2.25e-1)"	"unprognostic (7.92e-2)"	"unprognostic (3.63e-2)"	"unprognostic (5.90e-3)"	10.1	7.7	16.9	17.2	18.2	68.9	24.2	19.5	23.7	11.1	13.5	41.6	17.8	10.6	5.8	16.6	16.5	7.9	8.0	14.7	20.2	24.6	18.2	8.9	30.4	17.0	20.2	14.6	231.4	8.4	11.1	16.5	17.8	41.5	44.4	16.3	8.7	24.9	7.4	40.3	16.1	12.5	16.4	19.1	22.6	37.4	19.8	37.4	10.8	14.3	23.7	28.4	13.9	15.5	110.9	64.2	159.2	66.2	22.2	23.5	106.0	106.0	55.9	124.4	135.5	125.1	38.8	110.1	131.3	34.4	91.3	63.3	139.4	78.1	133.0	41.2	145.4	151.5	109.3	207.4	20.7	119.1	53.1	19.1	25.1	75.9	29.5	25.8	62.2	84.6	193.9	56.9	88.9	86.3	224.9	128.2	87.3	89.6	50.2	128.9	124.4	141.2	53.5	94.6	127.3	78.3	47.5	77.4	95.2	89.1	81.3	72.0	30.9	75.7	76.8	88.3	182.6	62.8	207.6	210.3	23.1	220.9	111.2	5.5	5.2	17.1	4.4	6.9	5.6	9.2	8.5	6.9	7.6	4.6	6.1	6.9	3.0	5.9	5.0	9.4	15.9	5.6	16.9	18.2	19.5	23.7	14.7	20.2	17.0	20.2	17.8	16.4	19.8	15.5	24.0	6.4	15.6	8.8	17.0	33.0	28.4	57.4	18.8	9.5	51.0	52.5	12.1	18.6	68.1	44.1	2.1	83.2	19.9	72.6	9.8	113.6	94.8	84.8	30.6	18.4	25.9	66.2	3.5	112.3	136.3	17.7	12.2	184.8	13.3	36.4	13.9	17.4	54.0	11.8	5.3	66.3	10.2	10.7	13.2	28.0	9.6	15.2	23.2	5.6	12.6	30.9	6.2	5.5	3.2	31.8	300.5	10.9	41.6	25.6	20.8	20.6	25.2	13.7	19.7	8.0	21.9	158.8	58.8	26.8	63.5	48.7	19.1	30.4	156.5	30.1
GPN3	"ATPBD1C, MGC14560"	ENSG00000111231	"GPN-loop GTPase 3"	Q9UHW5	12	110452486-110469268	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 187.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039764, HPA047793"	Uncertain		Approved	"Nuclear speckles,Cytosol"		Yes	No			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 24: NB-4 - Immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nuclear speckles"	Cytosol	"HPA039764: AB_2676669, HPA047793: AB_2680157"	"unprognostic (1.68e-3)"	"unprognostic (1.11e-2)"	"unprognostic (9.82e-2)"	"unprognostic (4.96e-2)"	"unprognostic (2.09e-1)"	"unprognostic (3.27e-3)"	"prognostic unfavorable (3.98e-5)"	"unprognostic (5.50e-2)"	"unprognostic (4.45e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.24e-1)"	"unprognostic (3.56e-2)"	"prognostic favorable (2.65e-6)"	"unprognostic (5.81e-2)"	"unprognostic (2.85e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.27e-1)"	25.6	18.9	10.4	16.3	11.7	15.4	24.4	12.9	12.9	15.7	11.6	15.6	8.1	17.8	15.2	16.3	18.5	13.8	34.2	10.0	11.0	31.4	32.1	16.9	22.9	12.2	11.2	23.3	19.9	29.2	11.1	21.3	12.8	22.2	13.1	23.4	24.2	18.0	47.9	11.1	10.6	19.5	13.0	16.2	15.6	41.3	10.9	18.1	21.2	51.1	18.1	17.6	13.8	14.9	42.3	65.8	43.2	42.8	47.5	30.1	57.6	57.1	34.1	62.2	50.3	59.7	24.6	81.5	38.5	31.0	46.0	37.9	54.2	50.5	83.9	46.9	50.6	47.7	33.8	50.5	33.2	75.2	42.2	32.2	31.4	61.1	39.5	34.9	45.6	67.0	82.1	17.9	44.3	28.2	69.8	142.8	53.4	58.6	64.8	23.5	59.9	62.2	39.3	37.8	34.7	34.8	57.7	39.0	49.9	55.0	66.7	87.7	25.4	51.6	38.0	51.3	66.6	24.7	68.0	85.1	38.2	68.5	60.3	41.0	54.4	79.4	30.0	71.9	32.8	46.5	32.0	34.2	51.1	47.9	40.5	26.9	27.4	28.4	75.3	62.5	30.1	41.6	10.4	11.7	12.9	12.9	10.0	11.0	12.2	11.2	12.8	13.0	10.9	14.9	23.8	25.6	34.5	3.3	24.5	29.8	49.3	57.9	15.9	18.8	28.8	32.5	43.8	20.0	36.0	33.1	14.6	62.4	26.6	3.8	107.6	30.4	111.1	24.9	24.6	20.8	8.3	26.9	4.3	21.3	74.0	25.4	8.2	21.5	31.0	18.6	18.2	38.1	94.7	21.9	5.6	9.1	40.7	19.1	17.7	22.6	19.9	33.2	16.0	14.0	39.6	25.7	19.6	3.5	6.4	22.4	11.0	23.7	20.9	55.5	5.3	72.1	34.2	33.0	26.3	31.0	35.3	187.2	77.6	20.8	25.4	46.7	19.2	22.1	13.7	40.2
GPR161	RE2	ENSG00000143147	"G protein-coupled receptor 161"	Q8N6U8	1	168079543-168137667	"G-protein coupled receptors, Predicted membrane proteins, Transporters"		"Developmental protein, G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 41.5;smooth muscle: 27.6"	"Cell type enriched"	"Detected in many"	8	"Horizontal cells: 158.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CACO-2: 44.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA015576, HPA072047"	Uncertain		Uncertain	Nucleoplasm,Nucleoli		Yes	No				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 62: Horizontal cells - Visual perception"	Nucleoplasm	Nucleoli	"HPA015576: AB_1849283, HPA072047: AB_2686484"	"unprognostic (1.45e-1)"	"unprognostic (3.78e-2)"	"unprognostic (2.68e-2)"	"unprognostic (1.58e-3)"	"unprognostic (1.87e-1)"	"unprognostic (6.84e-2)"	"unprognostic (3.24e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.04e-2)"	"unprognostic (5.45e-2)"	"unprognostic (1.31e-2)"	"unprognostic (5.57e-6)"	"unprognostic (3.93e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.03e-2)"	"unprognostic (6.34e-2)"	3.5	1.1	3.8	5.3	2.8	0.2	2.7	3.3	4.0	6.7	1.1	8.4	1.5	41.5	3.6	9.8	10.7	5.6	3.1	3.8	2.4	1.4	0.4	4.2	0.9	3.7	9.4	7.3	11.7	5.4	1.7	2.2	3.8	9.5	3.2	2.1	1.8	11.8	1.0	2.1	3.3	27.6	2.8	2.0	2.9	1.7	4.1	2.0	1.7	1.9	1.3	4.6	5.4	2.7	11.7	7.1	28.0	18.1	6.6	11.7	0.0	11.1	11.9	9.2	9.7	44.9	1.8	0.0	6.0	16.6	17.2	33.9	6.9	10.7	5.3	4.4	8.8	4.2	5.8	0.1	2.8	1.2	2.8	4.2	6.9	7.9	12.7	21.3	18.7	3.6	3.9	0.1	14.2	1.0	1.3	0.2	11.5	19.4	11.0	3.4	12.1	0.0	4.9	3.1	5.7	24.6	12.0	0.4	32.2	10.6	6.3	1.4	25.4	18.9	9.7	25.6	12.7	0.0	0.0	0.0	5.0	0.0	4.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.8	2.8	3.3	4.0	3.8	2.4	3.7	9.4	3.8	2.8	4.1	2.7	5.8	3.2	1.1	13.7	0.1	2.2	5.7	2.5	5.2	2.2	2.2	4.2	3.6	0.0	1.4	0.0	0.0	0.5	0.0	2.8	0.0	4.1	0.4	1.3	19.4	9.1	0.0	0.0	10.8	8.0	0.4	12.3	1.1	1.8	0.0	15.3	8.9	0.1	0.8	158.2	10.9	1.5	0.0	2.5	6.3	0.9	7.5	2.0	1.8	3.7	1.1	3.2	0.0	9.5	0.4	2.6	2.4	17.0	0.0	10.9	0.0	0.1	1.1	2.1	19.7	8.8	15.1	0.3	3.3	2.7	1.4	0.4	1.0	0.7	2.5	2.7
GTF2IRD1	"BEN, Cream1, GTF3, MusTRD1, RBAP2, WBSCR11, WBSCR12"	ENSG00000006704	"GTF2I repeat domain containing 1"	Q9UHL9	7	74453790-74602605	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 68.1"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 48.3;Inhibitory neurons: 42.1;Rod photoreceptor cells: 41.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044254	Approved		Supported	Nucleoplasm,Cytosol		Yes	No				"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm	Cytosol	"HPA044254: AB_10964747"	"unprognostic (8.92e-2)"	"unprognostic (6.94e-2)"	"unprognostic (1.61e-1)"	"prognostic unfavorable (9.71e-5)"	"unprognostic (2.24e-1)"	"unprognostic (3.35e-2)"	"unprognostic (2.71e-3)"	"unprognostic (3.77e-2)"	"unprognostic (1.84e-2)"	"unprognostic (6.26e-2)"	"unprognostic (4.89e-3)"	"unprognostic (3.31e-1)"	"unprognostic (2.53e-1)"	"unprognostic (8.61e-2)"	"unprognostic (1.08e-1)"	"unprognostic (3.06e-2)"	"unprognostic (2.25e-3)"	6.0	12.6	7.0	3.4	7.0	0.5	6.9	7.2	8.1	16.8	14.0	15.1	7.7	11.3	8.6	26.7	8.8	5.7	11.6	6.0	8.4	18.6	4.6	11.7	1.0	9.2	8.9	10.5	10.0	18.9	27.6	5.8	9.0	13.3	5.6	36.7	17.3	8.2	68.1	22.4	6.7	8.4	6.7	2.0	13.9	5.0	10.1	3.4	17.4	29.7	5.4	15.0	19.8	10.2	21.2	12.9	28.1	30.8	22.2	10.8	0.2	8.8	23.7	17.1	17.7	21.7	30.1	5.4	6.5	18.1	41.7	11.6	22.6	10.2	12.6	0.2	13.0	1.1	43.1	26.1	71.2	0.2	0.7	14.7	42.1	12.0	48.9	39.7	8.9	10.4	15.5	0.1	19.2	26.1	2.7	18.9	22.6	25.7	12.8	28.1	16.4	20.0	32.7	14.6	23.1	30.5	21.7	39.0	19.9	14.2	23.4	21.2	4.6	17.5	16.9	11.4	20.5	1.1	3.4	8.9	6.7	0.3	14.1	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	7.0	7.0	7.2	8.1	6.0	8.4	9.2	8.9	9.0	6.7	10.1	10.2	0.9	9.6	8.2	48.3	0.1	7.9	9.9	10.5	9.6	30.8	5.6	4.1	10.4	12.8	6.8	9.2	33.3	1.4	1.5	4.5	11.7	7.6	1.6	11.5	8.0	4.1	4.2	0.8	24.6	9.2	1.8	5.6	6.1	17.0	2.5	8.0	2.9	3.1	2.6	21.9	42.1	3.6	8.2	1.2	5.7	0.3	4.1	2.5	7.2	14.0	0.7	5.9	1.0	25.6	24.9	11.6	3.2	5.7	0.0	17.8	3.6	17.4	12.7	41.1	0.0	19.0	5.7	0.1	3.7	18.2	6.7	2.9	1.1	2.4	7.4	15.8
GTSE1	"B99, GTSE-1"	ENSG00000075218	"G2 and S-phase expressed 1"	Q9NYZ3	22	46296870-46330810	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 11.2;lymphoid tissue: 19.6"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 52.2;Extravillous trophoblasts: 31.2;Granulosa cells: 27.1;Spermatocytes: 73.6;Spermatogonia: 27.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA029457			Approved	"Plasma membrane,Centrosome"		Yes	Yes			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Centrosome	"Plasma membrane"	"HPA029457: "	"unprognostic (1.97e-1)"	"unprognostic (3.07e-2)"	"unprognostic (1.71e-3)"	"unprognostic (2.59e-1)"	"unprognostic (7.16e-2)"	"unprognostic (2.40e-2)"	"prognostic unfavorable (1.90e-10)"	"prognostic unfavorable (4.66e-4)"	"unprognostic (1.09e-1)"	"unprognostic (8.37e-2)"	"prognostic unfavorable (1.29e-4)"	"unprognostic (3.49e-3)"	"unprognostic (0.00e+0)"	"unprognostic (6.52e-3)"	"unprognostic (3.25e-1)"	"unprognostic (1.14e-1)"	"unprognostic (4.85e-2)"	0.6	0.6	0.2	5.1	0.2	11.2	0.5	0.5	0.3	0.7	0.2	2.4	4.1	0.8	0.0	3.6	0.2	0.5	0.3	0.2	0.3	0.3	0.4	0.6	9.2	0.4	0.3	0.2	0.2	0.1	0.1	2.6	0.4	0.2	2.6	0.1	0.7	0.1	0.1	2.5	2.9	1.2	0.1	2.4	1.9	7.2	0.5	19.6	0.2	0.2	8.7	1.0	1.2	0.4	59.5	27.6	53.2	42.2	1.1	3.0	25.5	50.3	23.5	71.7	58.8	29.3	21.9	55.7	13.0	19.4	32.8	30.3	48.0	12.7	45.7	33.7	52.0	37.4	38.9	22.8	0.1	67.5	43.8	0.6	1.0	30.9	15.6	7.5	31.2	39.7	29.0	67.8	43.4	33.1	60.9	33.0	37.2	24.2	30.7	59.6	59.7	36.3	11.7	10.7	27.5	37.5	48.1	30.7	21.5	23.8	26.2	25.8	25.1	40.6	75.8	33.4	53.7	38.6	19.7	56.3	25.8	32.2	60.5	0.0	0.0	0.3	0.3	0.0	0.0	0.3	0.1	0.1	0.0	0.1	0.0	0.0	0.5	0.3	0.0	0.4	0.3	0.2	0.2	0.2	0.5	0.3	0.2	0.3	0.4	0.3	0.4	0.1	0.5	0.4	1.1	0.0	0.0	0.7	7.0	2.8	1.1	2.1	0.6	0.7	2.8	3.4	1.6	0.0	0.5	0.0	0.0	19.2	6.8	7.6	0.0	0.9	5.6	2.1	4.7	3.9	1.2	52.2	0.3	0.2	31.2	5.1	16.8	4.3	0.0	27.1	6.4	1.2	19.9	0.0	0.5	9.4	2.0	7.5	4.0	3.9	0.3	4.7	0.0	0.0	0.1	0.4	0.0	0.5	0.1	0.8	0.2	0.7	19.1	1.8	0.5	0.5	0.2	0.3	6.6	2.6	5.4	73.6	27.8	11.7	2.6	1.5	5.0	1.2	13.8	1.6
H1-0	"H1.0, H1F0, H1FV"	ENSG00000189060	"H1.0 linker histone"	P07305	22	37805093-37807436	"Plasma proteins, Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 660.5"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 51.4;Cytotrophoblasts: 42.9;Extravillous trophoblasts: 125.7;Hofbauer cells: 73.2;Syncytiotrophoblasts: 219.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"dendritic cells: 8.1;granulocytes: 17.1;monocytes: 11.7"	"Cell line enhanced"	"Detected in many"		"OE19: 662.8;U-2 OS: 823.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000843	Supported		Supported	"Nucleoplasm,Nuclear bodies,Golgi apparatus,Actin filaments"		Yes	No		120000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Nuclear bodies"	"Golgi apparatus, Actin filaments"	"HPA000843: AB_1079062"	"unprognostic (1.29e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.31e-3)"	"unprognostic (1.19e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.85e-1)"	"unprognostic (7.68e-2)"	"unprognostic (1.86e-1)"	"unprognostic (5.95e-3)"	"unprognostic (4.86e-3)"	"prognostic favorable (7.68e-7)"	"unprognostic (3.40e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.37e-3)"	"unprognostic (1.73e-1)"	89.8	53.5	56.6	36.7	55.4	660.5	121.4	72.5	64.1	218.3	42.5	146.2	129.9	168.2	43.5	230.6	119.7	56.3	86.5	55.4	67.1	292.8	179.3	72.4	24.4	58.4	54.2	120.7	125.9	93.2	58.2	80.0	57.7	151.7	120.0	39.9	155.3	40.2	216.2	228.6	137.1	97.7	52.6	36.7	131.2	42.4	58.3	136.2	93.9	93.5	46.6	85.6	194.9	55.8	159.6	67.9	206.0	91.8	53.4	48.4	291.6	126.9	262.3	362.6	512.6	278.1	247.3	0.2	31.1	106.3	84.1	303.8	0.0	87.2	256.0	0.9	15.3	268.2	25.3	187.4	185.8	0.1	0.7	45.4	152.4	182.3	203.2	4.0	97.8	60.4	0.1	0.5	28.5	263.3	45.4	26.5	80.2	662.8	329.9	74.6	122.6	56.1	58.0	42.7	47.3	263.9	349.9	235.4	473.9	91.8	184.2	167.1	65.4	27.4	823.3	122.7	25.9	0.7	18.5	1.2	33.5	95.9	80.3	17.1	9.9	15.7	0.1	11.7	0.1	0.0	1.0	0.2	8.1	0.1	2.8	0.4	5.4	0.1	10.3	7.4	0.2	6.9	56.6	55.4	72.5	64.1	55.4	67.1	58.4	54.2	57.7	52.6	58.3	55.8	19.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	51.4	0.0	0.0	0.0	0.0	42.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	12.6	0.0	0.0	0.0	0.0	125.7	25.2	0.0	0.0	0.0	0.0	0.0	0.0	73.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.5	0.0	0.0	0.0	0.0	219.7	0.0	0.0	0.0	0.0
HEATR3	FLJ20718	ENSG00000155393	"HEAT repeat containing 3"	Q7Z4Q2	16	50065970-50107272	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041990, HPA058579"	Uncertain		Enhanced	Nucleoplasm,Cytosol		Yes	No			"Cluster 7: Monocytes - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Nucleoplasm	Cytosol	"HPA041990: AB_10793940, HPA058579: AB_2683762"	"unprognostic (7.36e-3)"	"unprognostic (2.72e-1)"	"unprognostic (2.01e-3)"	"unprognostic (1.97e-1)"	"unprognostic (1.20e-1)"	"unprognostic (4.80e-3)"	"prognostic unfavorable (4.11e-5)"	"unprognostic (7.68e-2)"	"unprognostic (5.11e-2)"	"unprognostic (8.79e-2)"	"unprognostic (4.96e-2)"	"unprognostic (1.96e-1)"	"prognostic unfavorable (5.16e-6)"	"unprognostic (2.26e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.86e-1)"	"unprognostic (3.17e-2)"	7.1	8.2	3.8	9.0	3.7	5.6	5.3	4.6	4.2	5.1	4.3	7.0	4.9	5.0	4.5	8.0	4.8	4.2	6.4	3.7	3.6	6.7	10.2	6.3	6.6	4.2	3.2	3.3	8.0	4.8	6.5	5.8	3.4	4.9	6.3	4.8	6.0	3.4	12.0	6.3	7.0	5.3	3.2	12.6	6.6	5.8	3.8	4.6	3.7	6.2	6.2	5.1	5.1	3.9	13.0	12.8	11.8	18.6	7.0	9.6	12.6	15.5	10.1	15.0	6.0	15.9	9.4	24.4	10.9	14.7	5.6	15.1	14.1	11.3	17.2	6.1	15.4	12.1	9.0	20.4	10.2	21.1	23.5	7.5	7.8	10.4	6.2	6.6	12.2	12.6	15.5	3.9	14.9	7.8	16.2	26.4	13.8	15.5	13.1	17.6	15.8	19.8	8.4	10.4	15.1	8.0	14.8	18.9	10.0	8.8	8.5	15.4	16.1	12.0	8.0	9.1	11.8	9.8	8.0	21.3	11.7	20.9	12.0	0.5	2.4	0.5	0.9	2.8	1.0	0.6	0.5	1.0	1.7	0.8	0.8	0.9	0.5	0.7	2.6	1.5	0.9	1.0	3.8	3.7	4.6	4.2	3.7	3.6	4.2	3.2	3.4	3.2	3.8	3.9	4.2	3.2	5.8	7.8	4.6	3.2	1.4	1.5	3.4	7.8	3.1	2.0	6.0	2.8	1.8	1.8	16.7	3.5	7.1	3.3	7.9	2.4	10.7	3.7	6.8	4.6	3.5	3.8	21.2	3.1	3.6	4.7	7.7	3.8	1.3	6.5	1.8	9.6	9.4	1.7	16.7	3.2	4.1	22.2	4.7	18.3	3.4	13.9	1.8	7.5	13.3	2.4	3.1	20.1	12.8	2.9	2.5	2.2	7.2	1.9	4.7	4.1	2.8	8.1	0.0	2.5	4.2	5.3	4.8	7.6	1.7	1.0	5.8	6.7	5.8	1.5
HEPN1		ENSG00000221932	"Hepatocellular carcinoma, down-regulated 1"	Q6WQI6	11	124919244-124920677	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in some"		"adipose tissue: 11.4;brain: 37.3;liver: 20.9"	"Group enriched"	"Detected in some"	23	"Astrocytes: 94.3;Muller glia cells: 29.1;Oligodendrocyte precursor cells: 49.3;Oligodendrocytes: 114.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	287	"Hep G2: 55.5"									"HPA043768, HPA063054"	Uncertain		Approved	"Golgi apparatus"		Yes	NA				"Cluster 15: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Golgi apparatus"		"HPA043768: AB_2678662, HPA063054: AB_2684932"																		11.4	0.2	6.1	0.1	23.1	0.0	8.3	0.3	9.4	0.4	0.0	0.9	0.0	0.0	0.0	0.1	0.1	0.0	0.6	5.0	6.1	0.2	20.9	0.1	0.1	37.3	10.3	0.1	0.2	0.0	2.4	0.0	13.5	0.8	0.0	2.2	0.4	0.0	0.2	0.3	0.7	0.0	5.1	0.1	0.5	0.5	19.0	0.0	0.2	0.0	0.0	0.2	0.5	17.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	55.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	23.1	0.3	9.4	5.0	6.1	37.3	10.3	13.5	5.1	19.0	17.9	0.2	0.0	0.0	94.3	0.0	0.0	0.1	0.0	0.0	0.8	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.4	3.1	0.0	0.0	1.1	0.0	0.0	0.0	0.6	0.5	0.6	0.0	0.0	1.9	0.0	29.1	0.0	49.3	114.6	0.0	0.0	1.2	0.0	0.1	0.0	2.2	0.0	1.9	0.0	0.1	0.1	1.8	0.5	0.0	0.0	0.0	0.1	0.0	0.1	0.0
HJURP	"DKFZp762E1312, FAKTS, hFLEG1, URLC9"	ENSG00000123485	"Holliday junction recognition protein"	Q8NCD3	2	233833416-233854566	"Predicted intracellular proteins"	"Cell cycle"	"Chaperone, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 47.4;lymphoid tissue: 30.4"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 17.4;Erythroid cells: 38.3;Extravillous trophoblasts: 16.1;Granulosa cells: 14.8;Spermatocytes: 37.5;Spermatogonia: 16.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"T-reg: 1.2"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"HPA008436, HPA027261"	Uncertain		Enhanced	"Nucleoplasm,Nucleoli,Nucleoli rim,Mitochondria"		Yes	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Nucleoli, Nucleoli rim"	Mitochondria	"HPA008436: AB_1850757, HPA027261: AB_2672184"	"unprognostic (5.63e-2)"	"unprognostic (9.15e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.44e-3)"	"unprognostic (3.62e-1)"	"unprognostic (1.75e-1)"	"prognostic unfavorable (3.37e-5)"	"prognostic unfavorable (2.46e-4)"	"prognostic unfavorable (6.49e-4)"	"unprognostic (9.48e-2)"	"prognostic unfavorable (7.72e-5)"	"unprognostic (7.60e-2)"	"unprognostic (0.00e+0)"	"unprognostic (7.42e-2)"	"unprognostic (5.58e-2)"	"unprognostic (1.89e-2)"	"unprognostic (5.74e-2)"	0.6	0.6	0.0	5.5	0.1	47.4	1.1	0.1	0.2	0.8	0.1	3.9	4.1	0.9	0.2	5.6	0.3	0.5	0.3	0.1	0.1	0.4	0.8	1.4	12.6	0.1	0.3	0.2	0.2	0.1	0.1	3.0	0.1	0.4	5.2	0.1	1.0	0.1	0.2	3.6	3.8	1.9	0.0	4.1	2.4	11.1	0.3	30.4	0.3	0.0	12.0	1.4	2.0	0.2	54.5	73.6	68.4	32.7	2.6	5.4	42.8	79.5	37.9	55.2	59.9	51.3	57.6	17.1	9.0	31.4	98.0	61.7	54.9	40.9	72.6	40.0	21.6	65.5	61.4	50.9	0.3	54.1	43.2	1.8	1.5	45.1	30.9	15.7	35.5	51.3	56.6	40.8	103.0	55.3	76.4	59.7	58.9	42.2	49.1	58.4	103.0	30.3	28.6	32.3	39.4	24.7	45.8	34.2	31.7	31.0	25.7	42.1	26.0	59.6	64.6	44.3	87.2	38.6	32.7	67.9	35.7	39.3	151.6	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.3	0.1	0.4	0.0	1.2	0.4	0.0	0.1	0.1	0.2	0.1	0.1	0.1	0.3	0.1	0.0	0.3	0.2	0.2	0.0	0.5	0.0	2.9	1.3	0.5	1.9	0.0	0.0	0.7	0.5	1.2	0.0	2.1	0.0	0.0	8.2	0.5	5.6	0.0	0.2	17.4	0.3	1.3	1.1	0.0	38.3	0.0	0.0	16.1	2.0	5.1	1.3	0.0	14.8	2.2	0.3	7.1	0.0	0.0	3.5	0.0	3.0	2.9	9.0	0.6	3.5	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.2	1.4	0.0	11.4	1.0	0.5	0.1	0.1	0.0	0.0	0.1	1.9	37.5	16.3	8.9	0.9	1.5	2.3	0.3	7.6	0.9
HLF	MGC33822	ENSG00000108924	"HLF transcription factor, PAR bZIP family member"	Q16534	17	55264960-55325187	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 122.4"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 120.7;Excitatory neurons: 77.5;Hepatocytes: 156.8;Horizontal cells: 92.5;Microglial cells: 74.0"	"Cancer enhanced"	"Detected in many"		"liver cancer: 13.6"	"Region enhanced"	"Detected in many"		"cerebral cortex: 53.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"Hep G2: 163.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA068156, HPA071210"			Enhanced	Nucleoplasm		Yes	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 62: Horizontal cells - Visual perception"	Nucleoplasm		"HPA068156: AB_2685963, HPA071210: AB_2686361"	"unprognostic (1.24e-1)"	"unprognostic (1.19e-3)"	"unprognostic (1.27e-1)"	"unprognostic (1.35e-1)"	"unprognostic (3.30e-1)"	"prognostic favorable (1.88e-4)"	"unprognostic (5.30e-3)"	"prognostic favorable (2.71e-7)"	"unprognostic (1.42e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.24e-3)"	"unprognostic (2.19e-1)"	"prognostic favorable (3.55e-6)"	"unprognostic (8.47e-2)"	"unprognostic (1.64e-1)"	"unprognostic (6.85e-2)"	"unprognostic (1.60e-2)"	15.1	21.5	9.8	1.9	23.1	0.4	15.4	0.0	53.3	14.4	0.0	18.0	1.4	14.4	11.0	26.3	12.2	7.8	24.1	17.6	0.0	12.7	122.4	13.4	2.2	0.0	0.6	50.0	2.9	4.0	9.9	1.0	0.0	13.2	3.4	43.2	24.1	12.4	7.7	16.7	4.3	12.3	0.0	8.2	6.1	4.1	3.9	3.4	34.3	9.9	7.7	12.3	7.8	17.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.9	0.5	0.0	0.0	0.0	0.4	0.2	0.0	27.3	0.7	0.0	0.1	163.0	0.1	0.9	0.2	0.1	0.7	0.0	0.1	0.3	0.0	1.4	0.0	0.6	0.0	0.6	1.1	0.0	0.1	0.0	2.4	0.0	0.4	0.4	13.0	0.1	11.1	0.6	0.0	7.2	0.2	0.0	0.2	0.0	0.1	0.8	0.2	0.6	0.5	5.1	4.9	0.0	0.3	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	9.8	23.1	0.0	53.3	17.6	0.0	0.0	0.6	0.0	0.0	3.9	17.2	13.8	3.2	42.8	22.2	0.4	22.3	4.4	1.4	56.9	120.7	5.9	16.4	38.6	12.8	6.3	7.3	10.4	0.1	0.5	0.0	11.7	1.9	1.3	0.1	6.2	19.7	3.0	0.8	77.5	0.9	0.0	17.6	0.0	0.6	0.0	0.5	6.1	156.8	0.1	92.5	36.6	0.6	0.0	3.5	4.0	4.7	28.3	0.7	10.6	74.0	0.1	60.7	0.0	24.6	6.9	0.4	0.0	39.1	1.5	1.3	2.8	23.3	1.0	15.0	13.1	4.5	7.4	0.4	5.0	33.7	27.6	1.2	3.8	0.5	0.4	0.4
HMBOX1	"FLJ21616, HNF1LA, HOT1, PBHNF"	ENSG00000147421	"Homeobox containing 1"	Q6NT76	8	28890395-29064764	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 20.0"	"Cell type enhanced"	"Detected in all"		"Astrocytes: 125.7;Oligodendrocyte precursor cells: 118.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055855, HPA058586, CAB070418"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		Yes	No			"Cluster 14: Monocytes - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoplasm	"Nuclear bodies, Cytosol"	"CAB070418: AB_11154826, HPA055855: AB_2682945, HPA058586: AB_2683764"	"unprognostic (2.68e-3)"	"unprognostic (2.30e-3)"	"unprognostic (4.52e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.03e-3)"	"unprognostic (1.20e-1)"	"unprognostic (2.75e-3)"	"unprognostic (1.49e-1)"	"unprognostic (4.25e-2)"	"unprognostic (1.89e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.51e-1)"	"unprognostic (3.84e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.47e-1)"	4.6	6.7	7.6	5.1	11.9	10.8	4.2	10.6	5.7	3.7	1.7	3.8	3.1	4.4	3.0	3.2	3.7	4.2	4.5	5.3	17.9	4.3	4.2	4.6	5.3	15.0	20.0	6.1	3.3	5.0	1.8	6.8	15.6	2.9	3.9	6.2	3.1	2.5	2.8	4.4	4.3	5.2	10.4	5.7	4.3	7.6	11.6	4.9	6.2	3.7	5.9	3.8	2.4	12.9	6.2	6.8	7.1	8.2	6.5	6.7	6.0	2.6	3.5	4.0	4.3	3.1	3.9	15.1	6.3	4.5	6.0	5.3	14.4	5.3	5.6	5.5	2.4	15.6	13.8	4.2	5.3	5.4	10.2	3.3	7.5	5.3	10.1	4.9	9.1	9.0	22.7	14.4	5.7	3.8	9.9	2.7	5.0	6.6	1.6	8.1	7.1	3.4	2.8	11.5	3.0	9.2	5.1	3.9	5.4	5.9	3.9	4.8	13.0	3.6	16.8	3.9	3.8	4.4	4.8	5.9	4.6	6.5	5.4	3.2	2.4	1.1	1.9	2.6	2.7	3.4	1.9	1.8	2.5	2.6	2.4	2.4	1.4	1.2	4.7	1.9	0.8	1.4	7.6	11.9	10.6	5.7	5.3	17.9	15.0	20.0	15.6	10.4	11.6	12.9	25.5	16.0	18.1	125.7	30.3	16.7	15.8	18.1	15.9	24.4	15.3	10.5	23.6	20.0	14.0	29.5	39.6	12.9	18.7	16.2	15.6	8.3	93.0	15.0	21.2	34.2	17.4	19.6	90.1	14.4	14.1	19.2	11.2	29.4	17.1	36.7	68.6	13.7	10.3	30.3	109.8	12.9	22.4	19.8	36.4	31.5	35.8	20.1	16.0	91.8	21.4	28.3	26.8	118.1	111.8	14.1	11.3	31.6	14.4	21.0	20.4	8.8	14.3	31.6	19.7	34.6	17.3	43.6	15.2	10.1	19.7	19.2	22.8	19.5	14.7	22.6
HMMR	"CD168, RHAMM"	ENSG00000072571	"Hyaluronan mediated motility receptor"	O75330	5	163460203-163491941	"CD markers, FDA approved drug targets, Predicted intracellular proteins"			"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 20.6;lymphoid tissue: 27.3;testis: 27.5"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 86.2;Erythroid cells: 133.3;Extravillous trophoblasts: 55.1;Late spermatids: 60.9;Spermatocytes: 100.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"T-reg: 1.5"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"CAB002433, HPA040025, HPA043926, HPA061524"	Enhanced		Enhanced	Microtubules,Centrosome,Cytosol		Yes	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Microtubules	"Centrosome, Cytosol"	"CAB002433: AB_564080, HPA040025: AB_2676805, HPA043926: , HPA061524: AB_2684551"	"unprognostic (3.53e-3)"	"unprognostic (1.01e-1)"	"unprognostic (3.38e-3)"	"unprognostic (8.88e-3)"	"unprognostic (2.12e-1)"	"prognostic unfavorable (5.52e-4)"	"prognostic unfavorable (1.93e-7)"	"prognostic unfavorable (1.09e-4)"	"unprognostic (5.68e-2)"	"unprognostic (2.50e-1)"	"prognostic unfavorable (3.71e-5)"	"unprognostic (1.02e-1)"	"unprognostic (0.00e+0)"	"unprognostic (1.65e-2)"	"unprognostic (4.98e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.77e-2)"	0.8	0.7	0.2	10.1	0.3	20.6	2.1	0.3	0.4	1.1	0.1	6.6	7.4	0.8	0.2	4.0	0.5	0.9	0.8	0.2	0.2	0.7	1.7	0.9	18.1	0.5	0.3	0.2	0.3	0.9	0.2	6.2	0.4	0.5	8.8	0.8	0.8	0.2	1.2	4.2	6.5	2.9	0.3	2.9	3.6	27.5	0.7	27.3	0.7	0.4	17.7	2.2	1.4	0.5	77.0	47.2	94.5	50.8	5.0	9.0	70.3	71.4	34.9	88.0	78.9	96.8	145.1	127.5	66.0	22.2	118.5	86.3	112.4	69.0	148.6	116.1	34.4	76.7	32.3	48.4	1.4	68.7	67.3	2.4	4.1	82.8	64.0	14.7	50.6	85.7	73.2	101.0	93.2	28.5	72.3	38.8	81.9	51.2	51.6	78.0	126.3	63.9	34.8	20.4	78.8	43.8	106.3	32.8	38.6	45.1	97.3	54.5	32.9	63.2	52.4	50.6	97.2	53.7	96.3	102.4	41.4	104.2	61.1	0.2	0.2	0.0	0.1	0.1	0.3	0.3	0.3	0.1	0.2	0.2	0.1	0.2	0.1	0.5	0.0	0.6	1.5	0.2	0.2	0.3	0.3	0.4	0.2	0.2	0.5	0.3	0.4	0.3	0.7	0.5	0.4	0.0	1.1	1.3	6.0	2.5	1.8	4.5	2.8	0.6	3.2	3.7	2.5	4.3	3.2	0.0	0.0	37.3	2.3	5.3	0.0	0.8	86.2	3.8	3.1	3.1	1.2	133.3	0.6	0.2	55.1	4.6	11.7	5.7	0.0	21.6	5.3	3.8	22.2	0.0	0.4	7.8	6.1	8.8	2.7	60.9	2.1	7.6	0.0	0.0	2.3	0.1	1.0	0.5	1.2	0.2	0.3	0.7	22.9	1.5	1.3	2.6	2.8	1.0	6.6	0.6	3.8	100.9	23.3	14.1	1.4	4.5	5.2	1.6	15.6	3.0
HMX3	NKX5-1	ENSG00000188620	"H6 family homeobox 3"	A6NHT5	10	123135970-123139423	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	8	"brain: 6.9"	"Cell type enriched"	"Detected in single"	10	"Cardiomyocytes: 1.0"	"Cancer enhanced"	"Detected in single"		"stomach cancer: 0.5"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"HAP1: 8.1;HEL: 6.1;HeLa: 7.0;K-562: 17.9;NB-4: 13.4;SiHa: 7.0;THP-1: 5.7"	"Region enriched"	"Detected in single"	4	"hypothalamus: 1.1"	"Group enriched"	"Detected in some"	5	"basal ganglia: 1.4;hypothalamus: 4.8"	HPA069659			Approved	"Nucleoplasm,Centriolar satellite"		Yes	No			"Cluster 17: Basophils - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 43: Cardiomyocytes - Nuclear processes"	Nucleoplasm	"Centriolar satellite"	"HPA069659: AB_2686165"			"unprognostic (1.79e-1)"								"unprognostic (9.65e-2)"			"unprognostic (6.07e-2)"				0.9	0.1	0.4	0.1	0.1	0.1	0.0	0.3	0.1	0.0	0.1	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	6.5	0.1	0.0	0.0	0.1	1.3	6.9	0.0	0.1	0.0	0.2	0.0	2.4	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.1	0.0	0.1	0.2	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.1	0.0	8.1	0.0	0.0	0.7	0.4	6.1	7.0	0.2	0.1	0.2	1.3	0.0	0.0	0.0	0.0	0.0	0.0	2.9	17.9	0.1	0.0	0.0	0.0	13.4	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.4	0.2	0.0	7.0	0.0	0.1	0.0	0.0	5.7	0.1	0.0	0.8	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.4	1.6	0.3	0.4	0.2	0.2	0.2	0.3	0.2	0.2	0.1	0.5	0.2	0.3	0.9	0.4	0.2	0.4	0.2	0.1	0.4	0.1	0.3	0.1	0.1	6.5	1.3	6.9	2.4	0.1	3.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
HORMAD1	"CT46, DKFZP434A1315"	ENSG00000143452	"HORMA domain containing 1"	Q86X24	1	150698060-150720895	"Predicted intracellular proteins"	"Differentiation, Meiosis, Oogenesis, Spermatogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	17	"testis: 117.8"	"Cell type enriched"	"Detected in some"	4	"Spermatocytes: 727.7"	"Cancer enhanced"	"Detected in many"		"testis cancer: 6.9"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.2"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"A549: 5.6;HeLa: 4.9;hTCEpi: 19.4;SiHa: 6.1;SuSa: 6.5;THP-1: 11.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA028346, HPA037850"	Enhanced		Approved	Nucleoplasm,Nucleoli		Yes	No			"Cluster 1: Neutrophils - Mixed function"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm	Nucleoli	"HPA028346: AB_2672564, HPA037850: AB_10696358"	"unprognostic (7.21e-2)"	"unprognostic (7.88e-2)"	"unprognostic (1.05e-1)"	"unprognostic (8.15e-2)"	"unprognostic (9.06e-2)"	"unprognostic (3.91e-3)"	"unprognostic (4.08e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.56e-2)"	"unprognostic (5.17e-3)"	"unprognostic (3.79e-9)"	"unprognostic (3.32e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.49e-2)"	0.2	0.0	0.1	0.5	0.1	0.5	0.1	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	3.6	0.0	0.2	0.0	0.1	0.1	0.0	0.1	0.2	0.4	0.1	0.0	0.0	0.1	0.0	0.0	0.5	0.1	0.1	0.4	0.1	0.4	0.0	0.0	6.8	0.2	0.1	0.0	0.9	0.1	117.8	0.2	0.0	0.0	0.0	0.8	0.0	0.2	0.2	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	2.6	0.0	0.0	0.0	0.1	0.0	0.1	4.9	0.0	0.0	0.1	0.1	0.0	19.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	6.1	0.0	0.1	6.5	0.0	11.3	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.5	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.2	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.3	0.1	0.1	0.1	0.0	0.1	0.0	0.2	0.2	0.1	0.0	0.0	0.0	0.2	5.4	0.0	1.4	0.0	0.0	0.2	0.0	0.0	0.0	0.7	0.0	0.0	3.4	0.0	0.3	0.0	0.1	88.3	0.5	0.1	0.5	0.0	0.0	2.7	0.0	2.1	0.4	0.0	0.1	0.0	0.1	0.4	0.0	0.8	0.0	2.0	0.0	0.0	1.3	0.9	35.1	5.3	0.8	0.0	1.0	1.5	0.0	0.0	1.0	0.1	0.0	0.1	4.9	0.0	0.0	0.0	0.0	0.5	0.0	32.9	0.0	0.4	727.7	163.5	0.0	9.2	2.2	0.0	0.3	0.2	0.1
HOXA2	HOX1K	ENSG00000105996	"Homeobox A2"	O43364	7	27100354-27102686	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Basal squamous epithelial cells: 23.3;Breast myoepithelial cells: 3.8;Enteroendocrine cells: 4.8;Hepatic stellate cells: 6.4;Squamous epithelial cells: 6.3"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	16	"medulla oblongata: 4.5;pons: 3.3;spinal cord: 4.7;white matter: 4.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 14.5;HaCaT: 6.2;RPTEC TERT1: 4.9"	"Region enriched"	"Detected in single"	36	"pons and medulla: 5.8"	"Group enriched"	"Detected in some"	17	"medulla oblongata: 4.2;pons: 1.1;spinal cord: 3.0"	HPA078220			Approved	Nucleoplasm,Vesicles		Yes	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 50: Fibroblasts - ECM organization"	"Nucleoplasm, Vesicles"		"HPA078220: AB_2686880"	"unprognostic (7.30e-2)"	"unprognostic (4.90e-4)"	"unprognostic (2.81e-1)"	"unprognostic (7.43e-4)"	"unprognostic (1.44e-1)"	"unprognostic (2.01e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.96e-1)"	"unprognostic (1.85e-3)"	"unprognostic (1.48e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.58e-2)"	"unprognostic (4.98e-9)"	"unprognostic (1.34e-1)"	"unprognostic (1.33e-1)"	"unprognostic (9.36e-2)"	"unprognostic (1.28e-2)"	1.9	1.0	0.0	0.6	0.0	0.0	1.6	0.0	0.0	1.6	0.0	3.3	0.9	2.0	5.1	2.3	4.1	1.0	0.2	0.0	0.0	4.4	0.2	1.7	0.2	4.5	0.2	0.6	0.3	5.7	0.0	0.0	3.3	1.7	1.8	0.0	0.0	2.1	0.7	1.6	2.6	0.9	4.7	1.2	2.2	0.1	0.1	1.8	0.8	3.0	0.6	2.0	0.9	4.3	1.1	0.6	4.0	14.5	0.0	0.0	0.0	0.2	0.1	0.0	0.1	1.6	3.4	0.1	1.5	0.1	1.8	6.2	0.2	0.0	0.0	0.0	2.0	0.0	0.1	0.2	1.8	0.1	0.3	0.8	0.0	3.1	3.1	0.0	2.5	0.3	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.1	0.9	1.0	0.7	0.0	4.9	0.5	0.9	0.0	0.2	0.0	0.9	0.2	0.0	0.0	2.5	0.0	0.2	1.1	0.5	0.0	0.0	0.1	0.0	0.6	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.2	3.3	4.7	0.1	4.3	1.0	0.0	0.0	0.0	0.0	1.0	0.4	0.0	23.3	0.0	1.2	3.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.4	0.1	1.3	2.5	4.8	0.0	0.0	0.0	0.0	1.7	0.0	0.1	0.0	0.0	6.4	0.1	0.1	0.0	0.0	1.3	0.0	0.0	0.7	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.0	0.1	1.1	0.5	0.0	0.0	0.0	1.0	1.9	0.0	0.0	6.3	0.3	0.0	0.1	0.0	1.7	0.7
ID1	"bHLHb24, dJ857M17.1.2"	ENSG00000125968	"Inhibitor of DNA binding 1, HLH protein"	P41134	20	31605283-31606515	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Developmental protein, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 1667.3;Basal respiratory cells: 1443.4;Hepatic stellate cells: 2131.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	4	"neutrophil: 1.1"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 1.1"	"Cell line enhanced"	"Detected in many"		"EFO-21: 509.6;HaCaT: 500.2;Hep G2: 425.3;PC-3: 515.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025915, HPA051456, HPA058518"	Approved		Enhanced	Nucleoplasm	"Intracellular and membrane"	Yes	No			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 72: Non-specific - Transcription"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm		"CAB025915: , HPA051456: AB_2681492, HPA058518: AB_2683740"	"unprognostic (3.89e-2)"	"unprognostic (3.45e-2)"	"unprognostic (2.62e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.27e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.35e-1)"	"prognostic unfavorable (4.85e-4)"	"unprognostic (2.29e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.14e-2)"	"unprognostic (7.83e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.71e-3)"	"unprognostic (2.97e-1)"	"unprognostic (6.17e-3)"	"unprognostic (3.41e-3)"	242.2	88.5	53.0	20.2	43.1	9.0	141.3	50.1	57.1	125.7	60.9	136.7	78.4	116.0	4.7	340.4	146.3	35.0	291.9	45.3	56.8	218.1	154.1	204.7	14.0	69.3	56.0	66.8	42.4	8.1	167.8	45.7	62.3	202.5	26.4	5.1	58.5	149.6	53.8	129.6	154.3	12.2	53.3	79.7	162.5	16.4	79.1	5.9	266.8	37.8	6.2	351.1	206.9	47.1	76.1	245.3	2.7	49.3	31.2	14.1	187.6	314.1	12.6	56.9	6.2	130.5	111.4	0.6	509.6	84.3	67.2	500.2	40.1	17.9	8.6	6.2	25.6	41.5	229.2	425.3	42.3	0.9	2.2	57.4	69.7	0.3	4.3	93.5	35.0	27.6	94.0	2.3	110.4	99.8	11.4	1.8	172.7	336.5	515.3	0.9	200.8	4.2	11.1	206.1	93.5	87.4	261.3	91.9	2.4	128.8	57.0	7.6	188.5	151.3	300.0	49.0	216.1	5.6	6.3	5.2	176.2	39.5	21.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	1.1	0.1	0.2	0.0	0.0	0.1	53.0	43.1	50.1	57.1	45.3	56.8	69.3	56.0	62.3	53.3	79.1	47.1	1667.3	237.2	171.7	88.2	25.1	102.3	992.2	1443.4	406.3	2.7	98.6	114.3	35.1	112.9	685.1	228.1	4.2	129.9	46.3	594.3	37.2	584.1	5.7	794.1	450.1	907.7	572.7	49.9	0.6	535.5	493.7	195.3	675.3	707.6	22.2	8.9	2131.4	109.1	25.6	0.0	0.5	557.4	321.4	72.2	52.4	8.7	28.6	38.9	90.7	92.8	8.2	85.0	1.0	4.0	0.3	257.4	924.9	0.4	26.7	519.7	579.8	7.1	168.1	8.3	13.1	229.7	206.1	3.2	53.7	455.8	87.9	89.1	39.8	15.9	389.1	591.6
IDH3G		ENSG00000067829	"Isocitrate dehydrogenase (NAD(+)) 3 non-catalytic subunit gamma"	P51553	X	153785766-153794523	"Citric acid cycle related proteins, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Tricarboxylic acid cycle"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 284.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000425, HPA002017"	Supported		Approved	Nucleoli,Mitochondria		Yes	No		19000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoli, Mitochondria"		"HPA000425: AB_1079097, HPA002017: AB_1079096"	"unprognostic (4.24e-2)"	"unprognostic (1.43e-3)"	"unprognostic (5.75e-2)"	"unprognostic (1.05e-1)"	"unprognostic (6.57e-2)"	"unprognostic (2.25e-1)"	"unprognostic (4.35e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.24e-2)"	"unprognostic (1.59e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.96e-1)"	"prognostic favorable (5.73e-6)"	"unprognostic (1.50e-1)"	"unprognostic (3.35e-1)"	"unprognostic (2.91e-2)"	"unprognostic (2.46e-1)"	52.0	67.1	45.5	38.5	50.0	60.3	49.9	47.8	61.3	44.1	46.5	57.2	52.3	50.7	23.5	50.2	44.8	35.0	91.9	54.9	48.8	68.5	49.2	42.0	40.3	50.5	45.7	49.3	48.3	45.5	47.9	28.3	52.3	43.8	34.6	24.4	51.7	39.9	100.5	51.7	54.7	34.5	43.9	51.8	52.2	32.1	49.1	35.2	48.0	82.9	34.9	44.3	43.2	47.2	94.9	90.0	47.3	65.9	74.4	59.4	62.0	47.3	64.1	80.5	84.3	76.0	66.5	121.4	80.2	74.7	68.2	67.2	72.6	69.2	30.0	38.9	101.7	43.0	118.9	59.0	85.5	61.6	87.5	76.1	48.0	64.4	69.4	50.4	65.3	50.3	24.7	60.4	64.7	138.5	72.0	76.0	21.6	84.2	118.0	62.7	43.3	105.8	94.4	61.1	59.5	42.8	30.2	96.3	48.0	20.8	39.6	51.9	56.0	49.9	34.1	76.8	112.5	89.0	22.6	152.1	81.8	75.8	57.6	178.1	159.3	165.8	71.8	163.9	68.0	68.5	73.2	71.2	163.1	78.9	57.9	63.7	57.8	86.5	169.6	101.3	107.5	140.1	45.5	50.0	47.8	61.3	54.9	48.8	50.5	45.7	52.3	43.9	49.1	47.2	44.4	35.3	33.8	5.5	49.2	80.9	67.5	103.9	37.5	34.9	48.4	57.9	55.1	50.1	55.0	51.5	29.2	99.8	48.2	145.0	207.4	93.4	132.0	42.2	39.4	44.6	62.3	41.4	5.6	90.5	98.7	48.2	47.9	39.8	93.8	43.6	43.2	35.4	131.0	18.5	6.4	107.0	79.3	98.0	77.0	284.2	53.4	75.6	67.6	3.7	116.4	50.8	64.9	3.0	5.0	73.5	133.8	58.6	49.7	35.6	222.4	253.1	50.7	49.3	52.6	47.4	68.2	15.9	18.3	50.3	77.4	110.8	55.2	103.0	112.7	64.2
IMPA2		ENSG00000141401	"Inositol monophosphatase 2"	O14732	18	11981025-12030877	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 359.1;skeletal muscle: 257.1"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 440.3;Extravillous trophoblasts: 272.2;Proximal tubular cells: 498.6;Squamous epithelial cells: 202.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 26.0;neutrophil: 31.3"	"Group enriched"	"Detected in many"	11	"dendritic cells: 9.0;granulocytes: 31.3;monocytes: 11.4"	"Cell line enhanced"	"Detected in many"		"BEWO: 258.2;OE19: 299.8;SiHa: 155.1"	"Low region specificity"	"Detected in all"							HPA029561	Approved		Approved	Nucleoplasm,Mitochondria		Yes	No			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 59: Non-specific - Translation"	"Cluster 21: OE19 - Mitochondria"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm	Mitochondria	"HPA029561: AB_10601932"	"unprognostic (1.16e-1)"	"unprognostic (1.28e-2)"	"unprognostic (4.76e-3)"	"unprognostic (2.50e-2)"	"unprognostic (4.25e-2)"	"unprognostic (3.25e-3)"	"unprognostic (4.26e-3)"	"unprognostic (4.08e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.96e-2)"	"unprognostic (4.56e-2)"	"unprognostic (4.24e-3)"	"prognostic favorable (0.00e+0)"	"unprognostic (1.95e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.08e-2)"	"unprognostic (3.35e-2)"	19.8	11.1	2.5	12.3	3.2	31.5	14.8	1.8	4.4	31.0	5.3	50.0	22.4	16.2	1.7	131.2	16.3	19.9	29.5	2.5	2.4	129.4	47.4	23.2	5.7	2.2	2.4	7.8	359.1	5.3	11.1	22.0	2.1	13.7	30.7	0.8	31.0	5.9	257.1	150.0	29.2	15.6	2.3	19.0	53.7	2.9	2.6	5.0	17.4	89.8	7.3	61.0	50.8	2.3	29.3	41.7	11.3	20.4	14.1	10.5	258.2	7.2	18.4	2.9	4.2	35.4	21.7	6.1	17.4	10.1	24.1	19.8	13.2	6.9	0.8	33.5	22.5	0.0	56.0	30.6	8.3	47.5	2.3	23.9	36.3	10.0	5.2	8.5	3.9	30.7	7.4	0.0	10.7	31.8	19.4	27.1	40.5	299.8	42.7	36.0	29.6	28.6	122.1	15.6	15.0	0.3	155.1	35.8	16.2	14.5	33.3	58.5	0.0	5.6	11.5	73.7	7.3	24.5	66.3	17.9	24.0	31.7	9.6	9.4	11.4	26.0	0.7	8.7	0.3	1.5	0.7	0.2	9.0	0.3	0.3	0.5	31.3	0.1	5.8	6.7	1.1	3.1	2.5	3.2	1.8	4.4	2.5	2.4	2.2	2.4	2.1	2.3	2.6	2.3	9.2	19.2	32.7	17.6	7.8	105.5	22.7	32.1	159.4	0.7	16.8	20.2	11.6	72.9	16.1	22.0	0.0	52.5	5.8	72.9	440.3	83.4	2.8	5.7	20.2	6.9	17.5	15.3	4.7	110.6	272.2	16.1	65.2	30.4	2.5	13.4	10.0	66.8	42.5	0.0	1.8	90.2	65.1	37.7	17.0	7.1	4.7	34.2	14.2	5.6	25.5	22.3	2.1	0.5	0.5	56.1	50.1	3.8	8.6	42.9	36.9	498.6	12.3	1.0	105.2	16.0	27.6	0.8	10.1	202.1	141.4	106.3	6.1	14.0	84.4	52.8
ING4	"my036, p29ING4"	ENSG00000111653	"Inhibitor of growth family member 4"	Q9UNL4	12	6650301-6663142	"Predicted intracellular proteins"	"Apoptosis, Cell cycle"	"Chromatin regulator"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031817, HPA057338"	Approved		Supported	Nucleoplasm		Yes	No			"Cluster 24: B-cells - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoplasm		"HPA031817: AB_2674056, HPA057338: AB_2683412"	"unprognostic (2.95e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.71e-3)"	"unprognostic (9.44e-2)"	"unprognostic (5.76e-3)"	"unprognostic (1.65e-2)"	"prognostic favorable (5.16e-4)"	"unprognostic (3.67e-2)"	"unprognostic (1.80e-1)"	"unprognostic (7.66e-3)"	"unprognostic (1.52e-1)"	"unprognostic (4.32e-2)"	"unprognostic (1.31e-1)"	"unprognostic (9.88e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.42e-2)"	22.9	26.4	43.8	15.5	44.5	11.6	27.9	45.8	51.7	34.9	40.7	33.7	17.9	27.4	30.7	22.8	27.4	18.1	23.9	44.0	43.9	29.7	25.7	18.6	27.6	44.9	44.0	31.3	19.7	32.0	27.7	21.6	44.8	33.0	21.8	22.3	25.9	23.1	19.3	31.0	26.7	22.5	44.8	37.7	26.9	20.4	44.7	38.5	34.9	23.8	24.5	29.5	27.2	49.3	9.2	12.3	35.8	17.0	27.3	26.9	22.9	12.0	19.4	19.6	23.4	5.6	41.1	15.9	7.8	16.8	15.6	14.3	17.8	14.1	21.7	31.1	26.4	22.9	22.5	11.5	16.0	9.1	10.4	27.3	32.3	10.4	13.3	63.4	29.8	30.6	10.9	8.9	19.0	6.6	33.2	13.9	52.8	20.3	11.7	30.9	18.8	17.0	24.7	10.4	14.7	38.3	18.6	6.2	23.2	51.5	8.2	25.0	22.7	8.1	16.1	9.1	7.9	10.7	15.6	21.6	21.6	14.0	8.3	32.2	31.1	26.8	33.5	43.5	31.2	30.9	27.8	28.7	34.3	48.2	37.9	32.9	20.1	38.0	51.0	26.5	30.9	37.9	43.8	44.5	45.8	51.7	44.0	43.9	44.9	44.0	44.8	44.8	44.7	49.3	20.5	22.4	19.0	15.0	26.8	8.2	11.1	19.1	13.6	31.2	22.2	27.6	10.9	17.2	17.9	18.4	18.8	43.3	37.0	14.4	29.4	25.0	2.0	17.1	21.6	22.4	25.2	18.1	23.1	8.1	11.7	21.8	10.2	14.8	27.9	40.7	20.0	8.9	24.6	35.3	23.0	18.6	30.5	16.6	12.4	6.7	34.5	27.0	10.6	13.1	32.6	34.6	52.5	18.6	20.7	11.9	16.9	37.6	11.7	11.8	21.3	24.4	12.5	26.4	32.9	13.6	21.2	20.7	19.1	9.9	10.1	30.6	22.3	31.8	14.6	9.7
INTS8	"C8orf52, FLJ20530, INT8, MGC131633"	ENSG00000164941	"Integrator complex subunit 8"	Q75QN2	8	94813311-94881746	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057299	Approved		Approved	Nucleoplasm		Yes	No			"Cluster 26: Non-specific - Mitochondria"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 21: OE19 - Mitochondria"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA057299: AB_2683403"	"unprognostic (1.08e-2)"	"unprognostic (3.12e-2)"	"unprognostic (1.28e-1)"	"unprognostic (5.86e-2)"	"unprognostic (1.96e-1)"	"unprognostic (4.81e-2)"	"prognostic unfavorable (2.54e-6)"	"unprognostic (3.07e-2)"	"unprognostic (6.87e-2)"	"unprognostic (9.77e-3)"	"unprognostic (4.84e-2)"	"unprognostic (1.53e-1)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (1.24e-1)"	"unprognostic (5.60e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.96e-2)"	8.8	7.5	4.4	13.9	4.8	15.5	8.1	8.3	6.4	14.5	6.9	12.8	7.8	13.2	4.2	10.5	9.5	7.3	10.2	4.8	6.4	6.4	8.9	7.5	17.4	5.7	4.4	11.4	13.5	10.1	8.3	9.4	4.6	10.4	14.8	10.3	11.0	8.7	12.6	10.3	10.6	13.6	4.0	9.9	10.6	30.6	6.3	20.6	8.8	12.0	13.6	10.4	10.4	6.1	52.4	31.9	49.2	43.4	17.7	41.7	25.5	27.5	26.0	35.7	33.0	22.5	38.0	52.3	25.2	20.7	44.3	31.5	61.3	29.2	47.6	58.1	28.8	45.7	19.3	22.1	21.1	24.6	31.7	17.1	13.5	34.7	29.6	40.8	40.1	35.1	44.4	38.9	22.0	34.5	53.7	20.4	28.1	114.9	55.8	42.7	19.7	29.0	30.0	26.6	34.6	18.4	26.8	7.7	24.1	40.3	37.3	31.6	28.1	16.1	18.9	31.1	25.1	22.0	43.0	45.2	21.6	49.4	32.2	2.1	9.6	15.1	4.6	6.8	7.5	13.4	10.8	11.8	9.3	10.4	11.0	6.5	9.3	9.6	6.6	5.5	10.0	4.5	4.4	4.8	8.3	6.4	4.8	6.4	5.7	4.4	4.6	4.0	6.3	6.1	11.0	16.0	8.6	16.6	19.4	5.9	11.6	9.1	9.6	13.7	6.1	4.6	8.3	5.7	11.6	7.3	33.3	10.0	9.7	10.3	3.9	8.3	36.0	15.0	12.1	11.8	18.0	17.7	44.8	13.4	12.9	10.8	8.6	6.1	12.7	15.2	8.9	5.5	9.5	28.6	40.9	11.8	8.2	11.6	6.6	6.4	16.1	14.0	7.2	25.3	21.6	8.0	16.5	33.2	31.2	10.9	14.6	16.1	18.0	8.8	9.5	5.1	19.7	18.9	6.6	10.6	13.1	54.7	32.5	9.0	7.0	8.5	14.2	11.0	11.1	8.1
INTS9	"CPSF2L, FLJ10871, RC-74"	ENSG00000104299	"Integrator complex subunit 9"	Q9NV88	8	28767661-28890242	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 28.7;Excitatory neurons: 29.5;Inhibitory neurons: 31.3;Oligodendrocyte precursor cells: 32.2;Oligodendrocytes: 39.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051615, HPA066822"			Enhanced	Nucleoplasm		Yes	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 16: Immune cells - Immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA051615: AB_2681552, HPA066822: AB_2685729"	"unprognostic (2.19e-2)"	"unprognostic (1.45e-2)"	"unprognostic (1.79e-2)"	"prognostic favorable (9.45e-4)"	"unprognostic (2.46e-1)"	"unprognostic (1.56e-3)"	"unprognostic (6.91e-3)"	"prognostic favorable (7.71e-4)"	"unprognostic (3.64e-2)"	"unprognostic (5.01e-2)"	"unprognostic (4.72e-2)"	"unprognostic (2.48e-3)"	"prognostic favorable (1.91e-5)"	"unprognostic (2.51e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.52e-1)"	8.6	22.0	7.9	11.1	8.9	6.8	8.3	8.7	9.4	9.1	10.5	8.8	6.9	9.2	11.3	11.1	9.7	6.7	12.2	7.9	8.6	10.7	5.9	8.8	14.6	8.5	8.8	8.2	9.7	9.5	12.5	7.9	8.6	9.1	9.3	10.5	8.9	7.2	11.6	9.9	9.6	9.0	8.6	15.7	9.4	12.8	8.9	17.5	10.6	6.9	17.9	11.0	8.7	9.4	24.7	17.0	20.1	21.4	24.3	11.3	8.8	11.1	15.1	19.0	20.9	11.9	13.4	24.4	15.2	11.4	17.0	20.1	39.2	22.7	26.1	10.3	16.1	24.4	9.5	21.0	17.6	12.3	18.2	13.0	16.0	22.9	16.3	10.2	23.8	34.5	52.2	13.7	12.8	13.5	57.5	22.3	27.4	28.8	10.9	36.5	23.3	12.8	13.4	16.8	14.4	26.4	11.5	14.8	20.5	16.0	14.4	13.8	14.1	10.9	27.6	18.7	14.2	7.0	5.3	29.8	16.8	20.3	15.8	17.0	20.6	19.0	17.3	23.0	16.1	18.0	15.1	19.3	29.1	19.5	13.4	14.5	8.3	25.1	17.4	15.4	20.3	12.0	7.9	8.9	8.7	9.4	7.9	8.6	8.5	8.8	8.6	8.6	8.9	9.4	3.6	6.4	4.2	28.7	10.9	2.3	2.4	4.7	1.8	2.1	2.7	2.3	5.8	5.7	3.7	3.7	6.2	7.7	6.1	2.8	1.9	3.7	8.3	4.8	6.2	4.6	6.0	4.2	29.5	5.1	4.8	4.7	9.2	5.9	0.0	6.7	3.9	2.5	7.5	1.7	31.3	3.6	4.1	3.8	6.1	4.1	7.8	4.1	3.6	23.4	5.4	2.4	4.1	32.2	39.9	4.9	1.7	4.5	4.3	1.9	3.3	4.3	3.4	6.1	0.0	4.2	4.0	5.1	3.5	7.7	3.0	4.8	5.4	11.2	3.5	1.7
IP6K3	"IHPK3, INSP6K3"	ENSG00000161896	"Inositol hexakisphosphate kinase 3"	Q96PC2	6	33721662-33746905	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"skeletal muscle: 308.1;tongue: 83.3"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 8.5;Cardiomyocytes: 11.2;Hepatocytes: 8.9;Horizontal cells: 10.1;Oligodendrocytes: 15.3;Proximal tubular cells: 8.2;Skeletal myocytes: 51.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HHSteC: 21.9;HSkMC: 7.9;LHCN-M2: 36.2;RH-30: 15.7"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"HPA053644, HPA062531"	Enhanced		Approved	Nucleoplasm,Cytosol		Yes	NA				"Cluster 80: Striated muscle - Unknown function"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 37: Myocytes - Muscle contraction"	Nucleoplasm	Cytosol	"HPA053644: AB_2682214, HPA062531: "	"unprognostic (3.23e-2)"	"unprognostic (2.87e-1)"	"unprognostic (2.07e-5)"	"unprognostic (1.07e-3)"	"unprognostic (2.20e-1)"	"unprognostic (5.10e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.45e-1)"	"unprognostic (2.47e-2)"	"unprognostic (1.24e-2)"	"unprognostic (2.94e-3)"	"prognostic unfavorable (6.09e-4)"	"unprognostic (1.63e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.66e-3)"	"unprognostic (1.33e-1)"	1.4	0.7	4.8	0.4	15.5	0.0	1.3	12.2	9.5	1.9	5.7	6.8	0.4	3.8	0.1	6.5	1.2	0.1	29.6	5.9	8.8	6.0	18.8	5.2	0.1	14.7	13.1	0.5	0.6	0.0	0.5	4.7	15.0	5.3	0.6	0.9	2.7	1.6	308.1	0.7	2.3	1.8	7.0	3.3	1.6	0.2	12.4	0.5	12.9	83.3	0.0	2.4	1.9	27.1	0.1	0.0	0.5	0.0	0.0	0.1	3.6	0.1	0.4	0.3	2.6	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.1	21.9	0.0	0.1	7.9	1.2	0.1	0.6	0.1	0.0	0.0	0.0	0.0	36.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	15.7	0.0	0.0	0.0	0.4	0.1	0.0	0.7	0.5	5.3	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	15.5	12.2	9.5	5.9	8.8	14.7	13.1	15.0	7.0	12.4	27.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.2	0.0	8.5	0.4	0.4	11.2	0.0	1.4	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.4	5.0	0.2	0.0	0.0	0.2	0.0	0.1	0.9	0.0	0.2	0.0	0.0	0.0	8.9	0.3	10.1	0.1	0.0	0.0	0.0	0.0	0.1	0.9	0.1	0.0	0.0	0.0	1.1	0.0	0.0	15.3	0.0	0.0	0.0	0.0	0.0	0.0	8.2	1.0	0.4	6.6	51.7	1.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.2
IQCE	KIAA1023	ENSG00000106012	"IQ motif containing E"	Q6IPM2	7	2558972-2614733	"Disease related genes, Human disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"Early spermatids: 410.0;Late spermatids: 419.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 4.6"	"Group enriched"	"Detected in many"	4	"dendritic cells: 2.6;granulocytes: 4.6;monocytes: 1.2"	"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA019515	Approved		Approved	Nucleoplasm,Cytosol		Yes	No			"Cluster 6: Non-specific - Transcription"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 6: T47d - Mammary gland"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA019515: AB_1851855"	"unprognostic (2.29e-1)"	"unprognostic (2.54e-1)"	"unprognostic (3.78e-2)"	"prognostic favorable (5.91e-4)"	"unprognostic (7.96e-3)"	"unprognostic (3.75e-1)"	"unprognostic (2.54e-3)"	"unprognostic (1.31e-1)"	"unprognostic (4.04e-3)"	"unprognostic (1.30e-2)"	"unprognostic (1.66e-2)"	"unprognostic (2.84e-1)"	"unprognostic (2.04e-2)"	"unprognostic (2.82e-2)"	"unprognostic (6.97e-2)"	"unprognostic (7.56e-3)"	"unprognostic (3.13e-2)"	4.5	6.6	19.3	6.5	16.7	5.6	6.2	9.6	19.3	7.5	22.5	9.4	12.0	8.3	10.3	5.3	14.6	7.2	6.6	17.3	16.3	6.6	3.3	7.5	4.3	16.5	18.6	7.7	7.6	11.0	14.4	3.5	11.3	7.8	8.7	9.8	9.1	9.3	4.9	7.3	10.1	6.6	13.3	4.6	9.6	31.7	18.6	4.3	10.5	5.5	3.5	5.7	4.3	15.1	35.5	18.2	7.0	23.0	9.2	13.4	13.2	7.2	11.7	8.8	9.4	9.5	19.6	2.5	8.0	16.7	19.7	17.9	5.1	7.4	8.9	6.3	10.9	4.9	21.9	2.6	6.8	12.8	6.4	5.8	13.5	8.3	9.9	10.4	10.3	8.9	15.4	4.5	11.8	35.8	5.2	8.6	6.6	15.7	12.4	4.9	8.4	8.8	10.1	15.9	15.7	18.7	8.2	33.9	7.1	4.9	41.5	17.1	10.3	7.6	15.7	30.2	12.2	4.9	8.0	0.5	15.3	8.5	22.1	0.8	0.8	2.3	0.6	1.2	0.2	0.2	0.3	0.3	0.3	0.3	0.2	0.6	4.6	0.2	0.4	2.6	0.2	0.2	19.3	16.7	9.6	19.3	17.3	16.3	16.5	18.6	11.3	13.3	18.6	15.1	4.8	12.8	14.3	14.4	2.1	5.5	5.7	5.3	6.2	8.9	12.3	7.9	9.1	14.3	11.4	12.9	60.5	4.1	13.8	27.4	17.6	20.6	410.0	44.8	15.3	5.7	8.4	1.7	16.6	19.7	10.0	7.0	24.5	9.4	1.3	7.6	6.4	2.8	10.1	20.2	17.4	12.3	12.2	8.1	5.3	419.3	14.0	9.3	0.0	3.7	12.0	14.9	12.3	4.5	4.2	24.1	18.9	15.4	8.0	5.4	12.1	9.5	58.7	36.7	19.7	7.8	6.6	40.9	43.8	3.5	4.3	1.9	4.9	11.2	12.4	4.0
ITGA2	CD49B	ENSG00000164171	"Integrin subunit alpha 2"	P17301	5	52989340-53094779	"Cancer-related genes, CD markers, Human disease related genes, Plasma proteins, Predicted membrane proteins"	"Cell adhesion, Host-virus interaction"	"Host cell receptor for virus entry, Integrin, Receptor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 406.2;Oligodendrocytes: 370.9;Pancreatic endocrine cells: 558.7;Prostatic glandular cells: 299.3;Urothelial cells: 363.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 91.4;HaCaT: 92.5;hTERT-RPE1: 83.2;HUVEC TERT2: 83.5;TIME: 71.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB017690, HPA060991, HPA063556"	Enhanced		Approved	Nucleoplasm,Cytosol		Yes	No		43000000		"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm	Cytosol	"CAB017690: AB_1124939, HPA060991: AB_2684405, HPA063556: AB_2685040"	"unprognostic (8.35e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.85e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.22e-1)"	"unprognostic (3.70e-2)"	"unprognostic (2.67e-3)"	"unprognostic (2.38e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.69e-2)"	"prognostic unfavorable (1.02e-5)"	"unprognostic (4.27e-1)"	"unprognostic (3.88e-2)"	"unprognostic (2.87e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.11e-1)"	1.4	12.8	2.4	4.9	6.7	0.4	7.8	4.4	3.7	5.0	0.9	6.1	7.7	4.9	7.4	11.0	2.6	9.0	1.1	2.4	4.2	9.8	0.5	12.5	0.9	4.8	4.9	1.0	1.6	9.3	1.2	4.8	5.4	6.6	5.9	2.4	10.4	11.1	0.5	17.1	7.7	2.4	3.3	6.8	7.5	0.4	4.8	4.3	2.3	0.7	4.6	15.6	8.0	12.9	60.4	15.4	1.3	0.8	3.9	7.1	4.5	60.2	91.4	2.2	3.6	29.0	41.8	0.1	9.8	25.4	33.5	92.5	4.9	67.1	8.5	0.0	4.4	4.3	3.7	17.5	13.3	0.7	1.3	2.9	11.4	59.2	10.5	83.2	83.5	3.1	0.1	0.2	1.6	11.4	0.6	0.1	3.7	15.7	29.6	0.0	0.4	0.1	18.9	32.0	0.6	3.2	3.2	4.1	6.1	2.3	9.6	0.2	71.2	10.8	6.3	1.7	12.1	0.0	0.1	0.1	64.0	0.0	48.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	2.4	6.7	4.4	3.7	2.4	4.2	4.8	4.9	5.4	3.3	4.8	12.9	7.4	57.7	13.7	9.1	0.6	151.0	406.2	141.3	56.9	2.7	24.4	39.0	1.3	15.7	133.2	53.3	4.2	1.9	0.9	23.2	9.8	144.0	0.1	20.3	5.0	39.0	13.8	0.0	0.5	169.3	2.2	11.6	13.3	90.6	1.3	45.4	5.3	0.2	0.3	0.0	0.9	37.8	20.3	0.0	6.1	0.2	1.2	2.5	12.4	14.0	1.1	14.7	0.0	0.0	370.9	558.7	20.3	0.0	2.6	299.3	20.6	3.8	103.6	4.3	0.0	4.4	12.1	0.0	1.3	57.0	37.2	0.4	5.8	23.7	30.9	363.9
JPH3	"CAGL237, HDL2, JP-3, JP3, TNRC22"	ENSG00000154118	"Junctophilin 3"	Q8WXH2	16	87601835-87698156	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"brain: 59.1"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 24.4;Cone photoreceptor cells: 22.9;Early spermatids: 41.1;Excitatory neurons: 33.2;Horizontal cells: 50.5;Inhibitory neurons: 28.7;Late spermatids: 14.4"	"Cancer enhanced"	"Detected in some"		"glioma: 1.7"	"Group enriched"	"Detected in all"	5	"amygdala: 17.1;basal ganglia: 24.6;cerebral cortex: 59.1;hippocampal formation: 42.7;white matter: 20.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"MCF7: 6.5;NTERA-2: 5.7;SH-SY5Y: 7.2;SiHa: 5.0;U-2 OS: 22.5"	"Low region specificity"	"Detected in all"							HPA076304			Approved	Nucleoplasm,Cytosol		Yes	No				"Cluster 10: Brain - Neuronal signaling"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 62: Horizontal cells - Visual perception"	Nucleoplasm	Cytosol	"HPA076304: AB_2686793"	"unprognostic (8.97e-3)"	"unprognostic (3.17e-2)"	"unprognostic (1.57e-3)"	"unprognostic (4.82e-3)"	"unprognostic (3.43e-1)"	"unprognostic (9.12e-2)"	"unprognostic (1.68e-2)"	"unprognostic (8.10e-2)"	"unprognostic (5.53e-2)"	"unprognostic (1.48e-1)"	"unprognostic (5.61e-3)"	"unprognostic (2.80e-2)"	"unprognostic (1.28e-4)"	"unprognostic (3.01e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.87e-2)"	"unprognostic (1.36e-2)"	0.2	1.3	17.1	0.2	24.6	0.0	0.1	1.1	59.1	0.7	0.0	1.1	0.1	0.2	0.0	0.6	0.4	0.0	0.1	42.7	5.6	0.0	0.1	0.1	0.0	6.4	5.8	0.1	0.3	0.0	14.1	0.0	1.1	0.2	0.0	1.8	0.0	0.3	0.0	0.1	0.5	0.0	1.1	0.1	0.5	1.4	1.1	0.0	0.1	0.0	0.0	0.1	0.3	20.6	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.3	0.0	0.1	3.0	0.0	0.9	0.0	1.2	0.0	0.0	0.1	0.9	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	6.5	0.0	0.0	5.7	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.5	7.2	5.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	22.5	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.1	24.6	1.1	59.1	42.7	5.6	6.4	5.8	1.1	1.1	1.1	20.6	0.0	0.0	0.0	2.3	0.1	0.0	0.2	0.0	0.0	24.4	0.0	0.0	3.7	0.0	0.0	0.0	22.9	0.0	0.0	0.1	0.0	0.0	41.1	0.0	0.0	0.8	0.0	0.0	33.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	2.2	0.0	0.1	50.5	28.7	0.0	0.0	0.0	0.0	14.4	0.3	0.0	0.0	0.0	0.0	1.3	0.0	10.6	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	9.6	0.0	0.2	0.1	1.1	3.7	0.0	0.0	0.1	0.1	0.5	0.0	0.1
JUN	"AP-1, c-Jun"	ENSG00000177606	"Jun proto-oncogene, AP-1 transcription factor subunit"	P05412	1	58776845-58784048	"Cancer-related genes, FDA approved drug targets, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"RH-30: 295.6"	"Low region specificity"	"Detected in all"							"CAB003801, CAB007780, HPA031174, HPA059474"	Enhanced		Enhanced	Nucleoplasm		Yes	No			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"CAB003801: AB_365485, CAB007780: AB_562268, HPA031174: , HPA059474: AB_2684030"	"unprognostic (2.06e-2)"	"unprognostic (1.76e-2)"	"unprognostic (1.34e-1)"	"unprognostic (7.85e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.70e-1)"	"unprognostic (4.11e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.24e-1)"	"unprognostic (5.00e-2)"	"unprognostic (2.14e-1)"	"unprognostic (2.82e-1)"	"unprognostic (5.15e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.83e-1)"	"unprognostic (2.37e-1)"	"unprognostic (2.81e-3)"	331.1	92.7	34.4	36.3	37.0	129.1	308.2	41.6	38.1	172.0	28.0	154.7	34.7	116.4	15.8	100.2	314.1	89.6	158.4	39.1	37.2	94.0	205.2	202.8	52.1	32.7	30.7	197.0	192.2	59.8	75.0	40.1	30.5	153.4	55.0	29.7	154.5	71.7	114.3	286.6	79.1	113.3	34.3	62.0	239.5	20.2	33.8	71.5	189.5	158.8	5.4	156.4	164.5	36.9	49.8	2.8	22.4	2.6	35.3	40.0	0.2	69.4	27.0	57.1	34.3	10.1	3.5	1.7	23.8	57.4	133.6	12.9	2.0	27.7	40.6	29.8	128.9	0.5	1.9	16.9	29.4	5.3	10.2	42.0	74.0	78.1	34.0	27.7	47.2	2.4	15.6	29.6	24.9	8.0	2.5	32.5	13.5	34.6	32.2	1.1	295.6	7.0	60.7	5.8	43.7	12.8	49.9	62.3	26.4	24.5	17.2	3.0	61.6	127.5	37.3	35.3	96.8	37.9	9.8	4.4	133.9	8.4	35.2	0.0	0.2	0.0	0.2	0.0	0.0	0.3	0.2	0.0	0.0	0.6	0.0	0.1	0.2	0.6	0.0	0.0	0.0	0.0	34.4	37.0	41.6	38.1	39.1	37.2	32.7	30.7	30.5	34.3	33.8	36.9	2721.4	538.5	543.8	187.7	1018.8	1235.5	2850.5	772.6	2825.1	103.4	1647.1	2067.3	1487.5	1315.4	449.3	104.8	262.7	675.8	651.1	1653.6	50.9	987.0	49.3	1337.1	2845.2	1443.8	1497.4	174.3	12.2	516.4	93.9	2730.7	2663.1	1822.2	541.9	333.4	737.2	158.6	650.5	87.5	4.9	1909.1	836.2	584.9	632.0	48.2	1227.4	1034.9	757.7	65.6	140.1	1234.2	8.2	17.6	10.0	562.8	1529.6	258.8	1540.3	1489.1	1654.1	48.6	216.3	453.5	1538.3	1892.9	2392.5	17.4	20.9	2146.3	964.4	415.6	1065.5	846.5	1199.5	545.7
KCND1	Kv4.1	ENSG00000102057	"Potassium voltage-gated channel subfamily D member 1"	Q9NSA2	X	48961378-48971844	"FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Enteroendocrine cells: 3.5;Peritubular cells: 3.8;Rod photoreceptor cells: 3.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HSkMC: 10.6;NB-4: 9.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000524, HPA001066"	Supported		Uncertain	Nucleoplasm		Yes	No			"Cluster 1: Neutrophils - Mixed function"	"Cluster 21: Non-specific - Transcription"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 46: Photoreceptor cells - Phototransduction"	Nucleoplasm		"HPA000524: AB_2666013, HPA001066: AB_1079662"	"unprognostic (6.00e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.01e-4)"	"unprognostic (2.19e-4)"	"unprognostic (1.41e-1)"	"unprognostic (3.79e-2)"	"unprognostic (2.79e-1)"	"unprognostic (8.13e-3)"	"unprognostic (1.13e-2)"	"unprognostic (2.41e-3)"	"prognostic favorable (2.66e-6)"	"unprognostic (2.61e-1)"	"unprognostic (4.30e-11)"	"unprognostic (3.13e-2)"	"unprognostic (3.49e-1)"	"unprognostic (7.64e-2)"	"unprognostic (2.22e-3)"	3.8	0.9	2.8	1.5	2.8	2.7	1.8	5.5	2.7	2.7	0.1	2.0	0.8	3.6	1.4	1.1	5.4	2.4	2.3	2.9	3.0	1.7	1.4	2.6	1.3	3.6	2.9	2.7	1.1	0.4	2.3	1.0	3.9	2.3	0.8	6.1	0.9	2.1	0.5	1.3	2.2	2.5	3.3	3.3	1.8	1.5	3.2	0.7	1.8	0.4	1.4	2.3	2.3	3.8	0.3	1.6	0.7	3.9	5.1	4.1	1.3	0.8	3.3	2.3	1.5	1.1	0.5	1.3	2.8	2.6	0.6	0.5	0.6	0.3	2.2	2.3	2.7	1.2	1.8	0.1	1.9	0.3	2.5	10.6	1.4	4.2	0.4	3.7	0.8	1.9	0.9	3.0	1.7	3.1	0.4	9.2	2.1	0.2	0.6	1.1	0.7	1.3	2.6	1.3	0.4	1.8	0.7	0.0	1.8	7.9	1.7	1.3	2.0	0.5	2.1	0.5	0.2	2.5	3.5	3.2	1.4	3.2	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	2.8	2.8	5.5	2.7	2.9	3.0	3.6	2.9	3.9	3.3	3.2	3.8	0.9	0.0	1.1	1.0	0.4	0.8	0.0	0.4	0.0	0.2	0.3	0.3	0.8	0.0	0.2	1.8	0.0	0.1	0.4	0.3	1.9	0.2	0.1	0.2	1.0	0.6	3.5	0.0	0.7	0.0	0.1	1.2	0.5	0.5	0.0	1.7	1.1	0.0	0.1	0.0	1.1	0.3	0.0	0.6	0.0	0.2	1.8	0.4	0.0	1.0	0.1	0.4	0.0	2.0	0.1	0.1	0.0	3.8	0.1	0.2	0.2	0.1	0.3	3.0	0.0	0.1	0.6	0.6	0.0	0.1	0.0	0.1	0.2	0.1	0.2	0.2
KCNN1	"hSK1, KCa2.1"	ENSG00000105642	"Potassium calcium-activated channel subfamily N member 1"	Q92952	19	17951293-18000080	"FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Transport"	"Calmodulin-binding, Ion channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	41	"brain: 92.2"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 12.8;Langerhans cells: 19.8;Skeletal myocytes: 6.8"	"Cancer enhanced"	"Detected in some"		"testis cancer: 3.5"	"Group enriched"	"Detected in many"	7	"amygdala: 34.8;basal ganglia: 30.6;cerebral cortex: 67.2;hippocampal formation: 92.2;white matter: 30.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	12	"REH: 155.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065938			Approved	"Actin filaments,Cytosol"		Yes	No				"Cluster 10: Brain - Neuronal signaling"	"Cluster 14: REH - Unknown function"	"Cluster 50: Fibroblasts - ECM organization"	"Actin filaments, Cytosol"		"HPA065938: AB_2685582"	"unprognostic (7.55e-2)"	"unprognostic (4.03e-2)"	"unprognostic (1.82e-1)"	"unprognostic (7.80e-2)"	"unprognostic (1.90e-1)"	"unprognostic (8.94e-5)"	"unprognostic (3.92e-3)"	"unprognostic (1.01e-1)"	"unprognostic (8.42e-2)"	"unprognostic (3.59e-1)"	"unprognostic (2.71e-3)"	"unprognostic (3.38e-1)"	"unprognostic (5.21e-3)"	"unprognostic (2.70e-2)"	"unprognostic (1.14e-1)"	"unprognostic (7.24e-3)"	"unprognostic (3.24e-1)"	0.3	0.2	34.8	0.4	30.6	0.1	0.2	0.0	67.2	0.9	0.0	0.3	0.1	0.6	0.1	0.2	0.1	0.1	1.1	92.2	0.0	0.2	0.0	0.1	0.1	4.4	0.0	1.8	0.1	1.6	1.0	0.0	6.8	0.6	0.0	0.8	0.4	0.2	0.1	0.1	0.2	0.0	0.0	0.1	0.2	2.2	0.0	0.1	0.1	0.0	0.1	0.1	0.2	30.6	0.1	0.6	0.2	6.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	1.6	0.0	0.5	0.2	5.3	0.0	0.2	0.2	2.5	5.0	0.3	0.1	0.0	0.0	12.8	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.3	0.2	0.0	0.4	0.0	0.0	1.8	0.0	0.1	155.3	0.0	0.2	0.0	0.0	0.2	8.6	0.0	0.0	0.1	0.4	0.3	0.2	0.1	0.0	4.7	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	34.8	30.6	0.0	67.2	92.2	0.0	4.4	0.0	6.8	0.0	0.0	30.6	0.4	0.0	0.0	3.6	1.1	2.5	3.7	0.0	0.0	2.3	0.2	0.3	0.8	0.0	0.7	0.0	2.1	0.1	1.5	0.2	0.0	0.0	0.2	1.3	1.5	1.9	0.0	0.0	12.8	0.0	0.2	2.6	0.0	1.9	0.0	3.6	0.4	0.2	0.1	0.0	4.4	0.0	0.0	0.3	19.8	0.4	0.9	2.1	5.4	1.9	2.2	1.4	1.0	3.0	0.7	0.2	0.0	1.9	0.7	2.8	0.0	0.2	0.0	1.0	0.0	6.8	1.8	0.6	4.0	0.0	3.8	0.1	1.5	2.2	0.0	1.8
KDM7A	"JHDM1D, KIAA1718"	ENSG00000006459	"Lysine demethylase 7A"	Q6ZMT4	7	140084746-140176983	"Predicted intracellular proteins"	"Neurogenesis, Transcription, Transcription regulation"	"Chromatin regulator, Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Microglial cells: 96.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012114	Uncertain		Approved	Nucleoplasm,Nucleoli		Yes	No			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	Nucleoli	"HPA012114: AB_1852429"	"unprognostic (1.55e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.54e-1)"	"unprognostic (4.08e-3)"	"unprognostic (3.52e-1)"	"unprognostic (1.69e-2)"	"unprognostic (4.00e-1)"	"unprognostic (3.44e-2)"	"unprognostic (2.56e-1)"	"unprognostic (3.84e-2)"	"unprognostic (9.74e-2)"	"unprognostic (1.29e-1)"	"unprognostic (9.55e-2)"	"unprognostic (3.42e-1)"	"unprognostic (2.59e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.18e-1)"	6.6	2.1	2.1	6.9	1.6	16.4	4.7	3.8	3.9	9.5	1.5	8.4	8.2	6.6	1.4	7.0	2.9	4.5	4.1	2.7	1.6	3.6	6.7	4.8	7.0	2.5	2.5	2.1	4.5	4.1	1.3	9.1	2.8	3.3	9.3	5.8	5.1	2.1	12.6	7.5	8.3	4.4	2.4	5.6	9.3	7.7	3.7	6.7	2.8	13.2	8.0	5.7	3.7	3.0	0.8	0.4	2.7	2.8	2.4	2.3	5.4	1.2	1.7	0.4	0.5	0.2	0.4	1.9	1.9	1.3	1.4	1.0	3.7	2.3	0.8	10.8	2.3	0.1	0.4	5.1	2.5	1.8	1.9	2.4	5.1	1.4	8.0	1.3	2.6	5.0	6.1	8.2	0.5	0.8	3.6	3.1	4.3	6.3	1.5	3.8	0.2	4.0	0.9	1.2	4.7	5.8	2.8	6.5	2.7	4.3	8.8	0.7	4.6	0.5	1.0	1.7	0.8	2.9	0.4	6.2	1.5	5.0	1.0	0.6	0.8	0.3	0.3	0.4	0.3	0.5	0.5	0.5	1.1	1.1	0.5	0.3	2.2	0.6	0.2	0.4	0.4	0.3	2.1	1.6	3.8	3.9	2.7	1.6	2.5	2.5	2.8	2.4	3.7	3.0	34.4	16.0	25.5	25.5	30.6	49.8	44.8	17.7	8.0	11.8	11.1	7.4	14.6	8.6	30.1	16.5	27.1	12.3	17.8	36.7	1.9	7.2	5.2	17.0	18.2	23.8	52.7	32.4	35.3	9.4	2.8	20.0	30.5	28.7	8.2	12.2	18.5	18.5	10.7	6.7	34.8	38.0	12.2	31.4	86.7	4.9	7.8	35.4	3.6	96.5	34.7	4.3	10.3	35.7	36.0	12.2	28.7	4.1	11.8	35.3	26.9	3.3	33.3	9.2	6.6	14.9	17.8	31.2	14.3	12.3	46.5	37.9	18.5	3.4	27.2	50.0
KIAA1143		ENSG00000163807	KIAA1143	Q96AT1	3	44737661-44761619	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 245.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045018, HPA061799"	Approved		Enhanced	"Nucleoplasm,Cytokinetic bridge"		Yes	No			"Cluster 49: Eosinophils - Unknown function"	"Cluster 52: Non-specific - Ribosome"	"Cluster 32: U-937 - Innate immune response"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoplasm	"Cytokinetic bridge"	"HPA045018: AB_10964578, HPA061799: AB_2684614"	"unprognostic (1.31e-1)"	"unprognostic (2.74e-1)"	"prognostic favorable (3.65e-4)"	"unprognostic (2.25e-1)"	"unprognostic (6.00e-2)"	"unprognostic (3.01e-3)"	"unprognostic (2.23e-3)"	"unprognostic (6.17e-2)"	"unprognostic (6.42e-2)"	"unprognostic (1.57e-3)"	"unprognostic (3.71e-1)"	"unprognostic (4.08e-2)"	"prognostic favorable (3.26e-6)"	"unprognostic (1.82e-1)"	"unprognostic (1.85e-1)"	"unprognostic (3.19e-2)"	"unprognostic (6.46e-2)"	9.2	7.4	3.6	4.9	4.5	4.4	8.2	3.9	4.7	7.7	2.1	8.9	4.5	10.4	3.5	6.5	7.8	5.4	9.8	3.4	4.0	7.0	4.9	5.7	6.4	4.4	4.3	11.0	7.5	8.1	4.7	6.4	4.4	9.0	5.1	5.8	7.0	6.2	17.4	7.0	6.5	7.4	3.7	6.4	7.0	3.1	4.1	9.2	8.4	9.0	7.2	8.1	6.5	6.0	8.3	5.3	14.7	10.2	9.8	15.1	7.3	9.3	13.1	11.7	11.9	5.3	7.2	20.2	6.9	9.8	5.6	5.6	17.5	9.9	15.4	11.2	5.9	14.7	9.6	6.5	6.7	18.6	9.9	10.9	11.7	12.0	11.3	13.0	9.9	12.3	21.2	10.8	11.6	4.7	20.9	13.1	13.9	8.7	6.8	8.5	14.0	11.5	7.5	7.0	7.3	12.5	10.9	8.3	7.5	9.8	13.9	15.8	11.5	6.5	5.8	17.2	10.7	6.9	21.1	12.1	12.0	17.8	9.7	2.6	2.3	4.0	2.8	2.5	2.4	2.5	2.4	2.2	2.2	2.3	2.5	2.4	2.3	3.1	3.8	1.5	2.1	1.9	3.6	4.5	3.9	4.7	3.4	4.0	4.4	4.3	4.4	3.7	4.1	6.0	35.8	38.5	39.4	5.9	32.9	34.5	31.6	44.1	25.0	20.0	24.5	24.0	28.4	32.9	43.6	23.9	8.4	40.6	32.5	18.8	68.4	45.5	245.7	29.0	32.4	34.6	15.6	27.3	5.4	62.6	55.8	28.9	18.3	29.3	38.6	17.6	37.1	26.4	35.0	15.2	6.0	24.6	26.4	42.9	27.3	84.4	37.6	30.3	14.2	5.6	37.7	44.8	41.2	5.5	10.1	48.9	24.0	49.2	19.1	51.0	23.5	45.2	30.5	14.0	0.0	43.3	28.3	53.8	40.5	22.3	27.8	57.2	35.3	25.7	25.7	46.7
KIF11	"Eg5, HKSP, KNSL1, TRIP5"	ENSG00000138160	"Kinesin family member 11"	P52732	10	92574105-92655395	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Motor protein"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 19.4;lymphoid tissue: 37.9"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 39.1;Granulosa cells: 20.7;Spermatocytes: 38.0;Spermatogonia: 23.4"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA006916, HPA010093, HPA010568, CAB017617"	Enhanced		Supported	"Mitotic spindle,Cytosol"		Yes	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Cytosol	"Mitotic spindle"	"CAB017617: AB_2131098, HPA006916: AB_1848033, HPA010093: AB_2668281, HPA010568: AB_1848034"	"unprognostic (1.53e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.59e-2)"	"unprognostic (3.35e-2)"	"unprognostic (2.12e-1)"	"unprognostic (7.82e-2)"	"prognostic unfavorable (8.19e-7)"	"prognostic unfavorable (3.27e-4)"	"unprognostic (1.24e-2)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (2.30e-4)"	"unprognostic (6.59e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (1.35e-3)"	"unprognostic (7.23e-2)"	"unprognostic (9.08e-2)"	"unprognostic (2.01e-1)"	1.1	0.7	0.5	8.5	0.7	19.4	2.5	0.4	0.6	1.4	0.5	6.3	5.5	1.8	1.0	6.7	1.0	1.2	0.6	0.5	0.5	1.0	1.1	1.3	17.5	0.6	0.6	0.6	0.5	0.7	0.3	3.9	0.6	1.0	7.4	0.8	1.3	0.7	0.2	6.0	5.3	2.5	0.5	2.9	3.9	11.6	0.4	37.9	1.6	0.3	18.5	2.3	2.3	0.6	103.1	45.2	100.6	94.5	7.3	10.5	24.2	72.6	62.8	78.8	78.1	39.6	67.2	111.1	36.5	34.4	32.9	72.0	72.1	36.5	92.4	68.3	41.3	70.5	41.4	42.4	1.4	116.0	63.0	3.6	3.3	61.4	55.9	18.3	50.0	46.1	51.2	126.4	61.1	41.4	99.3	65.8	40.3	42.5	30.7	106.6	98.8	40.2	21.0	30.1	30.0	42.9	56.4	25.9	29.2	34.1	67.9	37.6	28.6	35.7	51.3	37.1	96.9	35.4	58.3	113.4	29.5	82.3	50.3	0.8	0.0	0.1	0.0	0.3	0.3	0.6	0.4	0.4	0.2	0.1	0.1	0.2	0.2	1.0	0.1	0.1	1.1	0.2	0.5	0.7	0.4	0.6	0.5	0.5	0.6	0.6	0.6	0.5	0.4	0.6	0.4	0.0	2.0	1.3	3.5	2.9	1.1	1.6	3.4	1.0	1.8	1.8	1.7	1.5	2.5	1.8	0.0	6.7	2.3	2.9	1.9	0.5	16.3	3.4	4.3	2.0	0.0	39.1	2.1	0.6	11.4	4.7	9.2	4.9	0.0	20.7	2.2	0.4	8.2	0.0	1.8	4.3	4.1	4.6	3.4	4.4	0.9	4.0	0.0	0.0	1.0	0.7	2.1	2.5	1.1	0.2	0.4	0.7	15.2	0.8	0.5	0.6	3.7	0.4	0.0	1.7	3.7	38.0	23.4	12.6	3.3	1.5	4.5	2.5	8.0	1.7
KIF18B		ENSG00000186185	"Kinesin family member 18B"	Q86Y91	17	44924709-44947773	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 12.7;lymphoid tissue: 14.4"	"Cell type enhanced"	"Detected in some"		"Erythroid cells: 9.0;Extravillous trophoblasts: 3.8;Granulosa cells: 5.9;Oligodendrocyte precursor cells: 7.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"white matter: 1.4"	"Low region specificity"	"Detected in many"			HPA024205	Enhanced		Supported	"Nucleoplasm,Nuclear bodies,Microtubule ends,Cytosol"		Yes	Yes				"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Microtubule ends"	"Nuclear bodies, Cytosol"	"HPA024205: AB_1852472"	"unprognostic (1.88e-1)"	"unprognostic (9.92e-2)"	"unprognostic (4.61e-2)"	"unprognostic (1.13e-2)"	"unprognostic (4.17e-1)"	"unprognostic (7.27e-3)"	"prognostic unfavorable (2.44e-6)"	"unprognostic (3.34e-3)"	"prognostic unfavorable (6.90e-4)"	"unprognostic (1.98e-1)"	"prognostic unfavorable (2.16e-4)"	"unprognostic (8.18e-2)"	"unprognostic (0.00e+0)"	"unprognostic (4.69e-3)"	"unprognostic (1.93e-1)"	"unprognostic (3.08e-1)"	"unprognostic (1.68e-2)"	0.4	0.4	0.3	3.8	0.4	12.7	0.2	0.7	0.3	0.9	0.3	2.0	2.7	0.4	0.0	5.1	0.2	0.4	0.3	0.3	0.4	0.2	0.4	0.8	5.7	0.5	1.1	0.1	0.1	0.0	0.1	1.9	0.6	0.2	1.7	0.1	0.7	0.0	0.4	3.0	2.5	1.1	0.3	2.9	1.5	2.9	0.6	14.4	0.2	0.0	4.7	0.6	1.6	0.5	31.5	41.7	35.3	32.8	0.8	3.0	28.1	25.8	10.3	34.6	26.9	34.0	27.4	28.3	10.9	10.8	21.5	34.0	25.1	11.3	17.9	56.6	36.4	35.4	51.7	22.1	0.0	30.0	30.2	0.7	0.6	29.7	12.2	4.7	17.9	29.2	28.1	48.0	18.2	25.9	60.0	31.1	25.4	30.4	28.9	43.5	51.8	19.2	5.8	16.7	26.2	24.7	18.0	16.1	9.8	17.0	30.2	21.6	11.2	49.9	48.0	28.8	56.8	15.1	15.7	34.4	16.3	22.9	33.1	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.1	0.1	0.0	0.3	0.4	0.7	0.3	0.3	0.4	0.5	1.1	0.6	0.3	0.6	0.5	0.1	0.0	0.0	0.0	0.9	0.4	0.1	0.2	0.0	0.5	0.5	0.4	2.6	0.0	0.0	0.0	0.0	2.4	0.4	1.9	0.0	0.0	0.0	0.3	0.8	0.6	0.0	9.0	0.3	0.0	3.8	1.4	1.5	0.5	0.0	5.9	0.4	0.3	2.3	0.0	0.3	1.6	0.0	2.2	1.1	0.0	0.0	0.4	0.0	0.0	0.1	0.1	0.0	7.1	0.1	0.1	0.0	0.0	2.1	0.2	0.3	0.0	0.0	0.3	0.0	0.2	0.8	1.1	2.9	2.5	0.4	0.8	1.3	0.3	3.2	0.3
KIF20B	"CT90, KRMP1, MPHOSPH1, MPP1"	ENSG00000138182	"Kinesin family member 20B"	Q96Q89	10	89701590-89774939	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Motor protein"	Oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 10.2;lymphoid tissue: 9.8"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 89.2;Spermatocytes: 165.4;Spermatogonia: 96.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA050214	Supported		Supported	"Nucleoplasm,Cytokinetic bridge,Midbody,Cytosol"		Yes	Yes			"Cluster 6: Non-specific - Transcription"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Cytokinetic bridge"	"Midbody, Cytosol"	"HPA050214: AB_2681053"	"unprognostic (2.13e-1)"	"unprognostic (3.01e-2)"	"unprognostic (1.72e-2)"	"unprognostic (3.20e-2)"	"unprognostic (2.65e-1)"	"unprognostic (7.39e-2)"	"unprognostic (8.95e-5)"	"unprognostic (3.32e-3)"	"unprognostic (2.01e-2)"	"unprognostic (8.14e-2)"	"prognostic unfavorable (1.21e-4)"	"unprognostic (1.62e-2)"	"prognostic unfavorable (3.06e-6)"	"unprognostic (4.22e-3)"	"unprognostic (2.70e-1)"	"unprognostic (2.51e-2)"	"unprognostic (6.43e-2)"	1.3	0.7	0.3	4.5	1.0	10.2	2.5	2.4	0.4	1.5	0.1	3.2	3.6	2.3	0.4	3.3	1.2	1.3	0.9	0.3	0.3	1.3	1.3	1.5	8.0	0.5	0.3	2.7	0.7	1.1	0.2	2.4	0.6	1.3	4.0	1.1	1.0	0.9	0.4	2.5	3.4	2.2	0.4	3.3	2.5	6.9	0.6	9.8	1.8	0.7	7.5	1.6	0.7	0.6	84.8	17.0	24.3	21.7	4.7	8.0	20.2	33.8	30.9	34.8	36.3	22.6	38.1	32.5	10.4	17.3	13.0	41.8	27.3	18.9	46.4	39.5	18.6	33.1	30.5	19.5	1.4	57.1	26.3	3.4	2.8	33.7	33.9	12.2	22.8	17.0	32.2	36.5	31.3	14.6	33.6	10.8	25.0	13.8	16.1	23.1	47.8	14.3	10.7	11.2	7.7	13.9	24.4	11.0	12.2	17.3	28.5	16.3	17.9	22.2	22.1	29.1	55.3	10.1	29.5	43.2	21.1	49.4	16.8	13.1	2.4	4.2	5.5	4.1	6.8	13.0	7.4	6.1	1.3	16.0	8.6	8.0	0.2	3.0	4.5	5.2	9.5	2.2	0.3	1.0	2.4	0.4	0.3	0.3	0.5	0.3	0.6	0.4	0.6	0.6	11.5	3.2	13.5	2.3	36.4	17.7	6.2	20.8	6.8	14.3	8.3	8.5	8.7	1.5	10.7	0.0	10.4	21.4	32.3	8.8	3.9	6.9	13.1	10.6	13.2	11.0	1.2	89.2	8.1	4.7	38.1	13.2	14.8	12.9	44.4	37.2	9.3	4.4	20.7	13.5	9.5	8.6	16.2	21.0	17.9	10.5	8.1	17.1	5.4	23.4	11.3	7.5	24.7	9.0	9.1	4.1	5.7	8.6	51.4	3.7	8.9	3.2	6.6	9.8	6.6	16.9	17.1	165.4	96.7	26.1	14.1	5.2	34.2	12.9	25.5	5.2
KIF23	"KNSL5, MKLP-1, MKLP1"	ENSG00000137807	"Kinesin family member 23"	Q02241	15	69414246-69448427	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 21.6;lymphoid tissue: 15.9"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 24.2;Erythroid cells: 42.3;Extravillous trophoblasts: 32.4;Granulosa cells: 22.4;Spermatocytes: 70.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"eosinophil: 4.6"	"Group enriched"	"Detected in many"	13	"granulocytes: 4.6;monocytes: 1.2;T-cells: 1.2"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"CAB010414, HPA045208, HPA068831"	Uncertain		Enhanced	"Nucleoplasm,Midbody ring,Mitotic spindle"		Yes	Yes			"Cluster 49: Eosinophils - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Midbody ring, Mitotic spindle"	"CAB010414: AB_631959, HPA045208: AB_2679254, HPA068831: AB_2686045"	"unprognostic (1.29e-1)"	"unprognostic (2.40e-1)"	"unprognostic (5.57e-2)"	"prognostic unfavorable (8.62e-4)"	"unprognostic (1.86e-1)"	"unprognostic (7.99e-3)"	"prognostic unfavorable (3.18e-5)"	"unprognostic (1.43e-3)"	"unprognostic (4.25e-3)"	"unprognostic (2.60e-1)"	"prognostic unfavorable (3.69e-5)"	"unprognostic (5.85e-3)"	"unprognostic (0.00e+0)"	"unprognostic (1.15e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.17e-1)"	"unprognostic (9.17e-2)"	1.0	1.5	0.3	5.7	0.2	21.6	1.4	0.2	0.3	1.5	1.4	4.1	3.9	2.0	0.1	5.3	0.9	1.3	0.6	0.3	0.2	4.6	0.5	1.5	7.9	0.2	0.3	0.7	0.5	0.4	0.1	6.4	0.3	0.9	5.0	0.2	1.1	1.2	0.1	3.7	3.8	4.2	0.2	2.2	2.0	10.6	0.3	15.9	0.3	0.2	9.8	1.8	2.1	0.2	100.7	81.5	64.2	59.0	3.7	7.3	36.3	105.3	57.0	154.8	120.6	50.2	72.4	56.8	31.4	53.1	78.6	110.5	121.6	39.5	158.7	52.9	60.2	55.3	78.8	30.7	2.1	55.6	48.3	3.3	4.2	71.8	60.5	19.4	52.0	46.9	36.0	70.2	95.4	44.1	31.2	28.2	71.6	35.5	33.2	37.0	133.8	31.2	39.3	49.7	32.5	25.3	120.4	51.9	44.9	74.5	50.6	25.3	34.5	90.0	120.8	62.0	157.6	26.3	74.3	48.4	31.5	72.2	78.0	0.0	1.2	4.6	0.0	0.5	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.6	0.0	1.2	0.3	0.3	0.2	0.2	0.3	0.3	0.2	0.2	0.3	0.3	0.2	0.3	0.2	0.4	0.0	0.5	0.0	2.3	1.9	3.7	4.2	0.0	0.2	1.8	2.8	0.8	5.7	4.7	7.3	2.1	24.2	1.4	3.3	3.9	1.8	13.3	13.1	3.6	2.2	1.8	42.3	1.8	0.0	32.4	5.8	3.6	8.7	2.5	22.4	3.9	0.3	8.1	0.0	1.0	3.1	0.0	2.8	3.4	4.8	0.9	3.2	0.0	1.0	8.1	0.2	0.0	0.0	0.2	0.4	0.4	1.9	6.8	1.6	0.8	0.9	3.6	0.1	6.6	0.4	8.2	70.8	20.9	11.3	1.0	2.5	4.2	3.6	8.6	3.3
KIF2A	"HK2, KIF2"	ENSG00000068796	"Kinesin family member 2A"	O00139	5	62306162-62391025	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Differentiation, Mitosis, Neurogenesis"	"Developmental protein, Motor protein"	"Cancer-related genes, Disease variant, Lissencephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004715, HPA004716"	Approved		Enhanced	Nucleoplasm,Nucleoli,Centrosome		Yes	No		300000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 51: Myeloid cells - Hemostasis"	"Nucleoplasm, Nucleoli, Centrosome"		"HPA004715: AB_2667215, HPA004716: AB_1079211"	"unprognostic (2.40e-2)"	"unprognostic (3.43e-1)"	"prognostic favorable (1.70e-4)"	"unprognostic (2.74e-2)"	"unprognostic (1.43e-1)"	"prognostic favorable (5.45e-4)"	"prognostic unfavorable (3.17e-6)"	"unprognostic (8.77e-3)"	"unprognostic (4.69e-2)"	"unprognostic (9.10e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.34e-1)"	"prognostic unfavorable (3.81e-5)"	"unprognostic (3.53e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.58e-1)"	11.9	7.7	15.6	23.2	20.7	12.8	10.8	15.5	17.7	19.5	0.0	13.8	11.5	12.0	6.3	12.5	17.6	12.9	6.2	17.4	23.0	8.0	5.3	9.8	32.8	17.9	17.5	12.9	10.2	12.3	8.5	16.9	18.4	9.9	14.7	42.7	6.9	11.4	4.8	5.9	15.9	13.1	14.6	18.4	9.6	49.1	16.1	43.6	12.6	6.8	28.9	20.2	7.2	28.0	47.3	46.9	81.4	67.3	28.8	39.6	65.2	51.2	38.5	54.6	67.5	53.1	49.6	111.9	53.3	41.9	67.2	29.1	61.3	37.7	72.5	116.8	44.2	113.8	41.2	27.8	34.7	65.3	42.9	30.5	26.6	50.1	47.5	33.1	49.1	66.5	86.6	66.7	46.9	36.1	104.4	33.1	42.6	12.0	31.9	78.3	59.6	65.3	25.4	55.4	68.0	55.9	67.0	27.9	34.7	55.3	37.6	38.5	39.8	31.9	52.2	40.5	51.3	64.8	94.9	114.1	36.4	74.5	39.8	10.4	4.6	4.7	29.2	5.0	35.3	13.5	29.8	32.7	6.2	10.5	26.3	29.0	7.8	23.2	3.3	9.6	42.3	17.7	15.6	20.7	15.5	17.7	17.4	23.0	17.9	17.5	18.4	14.6	16.1	28.0	30.8	16.0	14.1	54.5	44.1	16.8	41.4	20.1	39.3	45.5	17.9	23.9	9.4	4.3	20.5	20.2	104.3	20.3	73.4	23.1	13.7	37.5	113.8	103.3	47.2	21.4	21.0	42.3	56.7	30.9	22.6	28.2	20.4	43.4	17.7	25.6	19.6	4.4	15.4	52.2	64.5	7.9	14.2	12.9	22.1	130.7	13.1	83.6	12.4	26.2	104.9	28.0	76.2	119.6	156.0	26.6	26.1	13.2	47.8	42.7	13.5	18.7	49.2	92.9	26.3	33.1	25.4	118.9	42.8	34.3	9.5	43.9	77.9	48.9	11.0	56.1
KIF2C	"CT139, KNSL6, MCAK"	ENSG00000142945	"Kinesin family member 2C"	Q99661	1	44739818-44767767	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Chromosome partition, Mitosis"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"bone marrow: 33.0;lymphoid tissue: 37.4;testis: 76.5"	"Cell type enriched"	"Detected in many"	4	"Late spermatids: 1860.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"T-reg: 2.9"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Region enhanced"	"Detected in some"		"white matter: 2.1"	"Not detected"	"Not detected"			"HPA006219, HPA079172"	Enhanced		Supported	Nucleoplasm,Midbody,Centrosome		Yes	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoplasm, Centrosome"	Midbody	"HPA006219: AB_2667540, HPA079172: "	"unprognostic (3.29e-2)"	"unprognostic (1.35e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.71e-3)"	"unprognostic (2.77e-1)"	"unprognostic (5.17e-2)"	"prognostic unfavorable (3.07e-7)"	"unprognostic (7.49e-3)"	"unprognostic (3.33e-3)"	"unprognostic (3.66e-1)"	"prognostic unfavorable (6.86e-4)"	"unprognostic (4.27e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (2.33e-3)"	"unprognostic (1.49e-1)"	"unprognostic (1.86e-2)"	"unprognostic (2.41e-1)"	0.7	0.8	0.7	7.0	0.7	33.0	1.6	2.3	0.7	1.8	1.1	6.2	5.5	1.8	0.7	7.3	0.9	1.3	1.3	0.6	1.1	0.8	0.7	1.3	16.4	1.1	0.9	0.6	0.5	1.3	0.4	5.4	1.4	0.8	7.6	0.8	1.3	0.7	0.9	6.0	5.1	3.2	0.9	3.7	3.5	76.5	0.8	37.4	1.1	0.7	19.2	2.1	2.7	0.8	119.7	45.8	99.6	79.8	5.3	11.6	66.6	86.9	62.1	175.0	151.3	77.6	84.2	136.2	41.3	43.2	121.7	55.2	102.8	59.6	158.2	89.1	44.4	162.1	83.3	65.5	0.6	121.5	71.8	2.7	5.8	125.0	60.3	16.5	57.6	95.4	130.4	113.1	112.4	46.5	127.5	72.9	97.1	58.4	56.5	101.1	149.3	86.4	29.6	42.8	68.3	48.5	116.1	81.6	71.5	71.9	47.2	90.7	34.7	62.9	124.2	69.0	155.6	59.4	65.0	195.3	40.3	115.4	123.9	0.0	0.0	0.0	0.9	0.0	0.0	0.6	1.7	1.2	0.1	0.1	0.3	0.2	0.0	2.0	0.1	0.8	2.9	0.5	0.7	0.7	2.3	0.7	0.6	1.1	1.1	0.9	1.4	0.9	0.8	0.8	0.1	0.0	0.5	1.6	1.3	1.8	0.5	2.4	0.0	1.0	0.9	0.9	1.6	0.0	1.7	1.8	2.1	12.2	1.9	2.9	1.9	0.3	461.1	1.2	1.4	1.6	0.0	34.5	0.8	0.4	23.4	3.2	3.1	2.1	0.0	13.0	2.9	0.2	9.2	0.0	1.0	3.5	0.0	1.9	1.5	1860.6	9.3	3.4	0.0	1.0	4.3	0.4	0.0	0.5	0.2	0.1	0.2	6.8	7.8	0.8	0.3	0.2	0.3	0.2	6.6	0.8	3.4	60.6	36.8	4.6	0.4	3.7	2.7	0.8	7.4	0.7
KLHL38	C8ORFK36	ENSG00000175946	"Kelch like family member 38"	Q2WGJ6	8	123645527-123652950	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"heart muscle: 56.7;skeletal muscle: 268.3;tongue: 76.9"	"Cell type enriched"	"Detected in single"	10	"Cardiomyocytes: 1.0"	"Group enriched"	"Detected in some"	5	"breast cancer: 1.3;melanoma: 1.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 1.7;SK-BR-3: 2.8;U-2197: 4.9"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"HPA024770, HPA027115"	Uncertain		Approved	Nucleoplasm,Cytosol		Yes	NA				"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 18: U-2197 - ECM organization"	"Cluster 43: Cardiomyocytes - Nuclear processes"	Nucleoplasm	Cytosol	"HPA024770: AB_10599286, HPA027115: AB_10599950"	"unprognostic (8.62e-3)"	"unprognostic (3.86e-3)"	"unprognostic (1.02e-2)"	"unprognostic (8.94e-2)"	"unprognostic (4.68e-1)"	"unprognostic (2.09e-2)"	"unprognostic (8.20e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.54e-1)"	"unprognostic (4.02e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.77e-2)"	"unprognostic (5.73e-6)"	"unprognostic (8.46e-3)"	"unprognostic (3.82e-2)"	"unprognostic (6.52e-2)"	"unprognostic (2.84e-2)"	0.2	0.0	0.1	0.2	0.2	0.0	0.2	0.0	0.5	0.2	0.1	0.9	0.1	1.3	0.0	2.5	0.7	0.7	56.7	0.2	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.5	0.1	1.3	0.0	1.5	0.0	0.8	0.1	0.0	0.7	0.1	268.3	0.2	0.2	2.8	0.0	0.0	0.3	0.0	0.0	0.0	0.0	76.9	0.0	0.6	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.9	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.9	0.0	0.5	0.0	0.0	0.0	0.1	4.9	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KMT2D	"ALR, CAGL114, MLL2, MLL4, TNRC21"	ENSG00000167548	"Lysine methyltransferase 2D"	O14686	12	49018978-49060794	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Transferase"	"Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.5"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035977	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		Yes	No			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 9: Photoreceptor cells - Phototransduction"	Cytosol	"Nucleoplasm, Plasma membrane"	"HPA035977: AB_10670673"	"unprognostic (8.33e-2)"	"unprognostic (1.49e-1)"	"unprognostic (9.14e-2)"	"unprognostic (2.52e-1)"	"unprognostic (8.07e-2)"	"unprognostic (6.91e-3)"	"unprognostic (7.35e-2)"	"unprognostic (2.29e-1)"	"unprognostic (3.57e-1)"	"unprognostic (5.14e-2)"	"unprognostic (7.23e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.68e-2)"	"unprognostic (7.10e-2)"	"unprognostic (1.87e-1)"	"unprognostic (3.20e-2)"	"unprognostic (7.60e-2)"	19.9	21.9	14.0	17.0	14.4	62.1	20.3	14.7	18.1	20.2	3.8	21.3	13.2	26.9	14.4	25.5	24.1	11.7	23.7	12.1	9.1	18.2	20.5	25.1	17.5	9.3	8.2	25.3	33.2	22.9	25.4	16.2	8.6	19.2	14.7	48.0	22.1	16.2	44.9	30.4	27.9	15.5	3.1	36.6	25.5	23.6	12.7	29.0	26.5	21.9	17.2	19.4	19.4	13.4	32.3	31.9	31.0	24.7	29.3	20.4	32.6	17.3	17.1	20.3	10.9	54.8	14.1	33.4	21.2	23.9	14.0	21.5	38.1	19.9	17.7	22.4	26.7	47.2	37.7	29.9	20.5	59.1	43.2	18.4	25.8	30.7	32.0	27.3	31.8	33.2	55.1	19.2	23.7	37.4	26.8	48.0	29.9	45.4	25.0	37.4	22.4	12.0	18.1	37.2	24.6	21.2	28.1	25.5	19.5	26.1	24.0	44.1	49.8	15.5	30.7	14.5	30.5	24.8	20.9	31.7	17.1	28.0	12.5	0.5	0.2	0.3	0.2	0.0	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.1	1.5	0.5	0.0	0.2	0.0	0.1	14.0	14.4	14.7	18.1	12.1	9.1	9.3	8.2	8.6	3.1	12.7	13.4	12.9	9.6	19.1	17.6	13.3	14.0	7.8	8.1	14.2	26.8	12.1	7.1	7.8	12.8	10.9	18.4	52.1	8.2	15.3	12.3	1.9	6.3	2.8	10.7	12.7	13.2	13.1	16.0	17.4	6.0	6.0	8.8	24.5	13.1	8.2	23.3	17.9	13.0	9.8	21.9	16.5	10.0	6.1	15.7	18.4	2.4	9.6	15.4	10.6	15.0	14.9	6.4	17.5	12.5	19.8	8.8	9.5	10.9	10.1	11.0	13.3	4.5	9.0	38.4	6.6	14.4	12.5	6.5	3.8	18.9	17.6	11.4	15.3	10.8	10.3	9.6
KNL1	"AF15Q14, CASC5, CT29, D40, hKNL-1, hSpc105, KIAA1570, MCPH4, PPP1R55, Spc7"	ENSG00000137812	"Kinetochore scaffold 1"	Q8NG31	15	40594020-40664342	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Chromosome partition, Mitosis"		"Cancer-related genes, Disease variant, Mental retardation, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"bone marrow: 5.3;lymphoid tissue: 7.4;testis: 16.9"	"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 8.5;Extravillous trophoblasts: 11.3;Granulosa cells: 22.8;Hofbauer cells: 7.1;Proximal tubular cells: 11.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"							"HPA026624, HPA049647"	Enhanced		Enhanced	"Nucleoplasm,Nuclear bodies"		Yes	Yes			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Nuclear bodies"	"HPA026624: AB_10601696, HPA049647: AB_2680840"	"unprognostic (5.35e-2)"	"unprognostic (1.01e-1)"	"unprognostic (5.59e-3)"	"unprognostic (4.22e-2)"	"unprognostic (1.59e-2)"	"unprognostic (5.66e-2)"	"unprognostic (1.41e-1)"	"prognostic unfavorable (2.11e-4)"	"unprognostic (2.06e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.20e-4)"	"unprognostic (2.22e-2)"	"unprognostic (1.93e-12)"	"unprognostic (3.07e-2)"	"unprognostic (3.08e-1)"	"unprognostic (8.45e-2)"	"unprognostic (7.36e-2)"	0.2	0.1	0.1	1.9	0.0	5.3	0.3	0.2	0.2	0.2	0.2	1.3	1.6	0.3	0.2	1.0	0.1	0.3	0.1	0.1	0.1	0.5	0.7	0.4	3.6	0.1	0.3	0.0	0.0	0.3	0.0	1.3	0.1	0.1	1.4	0.2	0.2	0.0	0.0	0.8	1.7	0.7	0.0	0.6	0.9	16.9	0.3	7.4	0.3	0.1	3.4	0.5	0.2	0.1	19.1	9.3	18.0	13.8	0.5	2.6	8.6	20.5	8.1	16.0	13.1	11.6	7.2	11.9	6.1	9.3	12.0	21.9	17.6	9.7	16.3	21.4	5.0	35.5	15.5	3.9	0.0	26.2	17.8	0.5	0.4	10.8	6.4	2.1	13.8	20.9	22.9	19.2	18.3	6.1	23.5	6.1	9.4	11.3	9.5	21.2	25.8	5.9	2.6	15.6	15.9	7.7	17.7	10.6	2.1	5.9	11.1	9.0	13.1	18.7	16.3	21.9	11.7	7.5	27.9	22.3	7.6	18.5	18.1	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.3	0.5	0.0	0.1	0.1	0.1	0.1	0.0	0.6	0.0	0.1	0.0	0.2	0.2	0.1	0.1	0.1	0.3	0.1	0.0	0.3	0.1	0.3	0.0	0.5	0.0	1.1	0.0	0.0	0.0	0.0	0.0	1.1	1.1	0.0	0.0	1.8	1.8	0.0	8.5	2.6	0.0	1.9	0.2	0.0	3.5	3.5	1.9	0.0	0.0	0.0	0.6	11.3	4.2	0.0	2.9	0.0	22.8	0.0	0.0	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	2.1	0.0	0.0	11.5	0.7	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	3.7	1.9	1.7	0.0	0.0
KPNA2	"IPOA1, QIP2, RCH1, SRP1alpha"	ENSG00000182481	"Karyopherin subunit alpha 2"	P52292	17	68035636-68047364	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Host-virus interaction, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 209.1"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 863.9;Extravillous trophoblasts: 279.7;Spermatocytes: 552.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"CAB015460, HPA041270"	Enhanced		Enhanced	Nucleoplasm,Cytosol		Yes	Yes		160000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	Cytosol	"CAB015460: AB_831493, HPA041270: AB_2677385"	"unprognostic (2.78e-2)"	"unprognostic (1.54e-1)"	"prognostic favorable (3.83e-4)"	"unprognostic (2.14e-2)"	"unprognostic (1.64e-1)"	"unprognostic (5.16e-3)"	"prognostic unfavorable (2.12e-10)"	"prognostic unfavorable (5.77e-4)"	"unprognostic (3.34e-2)"	"unprognostic (7.59e-2)"	"unprognostic (3.72e-3)"	"unprognostic (3.08e-2)"	"prognostic unfavorable (1.26e-13)"	"unprognostic (3.07e-2)"	"unprognostic (1.78e-1)"	"unprognostic (9.50e-2)"	"prognostic unfavorable (2.19e-4)"	25.9	15.9	18.9	45.2	19.3	99.2	15.2	18.7	23.3	17.4	15.7	30.7	26.1	17.6	25.7	41.4	10.8	19.4	23.9	20.8	24.7	16.2	23.1	17.9	72.1	19.1	20.5	6.5	10.0	10.6	15.6	43.8	22.2	8.2	35.8	22.2	15.4	11.6	14.8	21.0	23.3	34.6	20.5	28.3	19.0	209.1	20.0	94.7	10.9	16.7	104.9	38.6	17.7	22.7	556.0	712.3	667.1	264.4	95.7	93.9	421.1	467.9	372.9	758.1	587.9	499.5	250.4	514.4	146.7	273.4	375.1	297.4	753.8	359.4	870.7	203.8	437.5	446.5	311.7	482.7	101.9	387.6	294.3	58.1	69.3	426.0	267.2	105.8	746.8	211.0	360.8	346.0	686.1	517.3	484.4	249.8	451.4	455.2	365.8	271.5	605.1	280.6	304.0	250.0	262.2	286.3	269.5	839.1	291.9	609.6	495.6	196.9	288.6	416.7	506.2	290.6	647.3	291.5	451.9	504.7	203.0	334.9	458.0	30.1	31.0	12.7	24.1	46.5	19.2	45.8	18.8	27.3	56.2	39.6	13.3	21.5	0.9	43.9	39.6	41.4	37.7	31.3	18.9	19.3	18.7	23.3	20.8	24.7	19.1	20.5	22.2	20.5	20.0	22.7	41.0	12.8	31.0	6.2	49.4	109.7	32.2	73.7	43.3	20.1	39.8	45.5	13.8	7.2	39.7	18.4	8.4	128.3	96.4	27.7	15.6	31.4	863.9	70.8	55.1	48.6	42.9	70.9	8.5	25.5	279.7	64.9	31.1	68.0	44.4	68.2	21.8	17.2	126.0	32.0	7.3	27.6	97.6	42.9	132.1	266.6	19.3	60.0	53.4	3.7	72.1	31.2	18.6	6.6	5.9	20.7	11.9	14.7	60.3	27.6	9.3	31.2	22.7	20.0	32.9	52.4	74.1	552.9	185.2	61.3	88.5	118.9	79.8	28.0	49.3	24.2
KPNB1	"IMB1, Impnb, IPO1, IPOB, MGC2155, MGC2156, MGC2157, NTF97"	ENSG00000108424	"Karyopherin subunit beta 1"	Q14974	17	47649476-47685505	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Host-virus interaction, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029878, CAB034449, HPA050302"	Supported		Enhanced	"Nucleoplasm,Nuclear membrane,Cytosol"		Yes	No		1600000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 55: Plasma cells - Humoral immune response"	"Nuclear membrane"	"Nucleoplasm, Cytosol"	"CAB034449: AB_2133993, HPA029878: AB_10670041, HPA050302: AB_2681079"	"unprognostic (2.57e-1)"	"unprognostic (1.15e-1)"	"unprognostic (4.33e-3)"	"unprognostic (2.81e-2)"	"unprognostic (1.18e-1)"	"unprognostic (8.15e-2)"	"prognostic unfavorable (2.55e-7)"	"unprognostic (7.18e-3)"	"unprognostic (9.52e-2)"	"unprognostic (5.47e-3)"	"unprognostic (4.37e-2)"	"unprognostic (8.41e-3)"	"prognostic unfavorable (8.43e-6)"	"unprognostic (1.34e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.41e-2)"	"unprognostic (3.44e-2)"	57.6	44.9	31.6	74.4	33.6	35.9	53.4	34.7	32.2	49.9	30.5	55.3	35.9	47.5	29.5	66.0	49.6	47.2	53.6	31.2	37.1	48.8	50.6	42.6	81.7	38.2	39.8	64.3	38.1	56.3	28.1	55.4	37.1	44.4	63.6	49.0	39.2	45.7	91.0	38.7	38.8	66.6	37.2	54.0	43.3	100.9	33.9	117.3	57.4	88.3	108.7	79.6	40.5	47.3	273.2	485.0	324.6	259.1	152.8	265.8	271.6	345.4	307.0	441.6	339.3	853.2	161.5	385.8	210.4	343.8	301.8	186.3	607.2	316.3	691.1	212.1	344.7	421.2	408.7	241.6	148.4	485.5	238.9	209.6	140.5	511.7	509.2	202.3	305.8	203.0	461.3	237.5	349.4	288.8	464.9	97.2	270.6	199.4	300.2	250.1	563.3	216.4	156.2	444.2	267.5	240.5	233.3	121.7	176.6	388.4	253.9	157.6	248.7	463.9	264.7	252.8	412.9	258.8	373.0	542.6	216.1	224.2	325.8	3.1	2.9	6.1	4.1	3.6	5.8	4.0	4.7	5.1	1.8	4.0	4.5	4.3	12.2	3.5	4.4	3.0	3.4	2.4	31.6	33.6	34.7	32.2	31.2	37.1	38.2	39.8	37.1	37.2	33.9	47.3	76.8	128.2	71.9	42.7	138.3	125.7	101.1	67.8	165.0	96.5	110.8	89.5	132.7	88.6	75.2	44.1	68.8	132.7	93.9	69.5	41.1	117.1	55.8	71.2	123.1	110.5	123.8	148.7	51.4	119.5	147.5	102.9	72.4	106.3	76.1	147.2	128.8	97.5	124.1	80.8	48.2	82.2	44.7	115.0	91.6	41.7	96.9	102.7	60.5	30.9	152.8	83.4	80.3	39.2	58.2	147.0	69.8	121.5	163.4	149.7	49.2	48.0	60.6	90.2	98.6	107.0	104.6	291.6	186.0	163.9	143.5	158.2	108.1	138.8	128.4	128.1
KRT17	PCHC1	ENSG00000128422	"Keratin 17"	Q04695	17	41619442-41624842	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes, Disease variant, Ectodermal dysplasia, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 382.1;skin 1: 949.4;urinary bladder: 632.2"	"Group enriched"	"Detected in many"	5	"Basal prostatic cells: 13196.1;Prostatic glandular cells: 5931.6;Urothelial cells: 8499.3"	"Cancer enhanced"	"Detected in all"		"head and neck cancer: 3317.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	7	"hTCEpi: 20287.9;SiHa: 8539.7"	"Not detected"	"Not detected"							"CAB000029, HPA000452, HPA000453, HPA000539, HPA045062"	Enhanced		Enhanced	"Intermediate filaments"		Yes	No		610000000		"Cluster 31: Skin - Epidermis development"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 22: Epithelial cell types - Mixed function"	"Intermediate filaments"		"CAB000029: AB_2133155, HPA000452: AB_1079177, HPA000453: AB_1079176, HPA000539: , HPA045062: AB_2679204"	"prognostic favorable (4.44e-4)"	"unprognostic (1.43e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.65e-3)"	"unprognostic (4.46e-2)"	"unprognostic (4.34e-1)"	"unprognostic (4.36e-3)"	"unprognostic (1.32e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.29e-1)"	"unprognostic (7.86e-3)"	"unprognostic (1.53e-1)"	"prognostic unfavorable (5.74e-4)"	"unprognostic (1.82e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.20e-1)"	"unprognostic (3.89e-1)"	5.1	0.4	4.9	0.8	5.3	2.8	382.1	3.5	5.8	102.2	3.5	2.0	0.8	4.3	14.1	320.4	6.9	1.9	2.7	6.3	3.3	3.1	0.6	9.8	0.3	3.5	3.4	0.9	2.6	0.5	6.6	7.0	3.5	132.4	0.3	0.3	263.2	116.1	0.9	949.4	0.6	1.0	3.4	0.4	2.3	4.5	3.3	142.7	1.6	0.0	97.8	632.2	212.3	4.7	212.5	0.2	0.0	0.0	0.8	0.9	48.8	1.9	0.4	2.8	2.7	16.8	1.9	1.0	14.7	0.2	0.4	2101.7	0.1	2129.1	1.9	0.3	1.6	2.0	910.8	2.0	0.5	1.9	2.2	0.4	20287.9	1.3	1539.9	0.0	1.0	0.0	1.0	1.5	0.4	0.7	0.7	0.3	0.4	237.2	0.0	0.7	3.1	1.7	0.8	770.5	0.3	0.2	8539.7	3.8	0.9	4.8	0.3	1.4	0.8	0.0	401.5	0.2	1.0	0.9	0.4	3.1	1.4	77.9	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	5.3	3.5	5.8	6.3	3.3	3.5	3.4	3.5	3.4	3.3	4.7	5.6	22.4	7.2	0.3	0.5	139.6	13196.1	338.0	327.8	0.2	158.4	792.8	0.1	0.0	415.8	36.8	0.0	21.5	3.8	0.9	0.0	567.7	0.4	116.9	13.5	54.5	1.8	0.0	3.2	202.1	148.5	87.9	0.0	134.1	3.8	0.0	0.0	0.0	3.8	20.2	0.5	0.6	36.7	0.0	14.1	1.6	2.1	37.5	10.6	3.7	6.7	0.0	0.0	0.5	1.4	1754.5	2.5	212.5	0.0	5931.6	0.1	0.4	100.1	0.0	0.0	0.9	101.0	0.3	0.4	48.2	124.3	5.7	60.8	3.1	0.8	8499.3
LETM2	"FLJ25409, SLC55A2"	ENSG00000165046	"Leucine zipper and EF-hand containing transmembrane protein 2"	Q2VYF4	8	38386207-38409527	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"testis: 23.8"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 76.9;Late spermatids: 57.6;Pancreatic endocrine cells: 48.6;Spermatocytes: 54.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	4	"neutrophil: 21.5"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 21.5"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 25.2;hTERT-HME1: 26.9"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	6	"cerebellum: 24.0"	HPA025032	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		Yes	No			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA025032: AB_1852808"	"unprognostic (3.37e-2)"	"unprognostic (2.73e-1)"	"unprognostic (3.14e-1)"	"unprognostic (2.05e-2)"	"unprognostic (2.27e-4)"	"unprognostic (3.20e-2)"	"unprognostic (3.96e-2)"	"unprognostic (1.43e-1)"	"unprognostic (8.27e-2)"	"unprognostic (3.80e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.35e-1)"	"unprognostic (3.40e-2)"	"unprognostic (4.09e-3)"	"unprognostic (2.49e-1)"	"unprognostic (1.16e-1)"	"unprognostic (9.25e-2)"	1.2	1.0	3.4	1.1	3.6	5.3	0.7	5.7	4.9	1.6	2.9	0.7	0.8	1.4	1.1	1.1	1.4	1.2	0.8	3.2	2.8	2.3	0.7	2.0	1.3	2.3	2.9	2.1	0.7	1.6	1.3	1.8	3.1	1.1	0.8	4.2	0.4	0.8	0.2	1.1	0.5	0.6	2.0	1.6	2.7	23.8	2.6	2.4	1.0	0.3	1.4	1.9	0.6	4.2	21.2	4.5	3.0	2.9	2.3	7.0	2.5	7.5	9.2	10.6	6.2	1.5	8.3	2.8	16.5	1.5	3.1	2.2	5.9	25.2	11.7	1.2	2.9	3.2	2.3	4.2	2.7	0.7	2.8	1.7	7.2	11.7	26.9	5.9	10.7	3.4	2.6	3.9	9.3	4.2	7.5	1.8	0.8	1.6	18.2	2.9	4.8	1.6	16.8	1.1	2.4	2.3	2.5	0.4	0.9	1.8	2.4	1.2	20.0	3.3	22.5	7.4	1.7	2.6	1.6	2.0	5.6	3.3	2.5	1.3	4.1	0.7	0.9	1.6	2.0	1.5	0.9	1.5	1.7	1.8	1.7	1.7	21.5	1.4	5.0	0.7	5.2	1.3	3.4	3.6	5.7	4.9	3.2	2.8	2.3	2.9	3.1	2.0	2.6	4.2	3.0	3.2	6.4	2.3	10.3	0.5	13.9	7.6	6.8	6.6	2.1	3.3	1.8	4.3	3.2	5.5	6.2	2.6	10.1	1.4	1.9	4.0	76.9	21.8	7.1	4.2	0.0	0.8	3.6	20.5	7.9	5.0	16.8	20.5	9.5	1.1	1.4	0.0	1.4	6.7	7.3	1.9	2.0	2.2	2.3	57.6	2.1	3.6	1.8	1.0	2.0	3.6	1.0	1.5	1.6	48.6	0.1	1.5	4.5	2.9	0.3	3.0	4.9	8.4	0.0	4.5	3.3	54.8	3.3	2.5	0.9	8.1	9.1	1.5	1.3	4.5
LPIN2	KIAA0249	ENSG00000101577	"Lipin 2"	Q92539	18	2916994-3013144	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism, Transcription, Transcription regulation"	Hydrolase	"Congenital dyserythropoietic anemia, Disease variant, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 165.8"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 154.4;Granulosa cells: 323.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in all"	7	"granulocytes: 23.4;NK-cells: 12.5;T-cells: 12.1"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015223, HPA017857, HPA030550"	Enhanced		Approved	"Plasma membrane,Actin filaments,Cytosol"		Yes	No			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 85: Liver - Metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 40: Granulosa cells - Unknown function"	Cytosol	"Plasma membrane, Actin filaments"	"CAB015223: , HPA017857: AB_1852904, HPA030550: AB_2673519"	"unprognostic (7.03e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.88e-1)"	"unprognostic (1.51e-3)"	"unprognostic (1.20e-1)"	"prognostic favorable (8.01e-4)"	"unprognostic (9.85e-3)"	"unprognostic (1.89e-2)"	"unprognostic (1.03e-2)"	"unprognostic (3.44e-3)"	"unprognostic (3.19e-1)"	"unprognostic (1.94e-1)"	"unprognostic (3.15e-3)"	"unprognostic (4.66e-2)"	"unprognostic (2.21e-1)"	"unprognostic (2.49e-1)"	"unprognostic (7.11e-2)"	9.7	9.3	17.9	21.2	19.9	19.8	9.8	14.6	17.4	9.7	16.6	13.9	62.8	9.8	6.7	10.0	9.5	25.7	7.2	16.1	24.2	26.4	165.8	21.2	24.3	22.7	22.0	13.2	16.4	13.5	10.9	15.7	24.2	9.0	12.5	10.7	7.4	8.0	2.7	3.6	39.9	9.6	15.6	20.3	28.1	22.0	28.8	18.9	12.1	3.0	19.2	9.9	6.0	14.3	8.7	12.0	17.1	6.6	31.7	27.4	10.5	17.4	22.8	18.9	16.9	16.7	7.1	5.4	10.8	30.2	30.2	0.2	13.8	6.3	13.2	11.2	2.7	13.3	10.0	19.4	27.2	11.2	17.0	27.4	4.6	18.5	17.2	28.2	23.4	14.8	12.8	3.5	28.2	7.2	15.0	12.0	5.7	13.7	13.1	26.7	14.0	23.2	17.6	20.0	14.4	10.2	18.4	9.1	6.8	10.7	0.0	18.0	31.2	25.3	28.7	31.7	14.6	5.0	7.9	12.3	22.1	12.2	8.1	8.7	2.4	7.8	11.8	1.5	12.1	1.0	9.2	7.2	1.0	1.7	9.1	6.3	23.4	12.5	0.8	1.5	9.2	3.2	17.9	19.9	14.6	17.4	16.1	24.2	22.7	22.0	24.2	15.6	28.8	14.3	17.7	67.3	44.0	55.2	20.4	5.6	9.8	8.5	5.7	35.7	12.1	11.2	11.2	154.4	23.9	38.6	14.6	25.2	41.9	45.3	17.6	11.8	3.3	48.2	33.3	18.9	14.9	138.1	26.3	19.0	11.3	25.4	103.0	64.4	12.6	323.0	19.2	131.1	23.1	116.1	65.6	36.8	16.2	26.8	8.9	11.0	22.7	31.1	8.8	79.6	31.2	16.7	59.8	37.7	21.0	22.2	21.6	31.2	16.1	21.2	92.4	54.9	17.1	16.7	6.6	16.6	20.1	26.5	73.0	0.6	2.0	49.5	58.9	20.3	14.0	14.1
LYST	"CHS, CHS1"	ENSG00000143669	"Lysosomal trafficking regulator"	Q99698	1	235661041-235883640	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Phagocytosis, Protein transport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 31.3;retina: 27.9"	"Cell type enhanced"	"Detected in all"		"monocytes: 277.4"	"Cancer enhanced"	"Detected in all"		"melanoma: 11.1"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 12.2"	"Group enriched"	"Detected in many"	5	"granulocytes: 12.2;monocytes: 6.1"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 30.8;SK-MEL-30: 27.1;THP-1: 99.5;U-937: 38.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053366, HPA055725"			Supported	"Nucleoplasm,Plasma membrane,Centriolar satellite"		Yes	No			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 34: Non-specific - Transcription"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Nucleoplasm	"Plasma membrane, Centriolar satellite"	"HPA053366: AB_2682129, HPA055725: AB_2682898"	"unprognostic (1.56e-2)"	"unprognostic (1.54e-1)"	"unprognostic (9.92e-2)"	"unprognostic (8.85e-2)"	"unprognostic (1.96e-2)"	"unprognostic (4.32e-2)"	"unprognostic (4.11e-2)"	"unprognostic (7.79e-2)"	"unprognostic (4.08e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.55e-1)"	"unprognostic (9.31e-2)"	"prognostic unfavorable (5.27e-5)"	"unprognostic (1.59e-1)"	"unprognostic (1.54e-1)"	"unprognostic (6.29e-2)"	"unprognostic (1.99e-1)"	5.2	2.7	2.0	8.5	2.7	31.3	6.4	10.1	3.3	7.1	9.1	4.5	3.0	4.3	2.7	4.2	3.9	5.1	2.2	2.0	2.5	3.6	5.5	5.5	7.5	2.2	2.6	4.5	2.2	6.2	1.8	4.6	2.5	3.4	4.3	27.9	4.3	3.3	1.7	9.7	3.3	4.4	1.1	10.8	7.7	6.1	3.3	25.7	6.4	3.8	6.5	5.7	5.2	3.4	8.6	1.9	0.9	2.0	12.7	14.4	1.3	3.1	12.5	3.3	3.1	0.0	2.3	1.1	1.2	6.8	7.7	4.1	1.2	1.6	2.9	30.8	2.7	2.8	1.9	0.6	2.3	4.2	3.7	4.8	7.8	4.0	10.0	4.8	2.8	1.3	0.2	1.7	2.6	0.4	5.3	8.7	0.2	1.6	0.9	0.4	1.2	0.0	9.2	9.2	5.4	1.1	3.4	0.2	27.1	1.0	1.2	99.5	5.8	2.4	1.1	2.8	2.8	2.1	0.1	0.2	4.1	38.0	7.0	0.4	2.9	5.7	0.6	3.4	0.8	1.0	0.2	0.7	1.7	1.4	0.2	0.4	12.2	1.7	6.1	0.2	0.2	0.7	2.0	2.7	10.1	3.3	2.0	2.5	2.2	2.6	2.5	1.1	3.3	3.4	66.3	19.2	41.1	71.2	70.9	71.0	89.8	14.6	18.8	67.4	17.6	15.6	11.6	15.7	28.4	11.0	93.8	6.7	77.3	25.0	11.7	6.6	24.6	22.6	23.8	51.2	9.6	21.0	151.5	12.3	5.0	27.0	41.3	22.4	112.5	9.4	26.0	15.4	31.9	52.2	155.9	14.3	28.5	65.6	81.3	17.7	28.0	111.4	120.9	159.3	277.4	25.6	88.6	112.1	81.6	39.6	24.2	21.8	37.3	56.0	12.7	10.9	26.7	162.5	13.1	31.2	22.7	93.3	28.0	18.7	65.1	8.8	71.3	13.6	7.6	98.5
MAD2L1BP	"CMT2, dJ261G23.1, KIAA0110"	ENSG00000124688	"MAD2L1 binding protein"	Q15013	6	43629540-43640941	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 221.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028729			Supported	"Nucleoplasm,Nuclear membrane,Nucleoli"		Yes	No			"Cluster 44: Non-specific - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 21: OE19 - Mitochondria"	"Cluster 51: Myeloid cells - Hemostasis"	Nucleoplasm	"Nuclear membrane, Nucleoli"	"HPA028729: AB_2672752"	"unprognostic (2.60e-1)"	"unprognostic (2.06e-1)"	"unprognostic (3.92e-2)"	"unprognostic (6.97e-2)"	"unprognostic (6.91e-2)"	"unprognostic (6.92e-2)"	"unprognostic (5.74e-3)"	"unprognostic (2.67e-3)"	"unprognostic (3.60e-1)"	"unprognostic (7.18e-2)"	"unprognostic (1.71e-1)"	"unprognostic (6.64e-2)"	"unprognostic (4.61e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.34e-1)"	"unprognostic (1.16e-1)"	"unprognostic (3.25e-3)"	13.3	16.2	13.6	14.1	13.8	53.5	17.3	14.1	15.8	14.6	15.4	25.9	23.6	12.4	17.3	17.6	16.7	14.4	25.4	14.3	14.9	17.5	21.9	14.9	21.7	13.8	13.2	13.0	16.7	21.1	12.6	14.0	14.2	14.4	27.7	15.2	22.8	13.5	28.5	13.2	18.8	14.5	13.6	17.4	19.3	20.4	14.3	29.3	15.6	44.6	26.6	21.4	10.6	13.8	53.9	24.4	37.7	42.2	32.1	34.7	22.7	31.7	50.9	68.5	63.8	50.3	21.4	41.6	17.6	37.3	62.2	34.4	59.2	43.9	52.6	38.5	46.0	51.5	26.1	43.8	34.6	30.6	29.9	35.3	53.0	51.1	31.0	34.5	52.2	32.8	67.2	21.8	48.4	50.6	27.4	56.5	23.3	221.1	31.3	31.3	29.3	39.4	48.9	42.5	44.7	45.3	22.8	34.5	152.2	28.6	40.6	80.3	28.7	36.5	30.7	24.4	51.3	27.7	25.8	99.0	33.2	51.3	41.0	105.4	41.4	49.4	46.3	42.8	46.5	52.6	54.7	51.4	52.7	47.9	56.5	51.2	35.2	55.6	41.3	34.9	78.9	43.6	13.6	13.8	14.1	15.8	14.3	14.9	13.8	13.2	14.2	13.6	14.3	13.8	11.6	25.6	12.7	3.3	18.2	14.4	20.5	44.9	17.6	12.8	11.6	9.3	10.8	15.7	32.5	3.7	12.5	21.1	11.1	30.7	27.4	28.0	47.0	13.2	8.6	12.5	17.4	20.6	3.0	21.2	21.5	12.0	14.3	10.8	31.6	7.8	11.4	12.7	17.6	10.1	3.2	17.1	32.6	10.4	8.6	36.5	12.2	19.6	28.4	1.9	17.3	13.9	11.3	3.0	5.0	24.7	29.5	12.0	11.1	11.5	28.2	21.2	21.1	15.1	26.3	8.3	13.4	26.4	18.3	12.6	9.7	6.2	14.8	11.9	23.4	27.2
MAGEC2	"CT10, HCA587, MAGE-C2, MAGEE1"	ENSG00000046774	"MAGE family member C2"	Q9UBF1	X	142202342-142205290	"Cancer-related genes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Tumor antigen"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	197	"testis: 19.6"	"Group enriched"	"Detected in some"	13	"Spermatocytes: 84.6;Spermatogonia: 91.5"	"Cancer enhanced"	"Detected in many"		"melanoma: 19.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"K-562: 87.3;U-266/84: 99.8"									HPA062230	Enhanced		Supported	Nucleoplasm,Cytosol		Yes	NA				"Cluster 36: Testis - Spermatogenesis"	"Cluster 16: U-266 - Nucleosome"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA062230: AB_2684718"					"unprognostic (1.25e-1)"		"unprognostic (5.68e-2)"	"unprognostic (3.99e-1)"	"unprognostic (2.82e-1)"						"unprognostic (1.04e-1)"		"unprognostic (4.00e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	9.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	87.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.9	3.7	0.0	0.0	0.0	0.2	5.7	0.9	11.3	0.0	0.1	99.8	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	84.6	91.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MCL1	"BCL2L3, Mcl-1"	ENSG00000143384	"MCL1 apoptosis regulator, BCL2 family member"	Q07820	1	150560895-150579738	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Differentiation"	"Developmental protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 685.1"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 106.3"	"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	12	"U-698: 4726.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002781, HPA008455, HPA031125, CAB068195"	Enhanced		Enhanced	Mitochondria		Yes	No			"Cluster 52: Eosinophils - Transcription"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 41: Macrophages - Immune response"	Mitochondria		"CAB002781: , CAB068195: AB_2665695, HPA008455: AB_1079334, HPA031125: AB_10602026"	"unprognostic (3.82e-2)"	"unprognostic (8.79e-2)"	"unprognostic (9.15e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.91e-2)"	"unprognostic (3.16e-2)"	"unprognostic (2.43e-2)"	"unprognostic (1.29e-1)"	"unprognostic (8.60e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.65e-2)"	"prognostic unfavorable (7.16e-4)"	"unprognostic (3.22e-2)"	"unprognostic (1.94e-1)"	"unprognostic (4.87e-2)"	"unprognostic (4.46e-2)"	297.8	149.2	72.9	264.9	75.0	685.1	175.0	77.0	84.2	143.4	85.0	137.1	99.4	98.5	41.8	199.3	190.7	278.8	139.1	65.3	81.5	125.2	404.6	237.1	161.2	86.4	77.8	105.3	161.7	89.2	82.8	146.9	79.4	96.3	120.1	90.1	124.7	56.4	153.8	189.2	133.6	171.4	80.6	171.5	167.0	41.3	91.4	128.9	133.3	160.1	157.1	302.6	124.6	75.8	140.2	74.8	131.9	73.3	262.9	262.2	175.8	164.8	174.5	173.0	139.4	91.9	112.3	184.9	102.2	120.2	80.3	187.7	101.7	203.3	166.7	154.8	68.3	76.4	109.9	106.2	204.7	130.6	151.3	147.3	221.3	170.6	330.0	159.5	192.7	49.4	168.1	225.3	234.2	160.3	64.6	80.7	242.0	122.9	131.9	94.7	111.1	85.9	195.2	103.7	95.9	134.2	125.6	135.9	232.4	191.2	100.4	195.2	251.6	109.2	119.4	55.5	212.8	310.2	409.5	4726.7	189.5	95.1	141.9	23.3	19.8	51.8	15.0	17.4	17.4	12.6	19.0	16.6	16.6	14.0	22.8	17.6	106.3	10.6	16.2	9.4	30.1	11.2	72.9	75.0	77.0	84.2	65.3	81.5	86.4	77.8	79.4	80.6	91.4	75.8	366.0	198.7	295.5	12.4	339.2	489.2	394.7	142.6	434.2	38.7	339.3	229.9	84.8	228.8	148.8	33.1	60.5	108.6	398.5	491.8	41.1	196.4	209.2	187.5	310.8	241.9	259.6	61.8	6.5	174.7	203.4	278.4	228.3	365.7	343.8	209.0	229.2	218.8	262.7	11.8	5.5	309.0	107.8	453.6	930.9	347.0	72.7	614.2	273.9	30.0	250.6	101.2	94.7	10.1	6.8	183.4	345.1	60.9	831.8	293.4	233.1	68.9	110.3	78.0	78.9	350.3	217.4	47.4	35.4	372.2	572.0	270.4	499.8	126.0	205.7	401.1
MCM2	"BM28, CCNL1, cdc19, CDCL1, D3S3194, DFNA70, KIAA0030"	ENSG00000073111	"Minichromosome maintenance complex component 2"	P49736	3	127598410-127622436	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, DNA replication"	"DNA-binding, Helicase, Hydrolase"	"Cancer-related genes, Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 67.7;lymphoid tissue: 37.6"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 63.3;Erythroid cells: 65.6;Extravillous trophoblasts: 28.8;Spermatogonia: 25.9;Syncytiotrophoblasts: 33.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"CAB000303, HPA031450, HPA031495, HPA031496"	Enhanced		Enhanced	Nucleoplasm		Yes	Yes		120000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"CAB000303: AB_322519, HPA031450: , HPA031495: AB_2673904, HPA031496: AB_2673905"	"unprognostic (2.43e-1)"	"prognostic favorable (4.66e-4)"	"unprognostic (4.44e-2)"	"unprognostic (3.12e-3)"	"unprognostic (1.68e-1)"	"unprognostic (2.25e-2)"	"prognostic unfavorable (1.51e-7)"	"unprognostic (8.43e-3)"	"unprognostic (1.92e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.41e-3)"	"unprognostic (1.21e-2)"	"unprognostic (1.16e-2)"	"unprognostic (8.16e-3)"	"unprognostic (1.56e-1)"	"unprognostic (3.29e-2)"	"unprognostic (2.82e-1)"	3.1	3.4	2.0	16.4	1.9	67.7	6.2	2.5	1.9	5.3	0.6	9.2	8.1	5.0	2.4	11.0	7.6	2.5	6.4	1.9	1.8	3.4	6.3	3.4	26.8	2.3	1.9	6.4	3.0	3.7	2.4	17.0	2.6	5.0	10.2	3.5	4.7	2.8	9.4	10.6	8.6	5.3	2.0	9.6	5.7	12.3	2.0	37.6	4.8	5.8	26.0	4.2	5.4	2.4	133.6	110.3	122.4	102.1	7.0	14.4	110.5	65.2	42.3	129.9	146.9	177.7	84.7	136.0	65.2	32.3	113.6	105.6	204.8	76.1	79.1	127.2	127.1	227.4	134.8	131.1	4.4	214.3	102.4	8.2	8.4	86.1	13.1	15.3	40.6	160.7	116.0	123.7	47.4	169.0	229.0	156.2	172.5	108.3	90.7	242.4	165.1	203.3	26.9	97.9	143.0	106.8	175.8	48.9	16.7	45.7	111.9	165.3	20.3	104.2	87.9	128.4	91.7	127.1	163.5	362.6	73.2	159.7	41.0	0.0	0.6	0.3	4.4	1.4	5.5	9.7	3.9	5.4	2.9	8.1	3.6	4.7	0.9	6.5	0.4	3.7	11.2	3.5	2.0	1.9	2.5	1.9	1.9	1.8	2.3	1.9	2.6	2.0	2.0	2.4	1.2	3.2	2.0	0.7	8.5	4.6	2.6	4.6	2.2	2.5	4.1	5.3	8.3	0.0	3.9	0.0	0.0	63.3	1.8	4.8	0.0	5.3	0.9	5.2	3.5	2.9	3.6	65.6	0.3	1.9	28.8	4.2	6.6	4.8	1.3	18.8	1.4	1.7	18.2	0.0	0.4	8.2	0.0	1.6	3.2	0.7	1.8	2.7	1.8	0.0	9.2	2.1	0.0	0.0	0.7	2.1	1.7	1.5	20.5	0.8	1.1	0.8	7.4	2.1	0.0	2.6	4.1	8.1	25.9	7.1	3.0	33.5	6.3	3.8	13.8	2.3
MCM5	CDC46	ENSG00000100297	"Minichromosome maintenance complex component 5"	P33992	22	35400134-35425431	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, DNA replication"	"DNA-binding, Helicase, Hydrolase"	"Cancer-related genes, Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 138.7"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 147.8;Erythroid cells: 96.6;monocytes: 137.7;Syncytiotrophoblasts: 82.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000101, HPA000845, HPA052880"	Enhanced		Enhanced	Nucleoplasm		Yes	Yes		44000	"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"CAB000101: AB_2235163, HPA000845: AB_1079338, HPA052880: AB_2681979"	"unprognostic (6.71e-2)"	"prognostic favorable (2.81e-6)"	"unprognostic (5.29e-3)"	"unprognostic (7.94e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.46e-2)"	"prognostic unfavorable (1.78e-4)"	"prognostic unfavorable (3.95e-4)"	"unprognostic (1.29e-1)"	"unprognostic (3.34e-2)"	"unprognostic (1.37e-1)"	"unprognostic (8.07e-2)"	"prognostic unfavorable (3.58e-5)"	"unprognostic (3.26e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.77e-3)"	"unprognostic (1.53e-1)"	15.2	7.1	5.8	49.1	10.4	138.7	14.4	8.3	7.4	14.5	5.8	20.2	19.6	16.3	3.3	25.1	13.7	9.6	8.9	5.8	7.0	9.1	14.9	14.8	70.1	10.3	7.7	25.6	12.6	10.3	5.3	25.2	9.6	10.2	16.7	2.3	13.9	9.6	13.3	17.6	28.3	12.2	8.1	47.3	17.9	20.6	9.0	58.9	12.1	8.0	53.6	12.7	15.6	12.3	213.0	147.5	115.7	118.8	11.0	22.2	100.6	138.1	71.2	199.4	188.3	98.9	102.4	137.9	78.8	70.5	83.6	103.8	116.0	108.3	64.4	112.7	212.6	198.3	141.5	203.7	3.9	414.0	172.4	12.3	9.7	120.0	32.4	18.4	88.7	124.5	124.0	201.2	76.9	172.7	341.8	137.9	154.9	143.4	86.7	379.6	164.8	173.0	39.4	120.1	88.2	94.8	188.3	75.4	41.8	60.9	78.8	155.6	54.1	201.3	153.1	127.2	145.4	111.9	150.2	265.2	130.9	153.5	157.6	66.5	59.8	43.4	49.5	69.6	35.8	127.5	43.1	53.1	77.8	106.1	34.0	39.0	28.4	65.5	81.2	88.8	96.6	77.1	5.8	10.4	8.3	7.4	5.8	7.0	10.3	7.7	9.6	8.1	9.0	12.3	8.1	6.4	7.3	1.3	49.5	10.6	13.6	12.1	8.6	1.5	9.2	10.8	3.5	8.6	6.0	7.3	0.0	147.8	30.4	12.0	5.9	19.8	2.8	6.2	4.1	11.8	3.5	96.6	0.3	12.7	77.1	11.2	18.8	9.0	15.2	65.7	13.2	5.3	53.1	1.7	0.4	16.6	4.1	24.0	29.4	5.1	10.8	28.4	7.2	7.5	137.7	5.7	13.4	3.0	6.0	11.0	8.6	6.0	49.3	4.0	6.5	5.7	4.8	3.7	19.7	8.8	14.5	16.1	58.8	14.9	6.3	82.2	19.4	8.5	34.6	9.8
METTL14	KIAA1627	ENSG00000145388	"Methyltransferase like 14"	Q9HCE5	4	118685392-118715433	"Cancer-related genes, Metabolic proteins, Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	RNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 96.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038002	Supported		Supported	Nucleoplasm		Yes	No			"Cluster 44: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoplasm		"HPA038002: AB_10672401"	"unprognostic (4.48e-1)"	"unprognostic (5.13e-2)"	"unprognostic (5.98e-3)"	"unprognostic (3.44e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.83e-1)"	"unprognostic (3.75e-2)"	"unprognostic (4.40e-1)"	"unprognostic (9.97e-2)"	"unprognostic (2.40e-2)"	"unprognostic (3.64e-2)"	"unprognostic (3.33e-3)"	"prognostic favorable (1.46e-5)"	"unprognostic (1.05e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.76e-3)"	"unprognostic (7.76e-3)"	8.9	8.8	5.2	8.6	6.0	19.5	11.5	6.8	6.3	8.8	5.5	8.8	8.8	11.7	10.7	8.9	8.8	7.7	8.3	4.8	6.3	10.2	14.9	9.1	11.6	5.5	5.2	12.7	7.8	10.9	8.2	9.0	6.3	9.7	8.2	11.7	7.6	8.0	8.4	10.9	9.2	9.2	5.4	10.8	7.9	15.1	5.7	12.5	10.6	7.7	11.0	8.5	7.9	7.4	19.6	8.9	19.0	17.8	11.7	14.7	13.8	17.1	13.0	12.6	14.4	12.9	22.8	22.0	9.8	12.0	12.6	9.4	16.2	14.1	16.1	17.5	9.8	18.5	11.4	14.4	13.3	30.2	21.2	13.1	15.8	14.6	9.6	16.5	11.5	17.4	20.1	18.2	17.5	13.2	29.7	24.7	16.2	16.7	7.7	16.8	23.7	11.2	13.8	12.7	15.4	17.3	12.0	22.0	17.2	17.2	10.0	28.5	15.8	18.1	16.6	16.3	13.7	15.2	17.0	24.9	12.9	16.5	15.1	37.7	12.8	29.0	17.0	19.6	19.3	24.3	17.8	17.7	15.3	25.3	21.0	19.0	10.3	21.8	23.7	12.1	20.8	13.7	5.2	6.0	6.8	6.3	4.8	6.3	5.5	5.2	6.3	5.4	5.7	7.4	18.6	25.6	25.9	14.7	20.6	10.8	18.3	10.6	16.5	16.8	13.4	12.6	15.7	17.2	20.8	23.9	22.9	18.7	28.3	13.7	11.7	11.9	96.9	14.5	21.7	17.3	12.1	8.4	18.7	15.6	10.2	16.8	9.2	18.0	22.1	18.3	16.4	32.1	12.1	8.4	17.0	15.2	6.1	17.9	7.6	16.7	18.6	13.3	7.2	14.0	14.0	13.4	25.7	14.1	26.9	14.8	13.0	13.9	8.2	17.1	15.4	20.6	15.2	25.4	13.1	15.3	15.5	42.2	28.1	12.4	11.9	15.3	20.6	17.0	12.8	16.0
METTL22	"C16orf68, FLJ12433,MGC2654"	ENSG00000067365	"Methyltransferase like 22"	Q9BUU2	16	8621683-8649654	"Metabolic proteins, Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"Early spermatids: 119.9;Late spermatids: 357.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 9.7"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040803, HPA059882, HPA074173"	Uncertain		Supported	"Nucleoplasm,Nucleoli rim"		Yes	No			"Cluster 1: Neutrophils - Mixed function"	"Cluster 21: Non-specific - Transcription"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoli rim"	Nucleoplasm	"HPA040803: AB_10795479, HPA059882: AB_2684150, HPA074173: AB_2686672"	"unprognostic (1.74e-1)"	"unprognostic (6.50e-2)"	"unprognostic (3.02e-1)"	"unprognostic (1.41e-1)"	"unprognostic (7.83e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.58e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.94e-3)"	"unprognostic (3.82e-2)"	"prognostic unfavorable (2.79e-8)"	"unprognostic (1.78e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.15e-2)"	"unprognostic (8.90e-2)"	4.4	5.8	9.0	5.7	10.2	7.7	4.5	16.4	13.2	6.7	9.5	5.9	4.9	5.9	6.1	5.3	5.4	4.4	9.3	8.8	9.1	5.1	6.6	4.7	6.1	12.7	10.7	6.4	6.1	3.1	5.1	5.0	13.3	7.2	4.0	10.4	4.7	5.2	20.2	8.4	4.1	4.7	9.1	4.7	5.1	13.7	12.6	4.0	5.2	5.9	5.0	5.5	5.8	12.9	4.3	8.7	9.7	9.3	3.6	9.1	8.4	7.2	3.8	8.4	9.5	8.5	9.8	6.7	6.3	6.4	3.1	7.9	6.1	11.5	5.5	9.8	8.4	6.9	17.3	24.6	10.8	7.2	5.1	9.2	8.2	9.2	10.1	5.1	6.8	9.2	9.4	6.6	6.5	15.2	7.4	17.0	5.2	1.9	8.5	11.1	7.3	13.9	4.1	4.5	11.9	7.9	6.3	7.3	4.7	5.2	8.0	5.9	5.4	10.0	8.7	8.2	3.3	8.9	5.3	10.4	3.6	9.3	4.7	1.6	2.5	2.0	0.9	1.9	0.9	0.9	0.9	1.0	2.3	0.8	1.1	0.5	9.7	1.6	2.2	1.3	1.2	1.0	9.0	10.2	16.4	13.2	8.8	9.1	12.7	10.7	13.3	9.1	12.6	12.9	5.1	9.6	5.6	8.5	7.6	3.3	6.9	7.5	8.6	13.8	5.8	6.1	18.3	4.3	6.0	0.0	4.2	12.8	2.7	4.9	11.7	9.3	119.9	3.5	6.5	7.2	7.2	18.5	13.4	9.8	9.8	7.4	9.2	3.5	8.2	11.3	5.7	7.4	29.5	1.7	14.3	7.0	2.0	31.8	9.6	357.8	10.8	27.5	1.8	12.2	17.6	4.9	11.3	12.5	13.3	8.4	6.8	13.9	7.7	11.0	8.3	8.9	3.4	11.8	0.0	9.0	8.5	39.6	15.7	7.5	2.7	13.3	6.6	7.8	6.5	8.1
MGAT5B	"FLJ25132, GnT-IX, GnT-VB"	ENSG00000167889	"Alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase B"	Q3V5L5	17	76868404-76950393	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"brain: 12.0"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 16.0;Early spermatids: 7.3;Excitatory neurons: 26.2;Inhibitory neurons: 21.9;Late spermatids: 8.1"	"Group enriched"	"Detected in many"	5	"glioma: 2.6;melanoma: 7.1;testis cancer: 2.4"	"Region enhanced"	"Detected in many"		"cerebral cortex: 12.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 32.1;SCLC-21H: 15.9;U-138 MG: 19.2;U-2 OS: 20.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011082			Approved	"Nucleoplasm,Cytokinetic bridge,Mitotic spindle"		Yes	No				"Cluster 10: Brain - Neuronal signaling"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Mitotic spindle"	"Cytokinetic bridge"	"HPA011082: AB_2668423"	"unprognostic (6.37e-2)"	"unprognostic (9.16e-3)"	"unprognostic (8.51e-2)"	"unprognostic (1.43e-3)"	"unprognostic (5.68e-3)"	"unprognostic (1.33e-1)"	"unprognostic (2.28e-3)"	"unprognostic (1.52e-3)"	"unprognostic (5.30e-2)"	"unprognostic (3.89e-2)"	"unprognostic (1.68e-1)"	"unprognostic (5.67e-2)"	"unprognostic (1.46e-7)"	"unprognostic (1.66e-1)"	"unprognostic (8.09e-3)"	"unprognostic (1.04e-1)"	"unprognostic (3.01e-1)"	0.2	0.2	2.4	0.2	2.1	0.1	0.1	0.0	12.0	0.2	0.0	0.1	0.0	0.2	0.0	0.1	0.1	0.1	0.0	5.2	0.0	0.2	0.0	0.3	0.1	0.3	0.0	0.2	0.0	0.2	0.9	0.2	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.3	0.1	1.2	0.0	0.2	0.2	0.1	0.0	0.1	0.1	0.0	3.7	32.1	6.4	3.4	0.0	0.0	3.7	0.4	1.3	11.7	6.9	0.1	0.7	0.0	2.5	1.5	13.7	0.2	1.6	0.2	3.0	0.1	0.5	0.0	1.7	0.1	0.0	0.0	0.2	0.1	0.2	0.0	1.8	5.2	2.0	0.7	0.2	0.0	0.0	1.5	0.1	0.0	1.8	0.8	3.5	4.8	5.6	7.1	8.9	0.1	15.9	6.1	5.5	2.4	5.0	0.4	0.2	0.2	5.8	19.2	20.9	0.3	6.3	0.0	0.0	0.7	0.6	0.0	14.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	2.1	0.0	12.0	5.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	16.0	0.1	0.1	0.1	0.0	0.0	5.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.3	0.1	0.1	0.8	0.0	0.0	26.2	0.0	3.2	0.2	0.0	0.2	0.0	0.6	0.7	0.0	0.1	0.0	21.9	0.0	0.0	0.0	0.0	8.1	0.6	0.0	0.0	2.8	0.0	0.2	0.0	5.0	1.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	1.8	0.0	0.0	0.1	1.1	2.4	0.0	0.0	0.1	0.1	0.2	0.0	0.0
MIDN		ENSG00000167470	Midnolin	Q504T8	19	1248553-1259140	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 455.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	7	"neutrophil: 11.8"	"Lineage enriched"	"Detected in many"	9	"granulocytes: 11.8"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042018, HPA049432"	Uncertain		Approved	Nucleoplasm		Yes	No			"Cluster 1: Neutrophils - Mixed function"	"Cluster 59: Non-specific - Translation"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA042018: AB_2677800, HPA049432: AB_2680765"	"unprognostic (1.82e-2)"	"unprognostic (6.21e-2)"	"unprognostic (2.27e-2)"	"unprognostic (2.18e-2)"	"unprognostic (2.40e-1)"	"unprognostic (2.24e-3)"	"unprognostic (1.06e-2)"	"unprognostic (2.04e-2)"	"unprognostic (2.29e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.03e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.56e-1)"	"unprognostic (1.19e-2)"	71.4	61.9	25.6	25.2	25.0	82.6	42.7	24.9	32.3	48.0	16.1	53.9	22.3	34.2	6.3	99.2	64.6	31.4	72.9	21.1	32.1	46.9	50.5	67.0	19.1	44.8	30.1	61.4	37.4	8.2	81.9	15.5	29.8	39.2	12.0	12.4	46.6	11.5	141.6	79.1	52.6	12.4	29.8	50.3	56.1	19.6	32.4	19.0	35.0	17.4	15.1	42.2	55.7	23.1	14.7	31.8	53.5	25.0	11.2	19.0	39.2	25.0	14.9	12.6	8.9	41.8	16.1	23.3	26.6	18.9	6.8	29.6	16.3	26.5	4.9	32.9	30.0	32.8	21.8	33.3	22.7	33.3	46.9	29.4	24.4	15.1	14.3	19.5	20.8	27.3	42.7	24.0	13.5	58.9	44.6	13.6	117.6	28.6	21.1	68.8	15.2	10.7	23.8	17.2	42.7	55.9	52.9	50.1	33.7	27.7	20.2	37.7	26.2	22.9	25.4	106.2	27.3	22.4	13.2	32.2	43.9	14.6	79.5	1.6	1.0	1.1	1.0	1.0	0.7	0.2	0.3	0.7	0.4	0.3	0.2	0.5	11.8	1.3	1.1	0.4	0.1	0.7	25.6	25.0	24.9	32.3	21.1	32.1	44.8	30.1	29.8	29.8	32.4	23.1	330.7	38.5	60.5	17.3	101.1	98.9	128.3	114.4	175.8	53.9	290.6	224.2	84.3	117.2	86.2	134.3	31.3	15.8	184.8	455.8	19.6	125.5	34.7	220.6	84.5	186.1	164.5	19.4	8.0	155.5	47.3	84.0	132.0	294.7	61.5	60.6	197.4	80.9	77.9	21.9	5.6	219.5	59.0	100.0	134.9	33.3	49.7	150.9	42.7	24.4	49.7	77.8	96.8	32.2	10.3	259.0	306.8	33.1	69.9	190.9	242.1	35.8	109.6	35.7	39.5	219.8	142.4	3.3	12.0	227.3	148.0	81.3	122.9	33.2	167.8	190.7
MKI67	"MIB-1, PPP1R105"	ENSG00000148773	"Marker of proliferation Ki-67"	P46013	10	128096659-128126423	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 46.3;lymphoid tissue: 52.7"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 232.9;Extravillous trophoblasts: 86.1;Granulosa cells: 87.0;Plasma cells: 107.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"CAB000058, HPA000451, HPA001164, CAB068198"	Enhanced		Enhanced	"Nucleoplasm,Nucleoli rim,Mitotic chromosome"		Yes	Yes				"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Nucleoli rim"	"Mitotic chromosome"	"CAB000058: AB_2142367, CAB068198: AB_2665702, HPA000451: AB_1079186, HPA001164: AB_1079187"	"unprognostic (2.54e-1)"	"unprognostic (1.29e-1)"	"unprognostic (3.37e-1)"	"unprognostic (9.92e-3)"	"unprognostic (3.17e-1)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (3.61e-6)"	"unprognostic (7.16e-3)"	"unprognostic (1.45e-2)"	"unprognostic (3.73e-1)"	"prognostic unfavorable (9.47e-5)"	"unprognostic (2.45e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (1.42e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.50e-1)"	"unprognostic (4.61e-1)"	0.9	0.7	0.0	8.5	0.1	46.3	1.7	0.0	0.1	1.2	0.2	8.1	6.2	1.0	0.0	10.0	0.3	0.9	0.3	0.1	0.1	0.4	0.8	1.4	14.9	0.1	1.0	0.2	0.2	0.1	0.1	4.1	0.6	0.4	9.2	0.0	1.4	0.1	0.0	6.6	5.8	2.6	0.0	4.8	4.2	2.3	0.9	52.7	0.4	0.1	16.4	1.8	2.8	0.3	204.6	101.5	103.2	73.6	4.3	8.7	32.1	75.7	55.3	70.3	62.3	83.9	82.3	152.6	21.3	51.9	46.4	120.7	109.3	56.8	104.7	161.8	53.1	131.0	79.4	52.7	0.1	186.0	68.0	2.0	2.5	72.2	73.2	17.2	69.8	69.5	61.2	142.1	70.5	80.9	111.7	56.6	41.3	52.7	45.7	82.2	135.1	20.3	25.6	56.2	35.9	38.9	107.1	38.0	17.3	33.9	31.4	39.3	65.0	37.0	73.6	53.0	206.8	64.2	54.9	177.2	30.7	83.3	32.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.1	1.0	0.6	0.0	0.9	0.3	0.6	0.0	5.4	0.0	16.0	6.4	1.6	5.3	0.6	0.0	3.9	3.2	1.6	1.5	5.3	0.0	0.0	30.6	7.4	25.0	0.0	0.8	4.2	2.3	10.2	6.7	6.7	232.9	0.0	0.0	86.1	13.5	34.7	13.2	1.3	87.0	5.7	1.7	42.1	0.0	0.0	22.4	2.0	12.9	13.7	0.9	0.3	16.6	3.6	0.0	0.2	0.0	8.2	0.0	0.0	0.1	3.0	0.4	107.4	4.6	2.6	0.1	1.6	0.0	0.0	0.5	13.6	8.1	24.1	50.4	3.0	7.8	23.0	2.7	47.1	4.8
MRPL52		ENSG00000172590	"Mitochondrial ribosomal protein L52"	Q86TS9	14	22829879-22835037	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal tubular cells: 549.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012319	Approved		Supported	Nucleoplasm,Mitochondria		Yes	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 35: Non-specific - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 7: Non-specific - Mitochondria"	Mitochondria	Nucleoplasm	"HPA012319: AB_1854118"	"unprognostic (8.98e-2)"	"unprognostic (9.07e-2)"	"unprognostic (1.36e-1)"	"unprognostic (3.18e-1)"	"unprognostic (1.36e-1)"	"unprognostic (4.74e-2)"	"unprognostic (4.01e-3)"	"unprognostic (1.29e-1)"	"unprognostic (6.52e-2)"	"unprognostic (8.05e-3)"	"unprognostic (8.07e-2)"	"unprognostic (2.87e-1)"	"unprognostic (7.46e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.40e-1)"	"unprognostic (3.16e-1)"	"unprognostic (1.41e-1)"	76.5	105.6	106.9	53.7	109.6	51.9	72.4	113.6	130.8	66.5	109.4	88.3	70.0	72.8	30.8	141.6	61.0	20.6	193.7	107.7	110.4	130.8	154.2	73.5	41.7	113.4	109.8	59.9	108.7	70.6	70.1	32.9	113.6	83.5	33.9	15.2	79.6	35.6	155.2	96.6	77.7	25.6	111.5	96.3	113.4	67.7	112.0	62.0	83.2	55.4	41.3	85.0	78.2	112.9	237.5	181.4	97.4	121.4	59.3	69.1	236.8	161.2	115.0	140.8	133.4	224.1	321.9	178.8	172.5	111.3	143.4	210.8	79.8	223.4	105.6	190.8	132.6	133.6	65.6	518.5	180.3	211.9	183.6	104.8	150.4	182.7	154.5	111.2	226.6	222.7	139.4	172.8	104.6	329.2	172.5	320.0	180.1	292.5	397.5	210.2	121.5	210.4	149.9	138.7	96.8	125.1	124.5	120.6	178.3	68.9	116.0	198.9	176.5	146.4	172.0	185.1	249.2	169.4	219.1	228.0	133.3	143.3	239.6	101.5	111.2	60.2	74.5	128.9	69.5	140.9	82.2	68.2	159.1	111.6	75.9	74.2	19.1	74.5	96.4	131.3	100.7	98.5	106.9	109.6	113.6	130.8	107.7	110.4	113.4	109.8	113.6	111.5	112.0	112.9	105.5	73.7	85.4	5.2	132.5	121.2	88.0	169.2	98.4	23.2	131.2	145.2	103.4	167.3	118.0	136.1	18.8	177.3	82.5	220.9	277.8	245.2	72.4	106.5	89.8	104.4	138.0	112.5	5.7	314.5	287.7	65.8	165.1	116.3	123.0	70.5	106.4	291.0	236.2	20.2	6.2	268.0	107.8	140.2	125.1	58.3	55.9	120.1	124.5	6.5	221.5	80.4	107.1	5.5	9.1	396.9	215.6	49.2	156.4	111.8	313.7	549.8	99.9	33.7	65.7	70.7	147.7	135.4	105.3	190.8	149.2	126.0	85.0	80.3	233.8	98.8
MRTO4	"C1orf33, dJ657E11.4, MRT4"	ENSG00000053372	"MRT4 homolog, ribosome maturation factor"	Q9UKD2	1	19251805-19260128	"Predicted intracellular proteins, Ribosomal proteins"	"Ribosome biogenesis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026446	Approved		Approved	"Nucleoplasm,Nuclear membrane,Nucleoli"		Yes	No			"Cluster 15: NK-cells - Transcription"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Nuclear membrane"	Nucleoli	"HPA026446: AB_10601441"	"unprognostic (3.99e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.18e-2)"	"unprognostic (2.94e-1)"	"unprognostic (4.12e-1)"	"unprognostic (4.22e-2)"	"prognostic unfavorable (1.56e-8)"	"unprognostic (7.46e-2)"	"unprognostic (5.58e-2)"	"unprognostic (2.61e-2)"	"unprognostic (2.69e-2)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (4.11e-8)"	"unprognostic (5.87e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.50e-1)"	"unprognostic (3.23e-2)"	18.9	18.5	17.0	16.8	17.1	13.4	20.2	14.8	17.9	13.0	13.7	13.5	16.8	15.8	12.9	23.7	17.6	8.9	14.4	17.4	16.1	17.9	20.3	11.1	20.0	15.8	16.0	17.0	23.4	12.5	8.9	12.1	16.1	12.9	16.5	7.2	12.3	10.5	22.7	17.4	19.5	16.7	15.4	13.8	15.5	14.0	16.1	14.8	11.1	11.4	22.8	21.4	14.1	16.4	90.9	65.9	51.1	67.0	24.2	38.6	44.7	69.0	38.9	116.7	76.1	92.9	92.0	133.6	56.7	60.5	50.4	70.1	142.7	104.6	114.0	47.4	109.6	98.4	55.4	80.8	30.3	133.4	38.7	34.0	69.8	131.6	69.6	31.7	66.1	59.0	151.1	42.3	68.9	68.0	106.3	96.5	65.0	95.6	95.4	99.3	62.7	100.5	64.8	31.3	82.9	59.2	54.0	73.0	75.4	37.6	50.8	76.5	44.2	61.9	77.5	97.6	118.0	33.8	64.3	178.2	61.2	172.4	102.5	1.4	11.6	1.3	11.4	12.7	22.9	23.1	13.7	15.9	17.6	19.7	18.4	16.7	1.4	16.6	10.2	19.7	10.6	11.4	17.0	17.1	14.8	17.9	17.4	16.1	15.8	16.0	16.1	15.4	16.1	16.4	30.0	6.4	14.5	6.2	31.2	37.3	59.1	45.8	42.7	20.4	23.6	37.7	10.3	38.6	26.4	7.3	10.4	50.4	14.9	15.7	41.1	61.8	23.3	19.1	46.8	32.1	21.6	31.3	8.4	55.0	69.9	29.5	19.4	21.1	26.0	36.8	15.4	16.3	47.1	15.2	7.3	25.4	36.7	13.3	18.2	36.5	23.0	21.0	19.6	1.9	32.0	25.7	16.5	4.5	4.3	57.5	17.0	20.3	29.0	57.4	6.0	37.9	15.8	16.4	19.7	44.8	35.9	55.6	49.7	48.2	33.5	26.0	18.6	58.1	34.8	36.7
MTBP		ENSG00000172167	"MDM2 binding protein"	Q96DY7	8	120445400-120542133	"Predicted intracellular proteins"	"Cell cycle, Growth arrest, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Erythroid cells: 12.8;Excitatory neurons: 14.7;Oligodendrocytes: 16.1;Spermatocytes: 16.2;Spermatogonia: 10.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 44.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"HPA025694, HPA050594"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies"		Yes	No			"Cluster 22: NK-cells - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Nuclear bodies"	"HPA025694: AB_1854169, HPA050594: AB_2681185"	"unprognostic (1.92e-2)"	"unprognostic (1.07e-1)"	"unprognostic (4.47e-1)"	"unprognostic (3.53e-4)"	"unprognostic (1.20e-1)"	"unprognostic (5.40e-3)"	"unprognostic (2.77e-6)"	"unprognostic (3.99e-3)"	"unprognostic (1.50e-2)"	"unprognostic (7.86e-3)"	"unprognostic (3.38e-3)"	"unprognostic (3.29e-1)"	"unprognostic (5.20e-10)"	"unprognostic (3.41e-3)"	"unprognostic (2.51e-1)"	"unprognostic (3.02e-2)"	"unprognostic (5.86e-2)"	1.3	1.1	1.0	2.5	1.2	4.0	2.6	3.6	1.7	1.6	0.7	1.7	1.5	2.1	2.4	1.4	1.7	1.2	0.6	1.0	0.9	1.0	0.8	1.3	4.3	1.0	1.0	2.4	0.9	1.0	0.8	2.1	1.2	1.5	2.6	4.3	1.1	1.0	0.7	3.0	1.3	2.0	0.9	1.8	1.1	5.0	1.1	4.6	0.8	0.8	4.0	1.0	1.3	1.4	15.3	4.5	14.6	6.0	2.1	3.5	7.1	11.4	6.5	16.4	21.0	4.9	8.3	13.8	11.2	3.8	4.9	13.0	13.9	6.8	20.3	11.5	10.6	11.6	6.7	5.6	1.1	12.4	8.6	1.3	2.9	12.7	8.1	2.5	7.3	12.6	7.6	10.2	9.7	6.9	19.8	7.6	6.5	12.0	9.0	11.3	15.0	9.8	3.9	5.3	7.4	8.6	7.7	44.8	7.0	7.9	8.5	8.9	4.5	7.0	12.7	9.0	18.6	3.9	8.9	8.0	6.6	15.1	8.3	0.0	0.1	0.1	0.3	0.6	0.5	0.7	0.5	0.7	0.2	0.5	0.8	0.7	0.0	0.5	0.3	0.0	0.7	0.3	1.0	1.2	3.6	1.7	1.0	0.9	1.0	1.0	1.2	0.9	1.1	1.4	1.6	0.0	1.5	7.5	2.9	0.8	1.7	1.5	1.8	0.0	1.4	1.3	1.1	0.0	1.1	1.8	0.0	2.3	2.5	0.5	0.0	0.9	0.8	1.3	2.6	1.1	0.0	12.8	14.7	1.8	3.0	2.5	2.6	1.5	2.5	5.0	1.8	0.9	1.6	0.0	9.1	0.9	0.0	0.3	1.8	0.4	1.5	1.7	1.8	3.7	1.0	0.0	2.1	9.0	16.1	0.6	0.1	1.2	2.3	1.2	0.3	0.3	2.4	0.0	0.0	5.6	2.6	16.2	10.2	1.4	0.6	0.7	3.3	1.5	0.8	0.8
MTERF4	"MGC61716, MTERFD2"	ENSG00000122085	"Mitochondrial transcription termination factor 4"	Q7Z6M4	2	241072169-241102332	"Predicted intracellular proteins"	"rRNA processing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA027097	Uncertain		Supported	Mitochondria,Cytosol		Yes	No			"Cluster 32: T-cells - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 63: NK-cells & T-cells - Immune response"	"Mitochondria, Cytosol"		"HPA027097: AB_10603879"	"unprognostic (4.58e-2)"	"unprognostic (3.66e-1)"	"unprognostic (2.82e-1)"	"unprognostic (5.95e-2)"	"unprognostic (1.50e-1)"	"unprognostic (6.70e-2)"	"unprognostic (1.17e-3)"	"unprognostic (2.99e-2)"	"unprognostic (2.68e-2)"	"unprognostic (1.20e-2)"	"prognostic favorable (3.48e-4)"	"unprognostic (2.28e-2)"	"unprognostic (1.65e-2)"	"unprognostic (1.92e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.13e-1)"	15.4	15.7	8.7	22.7	10.6	23.8	21.8	17.5	14.5	21.8	6.7	18.2	16.1	25.3	16.1	19.4	19.0	14.2	17.3	9.1	10.3	15.7	20.4	17.0	38.8	9.1	8.3	27.9	17.5	16.2	15.3	14.2	9.6	33.8	19.9	29.4	19.8	18.1	54.4	17.6	22.0	20.1	6.4	22.0	18.3	10.2	9.1	25.1	34.7	41.8	30.8	14.8	16.0	12.7	17.2	14.9	29.7	16.4	38.2	17.5	22.1	27.4	31.5	25.8	36.0	10.5	23.2	24.7	10.0	31.0	30.8	17.6	41.0	38.5	33.8	35.4	28.9	32.2	30.5	46.5	25.5	40.2	23.3	29.0	37.8	30.2	35.6	32.8	30.2	32.4	29.4	10.5	31.9	24.0	28.2	26.4	33.7	35.5	25.8	27.7	33.1	14.1	24.8	31.5	26.2	22.9	20.3	26.8	20.7	19.5	19.6	19.4	39.3	23.4	23.0	27.3	25.7	28.0	7.9	61.2	19.8	24.1	21.4	8.3	10.8	24.9	18.6	10.5	22.7	32.3	29.1	26.8	12.3	31.8	46.0	36.7	3.4	18.1	8.7	9.1	32.5	22.1	8.7	10.6	17.5	14.5	9.1	10.3	9.1	8.3	9.6	6.4	9.1	12.7	20.7	12.8	27.7	40.8	45.6	0.0	20.3	0.0	15.9	0.0	19.8	23.9	19.8	27.1	13.0	20.2	0.0	30.2	34.1	12.1	41.1	24.1	49.2	11.7	19.1	22.4	10.9	22.9	31.2	24.6	28.2	18.6	14.3	12.0	11.4	37.9	20.0	30.6	24.8	0.0	28.8	20.7	0.0	24.5	0.0	61.0	23.3	17.0	0.0	25.3	31.6	0.0	42.2	33.2	39.8	23.7	20.7	26.4	44.8	22.0	43.4	51.4	17.5	0.0	39.5	22.7	18.4	59.0	34.3	23.4	0.0	23.7	37.0	42.9	17.2	17.1
MXI1	"bHLHc11, MAD2, MXD2, MXI"	ENSG00000119950	"MAX interactor 1, dimerization protein"	P50539	10	110207605-110287365	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Cancer-related genes, Disease variant, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Erythroid cells: 264.7;Oligodendrocytes: 214.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"hTERT-RPE1: 108.2;SK-MEL-30: 167.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035319, HPA035320, HPA056762"	Approved		Supported	"Nucleoplasm,Nucleoli,Nucleoli rim,Cytosol"		Yes	No			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	"Nucleoli, Nucleoli rim, Cytosol"	"HPA035319: AB_10670588, HPA035320: , HPA056762: AB_2683229"	"unprognostic (1.77e-2)"	"unprognostic (2.02e-1)"	"unprognostic (3.34e-1)"	"unprognostic (3.03e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.37e-2)"	"unprognostic (1.59e-1)"	"unprognostic (9.26e-3)"	"prognostic unfavorable (9.17e-4)"	"prognostic unfavorable (1.02e-5)"	"unprognostic (3.05e-2)"	"unprognostic (1.36e-2)"	"unprognostic (2.29e-1)"	"unprognostic (2.96e-1)"	34.0	32.7	86.8	13.2	98.0	68.0	45.1	92.9	106.1	38.8	67.0	55.9	24.4	45.6	36.2	52.3	42.4	32.8	63.2	84.9	91.1	39.2	51.1	26.4	13.8	93.9	91.8	81.4	44.7	50.6	22.1	28.5	94.7	41.0	35.0	80.2	80.1	52.1	47.3	47.6	29.6	29.8	89.3	14.8	28.0	23.3	94.9	31.2	54.5	53.2	12.3	34.6	41.2	110.8	18.2	8.3	18.0	39.6	30.7	21.4	7.4	11.1	39.2	7.1	23.1	3.2	33.5	24.6	17.6	20.0	11.3	24.3	23.5	27.8	20.0	13.5	30.9	7.3	15.7	14.5	19.5	14.3	14.4	21.7	96.0	12.4	55.2	108.2	7.1	17.5	26.9	54.9	11.3	12.3	10.1	26.1	7.7	31.0	21.2	6.1	26.0	39.9	22.8	1.6	34.3	52.4	11.1	7.3	167.1	23.3	9.9	42.2	7.7	13.5	21.0	13.6	5.6	44.6	26.1	10.0	34.3	46.1	12.7	1.8	2.7	9.7	2.7	2.3	5.1	3.9	5.1	2.8	1.6	3.6	7.7	1.9	5.6	1.4	5.0	1.7	4.8	2.0	86.8	98.0	92.9	106.1	84.9	91.1	93.9	91.8	94.7	89.3	94.9	110.8	28.9	16.0	16.8	139.1	27.9	58.0	57.9	22.8	51.2	49.9	67.2	66.8	80.2	41.5	27.6	33.1	47.9	5.4	23.0	160.7	46.9	19.3	5.1	29.1	36.4	34.1	16.9	264.7	60.8	14.8	20.1	36.0	15.8	37.3	3.8	19.1	27.8	56.6	11.1	52.2	102.5	20.1	18.3	24.1	20.5	8.8	45.1	22.6	104.9	30.9	29.9	144.2	9.2	131.7	214.9	10.4	52.5	55.7	22.5	73.4	57.0	67.1	25.3	46.0	46.0	69.6	63.0	23.8	28.2	37.4	67.3	9.7	36.9	27.4	16.6	36.9
MYBL2	"B-MYB, BMYB"	ENSG00000101057	"MYB proto-oncogene like 2"	P10244	20	43667019-43716495	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 91.8;lymphoid tissue: 55.5"	"Cell type enhanced"	"Detected in many"		"B-cells: 33.0;dendritic cells: 32.6;Erythroid cells: 82.3;Extravillous trophoblasts: 32.3;Plasma cells: 139.6;Spermatogonia: 33.6"	"Cancer enriched"	"Detected in all"	5	"testis cancer: 295.8"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in some"	34	"plasmacytoid DC: 91.5"	"Lineage enriched"	"Detected in many"	34	"dendritic cells: 91.5"	"Cell line enhanced"	"Detected in many"		"MCF7: 763.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB017114, HPA030530, HPA055416"	Uncertain		Supported	Nucleoplasm,Cytosol		Yes	Yes			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Nucleoplasm	Cytosol	"CAB017114: , HPA030530: AB_2673515, HPA055416: AB_2682811"	"unprognostic (9.75e-3)"	"unprognostic (1.29e-2)"	"unprognostic (3.20e-1)"	"prognostic unfavorable (9.73e-4)"	"unprognostic (2.35e-1)"	"unprognostic (1.67e-1)"	"prognostic unfavorable (2.11e-7)"	"unprognostic (2.66e-3)"	"unprognostic (9.23e-3)"	"unprognostic (1.78e-1)"	"unprognostic (2.38e-3)"	"unprognostic (1.32e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (1.42e-1)"	"unprognostic (2.27e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.84e-1)"	1.6	0.6	0.1	24.2	0.1	91.8	1.6	0.1	0.2	1.1	0.2	8.6	7.0	1.4	0.1	10.1	0.4	1.0	0.4	0.1	0.1	0.6	1.1	1.8	55.5	0.1	0.1	0.3	11.2	0.1	0.2	5.7	0.1	0.5	6.9	0.0	1.6	0.2	0.1	4.2	7.8	2.1	0.1	27.8	6.1	15.6	0.4	33.3	0.5	0.0	53.5	3.5	2.5	0.1	195.8	121.8	105.4	109.6	1.0	3.5	136.2	87.0	29.0	265.6	194.6	600.2	118.8	393.6	49.2	37.8	55.8	116.1	192.1	59.6	98.8	74.2	124.1	183.2	118.7	164.2	0.2	168.6	121.7	2.4	5.1	101.6	22.9	5.9	72.2	189.6	188.1	470.3	23.8	763.7	346.0	236.3	121.8	155.4	105.4	237.3	216.3	222.1	49.6	39.7	96.7	140.6	255.6	253.3	26.1	110.4	167.2	183.1	34.0	16.3	264.3	118.3	151.5	162.1	363.8	606.5	34.2	142.3	103.9	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.3	0.0	1.4	0.0	0.0	0.1	0.2	0.0	91.5	1.3	0.8	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.4	0.1	0.2	0.0	0.0	0.0	33.0	4.2	0.8	0.8	0.0	0.0	2.5	3.4	2.0	1.5	0.1	0.0	0.0	14.4	32.6	3.4	0.0	0.4	5.9	0.9	1.3	1.8	0.0	82.3	0.4	0.9	32.3	4.8	10.2	2.9	0.0	18.9	0.7	1.4	13.5	0.0	0.3	5.1	0.0	2.4	2.6	14.1	0.0	3.2	1.8	0.0	0.0	0.0	1.0	0.0	0.5	0.7	1.1	0.0	139.6	0.3	0.5	0.0	0.0	0.0	0.0	0.1	3.9	7.0	33.6	8.2	2.4	3.7	3.0	1.2	8.6	2.4
N6AMT1	"C21orf127, HEMK2, KMT9, MTQ2, N6AMT, PRED28, PrmC"	ENSG00000156239	"N-6 adenine-specific DNA methyltransferase 1"	Q9Y5N5	21	28872191-28885371	"Metabolic proteins, Predicted intracellular proteins"		"Chromatin regulator, Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034133, CAB034135, HPA059242"	Approved		Approved	Nucleoplasm,Centrosome		Yes	No			"Cluster 22: NK-cells - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 24: Non-specific - Transcription regulation"	Centrosome	Nucleoplasm	"CAB034133: AB_2147189, CAB034135: AB_2250945, HPA059242: AB_2683957"	"unprognostic (2.20e-2)"	"unprognostic (4.93e-2)"	"unprognostic (5.06e-2)"	"unprognostic (2.82e-1)"	"unprognostic (7.46e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.09e-1)"	"unprognostic (3.67e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.94e-2)"	"unprognostic (2.67e-1)"	"unprognostic (1.03e-1)"	"unprognostic (5.24e-2)"	"unprognostic (6.99e-2)"	"unprognostic (5.43e-2)"	"unprognostic (5.51e-3)"	2.4	5.0	4.9	2.5	5.6	0.9	5.0	4.8	5.3	6.2	4.8	3.4	3.2	6.4	6.1	2.5	4.7	2.8	5.3	4.5	5.3	4.9	2.8	2.5	3.4	5.7	5.0	7.9	2.9	5.7	4.4	6.4	5.6	4.6	3.4	8.4	3.1	4.0	6.1	3.8	2.8	3.5	4.7	3.6	3.1	3.7	5.0	2.2	5.3	5.6	3.3	3.9	4.1	8.8	2.8	2.5	6.2	8.6	5.1	5.6	4.8	6.1	2.5	3.5	2.0	3.2	5.0	3.1	3.0	3.3	6.2	3.3	5.4	3.0	4.3	4.0	4.1	6.7	4.2	4.0	4.5	4.0	2.5	2.9	6.4	3.5	2.4	6.3	2.6	3.8	8.4	5.5	7.3	2.9	1.9	3.2	7.9	6.0	3.5	2.8	5.9	2.4	6.0	4.1	4.7	6.6	5.5	1.9	2.3	5.6	2.7	3.5	5.4	2.9	5.2	5.4	3.7	3.3	4.0	1.7	4.6	10.4	5.5	0.3	0.4	0.6	0.5	0.7	0.6	0.7	1.0	0.7	0.6	0.6	1.4	1.0	0.1	1.4	0.5	0.5	0.4	0.5	4.9	5.6	4.8	5.3	4.5	5.3	5.7	5.0	5.6	4.7	5.0	8.8	7.8	3.2	5.4	5.2	7.1	1.9	5.8	10.3	1.8	10.8	6.3	6.5	17.0	7.2	8.7	12.9	8.4	18.3	4.0	1.5	7.9	11.0	2.9	10.7	9.6	6.9	0.0	13.0	4.6	6.4	12.2	7.9	8.6	4.2	1.3	15.1	5.3	3.5	7.2	10.1	5.1	3.0	10.2	1.3	0.9	4.5	9.6	2.6	1.8	1.0	2.7	11.1	4.1	6.6	15.1	7.7	4.3	10.1	1.2	4.5	2.5	9.3	15.8	10.5	0.0	7.7	8.9	4.5	10.5	4.2	3.7	14.9	5.1	20.1	3.1	4.8
NCAPH	"BRRN1, CAP-H, hCAP-H"	ENSG00000121152	"Non-SMC condensin I complex subunit H"	Q15003	2	96335766-96377091	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA condensation, Mitosis"		"Disease variant, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 35.2;lymphoid tissue: 37.4;testis: 35.4"	"Cell type enhanced"	"Detected in many"		"Plasma cells: 26.3;Spermatocytes: 89.3;Spermatogonia: 29.4"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"T-reg: 6.2"	"Group enriched"	"Detected in many"	5	"granulocytes: 3.8;T-cells: 6.2"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"HPA002647, HPA003008"	Enhanced		Supported	Nucleoplasm,Cytosol		Yes	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Cytosol	Nucleoplasm	"HPA002647: AB_1078300, HPA003008: AB_1078301"	"unprognostic (5.52e-2)"	"unprognostic (7.37e-2)"	"unprognostic (2.93e-2)"	"unprognostic (2.85e-3)"	"unprognostic (1.92e-1)"	"unprognostic (7.51e-2)"	"prognostic unfavorable (9.53e-6)"	"prognostic unfavorable (6.73e-4)"	"unprognostic (1.50e-3)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (1.02e-4)"	"unprognostic (3.16e-2)"	"unprognostic (0.00e+0)"	"unprognostic (3.00e-2)"	"unprognostic (2.38e-1)"	"unprognostic (2.14e-1)"	"unprognostic (2.30e-2)"	1.2	0.7	0.3	9.9	0.4	35.2	1.8	0.9	0.9	1.3	0.1	7.7	5.6	0.9	0.2	6.3	0.5	1.6	0.4	0.3	0.2	0.4	1.0	1.1	20.3	0.1	0.0	0.3	0.3	0.5	0.2	5.2	0.3	0.4	9.3	1.8	1.5	0.2	0.3	4.7	6.2	2.8	0.0	3.7	3.6	35.4	0.1	37.4	0.4	0.1	22.0	2.6	2.0	0.3	134.1	52.0	115.1	60.6	3.9	6.1	80.8	58.7	40.3	115.1	118.4	93.5	71.5	121.0	41.8	26.6	106.2	57.2	100.2	39.6	117.2	110.0	63.4	123.7	49.3	74.5	0.7	112.2	101.3	1.8	4.2	89.1	35.9	10.2	46.6	89.7	89.5	88.8	53.0	59.5	183.8	104.2	85.9	57.6	56.6	133.4	106.7	95.5	23.6	49.6	71.2	52.3	34.8	46.5	19.9	42.4	36.6	80.0	24.1	83.5	126.3	76.9	101.9	44.4	70.1	134.0	33.7	111.5	95.3	3.8	0.0	0.2	0.8	0.9	0.1	0.9	1.2	1.0	0.4	0.9	0.0	0.4	0.3	0.1	0.0	0.0	6.2	0.5	0.3	0.4	0.9	0.9	0.3	0.2	0.1	0.0	0.3	0.0	0.1	0.3	4.9	0.0	0.0	0.0	3.5	0.6	0.7	1.9	1.2	0.4	1.0	0.8	0.5	0.0	1.6	0.0	8.4	9.4	2.0	2.1	0.0	0.5	5.9	1.7	0.9	1.8	0.0	16.4	0.4	0.0	16.3	1.8	4.1	1.2	1.3	5.5	1.4	0.4	8.5	0.0	0.3	2.8	0.0	3.8	3.7	4.9	0.9	2.2	1.8	0.0	0.2	8.5	0.0	0.5	1.0	0.2	0.1	0.4	26.3	0.7	0.4	0.0	1.6	2.3	0.0	0.2	3.5	89.3	29.4	8.8	0.9	1.9	5.1	0.6	5.7	1.1
NEK7		ENSG00000151414	"NIMA related kinase 7"	Q8TDX7	1	198156994-198322420	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Transporters"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 140.4"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 172.6;Oligodendrocyte precursor cells: 131.2;Oligodendrocytes: 153.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BJ: 554.5;fHDF/TERT166: 753.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015520, HPA018193"	Approved		Supported	Nucleoplasm		Yes	No			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Nucleoplasm		"HPA015520: AB_1854371, HPA018193: AB_1854372"	"unprognostic (2.08e-1)"	"unprognostic (2.98e-2)"	"unprognostic (1.65e-1)"	"unprognostic (5.38e-2)"	"unprognostic (4.26e-2)"	"unprognostic (3.00e-2)"	"unprognostic (2.14e-2)"	"unprognostic (5.47e-2)"	"unprognostic (4.77e-2)"	"unprognostic (3.21e-1)"	"unprognostic (1.46e-3)"	"unprognostic (2.82e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.56e-1)"	63.8	49.9	48.3	29.3	58.7	11.1	27.7	45.9	53.3	26.1	35.7	30.0	21.1	26.6	19.7	31.2	22.3	27.2	140.4	39.5	56.1	29.3	30.0	41.6	30.8	61.1	51.3	29.6	20.3	25.1	12.3	42.1	60.0	27.1	23.3	19.6	22.3	36.5	56.6	14.9	25.3	32.2	59.7	32.1	20.1	13.7	49.1	27.7	26.8	63.7	23.6	30.9	20.1	64.2	47.8	12.3	14.8	6.0	37.5	42.6	17.4	554.5	227.6	218.7	102.9	23.0	46.2	17.1	39.4	753.3	12.6	29.0	22.7	30.3	220.8	56.0	32.7	23.6	48.7	9.6	45.3	40.2	46.3	26.7	25.3	144.8	43.5	82.2	42.4	140.0	18.8	41.2	102.3	15.1	34.7	23.4	8.4	37.5	9.9	18.5	36.5	30.7	37.3	24.5	9.5	17.0	92.1	53.0	63.5	20.6	38.8	36.0	95.7	61.8	52.0	178.6	58.9	29.3	28.5	11.8	26.9	36.3	48.7	1.8	2.2	3.3	2.9	1.8	12.8	1.4	3.2	4.1	2.0	1.9	2.7	3.1	6.0	3.6	1.6	1.3	6.0	1.4	48.3	58.7	45.9	53.3	39.5	56.1	61.1	51.3	60.0	59.7	49.1	64.2	34.3	28.9	30.7	78.0	32.4	51.4	15.0	10.2	33.6	8.2	22.8	18.2	172.6	10.0	18.7	18.4	14.6	15.0	32.9	25.8	11.7	10.6	2.8	21.6	20.9	29.3	19.8	32.6	17.0	19.6	15.9	30.0	18.8	19.6	8.8	11.8	40.4	23.5	17.5	3.3	34.6	19.5	8.2	49.5	51.6	3.3	29.2	35.5	30.2	124.6	29.0	11.4	15.5	131.2	153.5	50.1	19.3	38.4	28.5	30.6	25.1	16.6	27.9	24.2	19.7	28.1	35.9	7.7	6.0	29.2	49.2	64.3	41.6	28.7	15.6	33.1
NEPRO	"C3orf17, DKFZP434F2021, NET17"	ENSG00000163608	"Nucleolus and neural progenitor protein"	Q6NW34	3	113002444-113019861	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		"Developmental protein"	"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Theca cells: 33.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA069654			Supported	Nucleoplasm,Nucleoli		Yes	No			"Cluster 15: NK-cells - Transcription"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 36: HEL - Hemostasis"	"Cluster 7: Non-specific - Mitochondria"	"Nucleoplasm, Nucleoli"		"HPA069654: AB_2686164"	"unprognostic (8.45e-3)"	"unprognostic (3.84e-2)"	"unprognostic (1.14e-1)"	"prognostic unfavorable (1.13e-4)"	"unprognostic (2.29e-2)"	"unprognostic (2.43e-2)"	"prognostic unfavorable (4.25e-4)"	"unprognostic (2.04e-1)"	"unprognostic (1.49e-2)"	"unprognostic (4.98e-2)"	"unprognostic (1.72e-2)"	"unprognostic (9.29e-3)"	"unprognostic (5.40e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.78e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.28e-2)"	6.7	6.7	4.7	7.0	5.4	10.6	8.8	6.9	6.5	6.5	6.3	7.0	7.1	8.4	10.3	6.0	6.5	7.4	8.4	5.2	4.9	6.3	5.9	6.4	12.3	5.8	5.3	8.1	8.2	6.9	6.6	6.7	5.6	6.6	5.4	11.7	6.9	6.1	18.7	10.8	7.0	5.8	5.1	8.8	8.3	11.3	5.3	9.4	11.5	7.7	7.8	6.7	5.3	7.9	13.6	10.9	17.3	13.0	5.5	10.1	9.2	12.6	8.1	6.9	4.7	10.1	8.5	17.6	6.6	4.3	9.6	13.7	12.7	5.8	9.4	3.5	8.0	27.3	10.0	7.5	10.0	17.4	9.4	15.7	10.0	5.5	14.2	18.8	6.1	17.2	9.5	13.5	5.2	8.6	15.1	10.3	18.1	12.0	14.0	12.1	13.7	9.3	7.8	11.2	11.9	17.3	7.3	9.1	21.4	12.7	10.4	14.7	12.4	9.4	9.3	3.6	9.1	13.3	11.2	20.6	15.2	13.6	7.0	1.9	1.3	1.6	2.2	1.6	2.3	1.8	2.6	1.9	1.8	1.4	3.2	3.2	0.8	4.3	0.7	1.3	1.2	1.4	4.7	5.4	6.9	6.5	5.2	4.9	5.8	5.3	5.6	5.1	5.3	7.9	16.3	9.6	12.8	0.0	7.6	0.0	0.0	0.0	0.0	0.0	17.4	16.9	0.0	0.0	10.5	18.4	0.0	18.4	23.4	0.0	17.6	14.1	0.0	11.9	20.7	6.3	0.0	0.0	0.0	12.6	15.5	9.3	0.0	16.1	17.7	24.0	0.0	0.0	15.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.1	0.0	0.0	9.3	0.0	0.0	0.0	0.0	14.4	0.0	0.0	4.5	0.0	0.0	14.8	8.7	0.0	0.0	0.0	10.2	0.0	0.0	0.0	0.0	20.4	9.1	33.9	0.0	0.0
NET1	"ARHGEF8, NET1A"	ENSG00000173848	"Neuroepithelial cell transforming 1"	Q7Z628	10	5412557-5459056	"Plasma proteins, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 242.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"naive CD4 T-cell: 8.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"BEWO: 252.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020068	Uncertain		Approved	Nucleoplasm,Vesicles		Yes	Yes			"Cluster 32: T-cells - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	Vesicles	"HPA020068: AB_2670348"	"unprognostic (1.77e-2)"	"unprognostic (1.87e-1)"	"unprognostic (3.40e-1)"	"unprognostic (4.05e-2)"	"unprognostic (3.37e-3)"	"unprognostic (2.15e-1)"	"prognostic unfavorable (3.87e-5)"	"unprognostic (6.31e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.77e-2)"	"prognostic unfavorable (8.27e-4)"	"unprognostic (2.26e-1)"	"unprognostic (5.41e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.90e-1)"	"unprognostic (3.01e-1)"	"unprognostic (2.46e-1)"	48.8	10.8	35.5	23.4	34.2	40.5	52.8	38.5	57.6	43.7	52.8	92.2	56.2	41.8	56.2	68.4	46.2	35.9	13.2	30.2	32.4	49.3	45.1	22.2	26.7	41.8	37.2	28.5	37.9	5.4	10.6	65.7	43.8	41.3	88.2	6.5	93.1	24.3	25.0	39.8	74.7	36.9	37.5	8.1	77.8	14.4	41.1	30.4	26.2	28.0	33.0	60.8	59.3	40.1	115.9	67.7	45.2	51.0	26.8	11.9	252.9	69.1	37.6	53.4	50.4	36.4	215.2	40.6	27.7	42.4	11.4	185.5	54.9	104.3	63.9	38.1	38.5	77.5	22.9	84.0	7.2	21.5	31.1	18.2	61.0	54.0	12.3	47.6	31.1	42.6	138.5	64.4	30.0	54.3	74.3	30.6	61.5	158.6	51.0	45.0	85.0	32.4	33.4	57.6	38.5	20.6	60.7	110.9	20.3	76.2	36.7	65.3	29.5	20.3	30.9	30.7	56.0	39.3	23.1	53.4	18.1	33.1	43.4	2.0	0.6	1.4	0.6	1.0	0.0	1.4	1.2	0.4	4.9	0.6	8.7	1.7	0.1	0.8	0.4	2.0	4.0	2.2	35.5	34.2	38.5	57.6	30.2	32.4	41.8	37.2	43.8	37.5	41.1	40.1	18.4	32.1	55.8	2.6	12.7	40.3	127.2	49.0	103.0	11.0	52.6	28.3	12.1	41.5	84.3	12.9	4.2	110.2	8.4	242.2	5.9	13.1	2.4	97.7	30.6	42.7	80.8	54.1	5.1	24.4	109.1	33.2	107.0	131.4	15.2	16.9	12.5	55.7	14.5	3.3	7.7	145.3	34.6	10.5	59.8	2.4	21.8	31.2	35.6	44.0	48.7	3.8	0.0	8.5	5.7	62.1	148.3	87.6	39.2	67.8	123.6	29.2	85.7	3.5	111.7	183.0	185.0	26.3	16.0	158.1	32.4	117.5	9.3	2.9	145.0	186.5
NFAT5	"KIAA0827, NF-AT5, NFATL1, NFATZ, OREBP, TONEBP"	ENSG00000102908	"Nuclear factor of activated T cells 5"	O94916	16	69565094-69704666	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 281.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"SiHa: 22.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA057304, HPA069711"	Approved		Supported	Nucleoplasm,Cytosol		Yes	No			"Cluster 10: Basophils - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	Cytosol	"HPA057304: AB_2683407, HPA069711: AB_2686180"	"unprognostic (2.71e-1)"	"unprognostic (1.50e-2)"	"unprognostic (1.77e-1)"	"unprognostic (3.57e-2)"	"unprognostic (5.65e-3)"	"unprognostic (2.08e-1)"	"unprognostic (2.97e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.83e-1)"	"unprognostic (3.56e-2)"	"unprognostic (4.05e-3)"	"unprognostic (1.87e-1)"	"prognostic favorable (1.08e-4)"	"unprognostic (1.62e-1)"	"unprognostic (1.37e-1)"	"unprognostic (6.32e-2)"	"unprognostic (9.42e-2)"	2.3	3.1	0.6	2.8	1.2	5.6	2.1	0.5	3.7	3.7	0.0	2.0	0.7	3.3	0.7	2.9	1.9	1.5	2.0	1.4	2.2	2.6	2.3	3.1	1.1	0.0	0.6	2.5	1.6	4.0	2.0	4.2	0.0	2.3	1.5	4.2	3.7	2.4	2.7	3.5	1.9	1.8	0.0	2.5	2.3	1.4	3.0	2.2	3.6	4.8	1.4	2.7	3.1	0.0	8.4	10.1	4.8	5.0	5.8	6.0	6.4	7.2	8.6	6.6	4.2	4.5	4.2	4.5	5.8	5.8	3.4	7.3	3.9	3.1	4.2	2.9	3.2	2.6	2.8	6.2	3.4	3.5	5.5	3.5	1.1	6.4	5.9	5.4	5.5	2.3	7.2	1.1	3.3	3.2	2.8	1.7	2.5	1.1	2.5	4.5	2.2	1.7	2.5	8.0	3.1	0.9	22.2	1.3	2.6	4.1	3.3	1.3	13.1	5.7	5.6	4.8	2.2	4.6	4.9	7.3	5.1	3.4	3.6	0.4	0.1	0.2	0.2	0.1	0.2	0.2	0.1	0.3	0.1	0.2	0.1	0.0	0.9	0.0	0.2	0.5	0.1	0.0	0.6	1.2	0.5	3.7	1.4	2.2	0.0	0.6	0.0	0.0	3.0	0.0	65.0	48.1	49.7	236.7	55.7	148.1	94.8	42.5	155.4	51.8	61.6	42.9	9.2	30.0	43.3	145.3	85.5	60.6	69.4	27.8	5.9	17.8	7.2	93.7	87.8	93.6	24.5	27.3	281.8	12.7	15.9	60.9	38.2	158.3	19.7	31.0	52.8	28.3	17.6	60.6	189.3	29.1	28.5	21.7	169.5	6.9	59.4	58.2	58.7	172.4	37.4	45.7	36.0	177.4	167.2	23.7	29.3	54.9	50.2	83.1	24.7	14.6	31.8	62.4	26.3	72.0	51.4	84.5	48.8	77.9	140.1	50.9	57.4	43.1	20.8	105.7
NFRKB	"DKFZp547B2013, INO80G"	ENSG00000170322	"Nuclear factor related to kappaB binding protein"	Q6P4R8	11	129863636-129895590	"Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair, Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007082, HPA007128"	Approved		Enhanced	Nucleoplasm		Yes	No			"Cluster 46: Basophils - DNA binding"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 36: HEL - Hemostasis"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA007082: AB_1079481, HPA007128: AB_1079482"	"unprognostic (1.22e-1)"	"unprognostic (3.42e-2)"	"unprognostic (2.12e-1)"	"unprognostic (9.41e-2)"	"unprognostic (6.56e-2)"	"unprognostic (2.65e-2)"	"prognostic unfavorable (5.78e-4)"	"unprognostic (6.36e-3)"	"unprognostic (1.68e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.00e-1)"	"unprognostic (5.31e-2)"	"unprognostic (9.22e-2)"	"unprognostic (4.15e-2)"	"unprognostic (6.57e-2)"	"unprognostic (7.14e-2)"	"unprognostic (3.93e-2)"	9.8	9.0	7.2	10.8	9.9	22.7	11.0	9.7	7.3	15.0	9.1	11.8	13.1	15.6	17.5	13.2	17.9	9.9	7.5	8.3	6.5	10.6	11.8	10.8	14.5	4.9	5.5	20.6	13.9	10.5	11.7	13.1	5.5	12.4	10.1	9.8	14.3	13.3	15.4	21.9	12.4	13.5	4.5	11.2	11.2	20.3	7.2	15.0	20.0	9.7	13.4	12.6	13.8	6.7	17.9	16.8	37.4	20.3	15.6	15.4	23.5	12.2	11.0	14.2	13.9	52.6	30.1	42.6	32.5	9.4	20.8	44.8	36.5	23.8	13.2	16.9	31.9	84.2	32.8	22.2	11.4	21.7	27.3	9.9	25.9	23.3	24.3	16.3	24.9	28.1	49.9	31.5	14.4	16.2	18.6	37.1	19.1	26.2	39.1	27.2	16.3	19.6	17.7	55.6	19.0	20.0	27.4	26.7	7.3	27.5	62.3	19.9	19.7	21.1	20.6	15.6	15.4	10.0	13.3	39.0	8.8	41.9	18.5	6.6	5.1	6.3	6.0	5.8	6.3	3.3	6.1	5.1	5.1	3.9	5.0	4.2	6.0	2.4	5.2	4.5	4.4	4.5	7.2	9.9	9.7	7.3	8.3	6.5	4.9	5.5	5.5	4.5	7.2	6.7	6.2	9.6	15.0	17.0	10.0	29.3	16.8	17.5	18.8	10.2	12.1	10.0	7.6	20.0	17.0	7.3	10.4	19.2	7.8	9.5	7.9	11.9	14.8	12.9	14.4	9.5	8.5	9.4	13.1	10.0	15.6	9.7	6.1	17.8	10.8	14.1	8.9	10.9	10.4	8.4	10.7	9.7	8.2	7.7	6.2	7.1	14.6	8.4	14.2	9.4	12.4	9.7	12.3	12.1	7.7	10.9	8.0	10.5	10.5	15.4	15.6	8.1	12.9	11.1	32.9	10.8	14.2	43.0	49.0	10.7	35.2	23.3	13.1	9.4	12.2	17.9
NHLH2	"bHLHa34, HEN2, NSCL2"	ENSG00000177551	"Nescient helix-loop-helix 2"	Q02577	1	115836377-115843917	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 7.4;esophagus: 2.3;retina: 2.1;skin 1: 3.3"	"Cell type enhanced"	"Detected in some"		"Basal squamous epithelial cells: 14.8;Oligodendrocyte precursor cells: 4.5;Oligodendrocytes: 7.9;Spermatocytes: 5.1;Squamous epithelial cells: 7.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"SCLC-21H: 58.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA055238	Uncertain		Approved	"Nucleoplasm,Nuclear bodies"		Yes	NA				"Cluster 27: Brain & Skin - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 37: Myocytes - Muscle contraction"	"Nuclear bodies"	Nucleoplasm	"HPA055238: AB_2682752"	"unprognostic (2.20e-2)"	"unprognostic (2.28e-1)"		"unprognostic (1.97e-1)"	"unprognostic (1.82e-1)"	"unprognostic (2.17e-1)"		"unprognostic (1.58e-1)"	"unprognostic (4.82e-2)"		"unprognostic (1.11e-2)"	"unprognostic (5.26e-2)"	"unprognostic (9.55e-2)"	"unprognostic (2.80e-3)"	"unprognostic (1.53e-1)"	"unprognostic (3.09e-1)"	"unprognostic (2.25e-1)"	0.0	0.0	2.0	0.0	1.4	0.0	0.1	5.9	2.1	0.3	0.2	0.0	0.0	0.0	0.3	2.3	0.0	0.0	0.0	3.2	4.0	0.0	0.0	0.2	0.0	3.8	5.1	0.0	0.0	0.0	0.2	0.0	7.4	0.2	0.0	2.1	0.4	0.1	0.2	3.3	0.0	0.0	2.5	0.0	0.2	0.4	6.7	0.0	0.0	0.0	0.0	0.0	0.7	3.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	58.4	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	1.4	5.9	2.1	3.2	4.0	3.8	5.1	7.4	2.5	6.7	3.0	0.0	0.0	0.0	0.3	0.0	2.8	2.8	3.3	14.8	3.9	0.0	0.6	3.4	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.2	1.8	0.0	2.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.3	0.0	4.5	7.9	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.4	0.0	3.5	0.3	5.1	3.4	7.0	2.3	0.0	0.0	0.0	0.0	0.4
NLN	"AGTBP, KIAA1226"	ENSG00000123213	Neurolysin	Q9BYT8	5	65722205-65871725	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 52.8;Excitatory neurons: 58.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"classical monocyte: 2.6;intermediate monocyte: 3.4;myeloid DC: 2.2;non-classical monocyte: 2.3"	"Group enriched"	"Detected in many"	5	"dendritic cells: 2.2;monocytes: 3.4"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031862	Approved		Approved	Mitochondria		Yes	No		64000	"Cluster 7: Monocytes - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Mitochondria		"HPA031862: AB_10600827"	"unprognostic (5.91e-3)"	"unprognostic (4.52e-2)"	"unprognostic (1.34e-3)"	"unprognostic (4.37e-2)"	"unprognostic (3.85e-1)"	"unprognostic (1.45e-2)"	"unprognostic (7.29e-3)"	"unprognostic (3.24e-2)"	"unprognostic (3.19e-1)"	"unprognostic (3.58e-1)"	"prognostic unfavorable (7.51e-4)"	"unprognostic (1.27e-1)"	"prognostic favorable (5.58e-7)"	"unprognostic (1.52e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.29e-1)"	"unprognostic (6.18e-3)"	2.2	1.0	3.8	2.4	3.9	1.5	3.7	2.9	5.3	1.8	1.6	3.6	1.1	2.7	2.4	2.5	1.5	1.2	2.6	3.8	3.6	3.9	9.9	1.7	1.7	3.9	3.4	1.8	2.5	1.5	0.9	2.4	4.0	2.6	3.2	2.5	1.9	1.1	8.9	2.8	2.7	2.7	3.3	1.3	4.0	1.1	3.9	0.9	2.7	6.5	2.0	2.7	1.5	4.8	13.3	12.5	7.2	12.0	9.0	15.3	14.5	13.1	5.5	7.6	8.2	7.2	7.7	18.8	16.1	15.8	15.1	10.3	9.5	20.2	13.1	5.6	6.4	5.2	8.7	18.5	7.7	12.0	3.0	11.7	10.8	10.5	12.4	6.3	21.7	8.3	11.4	3.9	16.5	10.2	8.3	10.8	22.2	6.7	3.6	9.6	15.3	29.9	12.6	5.9	22.3	11.5	10.6	10.7	11.0	19.4	12.9	14.1	12.5	5.0	5.9	7.4	10.0	3.3	7.1	8.2	7.7	23.2	7.7	0.1	2.6	0.1	0.1	3.4	0.1	0.4	0.2	0.1	2.2	0.4	0.3	0.2	0.3	0.5	2.3	0.1	0.0	1.0	3.8	3.9	2.9	5.3	3.8	3.6	3.9	3.4	4.0	3.3	3.9	4.8	5.9	6.4	2.8	19.6	4.0	5.7	9.0	6.2	8.6	2.4	10.1	8.9	14.5	7.2	8.5	12.9	4.2	5.3	0.6	52.8	5.9	17.8	0.3	7.4	12.9	8.3	1.8	9.0	58.9	14.5	14.0	7.1	20.4	20.9	15.2	16.2	4.6	32.4	28.8	5.0	32.2	5.8	6.1	22.9	8.9	0.4	4.4	13.5	1.8	5.6	17.9	13.1	2.1	22.6	44.5	30.2	35.9	2.2	4.9	16.5	32.3	22.4	3.1	4.7	0.0	19.7	8.1	2.1	5.2	15.3	5.3	2.9	2.3	15.8	8.2	6.1
NME4	"NDPKD, nm23-H4, NM23H4"	ENSG00000103202	"NME/NM23 nucleoside diphosphate kinase 4"	O00746	16	396725-410367	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Lipid transport, Nucleotide metabolism, Transport"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 250.5;Erythroid cells: 311.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB045997, HPA072588"	Approved		Supported	Mitochondria		Yes	No			"Cluster 26: Non-specific - Mitochondria"	"Cluster 15: Liver - Metabolism"	"Cluster 14: REH - Unknown function"	"Cluster 33: Fibroblasts - ECM organization"	Mitochondria		"CAB045997: AB_11126630, HPA072588: AB_2686538"	"unprognostic (3.27e-1)"	"prognostic unfavorable (6.53e-4)"	"unprognostic (3.70e-2)"	"unprognostic (7.16e-3)"	"unprognostic (1.32e-1)"	"unprognostic (2.00e-1)"	"unprognostic (4.40e-2)"	"unprognostic (4.46e-3)"	"unprognostic (1.98e-1)"	"unprognostic (3.12e-1)"	"unprognostic (3.74e-2)"	"unprognostic (7.79e-3)"	"prognostic unfavorable (1.61e-7)"	"unprognostic (3.78e-2)"	"unprognostic (2.16e-1)"	"unprognostic (6.04e-2)"	"unprognostic (3.08e-1)"	89.3	136.1	78.3	26.2	75.6	127.7	72.9	73.5	101.5	88.1	77.3	192.9	21.9	79.5	55.7	50.1	89.1	41.2	101.2	76.4	81.7	60.4	175.2	48.3	21.1	88.6	77.9	86.8	43.7	56.7	64.3	30.8	79.8	143.7	23.5	11.1	70.4	81.9	34.7	31.4	59.7	51.9	78.6	43.8	97.7	44.7	80.3	29.3	51.6	27.2	15.8	145.6	64.3	73.6	1.0	305.4	265.6	366.7	104.0	181.0	59.5	143.6	170.4	211.8	180.6	205.4	176.2	3.0	105.8	230.2	76.9	3.9	145.0	153.9	62.0	126.5	218.7	151.9	40.2	279.9	195.7	111.0	53.1	234.7	79.8	130.5	12.8	152.2	137.6	210.7	159.6	25.8	160.4	255.4	98.5	139.2	271.8	76.1	67.8	485.8	59.3	79.0	150.6	1.2	77.7	419.2	36.8	2.7	139.9	97.2	178.3	257.5	174.0	149.7	216.8	101.8	36.8	2.7	2.0	83.1	65.8	19.8	177.2	12.9	13.3	39.8	14.9	11.9	12.7	27.6	14.4	16.3	17.6	29.9	26.0	13.4	4.2	2.5	10.6	58.3	0.9	10.7	78.3	75.6	73.5	101.5	76.4	81.7	88.6	77.9	79.8	78.6	80.3	73.6	52.2	0.0	13.9	18.6	40.6	32.2	56.3	49.0	40.9	15.2	116.6	135.8	44.5	52.9	25.1	58.8	2.1	71.7	45.7	19.3	250.5	116.5	5.0	30.8	113.3	55.3	45.1	311.8	16.8	40.3	26.1	87.3	29.6	59.8	29.9	199.9	55.6	132.2	131.2	8.4	21.1	38.6	26.4	46.5	68.6	21.6	89.2	35.4	62.2	10.3	46.5	45.9	19.6	10.1	3.6	58.3	23.8	94.8	34.5	121.8	9.0	75.5	7.9	5.6	52.6	40.1	105.8	1.7	32.7	38.6	24.6	21.8	26.2	89.4	54.9	60.9
NME5	"nm23-H5, RSPH23"	ENSG00000112981	"NME/NM23 family member 5"	P56597	5	138115175-138139443	"Metabolic proteins, Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 37.2;testis: 53.3"	"Group enriched"	"Detected in many"	4	"Early spermatids: 704.9;Endometrial ciliated cells: 205.8;Late spermatids: 256.5;Respiratory ciliated cells: 431.9;Spermatocytes: 326.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"RPTEC TERT1: 29.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035648, HPA044555, HPA058103"	Enhanced		Approved	"Nucleoplasm,Nuclear bodies"		Yes	NA				"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 49: Ciliated cells - Cilium organization"	"Nucleoplasm, Nuclear bodies"		"HPA035648: AB_2674719, HPA044555: AB_10960286, HPA058103: "	"unprognostic (2.49e-2)"	"unprognostic (7.63e-4)"	"unprognostic (9.97e-2)"	"prognostic favorable (7.24e-5)"	"unprognostic (3.27e-2)"	"unprognostic (2.27e-1)"	"unprognostic (3.04e-3)"	"unprognostic (3.06e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.39e-2)"	"unprognostic (1.83e-2)"	"unprognostic (2.14e-1)"	"prognostic favorable (1.76e-4)"	"unprognostic (9.14e-4)"	"unprognostic (1.11e-3)"	"unprognostic (3.45e-1)"	"unprognostic (3.16e-2)"	1.4	6.5	9.7	0.5	10.5	0.0	4.5	9.2	11.7	8.6	18.6	2.1	0.2	4.9	23.1	1.0	37.2	8.7	3.6	10.5	9.2	20.5	0.5	4.5	0.4	10.5	12.3	5.3	4.4	24.3	8.9	0.1	12.1	5.0	1.1	12.9	3.7	4.5	0.4	0.3	0.6	3.1	9.6	0.2	2.8	53.3	11.0	0.7	12.4	0.6	0.2	2.1	0.6	8.9	0.0	0.0	3.9	4.3	0.0	0.0	0.0	0.7	0.4	0.7	0.3	0.1	1.8	0.0	1.1	0.1	0.7	0.0	0.0	0.0	0.2	0.0	0.9	0.0	0.0	0.0	1.7	0.0	0.0	2.1	0.0	0.9	0.0	3.8	0.4	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.6	0.0	1.4	0.0	0.0	0.0	29.9	0.0	6.7	2.5	0.0	0.8	4.9	1.7	0.5	1.6	0.0	0.7	0.0	0.0	0.9	0.4	0.8	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.7	10.5	9.2	11.7	10.5	9.2	10.5	12.3	12.1	9.6	11.0	8.9	1.0	6.4	7.5	26.8	0.3	0.6	8.5	41.1	0.0	11.7	9.0	7.9	4.3	8.6	38.1	33.1	14.6	0.5	0.1	0.3	86.1	23.8	704.9	205.8	9.2	3.5	5.4	0.0	57.9	4.0	0.0	4.2	2.6	12.7	0.0	7.7	3.6	0.6	0.1	6.7	42.2	3.3	44.7	0.0	0.3	256.5	9.0	1.4	10.6	3.7	0.6	19.1	0.0	11.1	8.1	4.2	0.3	13.9	0.0	4.8	0.2	92.3	431.9	25.8	0.0	0.5	12.6	326.8	24.7	0.0	0.3	0.0	0.8	10.9	1.7	5.9
NOC2L	"DKFZP564C186, NET15, NET7, NIR, PPP1R112"	ENSG00000188976	"NOC2 like nucleolar associated transcriptional repressor"	Q9Y3T9	1	944203-959309	"Predicted intracellular proteins"	"Apoptosis, Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044258, HPA062195"	Approved		Enhanced	"Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	No		310000	"Cluster 27: Non-specific - Gene expression"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoli, Nucleoli rim, Mitotic chromosome"		"HPA044258: AB_10961284, HPA062195: AB_2684707"	"unprognostic (3.18e-2)"	"unprognostic (5.84e-2)"	"unprognostic (1.59e-1)"	"unprognostic (9.54e-3)"	"unprognostic (6.75e-2)"	"unprognostic (2.31e-3)"	"unprognostic (1.94e-3)"	"unprognostic (1.36e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.78e-1)"	"unprognostic (1.20e-3)"	"unprognostic (8.62e-2)"	"unprognostic (6.25e-2)"	"unprognostic (3.44e-2)"	"unprognostic (1.52e-1)"	26.7	23.6	17.1	23.0	17.1	30.1	26.4	16.8	21.2	29.5	14.3	28.0	17.9	30.3	10.3	47.3	27.7	14.1	32.8	18.1	18.5	27.1	33.7	23.6	23.1	18.5	17.0	26.0	35.6	21.2	24.4	15.8	19.5	26.8	11.6	9.6	26.5	16.0	73.0	45.0	25.2	15.0	15.1	28.0	28.4	36.0	17.6	20.1	24.3	26.4	15.9	32.7	31.7	18.5	112.8	110.4	19.8	129.5	34.5	31.0	70.2	82.3	38.9	114.4	62.1	148.5	110.5	126.3	113.3	56.0	94.0	102.2	147.6	122.8	49.2	79.2	161.5	67.0	141.2	132.0	77.4	151.1	63.8	50.3	35.0	125.3	84.3	35.3	56.4	44.6	190.8	58.2	51.6	182.1	98.7	92.6	112.0	82.3	128.8	120.0	81.5	155.9	53.6	47.4	136.0	133.0	109.3	166.3	105.1	30.3	74.8	81.1	64.1	68.3	95.9	75.2	143.0	97.6	112.5	225.7	84.3	209.1	57.7	21.3	30.9	22.2	23.9	46.4	31.3	23.9	23.3	23.4	36.8	19.3	23.3	18.6	2.8	34.5	57.5	23.6	19.9	31.7	17.1	17.1	16.8	21.2	18.1	18.5	18.5	17.0	19.5	15.1	17.6	18.5	21.5	16.0	23.1	12.4	42.7	69.3	90.8	42.9	47.8	54.6	33.4	34.7	4.5	28.6	29.8	36.8	62.6	63.7	24.7	27.4	17.6	49.9	10.2	34.8	40.9	27.8	30.0	23.8	12.6	46.2	65.5	29.9	28.1	36.9	13.9	36.4	24.7	24.0	39.6	45.4	12.4	27.6	36.7	24.6	29.2	10.3	29.5	24.4	24.9	12.2	35.7	20.6	60.8	9.5	10.6	39.2	21.4	21.4	42.6	71.9	22.9	19.6	27.1	77.0	32.9	41.2	34.6	43.0	83.9	47.4	82.0	58.8	36.6	51.8	53.1	69.3
NUAK1	"ARK5, KIAA0537"	ENSG00000074590	"NUAK family kinase 1"	O60285	12	106063345-106138954	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion, DNA damage"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Endothelial cells: 111.7;Excitatory neurons: 150.5;Hepatic stellate cells: 136.3;Microglial cells: 93.7;Oligodendrocytes: 73.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 58.0;EFO-21: 55.1;RH-30: 77.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057143			Approved	"Nucleoplasm,Nucleoli fibrillar center,Microtubules"		Yes	No				"Cluster 47: Non-specific - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoli fibrillar center"	"Nucleoplasm, Microtubules"	"HPA057143: AB_2683349"	"unprognostic (4.20e-2)"	"unprognostic (8.42e-2)"	"unprognostic (3.71e-2)"	"prognostic unfavorable (9.83e-4)"	"unprognostic (4.13e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.43e-1)"	"unprognostic (4.80e-2)"	"unprognostic (9.91e-2)"	"unprognostic (4.06e-3)"	"unprognostic (3.29e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.93e-3)"	"prognostic unfavorable (4.27e-4)"	"unprognostic (2.31e-1)"	"unprognostic (8.70e-2)"	"unprognostic (4.47e-2)"	17.5	3.6	12.6	2.3	17.5	0.6	12.1	9.4	25.4	9.8	0.0	4.1	2.2	9.5	3.1	3.5	9.0	4.9	18.8	17.4	5.6	4.2	4.0	9.3	3.2	6.1	5.9	6.1	3.2	17.5	2.7	4.5	8.3	6.0	3.9	5.4	3.4	6.0	20.6	20.8	4.3	10.2	5.5	0.8	3.8	2.6	5.5	3.3	4.3	17.2	2.3	4.8	8.1	31.8	13.0	8.3	58.0	0.6	23.7	2.5	27.0	14.2	9.5	9.9	8.0	4.3	2.1	0.0	55.1	27.4	5.0	11.9	12.6	11.2	4.8	0.2	3.4	0.0	9.7	4.7	5.0	0.1	0.1	11.0	8.1	6.0	1.7	19.2	21.2	0.1	0.0	40.3	7.8	1.3	0.2	0.6	11.1	0.2	3.3	0.1	77.7	10.5	6.6	13.3	6.8	0.4	6.9	1.9	0.5	37.2	2.9	0.4	16.6	9.4	29.7	3.3	17.0	0.0	0.0	0.7	2.8	0.0	9.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	12.6	17.5	9.4	25.4	17.4	5.6	6.1	5.9	8.3	5.5	5.5	31.8	56.4	0.0	2.4	15.7	0.6	13.5	32.9	29.8	10.2	32.3	2.1	4.2	48.9	10.0	7.2	7.3	0.0	0.8	13.5	0.9	3.9	6.2	0.4	5.1	6.6	111.7	0.0	5.3	150.5	9.6	5.2	17.9	2.0	3.8	0.0	2.9	136.3	12.1	8.0	40.4	55.4	2.3	12.2	8.4	8.8	2.6	4.1	1.3	10.6	93.7	0.6	1.9	1.0	15.6	73.5	18.4	0.5	3.0	3.2	10.6	0.2	1.8	2.2	2.9	0.0	7.1	26.4	1.0	5.5	2.5	15.9	0.3	2.7	0.4	0.8	5.2
NUDT15	"FLJ10956, MTH2"	ENSG00000136159	"Nudix hydrolase 15"	Q9NV35	13	48037726-48047221	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 79.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038968, HPA038969"	Approved		Supported	Nucleoplasm		Yes	No			"Cluster 22: NK-cells - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Nucleoplasm		"HPA038968: AB_10697402, HPA038969: AB_2676295"	"unprognostic (9.48e-2)"	"unprognostic (5.91e-3)"	"unprognostic (2.64e-2)"	"unprognostic (9.00e-3)"	"unprognostic (4.99e-2)"	"unprognostic (2.50e-3)"	"unprognostic (2.29e-2)"	"unprognostic (7.47e-3)"	"prognostic unfavorable (1.25e-5)"	"unprognostic (1.04e-1)"	"unprognostic (8.50e-2)"	"unprognostic (3.69e-1)"	"unprognostic (4.63e-2)"	"unprognostic (1.84e-3)"	"unprognostic (3.35e-1)"	"unprognostic (9.58e-2)"	"unprognostic (8.93e-3)"	12.2	13.0	7.1	10.1	7.2	18.0	16.4	8.6	8.3	12.9	6.9	20.2	20.8	9.7	13.8	16.3	11.6	9.0	11.0	6.9	8.5	17.2	14.1	9.2	7.5	7.2	7.7	8.6	9.4	8.2	9.4	12.6	7.8	15.1	22.1	10.3	12.1	10.0	11.9	8.7	16.3	10.5	6.8	5.5	13.0	10.7	7.6	10.7	13.4	18.7	10.3	12.9	10.3	7.8	47.5	28.4	52.4	23.1	21.2	30.3	37.8	37.7	35.8	41.3	39.7	42.1	45.2	34.6	20.7	30.3	36.7	54.3	51.3	56.1	63.4	18.3	41.8	34.1	28.0	46.2	19.8	52.0	31.2	20.9	35.3	33.3	46.7	18.4	45.3	34.5	30.7	13.5	67.2	23.2	40.5	48.4	83.0	72.8	32.2	27.6	33.8	22.7	46.2	35.8	31.4	33.1	25.6	43.8	30.3	44.7	22.5	38.7	23.0	28.5	34.7	36.2	53.3	6.9	12.5	43.6	14.8	40.1	47.4	1.6	4.8	3.5	2.9	6.9	2.9	3.1	4.6	3.6	4.9	2.6	5.3	5.8	1.0	2.8	4.8	3.7	3.4	2.7	7.1	7.2	8.6	8.3	6.9	8.5	7.2	7.7	7.8	6.8	7.6	7.8	12.0	12.8	15.7	0.7	14.7	16.6	34.6	18.1	19.9	9.2	14.0	11.6	12.5	12.8	20.7	7.3	2.1	36.2	12.6	30.4	49.0	17.3	16.7	45.7	20.4	15.1	8.4	10.5	3.9	17.6	79.4	12.8	18.3	39.5	9.5	8.7	7.5	17.4	16.8	38.7	3.1	23.5	26.4	7.8	10.5	9.3	16.8	11.4	10.6	1.9	10.3	10.8	6.2	0.5	3.0	16.4	18.3	12.4	16.8	41.9	18.9	40.8	13.6	9.0	0.0	9.5	17.1	8.9	34.4	34.9	20.5	38.0	13.2	15.3	31.9	42.0
NUFIP1	"NUFIP, Rsa1"	ENSG00000083635	"Nuclear FMR1 interacting protein 1"	Q9UHK0	13	44939249-44989471	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 63.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029958, HPA029959"	Approved		Enhanced	Nucleoplasm,Nucleoli		Yes	No			"Cluster 15: NK-cells - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm	Nucleoli	"HPA029958: AB_10598911, HPA029959: AB_10602308"	"unprognostic (2.01e-1)"	"unprognostic (5.32e-3)"	"unprognostic (1.58e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.70e-2)"	"unprognostic (2.98e-3)"	"unprognostic (2.32e-1)"	"unprognostic (1.45e-2)"	"unprognostic (2.91e-2)"	"unprognostic (9.74e-3)"	"unprognostic (4.52e-1)"	"unprognostic (3.95e-2)"	"unprognostic (3.73e-2)"	"unprognostic (4.04e-2)"	"unprognostic (4.89e-2)"	"unprognostic (3.31e-1)"	"unprognostic (5.24e-2)"	3.2	3.7	3.2	2.8	3.4	7.9	4.6	2.9	4.6	3.6	2.1	2.6	2.8	4.5	5.5	3.3	3.5	2.4	2.5	3.3	3.0	4.0	4.1	2.3	3.7	2.6	3.2	4.3	3.8	4.0	1.8	3.0	2.9	3.4	3.0	2.6	3.3	3.2	4.8	3.4	2.4	4.0	2.9	3.0	2.8	5.5	3.1	3.6	3.9	3.9	3.8	4.2	2.6	3.9	7.4	5.7	9.5	7.9	6.4	6.6	11.3	8.6	7.4	15.6	9.9	15.6	11.5	21.5	7.0	8.0	9.4	11.3	17.9	12.2	20.2	6.6	14.0	16.4	3.7	14.0	10.5	21.3	6.4	6.9	11.0	10.5	15.8	6.0	7.9	10.9	13.3	3.5	11.1	8.5	17.8	13.4	22.5	19.5	9.3	17.3	9.0	13.1	9.5	6.3	5.2	11.5	7.3	9.9	9.6	8.9	7.5	11.8	6.0	7.9	6.8	10.3	11.9	4.8	7.9	26.7	8.9	14.8	11.4	0.0	2.6	0.8	2.5	2.6	4.7	4.0	2.9	2.8	3.4	4.1	4.5	3.4	0.2	5.9	1.8	4.5	1.7	1.8	3.2	3.4	2.9	4.6	3.3	3.0	2.6	3.2	2.9	2.9	3.1	3.9	11.3	6.4	12.2	6.2	10.5	15.4	11.8	16.7	23.9	7.8	9.8	16.3	4.5	4.3	15.4	5.5	12.5	15.7	11.7	4.2	17.6	14.0	37.2	14.0	21.7	10.9	5.4	14.5	19.2	16.7	15.9	11.9	7.7	18.6	17.7	14.1	7.1	9.7	10.8	8.4	16.9	5.3	12.2	3.4	5.5	63.2	10.8	7.9	8.8	7.5	6.9	9.7	7.2	16.6	14.4	10.8	1.6	11.3	5.0	8.6	3.2	14.8	6.6	6.8	6.6	20.3	15.6	27.1	31.6	14.3	16.6	8.8	9.9	15.7	8.4	7.1
NUSAP1	"ANKT, BM037, FLJ13421, LNP, PRO0310p1, Q0310, SAPL"	ENSG00000137804	"Nucleolar and spindle associated protein 1"	Q9BXS6	15	41320794-41381050	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 88.6;lymphoid tissue: 101.5"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 266.7;Extravillous trophoblasts: 121.2;Granulosa cells: 93.3;Spermatocytes: 99.6"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	15	"basophil: 10.7;T-reg: 7.7"	"Group enriched"	"Detected in many"	15	"granulocytes: 10.7;T-cells: 7.7"	"Low cell line specificity"	"Detected in many"											"HPA042904, HPA074847"	Supported		Approved	"Nucleoplasm,Nucleoli,Nucleoli fibrillar center"		Yes	Yes			"Cluster 34: Basophils - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Nucleoli, Nucleoli fibrillar center"		"HPA042904: AB_2678220, HPA074847: AB_2732269"	"unprognostic (1.19e-1)"	"unprognostic (9.53e-3)"	"unprognostic (1.65e-1)"	"unprognostic (8.78e-2)"	"unprognostic (3.46e-2)"	"unprognostic (2.97e-2)"	"unprognostic (1.16e-3)"	"unprognostic (1.74e-3)"	"unprognostic (1.37e-2)"	"unprognostic (4.14e-1)"	"prognostic unfavorable (6.27e-4)"	"unprognostic (8.49e-3)"	"prognostic unfavorable (6.82e-14)"	"unprognostic (4.76e-3)"	"unprognostic (1.23e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.22e-1)"	1.8	14.1	0.2	7.8	0.2	88.6	1.5	0.3	0.4	3.6	0.3	6.1	7.0	1.1	0.1	17.7	1.1	1.0	1.1	0.2	0.2	2.6	5.0	3.8	28.7	0.3	0.4	4.4	1.3	0.0	0.6	6.5	0.3	1.1	8.0	0.1	3.6	0.6	5.4	9.4	7.4	2.7	0.2	7.8	4.5	10.9	0.3	101.5	0.9	0.1	31.5	1.9	6.4	0.3	146.0	38.3	165.1	64.6	3.5	5.9	37.0	107.4	74.6	138.9	130.6	58.4	67.0	63.5	42.5	44.4	99.1	107.6	104.2	46.2	132.4	98.5	62.3	149.6	102.0	50.7	0.2	67.3	57.2	0.9	1.3	69.1	37.3	21.7	72.0	104.2	70.1	237.5	105.7	30.7	147.5	82.2	59.8	139.8	55.0	136.5	156.5	67.5	42.4	29.3	85.7	55.2	129.8	88.5	25.7	46.0	106.2	76.1	33.7	89.9	104.8	101.5	206.2	81.3	145.8	200.5	42.1	163.6	171.2	10.7	0.1	0.5	0.1	0.0	0.0	0.3	0.5	0.5	0.3	0.6	0.0	0.3	0.2	0.4	0.0	0.3	7.7	0.5	0.2	0.2	0.3	0.4	0.2	0.2	0.3	0.4	0.3	0.2	0.3	0.3	1.9	0.0	1.5	1.3	14.2	38.5	10.3	21.2	31.9	0.9	9.9	13.7	1.1	17.2	5.0	0.0	0.0	72.2	13.4	14.4	3.9	2.3	33.2	10.7	11.6	7.3	3.0	266.7	1.4	0.5	121.2	14.6	25.5	21.8	7.0	93.3	10.8	3.9	36.7	0.0	1.5	15.5	24.4	13.8	22.7	14.6	0.3	17.5	3.6	1.9	6.1	1.9	4.1	1.0	1.3	1.5	0.4	1.9	57.2	5.3	2.6	5.4	1.1	1.0	0.0	2.8	12.1	99.6	59.9	69.5	24.9	19.3	22.9	38.8	30.0	10.3
OGT	"FLJ23071, HRNT1, MGC22921, O-GLCNAC, OGT1"	ENSG00000147162	"O-linked N-acetylglucosamine (GlcNAc) transferase"	O15294	X	71533104-71575892	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Biological rhythms, Host-virus interaction, Ubl conjugation pathway"	"Chromatin regulator, Glycosyltransferase, Transferase"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030751, HPA030752, HPA030753, HPA030754, CAB034099"	Approved		Supported	"Nucleoplasm,Plasma membrane"		Yes	No			"Cluster 39: Non-specific - mRNA processing"	"Cluster 50: Non-specific - Ribosome"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Nucleoplasm	"Plasma membrane"	"CAB034099: AB_2157067, HPA030751: AB_10600217, HPA030752: AB_10601445, HPA030753: AB_2673594, HPA030754: AB_2673595"	"unprognostic (1.37e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.32e-2)"	"prognostic unfavorable (8.33e-4)"	"unprognostic (3.40e-2)"	"prognostic favorable (1.97e-4)"	"unprognostic (9.56e-3)"	"unprognostic (1.96e-3)"	"unprognostic (5.58e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.06e-1)"	"unprognostic (9.74e-3)"	"prognostic unfavorable (2.36e-6)"	"unprognostic (2.99e-3)"	"unprognostic (2.28e-1)"	"unprognostic (8.03e-3)"	"prognostic favorable (6.85e-7)"	59.3	55.9	39.7	38.3	42.4	61.5	62.7	43.3	51.6	72.7	40.1	62.5	30.6	56.0	62.2	52.8	76.4	26.4	55.5	43.9	35.5	61.6	45.8	70.7	71.9	36.1	35.8	85.5	102.4	24.3	46.9	26.4	37.9	75.4	39.6	36.9	64.1	27.1	62.8	68.6	86.4	24.5	36.1	122.8	67.4	19.0	36.2	57.2	70.7	39.2	57.8	55.7	67.4	44.3	40.5	37.0	47.1	41.5	49.6	45.6	31.6	30.3	54.3	32.1	49.1	39.3	45.4	47.9	20.7	37.3	33.3	49.1	52.0	29.5	39.4	41.1	53.4	30.4	98.6	28.5	37.6	62.9	48.1	43.6	59.2	35.1	65.7	55.5	30.5	100.7	31.1	160.4	31.1	34.3	48.9	75.2	31.6	35.5	49.8	47.8	52.7	62.1	50.0	45.9	24.1	21.2	46.9	30.9	30.2	35.5	22.8	42.4	35.5	34.6	27.9	36.6	17.9	43.5	33.5	56.5	24.4	65.0	21.6	2.8	4.6	2.0	7.5	5.7	6.8	7.4	6.3	6.2	6.1	6.2	7.2	7.4	1.9	10.4	5.7	6.2	6.2	5.6	39.7	42.4	43.3	51.6	43.9	35.5	36.1	35.8	37.9	36.1	36.2	44.3	31.1	35.3	85.2	52.9	67.2	88.1	37.9	23.5	58.6	26.5	49.6	34.0	42.8	20.0	31.1	49.7	8.4	15.8	130.7	31.1	9.8	14.4	2.4	32.1	49.8	39.8	34.9	51.3	110.7	14.4	8.5	47.5	54.6	53.3	27.8	26.4	45.7	27.5	16.1	40.4	94.6	37.3	22.4	60.9	69.7	4.8	53.4	45.8	35.6	71.2	51.6	11.3	51.5	92.0	97.9	17.6	34.9	29.7	147.2	53.8	34.8	15.1	28.0	21.8	32.9	44.8	42.2	2.5	6.1	63.3	84.1	10.9	82.1	62.0	34.0	50.8
OVOL1	HOVO1	ENSG00000172818	"Ovo like transcriptional repressor 1"	O14753	11	65787063-65797214	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 57.2;skin 1: 51.0;testis: 35.5"	"Cell type enhanced"	"Detected in many"		"Glandular and luminal cells: 113.2;Squamous epithelial cells: 130.8;Syncytiotrophoblasts: 348.9;Urothelial cells: 114.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 19.0;BEWO: 52.2;CACO-2: 13.6;HaCaT: 31.4;MCF7: 12.6;RT4: 31.2;SK-BR-3: 24.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA003984	Uncertain		Approved	Nucleoplasm		Yes	NA				"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA003984: AB_1854854"	"unprognostic (4.26e-3)"	"unprognostic (3.39e-1)"	"unprognostic (3.96e-2)"	"prognostic unfavorable (1.87e-4)"	"unprognostic (1.37e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.37e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.31e-2)"	"unprognostic (2.01e-3)"	"unprognostic (1.91e-1)"	"prognostic favorable (1.00e-13)"	"unprognostic (4.26e-2)"	"unprognostic (3.51e-2)"	"unprognostic (2.42e-1)"	"unprognostic (9.04e-3)"	0.1	0.0	0.0	1.0	0.1	0.1	2.8	0.2	0.1	13.6	0.0	10.3	15.5	0.5	0.1	57.2	0.6	0.9	0.0	0.1	0.0	7.4	0.2	0.3	0.0	0.0	0.0	0.0	9.1	15.0	0.1	6.9	0.0	1.4	8.3	0.1	8.8	1.0	0.1	51.0	9.1	0.3	0.0	0.1	1.6	35.5	0.0	0.4	1.3	0.0	5.5	27.4	21.3	0.1	19.0	0.0	0.0	0.0	0.0	0.0	52.2	0.0	0.0	0.0	0.0	13.6	5.0	0.0	0.1	0.0	0.0	31.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.6	0.0	0.0	0.0	9.7	0.1	0.3	0.0	0.1	1.4	31.2	0.2	0.1	0.0	24.0	0.2	5.4	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	3.3	0.3	2.3	26.6	62.6	14.5	54.1	0.0	59.4	25.4	0.5	7.2	13.0	3.7	0.0	19.5	1.3	57.6	0.0	2.5	81.9	76.2	11.7	1.8	31.6	0.0	0.1	3.8	14.0	0.9	0.0	113.2	2.5	0.0	0.0	0.1	2.1	0.0	0.1	54.9	20.3	0.0	1.4	87.2	1.2	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	44.5	1.9	3.0	34.1	39.1	6.7	11.3	0.0	0.0	0.0	1.1	83.9	4.8	130.8	57.4	348.9	1.7	0.0	52.0	114.9
P4HA1	"C-P4Halpha(I), P4HA"	ENSG00000122884	"Prolyl 4-hydroxylase subunit alpha 1"	P13674	10	73007217-73096974	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"hTERT-RPE1: 494.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007599, HPA026593"	Enhanced		Supported	"Endoplasmic reticulum,Vesicles,Mitochondria"	"Intracellular and membrane"	Yes	No		60000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Endoplasmic reticulum"	"Vesicles, Mitochondria"	"HPA007599: AB_1854891, HPA026593: AB_1854892"	"prognostic unfavorable (9.01e-4)"	"prognostic unfavorable (3.19e-5)"	"unprognostic (2.76e-3)"	"unprognostic (3.04e-1)"	"unprognostic (1.69e-2)"	"prognostic unfavorable (1.19e-5)"	"unprognostic (2.30e-1)"	"prognostic unfavorable (5.10e-4)"	"unprognostic (1.28e-1)"	"unprognostic (2.29e-1)"	"prognostic unfavorable (2.85e-4)"	"unprognostic (9.15e-2)"	"prognostic unfavorable (9.40e-9)"	"unprognostic (3.14e-1)"	"unprognostic (4.22e-2)"	"unprognostic (1.02e-2)"	"unprognostic (5.75e-2)"	28.1	26.0	25.7	20.8	26.4	15.5	26.3	29.6	58.5	31.9	34.7	16.3	11.0	27.0	18.9	10.1	41.1	26.3	38.7	26.5	27.1	35.8	72.8	27.8	16.2	32.9	30.0	34.9	17.5	17.0	11.6	65.3	33.0	20.0	17.4	33.3	13.0	18.4	110.9	17.4	14.4	28.5	30.2	19.6	19.8	19.3	30.1	12.9	13.9	54.0	14.6	29.6	18.2	39.0	84.0	21.2	60.1	117.6	181.2	138.3	50.1	239.9	215.8	90.8	215.8	35.6	63.6	28.4	89.7	239.0	55.1	92.5	38.3	87.7	197.1	36.5	14.5	24.4	18.6	42.5	75.3	45.1	16.4	84.5	50.3	77.7	101.6	494.2	43.5	23.8	38.3	14.7	79.3	22.4	17.9	42.9	21.6	38.9	92.3	16.4	40.2	52.4	51.0	35.6	5.5	33.7	49.2	143.2	58.3	135.0	21.9	41.9	41.9	110.5	44.8	31.3	56.9	81.8	31.3	13.7	198.1	64.5	54.9	1.1	18.8	14.9	6.7	23.5	8.7	8.2	8.1	7.9	20.7	9.2	5.9	6.1	10.4	5.2	25.7	16.6	10.7	9.1	25.7	26.4	29.6	58.5	26.5	27.1	32.9	30.0	33.0	30.2	30.1	39.0	29.0	6.4	28.4	87.1	31.7	36.3	33.0	138.0	22.2	13.5	23.8	15.7	42.0	7.2	69.2	23.9	27.1	31.5	24.9	25.1	0.0	33.1	16.8	85.6	89.2	25.9	10.3	7.2	48.8	19.5	116.4	67.7	14.3	131.4	40.5	16.9	20.0	29.8	43.9	11.8	41.6	9.5	46.8	54.1	75.7	8.1	51.9	51.5	44.4	62.8	39.0	34.0	6.2	86.5	44.8	36.6	27.1	47.0	32.9	24.9	13.5	25.1	94.6	17.2	39.5	37.0	44.7	61.7	34.0	9.8	23.9	33.2	27.7	31.1	7.0	17.6
PAPSS1	"ATPSK1, PAPSS"	ENSG00000138801	"3'-phosphoadenosine 5'-phosphosulfate synthase 1"	O43252	4	107590276-107720234	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Multifunctional enzyme, Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Glandular and luminal cells: 444.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	6	"basophil: 321.8;eosinophil: 359.8"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 359.8"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049781	Approved		Approved	"Nucleoplasm,Nucleoli rim,Mitotic chromosome"		Yes	No		13000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 44: Endometrium - Transcription"	"Nucleoli rim, Mitotic chromosome"	Nucleoplasm	"HPA049781: AB_2680879"	"unprognostic (1.36e-2)"	"unprognostic (5.03e-2)"	"prognostic favorable (9.14e-4)"	"prognostic favorable (8.58e-4)"	"unprognostic (1.63e-2)"	"unprognostic (1.08e-1)"	"prognostic unfavorable (2.70e-5)"	"unprognostic (1.58e-2)"	"unprognostic (1.05e-1)"	"unprognostic (8.92e-2)"	"unprognostic (1.42e-1)"	"unprognostic (5.76e-2)"	"unprognostic (6.23e-3)"	"unprognostic (1.29e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.61e-2)"	"unprognostic (1.38e-1)"	26.3	14.2	36.8	30.8	43.9	26.0	49.9	46.4	50.0	49.6	26.5	20.4	16.0	47.1	43.0	36.2	48.4	26.4	15.9	41.9	40.8	31.7	10.3	44.4	32.9	53.2	41.4	29.2	49.3	26.9	15.8	17.2	51.8	41.1	24.7	22.3	66.0	25.9	6.1	49.7	15.8	33.6	51.1	17.4	62.8	17.0	41.8	35.4	20.3	9.9	51.7	31.7	23.7	66.3	33.6	29.7	49.1	62.1	59.1	74.0	39.6	42.4	77.2	39.4	53.1	45.7	46.7	51.3	26.0	76.1	30.4	40.7	46.8	81.6	50.5	124.2	35.5	60.4	62.6	103.0	32.3	93.0	99.8	61.7	41.2	45.7	37.1	95.2	88.7	63.9	13.6	97.0	111.6	50.7	77.3	28.2	52.6	35.3	33.1	62.4	78.0	15.0	59.6	45.6	55.5	81.4	42.9	63.3	51.9	61.9	37.9	14.1	52.9	49.3	51.0	33.6	35.4	76.9	57.2	48.7	60.1	69.3	79.2	321.8	49.9	359.8	15.6	56.2	18.8	44.8	21.2	18.0	51.4	26.4	13.2	14.9	55.5	27.6	60.8	9.8	39.9	36.7	36.8	43.9	46.4	50.0	41.9	40.8	53.2	41.4	51.8	51.1	41.8	66.3	19.7	96.1	20.2	41.4	25.4	32.0	36.3	73.2	33.6	19.9	48.4	41.5	7.4	50.1	92.3	57.0	10.4	20.6	7.0	10.5	17.6	36.8	6.2	124.2	84.6	25.1	23.4	15.3	112.2	44.7	48.7	35.2	62.2	444.3	42.5	25.0	20.3	10.2	55.1	30.3	64.7	17.5	32.6	46.5	27.8	6.7	18.0	53.5	60.5	29.0	37.4	35.0	10.3	100.0	150.3	33.6	9.1	25.6	86.4	29.1	6.9	28.8	110.0	13.3	26.3	45.2	29.1	19.6	14.7	62.9	40.9	8.9	22.2	19.2	14.8	29.4
PARP3	"ADPRT3, ADPRTL3, ARTD3, hPARP-3, IRT1, pADPRT-3"	ENSG00000041880	"Poly(ADP-ribose) polymerase family member 3"	Q9Y6F1	3	51942345-51948867	"FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Glycosyltransferase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Proximal enterocytes: 33.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020984, HPA067657"	Supported		Supported	"Nucleoplasm,Nuclear bodies"		Yes	No			"Cluster 15: NK-cells - Transcription"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 45: Enterocytes - Digestion"	"Nucleoplasm, Nuclear bodies"		"HPA020984: , HPA067657: AB_2685881"	"prognostic favorable (6.39e-5)"	"unprognostic (1.25e-1)"	"unprognostic (1.54e-2)"	"unprognostic (2.85e-2)"	"unprognostic (7.31e-2)"	"unprognostic (1.56e-1)"	"unprognostic (4.13e-1)"	"unprognostic (3.53e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.01e-1)"	"unprognostic (7.44e-3)"	"unprognostic (4.30e-1)"	"prognostic favorable (1.25e-8)"	"unprognostic (5.63e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.40e-2)"	"unprognostic (4.65e-3)"	16.0	33.4	12.7	9.9	13.5	3.1	15.3	12.9	14.6	9.6	14.4	17.1	28.1	11.4	5.9	10.4	11.2	11.3	13.6	11.6	14.2	21.2	29.2	13.4	10.9	13.8	14.9	8.9	4.4	35.8	10.9	5.9	13.7	14.6	10.2	4.7	14.5	15.5	15.8	7.5	25.2	9.3	12.9	14.8	16.4	5.4	14.9	8.2	19.6	17.6	8.0	15.4	10.8	12.4	10.0	6.6	2.0	17.3	17.8	30.0	4.8	15.4	29.0	23.1	24.9	3.9	28.1	14.1	4.5	29.4	12.6	1.6	5.0	14.5	9.1	34.8	1.2	7.8	15.1	13.2	18.8	5.3	10.9	24.4	12.4	16.2	9.1	35.7	10.8	10.2	3.5	14.7	19.9	3.4	4.6	12.5	2.4	4.2	16.4	7.3	2.8	13.9	14.0	13.5	2.0	6.4	16.3	4.8	10.7	1.4	6.5	5.9	24.0	42.5	9.9	7.4	10.4	22.5	26.0	6.0	27.2	14.4	13.6	0.0	1.6	1.2	2.4	3.0	2.2	6.3	2.6	1.8	2.6	2.5	3.6	3.5	0.1	5.7	1.6	0.9	3.2	1.8	12.7	13.5	12.9	14.6	11.6	14.2	13.8	14.9	13.7	12.9	14.9	12.4	5.3	6.4	10.0	6.2	8.1	2.7	10.6	15.9	21.1	2.0	8.6	8.9	7.4	8.6	8.6	0.0	0.0	0.6	2.1	13.1	7.9	9.7	7.8	2.4	3.8	5.3	3.0	1.7	2.6	6.3	0.4	4.7	17.3	2.7	4.5	0.8	2.5	9.5	3.7	0.0	3.0	11.3	6.1	3.2	2.2	15.3	4.7	3.7	7.2	3.7	5.0	3.8	0.0	1.0	1.8	11.5	6.5	1.5	4.9	4.3	33.4	20.6	9.5	2.1	6.6	4.1	5.7	3.4	3.3	7.8	1.4	0.5	5.9	1.6	13.8	9.3
PARP4	"ADPRTL1, ARTD4, p193, VAULT3, VPARP, VWA5C"	ENSG00000102699	"Poly(ADP-ribose) polymerase family member 4"	Q9UKK3	13	24420931-24512778	"Metabolic proteins, Predicted intracellular proteins"		"Glycosyltransferase, Ribonucleoprotein, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"granulocytes: 99.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011739	Approved		Supported	Nucleoplasm,Cytosol		Yes	No			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 9: Intestine - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 11: Alveolar cells - Smell perception"	Nucleoplasm	Cytosol	"HPA011739: AB_1854986"	"unprognostic (1.61e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.62e-2)"	"unprognostic (4.35e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.52e-1)"	"unprognostic (2.45e-1)"	"unprognostic (2.02e-2)"	"unprognostic (4.12e-3)"	"unprognostic (2.97e-2)"	"prognostic favorable (1.21e-5)"	"unprognostic (3.23e-2)"	"unprognostic (1.71e-1)"	"unprognostic (3.80e-2)"	"unprognostic (2.84e-3)"	18.6	22.8	8.4	24.2	11.9	22.1	16.7	11.2	8.2	24.3	12.1	38.7	38.9	17.9	18.0	22.0	21.1	29.5	12.7	7.5	10.4	26.9	24.9	28.7	23.6	15.6	11.3	18.6	14.8	18.5	5.8	15.9	15.2	13.1	39.5	8.3	16.8	18.6	6.4	11.0	39.1	19.5	11.3	26.3	34.4	9.0	11.8	21.6	21.2	11.3	25.2	28.3	14.0	15.6	42.9	37.7	18.1	32.7	48.7	68.8	15.3	48.7	63.5	41.8	37.1	15.5	108.5	32.0	47.3	44.5	46.3	48.5	27.2	49.4	34.1	73.7	19.0	45.9	33.0	35.9	27.8	59.3	43.3	39.9	16.3	34.6	18.3	81.4	69.7	24.5	13.2	13.8	50.2	19.9	37.6	28.5	20.5	100.6	45.9	35.0	33.8	45.0	77.6	86.7	16.4	20.9	35.7	14.2	33.5	23.4	7.1	48.2	99.7	18.9	19.8	24.4	50.4	15.6	19.3	41.4	34.3	30.6	42.1	50.0	21.1	45.9	20.4	25.7	20.4	14.2	16.8	20.5	27.9	8.0	12.2	14.8	24.0	21.1	34.6	10.4	21.9	20.1	8.4	11.9	11.2	8.2	7.5	10.4	15.6	11.3	15.2	11.3	11.8	15.6	20.5	51.3	51.8	21.2	20.5	2.8	6.9	29.2	6.2	6.3	10.2	5.8	17.6	17.2	52.6	25.8	2.1	5.0	33.8	74.2	5.9	26.1	5.4	35.9	19.4	19.8	4.9	13.9	1.5	22.5	8.9	18.3	42.8	50.9	99.2	30.7	31.1	16.0	17.7	1.7	2.1	27.0	18.3	23.4	6.9	4.7	11.8	35.3	8.8	36.5	37.1	6.7	36.0	21.1	40.8	30.9	53.8	8.2	27.0	10.6	59.7	18.2	69.7	7.4	6.6	12.2	10.4	2.5	8.9	13.5	3.8	1.9	28.9	24.1	30.8	20.5
PARP6	"ARTD17, pART17"	ENSG00000137817	"Poly(ADP-ribose) polymerase family member 6"	Q2NL67	15	72241181-72272999	"Metabolic proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 178.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026991	Approved		Approved	"Plasma membrane"		Yes	No			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 58: Brain - Synaptic function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 25: Spermatids - Spermatogenesis"	"Plasma membrane"		"HPA026991: AB_1854989"	"unprognostic (3.88e-2)"	"prognostic favorable (3.17e-5)"	"prognostic unfavorable (3.37e-4)"	"unprognostic (3.36e-1)"	"unprognostic (7.13e-2)"	"unprognostic (3.05e-1)"	"unprognostic (2.37e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.64e-1)"	"unprognostic (8.55e-2)"	"unprognostic (6.92e-2)"	"prognostic unfavorable (8.02e-8)"	"unprognostic (6.81e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.45e-1)"	"unprognostic (4.42e-2)"	20.0	20.9	63.2	14.6	64.8	30.5	20.0	62.2	84.6	22.2	61.2	28.7	15.3	24.5	24.0	17.7	22.6	21.3	19.6	64.5	57.7	23.8	15.5	19.7	19.4	55.7	55.9	29.2	32.5	12.6	49.7	18.3	55.3	25.1	14.8	52.9	23.2	17.3	34.8	23.0	21.7	20.2	51.0	20.6	24.2	34.5	57.1	21.0	30.2	21.2	17.4	22.7	19.1	64.9	15.9	27.6	29.0	37.8	30.5	25.2	23.7	13.8	19.9	21.8	31.1	18.5	28.2	22.3	8.4	20.3	31.4	20.9	32.4	18.1	12.4	26.5	30.6	31.7	55.0	0.2	25.4	16.7	30.1	32.6	43.5	20.1	55.2	33.7	14.6	35.6	16.6	24.3	17.5	28.4	14.4	28.7	14.2	13.2	0.0	26.7	20.8	17.2	19.9	30.4	81.4	43.1	22.6	17.8	37.0	38.2	22.8	18.8	14.0	26.7	24.7	35.7	20.7	27.9	27.7	23.2	19.1	31.4	19.1	1.1	3.6	8.2	2.3	3.1	1.6	2.4	1.7	2.5	2.6	2.3	2.6	2.0	3.6	3.0	3.5	2.2	2.9	2.1	63.2	64.8	62.2	84.6	64.5	57.7	55.7	55.9	55.3	51.0	57.1	64.9	11.5	22.4	21.2	54.9	15.3	14.4	9.6	6.9	31.3	16.4	13.0	13.7	20.9	2.8	12.9	9.2	20.9	7.3	12.0	8.0	7.9	9.7	61.4	8.0	10.3	11.1	17.4	4.6	19.7	12.7	5.3	13.9	21.4	10.0	15.8	17.3	6.4	6.1	8.9	18.5	20.5	6.5	6.1	14.8	11.1	178.1	12.5	14.0	16.0	20.6	9.3	8.8	6.2	27.2	54.6	9.2	9.0	9.8	12.3	9.0	17.7	12.3	5.8	15.5	6.6	13.7	12.5	44.3	12.6	19.3	15.8	6.4	13.3	8.6	7.5	9.3
PC	PCB	ENSG00000173599	"Pyruvate carboxylase"	P11498	11	66848417-66958386	"Citric acid cycle related proteins, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Gluconeogenesis, Lipid biosynthesis, Lipid metabolism"	"Ligase, Multifunctional enzyme"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 148.0"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 201.9;Late spermatids: 53.2"	"Cancer enhanced"	"Detected in all"		"liver cancer: 37.5"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HeLa: 57.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033742, HPA043922, HPA058765"	Enhanced		Enhanced	Mitochondria		Yes	No		200000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 15: Liver - Metabolism"	"Cluster 20: HeLa - Mitochondria"	"Cluster 15: Hepatocytes - Hemostasis"	Mitochondria		"CAB033742: AB_2283532, HPA043922: AB_2678732, HPA058765: AB_2683812"	"unprognostic (2.10e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.36e-2)"	"unprognostic (8.24e-3)"	"unprognostic (3.67e-1)"	"unprognostic (3.18e-2)"	"unprognostic (2.97e-1)"	"unprognostic (3.00e-1)"	"unprognostic (3.63e-1)"	"prognostic unfavorable (7.86e-5)"	"unprognostic (1.54e-1)"	"unprognostic (1.17e-1)"	"prognostic favorable (8.22e-5)"	"unprognostic (8.58e-3)"	"unprognostic (5.67e-2)"	"unprognostic (9.15e-3)"	"unprognostic (1.05e-1)"	60.9	23.7	35.7	2.9	35.5	3.5	28.4	36.6	35.8	3.7	17.5	4.7	6.5	3.8	1.8	9.3	3.2	2.8	4.3	32.4	41.0	23.3	148.0	2.6	1.3	43.4	40.1	5.1	4.9	18.2	8.6	4.4	37.6	7.2	2.8	2.4	35.3	9.3	12.1	4.7	7.7	1.4	37.8	1.5	9.1	10.7	49.0	2.0	4.6	6.6	2.0	2.9	4.4	37.0	6.1	19.3	6.5	17.2	25.4	8.9	6.6	3.4	15.5	6.9	7.5	8.8	6.0	0.0	7.4	6.0	9.6	6.8	7.7	39.5	1.5	2.8	11.0	10.3	57.4	41.2	21.0	0.1	10.8	40.2	10.1	5.8	12.4	4.4	5.7	14.3	17.4	0.0	2.1	44.6	9.2	4.6	12.0	15.1	16.2	8.3	13.0	3.2	5.7	1.9	15.2	21.0	33.6	18.0	15.5	4.8	14.6	2.7	6.3	7.8	6.6	8.8	4.7	3.5	4.8	0.1	7.7	5.7	6.7	0.0	1.3	0.0	0.5	0.3	0.5	0.0	0.1	0.5	0.9	0.2	0.9	0.5	0.1	0.1	0.1	0.3	0.5	0.7	35.7	35.5	36.6	35.8	32.4	41.0	43.4	40.1	37.6	37.8	49.0	37.0	0.9	0.0	3.0	26.4	1.4	1.3	1.6	9.1	2.8	5.6	4.8	5.8	4.4	11.5	3.0	3.7	2.1	17.4	0.6	27.6	1.9	3.1	18.4	2.3	7.1	1.5	9.0	28.0	18.5	1.8	4.2	3.2	5.6	3.0	8.9	16.0	4.6	201.9	12.3	0.0	18.6	5.0	0.0	7.0	1.8	53.2	0.6	1.8	5.4	7.5	18.9	9.4	2.1	10.1	16.7	2.3	8.5	4.1	0.1	3.1	23.6	39.0	1.5	4.8	0.0	2.2	2.2	11.2	4.7	4.1	0.6	25.4	1.2	6.0	6.4	1.3
PCP2	"GPSM4, MGC41903"	ENSG00000174788	"Purkinje cell protein 2"	Q8IVA1	19	7631611-7633719	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 53.4;retina: 33.3;testis: 112.4"	"Cell type enriched"	"Detected in many"	4	"Late spermatids: 4139.3"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"cerebellum: 53.4;white matter: 16.8"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HMC-1: 8.4;Karpas-707: 4.2;NB-4: 17.7"	"Region enriched"	"Detected in many"	44	"cerebellum: 2160.4"	"Region enriched"	"Detected in all"	28	"cerebellum: 552.9"	HPA057428			Approved	"Nuclear speckles,Vesicles"		Yes	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 21: Non-specific - Transcription"	"Cluster 24: NB-4 - Immune response"	"Cluster 25: Spermatids - Spermatogenesis"	"Nuclear speckles"	Vesicles	"HPA057428: AB_2683436"	"prognostic favorable (7.93e-4)"	"unprognostic (6.06e-2)"	"unprognostic (1.19e-2)"	"unprognostic (4.43e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.79e-4)"	"unprognostic (1.19e-1)"	"unprognostic (4.88e-5)"	"unprognostic (1.11e-1)"	"unprognostic (6.23e-2)"	"unprognostic (9.15e-3)"	"unprognostic (6.01e-2)"	"unprognostic (1.36e-2)"	"unprognostic (8.17e-2)"	"unprognostic (1.18e-1)"	"unprognostic (8.70e-2)"	"prognostic favorable (2.76e-5)"	0.4	1.6	0.4	1.1	0.6	3.7	5.5	53.4	2.3	2.1	0.0	0.6	1.4	0.9	3.3	2.0	2.4	2.3	2.2	0.5	0.0	8.0	3.7	2.2	3.0	0.1	3.5	0.1	5.4	1.1	1.4	0.4	5.5	5.9	0.3	33.3	16.3	1.9	0.2	7.0	1.6	0.0	0.1	3.0	3.1	112.4	0.0	3.1	5.7	0.0	1.4	0.9	1.6	16.8	1.8	0.4	0.0	0.2	0.0	0.0	0.8	0.0	0.0	0.0	0.0	1.7	1.6	0.7	1.1	0.0	0.0	1.3	0.0	0.2	0.0	0.8	0.6	2.6	2.8	0.1	0.0	0.3	8.4	0.0	0.6	0.0	0.0	0.0	0.0	0.7	0.2	4.2	0.0	0.3	0.3	17.7	0.4	0.3	0.0	0.8	0.2	0.7	0.8	0.1	0.1	0.0	1.4	1.4	0.0	0.4	3.7	3.4	0.2	0.0	0.5	0.4	0.0	1.4	0.7	0.2	0.0	2.0	0.0	0.0	0.1	0.0	0.3	0.0	0.4	0.1	0.1	0.1	0.2	0.3	0.2	0.3	0.8	0.2	0.0	0.6	0.0	1.7	0.4	0.6	53.4	2.3	0.5	0.0	0.1	3.5	5.5	0.1	0.0	16.8	0.1	0.0	2.3	0.0	0.2	0.8	1.1	1.4	0.0	734.7	7.7	5.8	0.0	2.8	1.8	5.5	22.9	0.2	2.7	0.7	9.8	0.8	836.5	1.0	0.1	2.6	0.0	0.0	0.0	0.2	0.1	0.1	0.0	1.5	1.3	1.3	0.0	0.5	0.4	23.5	0.0	0.4	0.0	0.8	1.3	4139.3	10.5	7.1	1.8	1.0	1.5	40.7	2.1	0.0	0.0	0.4	0.1	13.2	0.3	1.0	1.3	0.5	0.4	100.3	19.7	0.0	0.1	14.5	9.0	0.0	1.1	0.0	1.0	0.0	0.6	0.6
PDP1	"PDH, PDP, PPM2A, PPM2C"	ENSG00000164951	"Pyruvate dehyrogenase phosphatase catalytic subunit 1"	Q9P0J1	8	93857807-93926068	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 80.0;Early spermatids: 144.2"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in many"	8	"amygdala: 14.2;basal ganglia: 20.1;cerebral cortex: 41.7;hippocampal formation: 23.4;white matter: 18.5"	"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"GAMG: 117.8;hTERT-RPE1: 117.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018483, HPA019081, HPA021152"	Uncertain		Approved	Nucleoplasm,Mitochondria,Cytosol		Yes	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nucleoplasm, Mitochondria, Cytosol"		"HPA018483: AB_1855634, HPA019081: AB_1855633, HPA021152: AB_1855635"	"prognostic unfavorable (8.61e-5)"	"unprognostic (4.62e-1)"	"unprognostic (8.79e-2)"	"unprognostic (1.09e-1)"	"unprognostic (9.46e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.00e-1)"	"prognostic unfavorable (5.60e-4)"	"unprognostic (1.71e-2)"	"unprognostic (3.25e-1)"	"prognostic favorable (8.42e-9)"	"unprognostic (1.85e-1)"	"unprognostic (1.84e-1)"	"unprognostic (5.04e-2)"	"unprognostic (1.67e-1)"	10.6	62.6	14.2	10.5	20.1	14.4	16.1	0.0	41.7	14.2	1.2	8.9	7.2	15.5	17.0	14.2	12.2	19.4	49.2	23.4	0.0	12.8	4.2	12.6	12.9	0.0	2.3	19.3	19.9	29.9	5.4	13.8	0.0	10.3	12.4	14.1	11.7	9.4	72.9	4.3	7.6	11.2	0.0	13.2	11.7	26.7	3.0	11.6	18.8	16.9	12.4	14.0	6.8	18.5	25.7	12.0	25.9	10.9	21.0	37.9	8.6	19.3	21.7	22.1	25.8	12.7	90.3	13.9	63.8	30.8	117.8	54.4	11.0	16.1	32.8	1.5	5.6	6.6	15.7	4.5	23.9	3.3	9.0	24.5	31.5	37.7	59.8	117.1	50.9	12.4	2.4	22.8	27.6	6.0	20.3	10.3	12.1	26.8	15.4	4.8	15.5	2.6	15.3	17.0	2.4	11.4	12.7	1.4	61.8	20.9	4.0	3.9	90.9	27.5	17.2	63.8	23.3	12.6	5.8	12.1	34.2	11.7	25.1	6.4	27.9	14.5	9.2	25.3	8.9	15.6	15.1	12.0	22.5	17.9	8.9	7.8	3.1	5.4	41.1	3.7	34.9	18.0	14.2	20.1	0.0	41.7	23.4	0.0	0.0	2.3	0.0	0.0	3.0	18.5	10.7	12.8	7.8	15.0	18.0	13.0	12.7	36.3	68.9	38.3	11.6	7.0	80.0	14.3	35.6	16.5	8.4	4.3	13.7	27.5	5.9	33.3	144.2	33.3	14.9	15.0	10.2	1.3	73.6	14.0	3.9	20.8	16.3	70.2	6.3	3.7	12.5	3.3	6.3	10.1	23.4	5.5	10.2	19.2	19.1	28.1	11.5	19.9	10.6	19.7	22.4	18.8	10.3	13.0	8.5	24.5	9.6	13.5	8.1	15.6	4.9	11.4	30.5	11.5	6.6	35.4	13.1	10.1	11.4	26.5	10.9	4.4	19.3	7.1	10.7	23.9
PIAS2	"ARIP3, miz, PIASX-ALPHA, PIASX-BETA, ZMIZ4"	ENSG00000078043	"Protein inhibitor of activated STAT 2"	O75928	18	46803218-46920160	"Predicted intracellular proteins, Predicted membrane proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	"DNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 67.2"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 521.4;Late spermatids: 519.5;Spermatocytes: 238.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA068792	Enhanced		Supported	Nucleoplasm		Yes	No			"Cluster 26: Non-specific - Mitochondria"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA068792: AB_2686037"	"unprognostic (9.59e-3)"	"unprognostic (2.14e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.75e-2)"	"unprognostic (1.25e-1)"	"unprognostic (6.39e-2)"	"unprognostic (1.05e-3)"	"unprognostic (3.67e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.71e-3)"	"unprognostic (1.77e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.58e-1)"	"unprognostic (6.92e-2)"	"prognostic unfavorable (1.27e-4)"	"unprognostic (1.71e-1)"	4.8	5.4	7.3	4.1	8.1	7.4	5.1	16.9	9.8	4.9	6.4	4.9	2.8	5.0	7.5	3.7	4.5	4.6	6.8	8.7	6.2	6.4	5.9	4.3	6.2	4.7	6.9	5.0	4.2	11.8	5.6	3.9	5.4	6.5	7.0	10.9	5.5	4.4	16.1	7.7	4.2	4.7	3.7	6.0	4.5	67.2	7.9	4.6	8.2	10.2	5.2	4.1	4.4	8.0	13.7	5.5	6.1	8.7	6.0	7.5	2.9	7.0	5.6	6.0	5.5	6.5	5.1	13.7	3.7	5.3	6.1	4.5	12.3	7.5	8.5	6.6	4.6	8.5	5.4	7.7	5.9	14.3	5.8	7.7	4.5	5.3	5.6	9.7	5.5	11.9	6.4	3.5	12.0	7.4	8.2	8.3	6.7	2.5	3.5	15.0	13.1	0.1	5.5	10.4	11.7	9.0	6.4	4.1	4.7	6.8	6.1	6.3	6.9	12.8	5.5	4.5	5.3	10.1	5.4	17.7	9.5	15.1	12.8	0.7	1.7	1.2	2.0	1.3	1.3	1.6	1.8	2.4	2.0	3.0	2.5	2.1	1.0	1.9	1.3	2.1	1.9	0.8	7.3	8.1	16.9	9.8	8.7	6.2	4.7	6.9	5.4	3.7	7.9	8.0	26.3	19.2	21.9	60.4	25.0	20.6	19.9	15.2	23.9	57.7	21.8	13.2	30.7	12.8	12.6	25.8	89.6	2.6	32.8	18.1	19.6	13.5	521.4	16.6	25.4	26.0	28.5	16.6	137.9	8.9	2.3	20.6	19.4	15.9	14.5	48.4	34.2	22.3	28.1	32.0	134.9	18.0	16.2	50.3	15.7	519.5	33.5	24.2	12.4	73.1	34.7	21.9	40.2	133.7	94.0	7.9	17.1	35.0	30.3	28.4	11.8	23.1	13.9	36.0	6.6	42.5	18.2	238.7	72.4	24.7	15.3	1.4	19.2	35.6	25.5	18.0
PIGP	"DCRC, DSCR5, DSRC"	ENSG00000185808	"Phosphatidylinositol glycan anchor biosynthesis class P"	P57054	21	37062846-37073170	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"GPI-anchor biosynthesis"		"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 350.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026921	Uncertain		Approved	Vesicles		Yes	No			"Cluster 30: Non-specific - Translation"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Vesicles		"HPA026921: AB_1847874"	"unprognostic (4.47e-3)"	"unprognostic (9.45e-2)"	"unprognostic (3.03e-1)"	"unprognostic (2.40e-1)"	"unprognostic (2.85e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.92e-2)"	"unprognostic (5.54e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.22e-2)"	"unprognostic (4.21e-3)"	"unprognostic (1.12e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.93e-1)"	"unprognostic (5.48e-2)"	"unprognostic (1.02e-1)"	"unprognostic (6.55e-2)"	33.9	41.3	18.7	12.5	20.2	9.1	35.4	22.4	24.7	22.9	24.8	24.2	19.0	18.3	107.2	16.8	25.7	22.5	40.1	18.1	22.8	35.9	54.7	21.6	16.6	22.8	21.6	27.9	41.4	51.9	38.0	20.9	22.6	33.7	27.4	28.6	32.2	26.7	44.0	12.4	15.5	17.1	22.1	14.9	22.8	36.5	20.0	22.0	36.3	42.8	19.7	26.2	13.2	25.4	25.9	11.5	23.7	14.8	41.5	28.6	16.9	21.9	38.7	18.6	21.1	15.4	53.7	37.1	45.7	32.0	81.4	19.4	22.7	25.5	18.5	37.4	36.1	86.2	13.8	21.3	26.3	26.9	16.6	26.5	47.2	33.4	43.0	42.2	35.1	80.5	50.7	61.8	38.5	16.5	32.9	25.5	19.6	76.8	27.9	31.0	12.1	37.0	48.2	13.3	49.2	29.8	61.4	43.0	81.8	33.6	35.2	53.2	18.3	12.9	6.6	14.8	19.3	81.1	96.5	42.0	38.1	30.5	43.4	0.4	13.5	3.7	19.6	20.3	24.8	34.2	25.1	21.6	20.9	28.1	33.3	29.0	1.9	16.8	22.6	30.9	20.6	15.6	18.7	20.2	22.4	24.7	18.1	22.8	22.8	21.6	22.6	22.1	20.0	25.4	37.4	28.9	41.8	9.8	37.0	33.0	58.9	88.9	35.3	21.2	74.1	86.4	82.4	42.9	65.1	44.1	10.4	60.7	29.4	21.6	90.1	61.8	79.3	67.0	35.9	31.3	44.9	25.7	6.9	71.3	52.4	48.9	30.1	49.3	15.9	32.2	35.3	79.8	66.7	16.8	8.7	63.9	65.1	57.6	39.9	75.6	69.0	44.1	37.4	2.8	50.2	37.0	23.7	7.5	18.2	57.7	50.3	35.0	54.3	45.6	52.3	97.1	86.9	33.6	65.7	32.7	44.6	350.8	177.5	44.2	26.3	52.3	31.7	62.6	53.1	63.7
PIMREG	"CATS, FAM64A, FLJ10156, FLJ10491, RCS1"	ENSG00000129195	"PICALM interacting mitotic regulator"	Q9BSJ6	17	6444441-6451469	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 13.9"	"Group enriched"	"Detected in some"	6	"Fibroblasts: 5.5;Granulosa cells: 21.5;Hofbauer cells: 7.2;Smooth muscle cells: 14.5"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"cerebellum: 1.1"	"Immune cell enhanced"	"Detected in single"		"NK-cell: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"AF22: 161.8"	"Region enhanced"	"Detected in many"		"white matter: 5.7"	"Low region specificity"	"Detected in single"			"HPA043783, HPA049934"	Uncertain		Enhanced	Nucleoplasm		Yes	Yes			"Cluster 22: NK-cells - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 12: NES - Nervous system development"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm		"HPA043783: AB_2678669, HPA049934: AB_2680959"	"unprognostic (5.32e-3)"	"unprognostic (1.14e-2)"	"unprognostic (2.33e-1)"	"unprognostic (4.37e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.24e-2)"	"unprognostic (6.55e-3)"	"unprognostic (1.23e-3)"	"unprognostic (1.80e-1)"	"unprognostic (5.88e-2)"	"unprognostic (1.47e-3)"	"unprognostic (1.50e-2)"	"unprognostic (0.00e+0)"	"unprognostic (8.65e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.11e-1)"	0.5	2.5	0.3	1.3	0.0	2.5	0.8	1.1	0.4	0.9	0.0	3.3	3.0	0.8	0.0	3.3	0.3	0.7	0.3	0.1	0.1	0.3	0.3	0.7	1.5	0.2	0.0	0.8	0.2	0.1	0.1	0.6	0.0	0.3	4.1	0.4	0.7	0.1	0.0	2.7	3.1	2.0	0.0	6.0	1.2	0.3	0.1	13.9	0.4	0.0	2.1	1.3	1.3	0.2	42.1	54.1	161.8	73.1	1.5	4.5	12.6	47.9	29.8	78.6	52.5	32.8	17.9	0.0	18.8	39.8	39.9	29.9	82.6	21.6	41.9	64.6	33.9	0.1	33.8	41.2	0.2	1.7	48.9	2.4	1.5	32.2	12.4	8.0	24.8	36.8	10.1	23.0	49.9	30.5	9.2	0.5	70.9	34.0	37.8	74.9	64.8	29.6	12.9	6.4	36.5	51.3	41.7	42.5	39.1	20.4	19.9	4.0	11.9	59.9	48.4	36.0	80.7	8.2	31.5	0.2	23.6	20.4	94.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.1	0.0	0.1	0.2	1.0	0.1	0.0	0.3	0.3	0.3	0.0	1.1	0.4	0.1	0.1	0.2	0.0	0.0	0.0	0.1	0.2	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.3	1.8	0.0	0.0	0.0	0.0	0.0	0.2	0.9	0.0	0.0	0.2	0.0	0.4	1.2	0.6	0.0	0.0	0.0	0.0	0.6	5.5	0.0	0.7	1.3	21.5	0.0	0.0	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	14.5	0.0	0.0	0.0	0.0	0.1	0.8	1.1	0.0	0.0
PIN4	"EPVH, PAR14, PAR17"	ENSG00000102309	"Peptidylprolyl cis/trans isomerase, NIMA-interacting 4"	Q9Y237	X	72181353-72302926	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"DNA-binding, Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054483, HPA064504"	Approved		Supported	"Nucleoplasm,Nucleoli,Mitotic chromosome"		Yes	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Nucleoli"	"Mitotic chromosome"	"HPA054483: AB_2682503, HPA064504: AB_2685274"	"unprognostic (2.47e-1)"	"unprognostic (6.97e-3)"	"unprognostic (1.65e-1)"	"unprognostic (3.77e-2)"	"unprognostic (8.42e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.14e-2)"	"prognostic favorable (6.37e-4)"	"unprognostic (1.56e-1)"	"unprognostic (2.13e-2)"	"unprognostic (2.49e-1)"	"unprognostic (9.54e-2)"	"unprognostic (2.09e-3)"	"unprognostic (1.92e-1)"	"prognostic favorable (2.58e-4)"	"unprognostic (3.34e-3)"	"prognostic favorable (2.66e-4)"	14.1	14.8	23.5	10.4	24.0	8.7	16.9	25.2	36.3	15.2	24.0	16.2	11.5	14.7	21.5	14.4	12.9	7.3	19.0	23.6	24.8	19.7	28.6	10.6	10.5	24.4	24.2	16.1	13.1	20.4	13.9	11.8	24.2	15.6	12.7	18.3	16.1	10.1	19.4	10.6	12.7	10.8	24.0	13.9	15.8	5.7	23.8	17.5	16.5	20.4	11.1	13.2	14.9	25.4	36.8	41.2	42.5	29.9	28.1	23.4	23.1	24.6	26.8	28.7	29.1	20.8	26.4	11.2	68.6	25.2	39.2	25.8	38.6	43.0	35.6	26.9	83.3	18.8	51.1	55.3	14.9	29.9	14.8	15.7	22.5	32.0	11.1	32.4	29.1	32.5	32.1	46.6	20.4	43.4	25.3	49.9	30.3	42.4	36.7	25.8	34.7	32.3	37.1	24.7	27.0	48.1	28.5	13.3	27.0	32.0	20.3	25.9	30.7	13.4	19.9	36.8	17.7	15.4	18.5	17.9	38.5	28.3	14.7	42.7	37.1	40.6	41.8	41.1	41.7	49.2	43.7	40.3	38.0	45.6	44.1	44.8	15.7	41.1	39.4	44.6	58.1	39.6	23.5	24.0	25.2	36.3	23.6	24.8	24.4	24.2	24.2	24.0	23.8	25.4	68.3	67.3	48.2	14.0	44.4	43.2	63.3	167.9	36.5	26.7	67.2	94.5	84.9	78.6	89.4	119.5	8.4	162.8	44.5	99.2	181.9	125.0	13.5	78.6	66.7	71.5	92.7	71.7	17.8	117.9	89.0	59.9	45.3	56.6	57.6	46.3	92.4	288.5	110.3	28.6	17.8	93.7	128.1	72.9	44.9	9.3	74.6	50.7	60.5	7.5	69.6	90.7	80.3	16.6	27.3	136.3	114.9	81.3	38.7	51.5	162.0	296.1	95.9	42.9	85.5	65.9	94.6	19.6	42.6	51.3	46.9	120.7	44.8	53.9	88.5	54.8
PKN2	"Pak-2, PRK2, PRKCL2, STK7"	ENSG00000065243	"Protein kinase N2"	Q16513	1	88684222-88836255	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Cell adhesion, Cell cycle, Cell division, Cilium biogenesis/degradation, Host-virus interaction, Transcription, Transcription regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	5	"neutrophil: 80.5"	"Lineage enriched"	"Detected in all"	8	"granulocytes: 80.5"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034861, HPA057913"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Plasma membrane,Intermediate filaments,Centrosome,Cytosol"		Yes	No			"Cluster 1: Neutrophils - Mixed function"	"Cluster 34: Non-specific - Transcription"	"Cluster 15: RT4 - Unknown function"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Intermediate filaments"	"Nuclear bodies, Plasma membrane, Centrosome, Cytosol"	"HPA034861: AB_2674363, HPA057913: AB_2732617"	"unprognostic (7.52e-2)"	"unprognostic (1.46e-1)"	"prognostic favorable (5.67e-4)"	"unprognostic (5.95e-2)"	"unprognostic (3.39e-2)"	"unprognostic (2.51e-2)"	"unprognostic (4.64e-3)"	"unprognostic (1.38e-1)"	"unprognostic (4.43e-2)"	"unprognostic (1.27e-2)"	"unprognostic (2.90e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.51e-2)"	"unprognostic (5.98e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.99e-1)"	19.3	16.5	9.3	17.6	14.2	48.7	24.1	20.7	10.9	16.4	17.0	23.9	30.5	23.6	25.0	24.7	18.1	17.1	14.1	9.5	9.7	16.9	20.5	20.4	18.2	12.3	10.4	31.2	15.5	22.3	10.1	24.7	12.7	20.3	30.0	26.7	16.3	15.4	9.8	20.3	30.8	18.5	10.1	19.0	20.9	10.5	12.6	17.8	26.1	13.4	17.4	21.3	15.4	17.6	61.1	23.8	45.2	27.3	29.8	33.6	29.6	35.3	32.2	38.5	39.8	25.3	42.5	23.9	41.0	33.6	47.3	46.7	44.7	26.6	52.4	8.6	33.0	17.7	49.3	21.4	26.2	17.6	5.1	27.7	27.1	30.2	36.3	30.6	44.7	18.6	29.9	16.8	42.2	12.2	20.5	15.2	22.8	23.1	27.1	19.3	68.8	9.8	34.3	117.9	22.0	14.5	52.7	29.8	45.7	33.9	22.5	15.7	42.2	32.5	29.2	42.1	37.2	9.2	8.6	16.6	13.6	17.1	12.6	15.3	9.9	16.6	5.7	5.9	5.1	8.0	5.1	5.3	5.0	9.3	6.6	5.6	80.5	3.5	8.0	8.6	4.6	2.7	9.3	14.2	20.7	10.9	9.5	9.7	12.3	10.4	12.7	10.1	12.6	17.6	104.7	41.7	57.8	102.5	52.5	48.4	44.3	33.3	75.1	85.4	60.2	67.9	50.8	38.6	47.9	69.9	89.6	42.9	48.1	101.5	11.7	61.2	2.6	63.7	68.7	59.5	44.3	57.7	134.2	60.7	33.1	53.1	85.6	84.6	15.8	107.0	47.5	39.4	24.2	65.6	130.8	64.3	32.6	35.8	27.9	6.6	54.3	44.9	32.0	178.0	57.3	50.5	22.6	117.1	146.4	77.6	98.1	48.2	54.8	64.7	84.0	26.7	49.1	150.5	39.5	62.8	55.5	43.6	34.6	83.0	52.4	37.4	44.8	90.2	65.0	124.2
PLEKHG1	"ARHGEF41, KIAA1209"	ENSG00000120278	"Pleckstrin homology and RhoGEF domain containing G1"	Q9ULL1	6	150599883-150843665	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 31.2"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 91.2;Astrocytes: 98.6;Endothelial cells: 58.4;Microglial cells: 131.2;Oligodendrocytes: 168.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	31	"memory B-cell: 23.9;naive B-cell: 22.9"	"Lineage enriched"	"Detected in single"	31	"B-cells: 23.9"	"Cell line enhanced"	"Detected in many"		"AF22: 17.6;HAP1: 26.4;Karpas-707: 23.4;U-698: 16.6"	"Region enhanced"	"Detected in all"		"thalamus: 51.3"	"Low region specificity"	"Detected in all"			"HPA027128, HPA027319, HPA028270"	Approved		Enhanced	Nucleoplasm		Yes	No			"Cluster 37: B-cells - Transcription"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 57: B-cells - Immune response"	Nucleoplasm		"HPA027128: AB_2672124, HPA027319: AB_10600306, HPA028270: AB_10611388"	"unprognostic (2.93e-1)"	"unprognostic (3.44e-1)"	"unprognostic (3.04e-3)"	"unprognostic (2.34e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.80e-3)"	"unprognostic (1.85e-1)"	"unprognostic (4.82e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.60e-1)"	"unprognostic (3.47e-2)"	"unprognostic (1.50e-1)"	"unprognostic (4.62e-3)"	"unprognostic (3.63e-1)"	"unprognostic (4.30e-2)"	"unprognostic (3.83e-1)"	"unprognostic (2.15e-2)"	15.1	1.6	9.8	9.4	12.3	2.4	13.7	15.5	8.9	7.5	3.9	5.9	4.9	5.6	10.8	9.4	8.7	7.9	6.9	5.8	8.7	7.7	4.9	10.4	14.7	19.5	16.2	3.1	2.7	6.7	3.6	14.2	18.3	2.7	5.9	4.7	3.5	4.9	3.5	7.4	6.6	5.6	18.2	31.2	4.5	6.3	19.1	22.4	5.7	5.0	13.9	9.1	5.3	21.5	0.0	0.2	17.6	0.1	0.0	0.0	12.6	0.0	0.0	0.0	0.0	10.1	4.4	7.2	6.8	0.0	1.6	2.5	26.4	2.4	0.0	11.4	2.9	0.4	1.4	0.0	0.0	0.0	1.9	1.1	6.7	0.0	0.2	0.0	11.0	5.9	0.0	23.4	0.0	0.3	2.3	0.1	1.3	7.0	0.7	1.2	0.0	0.0	5.1	11.9	0.5	0.1	0.1	3.1	2.2	1.9	0.0	0.1	11.2	0.1	2.4	0.0	4.9	0.0	0.0	16.6	0.0	0.0	3.6	0.0	0.0	0.0	0.1	0.0	0.7	23.9	0.4	0.6	0.0	22.9	0.0	0.6	0.0	0.0	0.0	0.0	0.5	0.7	9.8	12.3	15.5	8.9	5.8	8.7	19.5	16.2	18.3	18.2	19.1	21.5	91.2	0.0	6.2	98.6	50.3	4.2	0.5	5.5	2.8	0.9	2.0	3.3	2.1	1.5	6.8	7.3	0.0	5.5	0.7	7.2	3.9	2.6	3.8	20.7	6.2	58.4	5.4	5.0	12.8	1.1	1.6	11.8	7.1	19.2	0.0	7.9	35.0	4.3	0.6	0.0	5.8	8.2	8.2	5.9	3.8	1.6	0.3	2.0	5.4	131.2	4.7	11.3	0.0	14.1	168.5	9.4	12.4	0.4	5.2	1.1	3.9	3.6	9.6	0.7	0.0	2.0	3.0	0.7	1.5	6.2	3.7	2.9	5.1	1.1	5.5	3.6
POLR3E	"C37, FLJ10509, RPC5, SIN"	ENSG00000058600	"RNA polymerase III subunit E"	Q9NVU0	16	22297375-22335101	"Metabolic proteins, Predicted intracellular proteins, RNA polymerase related proteins"	"Antiviral defense, Immunity, Innate immunity, Transcription"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 62.6"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041419, HPA041477"	Approved		Enhanced	Nucleoplasm		Yes	No			"Cluster 39: Non-specific - mRNA processing"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"HPA041419: AB_2677468, HPA041477: AB_10796345"	"unprognostic (3.09e-2)"	"unprognostic (8.59e-2)"	"unprognostic (8.23e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.51e-1)"	"unprognostic (7.28e-2)"	"unprognostic (2.42e-2)"	"unprognostic (7.73e-2)"	"unprognostic (2.96e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.03e-1)"	"prognostic unfavorable (1.74e-4)"	"unprognostic (8.14e-2)"	"unprognostic (1.91e-1)"	"unprognostic (8.96e-2)"	"unprognostic (8.19e-3)"	"unprognostic (3.41e-2)"	12.2	17.0	2.8	6.6	4.5	7.8	12.0	4.3	3.7	10.7	16.1	12.9	6.3	12.7	2.4	13.0	11.8	4.5	15.4	4.1	4.4	8.4	13.3	10.2	5.3	4.8	5.5	11.3	16.1	10.7	12.8	4.6	4.5	11.3	3.0	3.1	12.2	8.2	62.6	14.8	10.0	4.9	3.7	8.9	14.2	11.2	4.2	8.5	12.8	15.5	5.7	12.0	10.4	5.3	21.1	29.0	6.9	19.5	12.1	9.7	27.5	16.1	6.1	9.4	4.2	36.3	14.8	41.7	21.8	11.1	7.9	18.7	35.6	20.6	7.6	28.7	52.3	21.0	31.8	70.9	15.1	34.4	23.0	8.7	19.5	22.1	25.8	3.5	25.9	17.1	63.1	17.0	10.9	34.5	33.6	11.8	37.5	20.2	22.8	45.0	16.7	54.2	8.0	12.4	28.9	20.6	15.6	29.2	14.0	4.2	17.2	16.3	17.3	11.0	12.4	9.2	18.3	23.6	45.6	40.3	11.1	23.0	21.1	0.0	4.7	2.8	8.6	4.8	9.1	7.4	9.1	8.7	7.7	6.0	8.4	7.3	0.5	7.4	4.5	4.4	10.0	6.9	2.8	4.5	4.3	3.7	4.1	4.4	4.8	5.5	4.5	3.7	4.2	5.3	9.4	3.2	14.7	14.4	20.3	32.5	23.0	10.9	12.5	24.0	16.4	19.7	18.9	11.5	13.4	18.4	31.3	25.2	27.3	8.9	5.9	12.0	34.9	21.0	13.3	13.3	15.0	10.5	12.8	12.8	20.2	14.1	13.7	28.5	27.9	23.1	8.9	11.1	13.1	20.2	16.3	13.7	10.2	10.1	22.2	20.9	12.5	11.0	14.2	11.2	9.7	10.4	21.6	18.6	17.9	15.0	11.7	9.1	26.0	28.5	13.6	11.8	16.6	40.9	13.1	21.0	12.2	19.7	16.1	16.5	39.6	28.3	30.3	20.5	16.2	26.3
PRR11	FLJ11029	ENSG00000068489	"Proline rich 11"	Q96HE9	17	59155732-59206709	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 18.1;lymphoid tissue: 20.6"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 26.3;Extravillous trophoblasts: 22.3;Granulosa cells: 14.4;Kupffer cells: 18.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"non-classical monocyte: 9.5"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA023923, HPA052376"	Uncertain		Approved	"Endoplasmic reticulum"		Yes	Yes			"Cluster 14: Monocytes - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Endoplasmic reticulum"		"HPA023923: AB_1855783, HPA052376: AB_2681803"	"unprognostic (1.74e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.30e-2)"	"prognostic unfavorable (1.90e-4)"	"unprognostic (2.15e-1)"	"unprognostic (3.03e-2)"	"prognostic unfavorable (1.35e-7)"	"prognostic unfavorable (1.79e-4)"	"unprognostic (7.22e-3)"	"unprognostic (2.00e-2)"	"prognostic unfavorable (6.18e-4)"	"unprognostic (2.80e-1)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (2.56e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.55e-3)"	1.3	0.7	1.8	6.5	2.0	18.1	1.8	4.3	2.7	1.2	1.1	4.6	6.5	1.7	0.5	3.8	1.4	1.4	1.0	2.0	1.3	0.6	1.4	2.3	10.3	2.3	1.5	1.4	0.5	0.3	0.0	4.3	2.2	0.8	5.6	1.7	0.6	0.7	1.2	3.1	5.0	3.6	1.1	3.3	2.4	1.8	2.3	20.6	1.3	0.4	12.0	2.0	0.6	3.7	105.3	56.9	84.5	24.8	2.4	16.0	31.7	66.7	41.9	69.1	54.2	68.4	78.7	80.2	65.9	52.7	56.2	40.7	67.0	73.9	145.0	99.3	39.1	86.4	58.8	50.3	0.6	88.7	32.5	4.0	5.3	81.9	109.0	17.1	77.2	57.9	48.6	76.7	72.8	95.2	80.7	26.1	31.9	52.0	82.5	67.3	135.7	45.9	20.0	32.4	34.5	45.4	61.7	18.4	29.2	38.0	54.4	34.1	57.8	146.4	157.3	73.5	117.8	48.8	108.2	73.6	34.5	47.4	150.1	1.7	2.1	2.3	0.6	4.0	0.2	1.1	0.5	0.7	2.6	0.6	0.3	0.5	2.1	0.5	9.5	1.1	1.4	0.8	1.8	2.0	4.3	2.7	2.0	1.3	2.3	1.5	2.2	1.1	2.3	3.7	4.5	0.0	1.7	3.3	3.1	1.9	2.0	1.5	0.0	2.0	0.8	1.5	2.0	1.5	1.6	0.0	0.0	6.2	1.4	2.0	0.0	0.4	0.9	1.4	1.9	3.6	4.9	26.3	1.6	0.5	22.3	2.9	2.6	2.2	2.5	14.4	4.2	0.3	7.8	1.7	1.8	5.0	0.0	18.6	6.3	0.4	0.9	7.8	1.8	2.8	8.4	0.9	4.1	2.0	3.4	0.9	0.7	2.2	9.7	1.1	0.5	0.5	0.6	3.2	0.0	2.9	3.3	2.6	5.1	5.5	1.3	2.1	3.3	1.3	8.4	1.7
PRR19	MGC70924	ENSG00000188368	"Proline rich 19"	A6NJB7	19	42302098-42310814	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"testis: 21.6"	"Group enriched"	"Detected in some"	9	"Early spermatids: 26.7;Late spermatids: 60.1;Spermatocytes: 37.9;Spermatogonia: 22.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA070350			Approved	"Nucleoplasm,Nucleoli,Nucleoli rim,Nuclear bodies,Mitotic chromosome,Mitochondria"		Yes	No			"Cluster 15: NK-cells - Transcription"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Nucleoli, Nucleoli rim, Mitotic chromosome"	"Nucleoplasm, Nuclear bodies, Mitochondria"	"HPA070350: AB_2686259"	"unprognostic (2.05e-1)"	"unprognostic (8.03e-3)"	"unprognostic (4.02e-2)"	"unprognostic (7.55e-3)"	"unprognostic (7.33e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.44e-5)"	"unprognostic (3.57e-1)"	"unprognostic (1.92e-2)"	"unprognostic (8.10e-3)"	"unprognostic (3.85e-2)"	"unprognostic (2.77e-1)"	"unprognostic (2.87e-3)"	"unprognostic (4.21e-1)"	"unprognostic (7.26e-2)"	"unprognostic (1.78e-1)"	"unprognostic (4.36e-2)"	0.4	1.1	1.9	0.7	2.5	2.3	0.5	2.1	2.4	0.7	1.3	0.4	0.4	0.6	0.4	1.1	0.5	0.5	0.2	1.9	1.7	0.7	0.6	0.3	0.5	1.8	1.5	0.5	0.4	0.4	0.9	0.4	1.9	0.7	0.2	0.5	0.7	0.4	0.3	0.7	0.5	0.3	1.4	0.5	0.4	21.6	2.0	0.6	0.4	0.1	0.5	0.4	0.7	2.0	2.7	3.9	2.2	2.9	0.1	0.2	2.2	1.2	1.2	3.5	3.5	1.6	2.5	0.5	4.5	1.3	2.6	0.8	1.0	1.0	0.7	1.8	1.0	2.8	2.0	1.0	0.8	0.7	1.6	1.1	1.6	2.3	0.4	0.7	0.6	2.9	1.5	1.3	1.6	6.2	2.7	1.3	2.3	2.5	0.0	1.0	0.4	0.2	1.1	2.1	4.9	1.9	2.1	1.5	0.6	0.6	2.0	1.0	0.8	2.3	3.4	0.5	2.1	0.2	1.0	0.8	2.4	2.0	2.4	0.4	0.4	0.1	0.4	0.4	0.1	0.6	0.3	0.5	0.5	0.4	0.4	0.2	0.4	0.5	0.1	0.3	0.5	0.2	1.9	2.5	2.1	2.4	1.9	1.7	1.8	1.5	1.9	1.4	2.0	2.0	1.2	0.0	0.5	0.0	0.7	0.6	0.9	1.9	4.0	0.4	2.7	2.8	0.5	0.0	0.6	0.0	0.0	0.9	0.3	0.8	1.9	0.9	26.7	1.0	0.7	1.2	0.0	0.0	0.4	1.2	0.6	0.6	1.1	1.5	0.0	0.3	0.0	0.4	0.8	1.7	0.4	0.1	0.0	0.0	0.3	60.1	1.2	0.4	0.0	1.0	0.1	0.0	1.0	1.0	0.3	0.4	1.2	1.2	0.6	0.4	0.6	0.6	2.3	0.2	0.0	0.8	0.7	37.9	22.5	2.1	0.9	0.5	0.4	0.6	0.4	0.7
PRR36		ENSG00000183248	"Proline rich 36"	Q9H6K5	19	7868719-7874390	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 21.0;pituitary gland: 29.6"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 13.4;Breast glandular cells: 9.2;Cone photoreceptor cells: 12.5;Horizontal cells: 10.1"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebral cortex: 21.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"REH: 28.7;SCLC-21H: 8.0;SH-SY5Y: 17.9;T-47d: 9.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062741	Uncertain		Approved	"Nucleoplasm,Nuclear speckles,Golgi apparatus"		Yes	No				"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 14: REH - Unknown function"	"Cluster 35: Glandular cells - Unknown function"	"Golgi apparatus"	"Nucleoplasm, Nuclear speckles"	"HPA062741: AB_2684860"	"unprognostic (3.15e-2)"	"unprognostic (1.02e-1)"	"unprognostic (6.23e-2)"	"unprognostic (5.61e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.20e-2)"	"unprognostic (9.62e-2)"	"unprognostic (3.46e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.15e-3)"	"unprognostic (1.75e-2)"	"unprognostic (2.99e-1)"	"unprognostic (5.69e-3)"	"unprognostic (7.89e-2)"	"prognostic favorable (7.74e-4)"	"unprognostic (3.56e-1)"	"unprognostic (8.52e-3)"	0.1	0.9	3.5	0.1	4.0	0.0	2.5	3.0	21.0	0.8	0.0	0.3	0.2	0.6	0.3	0.3	1.2	0.1	0.2	7.5	0.0	3.3	0.2	0.9	0.0	0.0	0.0	0.7	2.8	2.0	29.6	0.0	0.0	2.5	0.0	5.0	4.1	0.3	0.0	0.7	0.2	0.0	0.0	0.1	0.8	0.8	0.0	0.0	1.1	0.0	0.0	0.3	0.3	0.0	0.1	0.9	6.6	5.1	0.0	0.0	1.1	0.0	0.0	0.0	0.0	1.4	2.9	0.0	1.9	0.0	0.6	0.1	5.1	0.0	0.0	0.0	6.4	0.0	0.3	1.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	3.2	0.1	0.1	0.0	3.0	0.3	0.3	2.5	0.4	0.6	28.7	0.0	0.3	3.7	5.4	8.0	17.9	0.0	0.3	0.0	0.5	9.1	0.0	0.0	0.0	3.2	0.1	0.0	1.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	4.0	3.0	21.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.0	0.5	0.0	0.8	0.0	2.2	13.4	9.2	7.7	1.3	2.8	0.0	5.5	12.5	0.2	0.2	0.2	5.9	3.0	5.4	4.5	0.7	0.2	3.6	0.0	6.9	0.9	0.4	0.3	2.6	6.7	0.0	1.1	0.0	0.5	0.1	10.1	5.8	0.7	0.0	0.0	0.0	0.7	0.6	0.4	0.0	3.7	0.0	5.4	0.0	4.5	0.8	0.9	0.1	0.0	0.6	1.3	0.1	1.5	0.0	4.5	0.0	0.3	1.1	0.3	3.7	3.1	0.0	0.3	0.3	0.5	0.3	1.0
PSD3	"DKFZp761K1423, EFA6D, EFA6R, HCA67, KIAA0942"	ENSG00000156011	"Pleckstrin and Sec7 domain containing 3"	Q9NYI0	8	18527303-19084730	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 62.4"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 558.3;Early spermatids: 686.7;Excitatory neurons: 284.7;Oligodendrocyte precursor cells: 488.1;Oligodendrocytes: 584.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 53.8;hTERT-RPE1: 48.0;LHCN-M2: 47.3;U-87 MG: 49.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002455	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol		Yes	No			"Cluster 11: Basophils - Unknown function"	"Cluster 6: Brain - Smell perception"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nucleoplasm, Vesicles"	Cytosol	"HPA002455: AB_2666597"	"unprognostic (3.87e-2)"	"unprognostic (2.52e-2)"	"prognostic favorable (7.55e-4)"	"prognostic unfavorable (5.76e-5)"	"unprognostic (2.56e-1)"	"unprognostic (2.66e-2)"	"unprognostic (1.04e-2)"	"unprognostic (8.84e-2)"	"unprognostic (7.27e-2)"	"unprognostic (3.39e-1)"	"unprognostic (2.50e-3)"	"unprognostic (2.13e-1)"	"unprognostic (7.18e-3)"	"unprognostic (3.71e-2)"	"unprognostic (8.77e-2)"	"unprognostic (3.83e-2)"	"unprognostic (1.45e-1)"	2.4	17.8	24.8	3.1	46.2	1.2	5.9	62.4	46.1	11.9	0.0	6.7	4.8	8.8	3.8	5.3	2.5	7.4	27.5	51.9	4.0	1.9	18.9	4.6	2.5	3.3	10.0	18.0	9.9	18.4	7.3	6.6	1.8	3.9	7.3	19.9	4.1	5.8	1.3	4.4	5.0	5.8	0.0	10.4	9.8	16.4	7.8	2.2	6.1	2.3	3.4	5.8	4.3	17.2	11.0	5.7	25.0	0.1	8.8	53.8	1.3	5.7	8.9	5.1	10.5	3.3	4.3	6.5	3.6	23.8	22.3	0.9	7.3	10.1	9.7	0.0	6.6	0.6	4.6	0.5	15.9	0.2	0.4	14.2	6.2	28.2	4.9	48.0	6.8	1.6	0.8	4.9	47.3	3.7	0.0	1.2	4.9	9.6	14.7	5.2	21.4	3.0	12.7	14.0	10.7	11.8	2.5	1.1	3.8	5.4	0.3	2.6	28.0	15.7	10.8	37.5	5.1	0.4	0.7	14.8	49.5	2.7	5.4	0.7	0.2	0.2	0.1	0.1	0.2	0.3	0.2	0.1	0.1	0.5	0.1	0.1	0.3	0.3	0.2	0.1	0.4	0.1	24.8	46.2	62.4	46.1	51.9	4.0	3.3	10.0	1.8	0.0	7.8	17.2	8.1	3.2	2.7	558.3	3.3	21.9	13.7	26.4	13.6	191.9	14.4	10.7	119.2	7.2	23.9	9.2	118.9	3.2	0.1	48.5	1.9	13.5	686.7	12.5	69.9	8.2	6.1	0.0	284.7	8.7	1.7	44.3	43.8	6.6	0.0	87.2	4.2	42.9	13.1	18.5	121.6	20.0	44.7	16.0	25.9	217.9	33.2	9.0	1.8	148.9	59.7	78.0	0.0	488.1	584.6	27.0	13.5	53.8	0.1	11.2	20.3	0.3	41.0	52.0	13.1	29.3	17.7	16.5	17.7	32.4	9.9	1.1	1.1	114.9	17.2	23.7
PSEN1	"AD3, FAD, PS1, S182"	ENSG00000080815	"Presenilin 1"	P49768	14	73136418-73223691	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Apoptosis, Cell adhesion, Notch signaling pathway"	"Hydrolase, Protease"	"Alzheimer disease, Amyloidosis, Cancer-related genes, Cardiomyopathy, Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	5	"Oligodendrocytes: 395.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB006844, HPA030760, HPA067496"	Approved		Supported	"Nucleoplasm,Golgi apparatus,Cell Junctions"		Yes	No			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 45: Intestine - Brush border"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Golgi apparatus"	"Nucleoplasm, Cell Junctions"	"CAB006844: , HPA030760: AB_10696211, HPA067496: AB_2685853"	"unprognostic (1.67e-1)"	"unprognostic (4.79e-2)"	"unprognostic (7.39e-2)"	"unprognostic (8.68e-3)"	"unprognostic (3.84e-1)"	"unprognostic (5.48e-3)"	"prognostic unfavorable (1.99e-5)"	"unprognostic (1.65e-1)"	"unprognostic (8.99e-2)"	"unprognostic (8.45e-2)"	"unprognostic (1.76e-3)"	"unprognostic (2.74e-1)"	"prognostic favorable (1.52e-8)"	"unprognostic (2.29e-1)"	"unprognostic (2.32e-1)"	"unprognostic (7.12e-3)"	"unprognostic (1.85e-1)"	25.1	22.6	44.3	26.5	80.7	39.6	28.2	62.4	56.0	28.1	48.9	49.5	50.2	25.3	26.9	35.2	22.9	31.7	18.0	47.4	51.6	35.5	31.9	32.1	22.4	73.0	63.8	22.0	22.9	35.1	11.6	43.1	71.5	24.3	46.3	23.4	22.9	23.4	18.4	38.2	49.0	27.1	55.7	22.6	31.0	32.5	60.8	26.2	36.9	23.3	30.7	35.0	19.2	119.1	37.1	55.9	50.6	20.0	68.9	49.9	46.7	52.5	60.1	52.6	66.7	69.9	88.9	23.7	34.1	50.5	43.0	94.9	43.2	40.1	57.3	54.6	26.7	27.1	35.1	34.4	63.8	27.7	50.7	50.4	71.9	44.3	54.4	48.5	43.2	26.2	31.0	46.6	50.0	72.8	21.0	35.7	22.0	64.5	40.4	26.4	42.7	30.2	73.7	76.5	28.1	38.3	57.4	53.0	47.1	45.4	66.3	60.7	45.7	53.1	43.5	44.1	25.3	30.3	47.9	23.7	44.9	32.8	33.3	126.8	94.5	96.3	23.1	106.0	22.6	23.1	22.3	19.0	83.4	31.8	20.7	20.1	129.3	42.8	125.0	43.6	37.0	70.3	44.3	80.7	62.4	56.0	47.4	51.6	73.0	63.8	71.5	55.7	60.8	119.1	22.2	28.9	30.5	35.9	25.8	28.6	24.6	24.7	12.0	17.1	25.0	17.7	12.5	15.7	30.2	23.9	39.6	27.1	30.7	79.1	5.9	27.1	22.9	26.3	26.4	22.3	16.2	12.0	38.9	26.7	29.2	23.7	32.1	47.4	18.3	29.6	15.7	24.6	30.5	13.5	40.2	39.5	24.4	50.5	40.8	12.9	16.4	52.3	16.0	39.4	51.8	13.8	14.4	48.7	395.8	38.2	58.8	15.4	23.6	38.8	76.2	13.0	29.0	28.0	26.3	20.0	19.0	40.2	14.4	20.4	33.0	49.9	21.6	18.6	41.3	51.5
PTPN23	"DKFZP564F0923, HD-PTP, KIAA1471"	ENSG00000076201	"Protein tyrosine phosphatase non-receptor type 23"	Q9H3S7	3	47381011-47413435	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Cilium biogenesis/degradation, Protein transport, Transport"	"Hydrolase, Protein phosphatase"	"Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016845	Approved		Supported	"Nucleoplasm,Nuclear bodies,Vesicles"		Yes	No			"Cluster 10: Basophils - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 15: RT4 - Unknown function"	"Cluster 44: Endometrium - Transcription"	"Nucleoplasm, Nuclear bodies"	Vesicles	"HPA016845: AB_1855926"	"unprognostic (1.17e-3)"	"unprognostic (8.68e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.63e-1)"	"unprognostic (6.24e-2)"	"unprognostic (1.07e-3)"	"unprognostic (2.07e-2)"	"unprognostic (9.55e-2)"	"unprognostic (7.12e-2)"	"unprognostic (5.67e-2)"	"unprognostic (4.34e-2)"	"prognostic favorable (1.82e-4)"	"unprognostic (3.05e-2)"	"unprognostic (4.40e-1)"	"unprognostic (9.53e-2)"	"unprognostic (4.68e-2)"	18.5	19.1	6.2	12.6	9.2	14.7	17.4	5.8	10.5	23.3	5.1	16.3	14.3	20.9	7.5	19.0	19.2	8.4	13.2	7.1	7.2	17.5	14.0	18.7	9.1	8.8	7.2	23.5	20.2	23.5	30.9	11.6	8.5	18.7	6.5	8.5	20.0	11.4	30.0	26.4	18.4	8.8	5.5	20.0	16.1	15.6	7.7	8.0	27.1	8.9	7.3	18.5	20.4	14.4	21.5	29.9	16.4	21.4	21.0	16.0	15.8	19.2	18.9	17.5	14.8	25.0	20.7	15.1	17.2	21.9	31.2	19.0	14.3	20.8	8.5	14.3	15.1	21.0	22.2	24.0	23.0	12.3	27.5	21.4	20.9	22.9	23.2	12.4	21.7	12.5	15.9	20.3	19.0	30.2	11.5	10.4	17.5	14.9	20.1	7.2	7.9	18.5	13.2	40.9	8.6	20.6	17.1	35.6	13.6	9.8	20.3	12.0	22.4	26.7	22.2	37.7	27.5	28.8	20.4	8.7	29.0	11.6	19.5	0.8	0.2	0.0	0.1	0.1	0.0	0.2	0.1	0.2	0.0	0.1	0.1	0.1	0.2	0.2	0.0	0.2	0.3	0.3	6.2	9.2	5.8	10.5	7.1	7.2	8.8	7.2	8.5	5.5	7.7	14.4	11.1	9.6	7.0	17.0	8.2	8.0	5.2	6.9	13.6	11.7	9.5	8.0	8.7	8.6	9.5	5.5	14.6	10.6	11.0	15.7	1.9	10.5	2.1	10.3	13.7	12.4	7.3	2.5	9.8	8.9	7.9	9.1	26.5	21.1	2.5	14.9	11.4	12.7	13.9	16.8	12.0	16.3	20.3	10.4	5.5	3.1	19.3	9.5	12.4	7.5	8.7	8.8	6.2	9.5	14.3	13.5	10.4	13.5	15.4	9.3	14.6	9.4	12.6	14.2	6.6	10.2	8.8	13.6	13.3	13.2	10.9	9.3	8.9	9.4	12.8	8.2
PWP1	IEF-SSP-9502	ENSG00000136045	"PWP1 homolog, endonuclein"	Q13610	12	107685799-107713162	"Predicted intracellular proteins"	"Ribosome biogenesis, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038708			Approved	"Nucleoli rim,Golgi apparatus"		Yes	No			"Cluster 19: B-cells - Humoral immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoli rim"	"Golgi apparatus"	"HPA038708: AB_2676163"	"unprognostic (7.06e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.70e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.81e-1)"	"prognostic unfavorable (9.65e-4)"	"prognostic unfavorable (1.40e-5)"	"unprognostic (1.97e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.89e-1)"	"prognostic unfavorable (2.26e-4)"	"unprognostic (2.00e-1)"	"unprognostic (6.95e-2)"	"unprognostic (6.13e-2)"	"unprognostic (1.10e-2)"	29.7	20.9	18.6	26.4	19.0	31.9	33.7	18.8	23.6	24.9	29.5	27.7	17.7	30.3	24.8	28.7	24.7	20.4	17.3	18.9	19.1	30.4	32.2	21.4	32.0	17.4	18.0	32.8	25.8	33.0	17.8	29.5	20.0	25.2	26.0	26.9	24.4	27.5	22.9	28.8	21.7	32.3	18.1	23.7	23.1	30.1	18.8	33.2	25.9	17.6	37.4	31.4	24.5	19.0	71.0	86.9	51.8	49.4	70.9	77.2	68.5	72.9	81.9	100.8	84.8	88.5	32.9	108.8	38.4	112.9	68.4	60.7	70.8	77.0	99.2	54.7	80.6	82.9	50.5	103.2	72.7	101.8	56.9	70.2	69.1	93.5	83.0	79.0	119.8	66.0	110.8	29.8	109.1	78.3	71.6	99.3	62.0	64.8	141.2	58.3	61.2	101.4	62.7	98.3	58.4	46.9	59.6	42.4	104.1	64.8	75.3	49.7	94.9	76.7	38.9	63.0	84.1	42.5	62.8	84.9	34.3	55.3	68.7	29.4	20.8	16.2	41.7	27.8	37.8	68.5	40.6	43.9	35.0	64.1	34.5	47.9	6.6	44.2	34.4	47.3	48.6	29.7	18.6	19.0	18.8	23.6	18.9	19.1	17.4	18.0	20.0	18.1	18.8	19.0	44.1	41.7	38.1	13.7	80.1	48.4	52.3	70.6	36.5	50.4	41.0	41.3	22.1	25.8	48.9	27.6	37.5	69.1	48.4	14.6	58.7	69.7	24.4	34.5	47.3	52.0	21.0	52.2	15.6	63.0	74.5	51.6	30.5	35.8	57.6	41.5	43.5	52.0	46.2	33.7	19.0	31.9	26.4	34.3	28.0	11.1	50.4	33.2	30.2	4.7	75.2	41.4	38.1	15.1	16.7	68.0	19.8	44.0	46.0	50.2	24.5	70.8	42.8	46.2	26.3	41.8	50.9	124.3	79.2	41.9	49.7	45.7	44.0	45.8	34.1	40.5
RACGAP1	MgcRacGAP	ENSG00000161800	"Rac GTPase activating protein 1"	Q9H0H5	12	49976923-50033136	"Predicted intracellular proteins"	"Cell cycle, Cell division, Differentiation, Ion transport, Spermatogenesis, Transport"	"Developmental protein, GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 38.9;lymphoid tissue: 43.0;testis: 45.5"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 55.7;Extravillous trophoblasts: 49.4;Spermatocytes: 79.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025859, HPA039427, HPA043912"	Enhanced		Enhanced	Nucleoplasm		Yes	Yes			"Cluster 44: Non-specific - Transcription"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"CAB025859: , HPA039427: AB_2676503, HPA043912: AB_2678728"	"prognostic unfavorable (1.51e-4)"	"unprognostic (1.91e-1)"	"unprognostic (3.74e-3)"	"unprognostic (1.53e-2)"	"unprognostic (1.58e-1)"	"unprognostic (4.82e-2)"	"prognostic unfavorable (1.86e-6)"	"unprognostic (1.15e-3)"	"unprognostic (3.07e-3)"	"unprognostic (5.31e-2)"	"prognostic unfavorable (4.12e-6)"	"unprognostic (5.56e-2)"	"prognostic unfavorable (3.98e-8)"	"unprognostic (3.13e-2)"	"unprognostic (4.94e-1)"	"unprognostic (6.16e-2)"	"unprognostic (2.15e-1)"	5.0	2.5	5.5	13.7	8.2	38.9	7.1	6.9	6.3	5.2	3.2	16.7	10.5	5.3	1.5	21.3	4.4	6.4	2.8	5.0	6.0	9.2	4.7	6.2	23.9	6.7	7.1	2.4	2.7	5.8	1.4	14.0	6.5	3.3	18.7	5.3	4.8	3.4	4.9	14.4	11.6	12.5	5.5	6.5	9.8	45.5	7.6	43.0	3.3	4.8	30.2	7.7	8.0	7.0	193.0	174.5	135.8	86.8	24.8	29.7	113.0	195.0	97.0	207.3	140.3	174.6	144.7	107.5	86.0	108.3	99.9	127.1	137.7	93.6	219.9	203.0	85.4	137.9	165.8	58.1	8.4	146.1	109.0	16.2	17.2	140.7	111.4	60.3	71.7	96.4	101.6	159.6	197.0	136.8	122.5	72.6	96.2	108.9	112.9	113.9	163.5	78.3	54.9	95.7	113.9	97.5	161.7	102.7	53.0	68.8	199.7	64.8	64.9	136.2	119.1	86.8	144.7	83.3	225.2	126.6	67.7	97.0	81.1	24.1	3.2	4.7	6.5	4.1	5.7	8.2	7.9	9.2	2.8	4.3	4.6	6.1	0.7	11.0	2.6	1.8	19.1	5.8	5.5	8.2	6.9	6.3	5.0	6.0	6.7	7.1	6.5	5.5	7.6	7.0	2.0	6.4	6.4	2.9	4.2	12.9	2.5	4.9	6.2	1.5	4.8	5.1	1.5	2.8	3.3	5.5	4.2	21.8	4.4	3.1	19.6	1.9	15.2	2.2	3.1	2.7	0.0	55.7	7.5	2.2	49.4	5.9	7.7	4.0	2.5	14.2	5.3	2.7	13.1	1.7	8.0	5.7	20.3	11.3	8.0	17.7	1.5	7.1	1.8	1.0	4.5	2.7	6.2	6.0	12.3	2.0	1.0	3.8	10.9	2.8	1.1	2.1	2.3	0.8	13.1	3.1	5.5	79.6	32.2	19.5	12.9	8.6	6.9	2.2	11.6	2.9
RAD51AP1	PIR51	ENSG00000111247	"RAD51 associated protein 1"	Q96B01	12	4538798-4560047	"Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair, Meiosis"	"DNA-binding, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 16.9;lymphoid tissue: 14.4"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 33.4;Erythroid cells: 47.8;Extravillous trophoblasts: 34.1;Hofbauer cells: 40.8;Late spermatids: 68.1;Spermatocytes: 35.9"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 6.9"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA051499			Approved	Nucleoplasm		Yes	Yes			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA051499: AB_2681508"	"unprognostic (1.03e-1)"	"unprognostic (5.44e-3)"	"unprognostic (1.84e-1)"	"prognostic unfavorable (9.42e-4)"	"unprognostic (6.30e-2)"	"unprognostic (5.25e-3)"	"prognostic unfavorable (3.53e-4)"	"unprognostic (2.15e-2)"	"unprognostic (2.26e-2)"	"unprognostic (6.29e-3)"	"prognostic unfavorable (1.22e-5)"	"unprognostic (1.00e-1)"	"prognostic unfavorable (4.44e-15)"	"unprognostic (2.68e-2)"	"unprognostic (2.22e-1)"	"unprognostic (6.88e-2)"	"unprognostic (3.75e-2)"	0.9	0.8	0.3	4.8	0.4	16.9	2.7	0.4	0.7	0.9	0.3	5.2	5.2	1.2	0.6	3.2	1.0	1.1	0.5	0.3	0.3	0.8	1.8	1.4	8.9	0.4	0.4	0.5	0.4	0.6	0.3	3.8	0.4	1.3	6.5	1.5	1.0	1.0	0.5	3.2	4.8	1.9	0.4	3.4	2.7	6.3	0.4	14.4	1.0	0.6	7.9	1.7	1.3	0.5	37.5	13.0	45.3	22.7	2.7	5.7	53.0	48.2	21.2	52.6	68.9	35.4	35.4	48.6	7.0	10.4	24.7	23.1	31.8	14.5	80.0	38.7	27.0	61.4	21.6	24.8	0.6	56.6	29.9	1.2	1.5	31.6	30.4	7.5	21.4	33.0	39.2	54.4	33.7	13.6	46.5	20.5	110.4	36.3	14.4	46.0	54.3	19.2	16.1	18.3	15.1	16.6	35.9	27.7	11.6	45.5	11.3	32.6	9.5	35.5	36.5	38.8	52.4	7.8	10.0	93.3	13.3	40.0	29.4	0.0	0.5	0.7	0.1	2.3	0.5	3.1	0.4	1.0	0.4	3.4	0.1	0.2	0.0	1.4	2.0	6.9	1.0	0.6	0.3	0.4	0.4	0.7	0.3	0.3	0.4	0.4	0.4	0.4	0.4	0.5	1.4	0.0	0.5	0.7	6.1	5.2	2.3	6.6	1.2	3.1	3.4	5.7	1.4	2.8	4.5	0.0	4.2	20.3	11.3	5.7	0.0	3.0	33.4	3.3	2.9	2.9	2.4	47.8	2.7	2.7	34.1	5.2	6.1	3.6	1.3	22.6	2.5	1.2	40.8	0.0	1.1	6.4	16.2	6.2	5.6	68.1	1.2	10.1	0.0	3.7	6.8	2.7	3.1	0.5	2.4	1.5	0.8	1.5	15.5	1.0	1.2	1.5	0.9	4.8	0.0	2.4	4.2	35.9	25.0	10.0	2.6	4.7	4.6	2.0	14.6	2.7
RANBP17		ENSG00000204764	"RAN binding protein 17"	Q9H2T7	5	170861870-171300015	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 2.3"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 112.7;Excitatory neurons: 100.6;Glandular and luminal cells: 59.5;Inhibitory neurons: 152.9;Oligodendrocyte precursor cells: 65.4;Oligodendrocytes: 87.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 4.0;SK-BR-3: 3.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029568, HPA029569"	Uncertain		Approved	"Nucleoplasm,Nuclear membrane,Nuclear bodies,Cytosol"		Yes	No				"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 12: NES - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Nuclear bodies"	"Nuclear membrane, Cytosol"	"HPA029568: AB_10599825, HPA029569: AB_10601571"	"unprognostic (4.63e-2)"	"unprognostic (2.63e-3)"	"unprognostic (1.06e-1)"	"unprognostic (8.28e-2)"	"unprognostic (1.75e-3)"	"unprognostic (5.12e-3)"	"unprognostic (1.50e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.54e-1)"	"unprognostic (9.59e-2)"	"unprognostic (1.64e-2)"	"unprognostic (2.19e-3)"	"unprognostic (2.72e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.56e-3)"	0.2	0.8	0.3	0.1	0.2	0.1	0.2	2.3	0.6	0.2	0.8	0.2	0.2	0.5	0.2	0.0	0.4	0.5	0.2	0.1	1.1	0.4	0.3	0.8	0.3	0.9	0.9	0.2	1.4	0.8	0.4	0.8	1.3	0.4	0.4	0.8	0.8	0.5	0.0	0.1	0.3	0.3	0.6	0.0	0.3	1.4	0.6	0.2	1.0	0.0	0.1	0.1	0.1	1.1	0.0	0.7	4.0	3.3	1.3	0.3	2.4	2.6	1.2	1.8	1.1	1.5	0.0	0.1	2.0	2.5	0.0	0.0	0.0	1.2	3.5	0.0	2.4	0.7	1.4	0.0	1.1	0.0	0.0	2.6	0.2	0.2	0.0	0.2	1.7	0.0	0.3	0.0	1.0	1.7	0.0	0.0	0.3	0.6	0.2	0.0	2.4	0.0	0.6	1.0	0.2	1.4	0.0	3.9	1.5	1.7	0.7	1.2	2.4	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	2.3	0.6	0.1	1.1	0.9	0.9	1.3	0.6	0.6	1.1	9.4	9.6	2.0	12.7	0.0	0.3	6.2	5.8	1.8	24.8	6.1	2.8	1.3	7.2	4.8	0.0	14.6	10.4	1.7	2.3	0.0	7.3	112.7	22.4	17.5	7.9	5.4	5.5	100.6	1.4	3.2	4.9	5.1	59.5	0.0	15.6	4.2	1.6	1.9	0.0	152.9	3.7	2.0	0.6	1.4	46.5	2.8	1.0	1.8	9.4	1.2	5.5	5.2	65.4	87.1	5.3	2.9	3.0	0.8	13.0	3.9	0.9	2.4	26.9	0.0	3.0	5.1	27.2	26.7	1.4	0.0	2.5	0.8	7.5	6.3	7.6
RANGAP1	"Fug1, KIAA1835, SD"	ENSG00000100401	"Ran GTPase activating protein 1"	P46060	22	41244779-41286187	"Plasma proteins, Predicted intracellular proteins, Transporters"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	6	"Late spermatids: 1717.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004293, HPA050110, HPA062034"	Supported		Enhanced	"Nuclear membrane,Vesicles,Cytosol"		Yes	Yes		75000	"Cluster 27: Non-specific - Gene expression"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 25: Spermatids - Spermatogenesis"	"Nuclear membrane"	"Vesicles, Cytosol"	"CAB004293: AB_2176987, HPA050110: AB_2681018, HPA062034: AB_2684667"	"unprognostic (1.30e-2)"	"unprognostic (3.16e-2)"	"unprognostic (1.66e-1)"	"unprognostic (7.97e-2)"	"unprognostic (2.57e-1)"	"unprognostic (2.54e-1)"	"prognostic unfavorable (1.08e-4)"	"unprognostic (8.28e-3)"	"unprognostic (8.09e-2)"	"unprognostic (9.87e-2)"	"unprognostic (5.84e-2)"	"unprognostic (7.56e-2)"	"unprognostic (7.07e-3)"	"prognostic favorable (5.39e-4)"	"unprognostic (2.06e-1)"	"unprognostic (2.74e-1)"	"unprognostic (2.68e-1)"	27.5	72.9	78.2	26.0	86.0	48.1	29.6	70.8	102.3	34.4	47.7	29.2	18.1	24.9	12.0	79.8	23.6	17.2	45.1	79.5	85.2	43.9	88.0	41.6	30.6	102.7	77.9	32.5	60.9	12.7	57.4	22.8	105.1	39.3	13.2	32.7	38.0	17.6	43.0	96.9	30.6	17.5	68.7	42.3	39.6	178.1	82.0	40.4	34.4	14.2	31.8	34.7	45.4	109.1	228.0	112.2	75.9	77.3	38.8	31.4	85.9	194.5	103.8	182.8	98.4	135.9	71.9	118.0	154.0	137.4	94.8	203.0	135.5	145.4	125.2	95.7	199.2	103.3	115.0	107.9	46.7	171.6	72.5	30.0	69.5	132.2	123.4	67.6	102.1	45.0	127.7	83.3	111.9	186.1	96.3	130.0	84.5	217.6	127.6	118.8	73.4	126.0	72.5	123.7	66.6	44.1	139.1	117.7	71.7	74.6	72.2	64.4	146.5	141.7	138.5	78.6	154.6	60.1	92.8	124.2	99.3	119.3	82.0	2.7	7.6	6.9	8.1	9.0	9.5	5.9	8.2	7.8	5.6	6.4	7.4	5.9	2.0	5.9	12.9	5.9	9.5	8.2	78.2	86.0	70.8	102.3	79.5	85.2	102.7	77.9	105.1	68.7	82.0	109.1	10.9	3.2	20.9	8.5	15.0	23.1	22.2	10.9	18.2	16.0	22.4	16.9	19.6	25.8	9.6	9.2	14.6	22.7	20.3	22.9	3.9	33.3	270.7	21.0	14.7	16.1	25.0	16.6	28.3	20.3	35.3	13.3	25.5	25.1	6.3	74.4	8.9	21.8	16.6	15.2	20.8	19.1	16.2	13.9	20.9	1717.0	14.9	16.8	12.4	5.6	8.9	10.1	14.4	6.0	32.2	39.8	5.7	12.0	25.8	37.4	7.1	13.1	11.4	26.4	0.0	6.8	18.2	25.6	17.7	38.8	31.0	23.7	24.3	42.5	24.8	23.3
RANGRF	"HSPC165, HSPC236, MOG1, RANGNRF"	ENSG00000108961	"RAN guanine nucleotide release factor"	Q9HD47	17	8288654-8290092	"Predicted intracellular proteins"	"Protein transport, Transport"	"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"Early spermatids: 435.1;Late spermatids: 1448.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA057280, HPA057888"	Approved		Supported	Nucleoplasm,Cytosol		Yes	No			"Cluster 35: T-regs - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA057280: AB_2683393, HPA057888: AB_2683549"	"unprognostic (2.87e-2)"	"unprognostic (2.93e-2)"	"unprognostic (7.41e-2)"	"prognostic favorable (1.65e-4)"	"unprognostic (1.47e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.90e-3)"	"unprognostic (2.26e-2)"	"unprognostic (2.45e-1)"	"unprognostic (2.01e-2)"	"prognostic favorable (4.39e-4)"	"unprognostic (1.43e-1)"	"unprognostic (6.34e-2)"	"unprognostic (3.11e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.13e-2)"	28.3	27.6	40.9	18.8	42.4	20.5	29.2	39.9	43.8	47.4	40.6	38.1	15.8	36.9	31.9	15.7	35.1	16.9	41.6	40.6	42.5	44.2	18.6	25.3	33.0	40.6	41.3	36.3	15.1	43.8	32.7	22.7	41.1	35.5	15.9	34.8	13.1	27.6	24.1	19.4	28.1	27.1	41.4	33.3	39.0	78.4	43.1	34.0	25.1	26.0	32.3	34.7	23.3	41.0	52.8	59.5	41.0	42.7	30.0	41.0	35.4	29.7	59.9	75.3	72.7	30.4	20.3	98.4	31.7	35.9	29.7	58.0	77.7	39.3	53.7	71.2	97.6	46.6	45.0	46.6	72.9	30.7	66.2	39.6	75.1	66.4	66.4	38.9	65.5	93.4	21.2	27.1	48.9	1.3	91.7	98.4	29.7	29.8	22.7	81.1	32.0	61.8	44.4	21.3	15.7	45.2	23.5	36.2	65.0	25.9	2.8	28.3	36.3	16.4	29.5	33.0	58.4	47.5	40.0	121.4	35.1	60.8	24.1	17.2	47.6	81.5	68.2	50.7	64.4	74.7	82.8	78.1	51.5	82.0	72.3	61.6	5.9	70.1	41.0	67.8	129.9	57.5	40.9	42.4	39.9	43.8	40.6	42.5	40.6	41.3	41.1	41.4	43.1	41.0	21.2	9.6	26.1	6.2	35.8	18.1	24.3	23.5	25.0	26.2	31.4	36.2	4.7	12.8	17.5	25.8	12.5	93.2	25.4	9.4	68.4	25.5	435.1	19.0	18.8	26.0	19.8	15.4	6.2	18.3	46.4	25.3	14.8	19.3	27.8	19.0	23.9	17.3	49.3	20.2	9.0	17.4	26.4	16.4	19.2	1448.8	28.3	18.9	17.8	1.9	29.5	33.6	58.7	3.0	9.5	21.1	21.2	31.6	37.5	22.9	14.3	66.7	14.3	38.4	19.7	16.3	34.0	180.6	23.0	10.6	19.6	112.9	35.6	28.1	21.8	16.1
RINT1	"FLJ11785, RINT-1"	ENSG00000135249	"RAD50 interactor 1"	Q6NUQ1	7	105532169-105567677	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle, ER-Golgi transport, Protein transport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019875, HPA031646"	Approved		Approved	"Golgi apparatus"		Yes	No			"Cluster 40: NK-cells - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	"Golgi apparatus"		"HPA019875: AB_1856283, HPA031646: AB_2673975"	"unprognostic (1.58e-2)"	"unprognostic (3.94e-2)"	"unprognostic (9.00e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.50e-1)"	"unprognostic (7.95e-2)"	"unprognostic (4.68e-3)"	"unprognostic (1.33e-2)"	"unprognostic (4.96e-3)"	"unprognostic (2.41e-1)"	"unprognostic (8.72e-2)"	"unprognostic (5.35e-2)"	"unprognostic (8.75e-3)"	"unprognostic (1.47e-2)"	"unprognostic (1.75e-1)"	"prognostic unfavorable (2.39e-5)"	"unprognostic (1.76e-1)"	7.3	6.1	2.8	9.0	3.1	15.2	10.0	6.9	3.7	8.2	5.6	8.1	9.4	8.6	7.2	11.3	8.0	6.7	8.2	3.1	3.1	9.3	10.5	6.7	13.4	2.8	2.7	8.0	11.6	9.7	5.4	8.8	3.1	7.8	9.3	10.3	11.3	6.1	16.7	8.7	7.1	6.4	3.2	8.8	9.7	11.1	2.7	9.9	8.8	13.3	13.7	8.4	5.7	4.1	28.8	23.5	12.1	27.8	18.8	24.9	15.9	27.2	19.2	26.4	29.6	27.4	18.4	31.6	31.3	24.1	29.4	19.0	22.5	21.0	34.7	17.0	25.9	18.3	26.1	18.5	14.5	38.9	17.8	17.9	16.4	28.1	16.3	20.3	29.1	16.3	39.5	23.2	30.3	46.9	29.3	28.6	26.1	23.8	23.1	17.5	20.5	45.4	14.2	23.6	20.5	22.4	28.9	47.7	20.6	20.9	19.4	12.5	20.3	30.2	24.0	83.1	34.8	46.6	59.7	61.4	20.0	31.8	34.6	4.4	3.9	4.4	6.7	5.8	11.6	9.0	9.8	9.2	6.0	7.8	8.6	9.4	0.7	9.1	4.8	4.0	10.5	6.2	2.8	3.1	6.9	3.7	3.1	3.1	2.8	2.7	3.1	3.2	2.7	4.1	6.7	3.2	9.8	10.4	12.4	6.6	9.6	7.7	8.6	5.8	5.9	5.3	10.5	1.5	9.4	3.7	8.4	11.2	13.4	6.0	9.8	8.1	10.8	9.0	6.4	6.8	5.4	4.6	25.6	6.3	10.3	9.4	12.2	5.5	10.1	7.5	4.2	5.1	7.3	6.7	26.0	5.8	10.2	5.6	3.4	6.2	8.7	5.2	5.4	9.4	5.7	7.8	7.2	9.0	18.2	6.7	4.0	9.8	17.9	6.5	5.5	6.8	18.1	8.9	6.6	8.3	8.0	29.2	12.4	8.3	7.7	12.0	10.8	7.5	6.4	8.3
RLF	"Zn-15L, ZNF292L"	ENSG00000117000	"RLF zinc finger"	Q13129	1	40161387-40240921	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054653, HPA057300"	Uncertain		Approved	Nucleoplasm,Nucleoli		Yes	No			"Cluster 42: Non-specific - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	Nucleoli	"HPA054653: AB_2682557, HPA057300: AB_2683404"	"unprognostic (1.71e-1)"	"unprognostic (2.24e-2)"	"unprognostic (6.46e-2)"	"unprognostic (1.88e-2)"	"unprognostic (6.78e-2)"	"unprognostic (2.70e-1)"	"prognostic unfavorable (1.75e-4)"	"unprognostic (5.84e-2)"	"unprognostic (3.43e-2)"	"unprognostic (2.18e-2)"	"unprognostic (2.60e-2)"	"unprognostic (9.38e-2)"	"prognostic unfavorable (7.68e-6)"	"unprognostic (1.86e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.12e-1)"	"unprognostic (4.69e-2)"	8.7	4.9	5.5	6.2	6.0	32.8	8.3	12.0	7.9	8.4	2.5	7.6	5.1	7.9	4.7	7.3	7.0	6.6	7.5	6.0	5.6	4.9	7.7	8.2	7.7	4.1	4.3	8.3	5.6	6.5	5.1	7.3	4.2	6.6	5.2	15.4	5.7	5.4	8.5	12.2	6.2	6.1	4.3	6.2	5.7	10.3	5.2	10.2	5.8	7.1	8.5	7.8	8.4	8.2	18.3	6.9	13.3	13.9	11.6	9.4	15.8	6.7	9.9	11.3	14.9	14.0	9.4	18.1	8.6	8.6	8.4	16.8	16.9	11.8	20.4	8.5	11.4	14.9	8.0	8.7	9.2	12.5	8.7	9.3	12.1	12.0	13.5	13.5	7.8	9.8	23.0	10.8	10.4	5.8	10.6	7.5	17.8	6.7	7.9	8.2	21.8	10.6	7.2	18.2	9.4	13.1	12.5	16.5	12.0	20.5	7.8	44.6	6.7	13.2	14.1	11.0	12.6	9.8	9.8	16.6	11.5	11.4	8.4	6.9	1.5	3.0	1.8	2.0	2.4	2.3	1.8	1.9	1.9	2.1	2.3	2.0	3.2	2.4	2.4	0.8	1.8	1.3	5.5	6.0	12.0	7.9	6.0	5.6	4.1	4.3	4.2	4.3	5.2	8.2	36.7	32.1	15.1	52.2	55.8	65.6	50.3	12.7	30.7	17.8	25.5	18.4	16.9	2.8	23.9	3.7	16.7	8.9	40.6	10.4	5.9	13.8	41.3	43.8	41.6	24.9	20.2	11.3	87.1	6.7	10.6	34.9	29.6	56.0	26.6	23.0	16.1	9.0	9.7	26.9	84.7	8.8	14.2	13.8	45.2	8.7	9.0	39.9	17.8	60.9	17.5	14.1	9.2	71.9	89.0	10.1	15.5	7.9	44.6	28.7	8.9	5.5	26.0	17.2	13.1	52.8	36.1	32.2	20.8	29.3	61.1	17.2	45.8	17.0	10.8	33.0
RRM2	"C2orf48, FLJ25102"	ENSG00000171848	"Ribonucleotide reductase regulatory subunit M2"	P31350	2	10120698-10211725	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted membrane proteins"	"DNA replication"	Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"bone marrow: 44.2;esophagus: 18.4;intestine: 19.7;lymphoid tissue: 58.1"	"Group enriched"	"Detected in many"	4	"Erythroid cells: 214.0;Extravillous trophoblasts: 254.1;Plasma cells: 248.0"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056994	Enhanced		Supported	Cytosol		Yes	Yes		13000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Cytosol		"HPA056994: AB_2683304"	"unprognostic (2.10e-2)"	"unprognostic (1.62e-1)"	"unprognostic (6.40e-3)"	"unprognostic (4.42e-3)"	"unprognostic (5.70e-2)"	"unprognostic (1.69e-1)"	"prognostic unfavorable (1.39e-5)"	"unprognostic (1.04e-3)"	"unprognostic (6.67e-3)"	"unprognostic (4.53e-2)"	"prognostic unfavorable (1.62e-4)"	"unprognostic (5.11e-3)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (3.05e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.09e-2)"	1.5	1.3	0.3	12.4	0.3	44.2	2.9	0.5	0.4	3.0	1.9	14.2	9.4	2.2	0.7	18.4	0.8	1.1	0.5	0.3	0.3	0.9	3.2	2.4	35.5	0.4	0.4	0.3	1.1	0.3	0.2	4.6	0.4	0.9	19.7	0.2	2.1	0.5	0.1	3.7	7.5	6.1	0.3	11.1	6.0	2.9	0.8	58.1	0.9	0.1	37.6	6.0	4.6	0.5	110.2	25.0	127.1	49.9	7.4	22.5	116.8	209.2	128.6	170.2	187.9	70.8	59.1	114.4	9.5	88.6	151.1	55.0	188.0	136.6	198.0	210.7	41.8	146.3	52.1	105.1	0.8	146.7	87.4	8.1	3.4	234.6	16.2	27.7	103.3	110.4	63.4	328.6	214.3	57.1	167.3	90.9	83.0	133.3	103.6	87.6	187.0	67.8	87.1	62.7	67.7	56.2	198.0	116.6	17.3	51.8	69.2	31.4	57.6	93.1	125.1	66.9	289.6	212.1	184.9	195.9	51.0	134.4	107.7	0.3	0.1	0.1	1.2	0.0	0.0	0.1	0.3	0.8	0.1	0.1	0.1	0.4	0.4	0.8	0.0	0.1	0.2	0.2	0.3	0.3	0.5	0.4	0.3	0.3	0.4	0.4	0.4	0.3	0.8	0.5	0.2	3.2	1.5	0.0	25.0	10.5	3.0	9.2	1.2	0.0	3.9	4.4	1.4	1.5	2.3	0.0	0.0	42.3	5.6	12.9	1.9	1.2	3.9	2.2	3.5	4.2	0.0	214.0	0.1	0.0	254.1	11.2	11.7	3.6	5.7	12.2	3.9	3.7	47.9	0.0	0.0	26.9	2.0	7.2	8.8	6.8	0.3	5.0	0.0	1.0	0.0	0.0	7.2	0.0	0.0	0.5	0.3	0.4	248.0	1.5	2.4	2.1	4.6	0.0	0.0	0.2	14.6	22.9	34.0	51.5	1.6	48.7	11.9	1.2	36.7	5.6
RRP36	"C6orf153, dJ20C7.4"	ENSG00000124541	"Ribosomal RNA processing 36"	Q96EU6	6	43021623-43034156	"Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029904, HPA029905"	Uncertain		Enhanced	Nucleoplasm,Nucleoli		Yes	No			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 21: OE19 - Mitochondria"	"Cluster 7: Non-specific - Mitochondria"	"Nucleoplasm, Nucleoli"		"HPA029904: AB_10611817, HPA029905: AB_2673244"	"unprognostic (1.76e-1)"	"unprognostic (4.47e-1)"	"unprognostic (3.78e-2)"	"unprognostic (1.46e-2)"	"unprognostic (3.25e-1)"	"unprognostic (1.33e-1)"	"prognostic unfavorable (5.95e-4)"	"unprognostic (2.61e-1)"	"unprognostic (6.83e-2)"	"unprognostic (1.32e-3)"	"unprognostic (1.39e-1)"	"unprognostic (3.38e-1)"	"prognostic unfavorable (2.48e-5)"	"unprognostic (3.53e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.09e-2)"	30.0	34.6	19.4	27.4	19.7	28.7	28.7	21.5	23.2	26.0	19.8	29.0	20.8	25.5	22.9	37.8	23.2	19.0	30.1	20.3	22.3	35.1	37.3	25.5	32.3	21.3	20.9	18.4	35.8	34.7	31.9	24.2	22.0	28.5	24.3	16.6	27.1	25.0	51.3	34.3	25.9	29.7	20.8	33.3	30.6	17.7	21.0	31.1	23.4	34.8	35.2	30.0	26.4	20.8	141.5	77.9	75.8	111.3	79.7	74.0	63.6	108.9	97.7	136.1	132.6	141.9	59.8	64.7	86.3	113.8	100.1	73.5	127.7	131.8	149.3	82.5	129.9	104.1	82.7	153.2	92.3	87.5	77.7	75.6	79.0	163.0	69.1	48.7	112.2	57.6	128.2	68.4	127.8	148.1	106.0	95.6	84.3	249.7	79.6	98.7	74.7	74.9	83.2	130.5	96.4	84.5	80.1	72.8	129.1	70.6	100.1	106.0	91.2	125.1	95.1	83.4	173.8	63.8	103.9	172.0	54.5	108.6	119.1	2.4	2.2	2.0	3.3	3.0	2.7	4.5	2.4	4.2	2.3	1.4	2.2	4.5	2.5	2.0	2.4	6.0	1.4	0.8	19.4	19.7	21.5	23.2	20.3	22.3	21.3	20.9	22.0	20.8	21.0	20.8	26.8	0.0	15.6	4.6	14.7	13.4	11.2	13.5	5.7	16.1	19.7	22.1	15.1	20.0	14.1	20.2	16.7	29.3	33.1	12.7	13.7	33.7	10.1	18.3	26.5	18.5	13.9	4.6	8.1	44.8	41.8	18.0	12.8	18.0	6.3	27.3	21.0	36.0	29.1	18.5	8.1	12.6	12.2	16.6	11.7	23.0	11.8	20.0	14.2	2.8	26.1	36.9	20.6	6.6	9.6	44.0	7.4	18.8	18.8	17.7	12.4	20.5	10.0	20.3	6.6	19.3	24.7	9.5	10.6	16.5	18.6	33.7	16.5	61.5	14.2	14.3
S100A5	S100D	ENSG00000196420	"S100 calcium binding protein A5"	P33763	1	153537147-153541765	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"skin 1: 3.6;thyroid gland: 5.2"	"Cell type enhanced"	"Detected in some"		"Collecting duct cells: 3.7;Distal tubular cells: 3.9;Extravillous trophoblasts: 8.5;Langerhans cells: 3.1;Theca cells: 6.8"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 11.7"	"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"dendritic cells: 3.0;granulocytes: 1.4;T-cells: 4.6"	"Cell line enhanced"	"Detected in many"		"OE19: 34.3;RPTEC TERT1: 11.9;RT4: 19.9;SCLC-21H: 17.3"	"Region enriched"	"Detected in many"	86	"olfactory bulb: 980.0"	"Region enriched"	"Detected in single"	15	"olfactory bulb: 5.6"	HPA064184			Approved	Nucleoplasm		Yes	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Nucleoplasm		"HPA064184: AB_2685206"	"unprognostic (6.09e-2)"	"unprognostic (2.92e-2)"	"unprognostic (8.92e-2)"	"unprognostic (1.63e-5)"	"unprognostic (2.43e-3)"	"unprognostic (2.45e-2)"		"unprognostic (1.52e-3)"	"unprognostic (4.11e-2)"	"unprognostic (2.69e-1)"	"unprognostic (7.39e-3)"	"unprognostic (3.08e-2)"	"unprognostic (2.20e-2)"	"unprognostic (1.07e-2)"	"unprognostic (9.53e-2)"	"unprognostic (5.70e-2)"	"unprognostic (4.68e-3)"	0.2	0.1	0.3	0.1	0.3	0.7	0.2	0.9	0.8	0.3	0.1	0.2	1.5	0.6	0.1	0.9	0.5	1.0	0.1	0.3	0.4	2.9	0.0	0.5	1.5	0.4	0.3	0.1	0.0	0.0	0.1	0.0	0.5	0.3	0.0	0.0	0.2	0.0	0.1	3.6	0.3	0.0	0.3	0.4	1.2	0.1	0.4	0.7	5.2	0.1	0.4	1.1	0.3	0.4	2.2	5.7	0.0	0.0	0.6	0.4	0.4	1.0	1.3	0.7	1.4	0.6	4.2	0.0	3.7	2.1	0.4	1.7	0.1	1.0	0.9	0.5	0.0	2.7	2.6	0.2	0.4	0.0	3.5	0.0	1.1	2.7	0.8	0.5	0.5	0.0	0.7	0.2	3.0	0.2	0.5	1.3	0.2	34.3	9.7	0.0	1.8	1.1	11.9	19.9	17.3	0.0	0.2	9.0	0.8	1.5	0.0	0.5	0.4	0.1	1.3	2.6	1.7	0.0	0.9	0.0	0.5	0.7	0.4	0.0	0.7	1.4	1.2	0.1	4.6	0.5	2.6	1.3	1.8	0.3	1.4	0.6	1.2	0.0	0.4	3.0	3.9	0.7	0.3	0.3	0.9	0.8	0.3	0.4	0.4	0.3	0.5	0.3	0.4	0.4	0.0	0.0	0.0	0.0	0.1	0.6	0.2	0.4	0.0	0.0	0.3	0.1	0.0	0.0	0.2	3.7	0.0	0.1	0.2	0.1	3.9	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.2	8.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	2.0	0.6	3.1	0.0	0.3	0.5	0.0	0.0	1.6	0.0	0.0	0.0	0.0	1.2	1.2	0.0	0.0	0.1	0.2	0.0	0.6	0.0	0.0	0.2	0.2	0.0	0.0	0.0	1.0	0.3	0.6	6.8	0.3	0.6
SALL4	"dJ1112F19.1, ZNF797"	ENSG00000101115	"Spalt like transcription factor 4"	Q9UJQ4	20	51782331-51802521	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes, Disease variant, Oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"testis: 3.9;thyroid gland: 5.8"	"Cell type enriched"	"Detected in some"	4	"Horizontal cells: 26.9"	"Cancer enriched"	"Detected in many"	11	"testis cancer: 22.7"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	9	"NK-cell: 2.5"	"Lineage enriched"	"Detected in single"	9	"NK-cells: 2.5"	"Cell line enhanced"	"Detected in some"		"AF22: 25.0;AN3-CA: 17.5;BEWO: 33.2;NTERA-2: 60.2;SiHa: 15.6;SuSa: 39.7"	"Not detected"	"Not detected"							"HPA015291, HPA015791"	Enhanced		Enhanced	Nucleoplasm		Yes	No			"Cluster 15: NK-cells - Transcription"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 62: Horizontal cells - Visual perception"	Nucleoplasm		"HPA015291: AB_1856548, HPA015791: AB_1856547"	"unprognostic (1.30e-1)"	"unprognostic (2.35e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.09e-3)"	"unprognostic (3.55e-2)"	"unprognostic (7.43e-2)"	"unprognostic (3.63e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.20e-1)"	"unprognostic (9.23e-2)"	"unprognostic (2.50e-2)"	"unprognostic (2.39e-2)"	"unprognostic (2.42e-8)"	"unprognostic (5.90e-3)"	"unprognostic (1.82e-1)"	"unprognostic (5.00e-5)"	"unprognostic (7.41e-2)"	0.2	0.3	0.2	0.2	0.2	0.8	0.2	0.4	0.2	0.2	0.3	0.2	0.1	0.2	0.4	0.2	0.2	0.0	0.1	0.2	0.4	0.8	1.6	0.2	0.1	0.2	0.3	0.1	2.1	2.0	0.5	0.2	0.2	2.4	0.2	0.5	0.9	0.2	0.1	0.2	0.4	0.1	0.2	0.5	0.2	3.9	0.3	0.0	5.8	0.0	0.1	0.4	0.1	0.4	0.0	1.7	25.0	17.5	0.0	0.1	33.2	0.0	0.2	0.1	0.3	9.0	0.2	0.0	0.3	0.3	0.3	4.3	0.2	0.1	0.3	0.4	0.0	0.0	7.0	0.4	0.1	0.0	1.9	0.7	0.5	0.1	0.1	0.0	0.4	0.0	0.0	0.1	0.0	1.8	0.0	0.1	60.2	0.2	0.4	2.3	0.0	0.0	0.0	0.5	5.7	3.1	15.6	0.1	1.5	39.7	0.1	1.0	0.0	0.9	3.3	0.4	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.5	0.0	0.0	0.0	0.0	0.2	0.2	0.4	0.2	0.2	0.4	0.2	0.3	0.2	0.2	0.3	0.4	0.1	0.0	2.0	1.6	0.0	0.0	1.1	0.1	0.0	0.4	0.3	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	3.6	0.0	0.2	0.1	0.2	1.2	0.0	4.1	0.2	0.0	0.4	0.0	0.4	0.0	0.2	0.0	0.6	0.2	26.9	3.5	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	4.7	0.0	0.2	1.0	2.0	2.0	0.2	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.4	0.0	0.2	0.2	0.7	5.5	0.0	0.0	0.0	0.0	0.1	0.0	1.2
SDC3	"N-syndecan, SYND3"	ENSG00000162512	"Syndecan 3"	O75056	1	30869466-30908758	"Human disease related genes, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 140.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 64.6;Endometrial stromal cells: 59.8;Kupffer cells: 174.8;Late spermatids: 82.4;Oligodendrocyte precursor cells: 108.6"	"Group enriched"	"Detected in all"	5	"glioma: 115.2;melanoma: 102.2"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"SK-MEL-30: 249.5;WM-115: 342.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017087, CAB025786, HPA048085"	Approved		Approved	Nucleoplasm,Mitochondria		Yes	No			"Cluster 42: Non-specific - Transcription"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 25: Spermatids - Spermatogenesis"	Mitochondria	Nucleoplasm	"CAB025786: , HPA017087: AB_1857706, HPA048085: AB_2680256"	"unprognostic (1.42e-3)"	"unprognostic (5.52e-2)"	"unprognostic (1.20e-1)"	"unprognostic (4.55e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.79e-3)"	"unprognostic (2.83e-1)"	"prognostic favorable (2.36e-4)"	"unprognostic (9.77e-2)"	"unprognostic (5.14e-2)"	"unprognostic (1.65e-2)"	"prognostic unfavorable (1.71e-4)"	"unprognostic (6.45e-2)"	"unprognostic (2.74e-1)"	"unprognostic (9.80e-3)"	"unprognostic (1.46e-1)"	33.9	99.1	103.9	22.9	123.9	3.0	17.9	97.0	105.4	36.5	38.1	57.3	12.3	62.3	12.3	17.6	29.8	30.0	22.7	91.6	111.1	10.4	22.3	22.5	36.4	140.3	121.2	9.3	7.5	13.2	11.8	18.1	107.9	26.9	14.6	27.2	15.9	52.7	27.1	10.1	16.5	66.2	112.4	91.0	19.7	3.3	124.4	6.4	9.8	9.1	7.6	32.7	13.4	91.9	12.9	10.4	80.4	36.5	60.6	14.8	13.8	31.4	48.0	15.0	9.5	2.0	12.3	0.9	68.6	95.3	21.8	16.3	8.7	7.6	10.0	5.7	6.3	0.0	4.1	1.8	56.9	0.3	8.2	35.4	35.9	1.0	15.4	86.6	20.1	3.6	6.2	0.5	30.6	15.0	0.3	0.2	36.4	10.2	9.4	0.8	75.2	2.8	19.7	14.9	28.9	17.5	40.3	5.7	249.5	50.8	5.7	6.1	19.3	18.6	28.2	2.0	7.5	0.1	0.5	0.9	1.9	0.2	342.9	1.1	0.3	0.2	0.1	0.6	0.2	0.1	0.1	0.2	0.2	0.2	0.2	0.2	0.5	0.4	0.4	0.2	0.2	0.2	103.9	123.9	97.0	105.4	91.6	111.1	140.3	121.2	107.9	112.4	124.4	91.9	37.3	0.0	2.2	64.6	0.5	2.5	3.4	4.7	4.0	9.6	14.9	25.5	4.9	14.3	2.6	47.8	0.0	2.1	0.2	0.8	0.0	10.7	17.7	14.1	59.8	17.9	3.0	0.0	14.7	3.1	3.4	16.6	3.1	28.6	0.0	17.5	20.3	1.0	14.3	0.0	13.9	1.1	6.1	174.8	3.1	82.4	2.1	24.4	19.6	18.7	4.0	2.5	1.0	108.6	6.8	6.0	1.3	7.9	1.5	8.5	0.0	0.6	0.4	27.8	0.0	1.1	9.1	0.7	0.4	1.3	2.3	3.6	2.3	15.4	1.6	5.7
SENP3	"DKFZP586K0919, DKFZp762A152, SMT3IP1, SSP3, Ulp1"	ENSG00000161956	"SUMO specific peptidase 3"	Q9H4L4	17	7561919-7571969	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 22.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"											HPA060290	Supported		Supported	Nucleoplasm,Nucleoli		Yes	No				"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Nucleoplasm, Nucleoli"		"HPA060290: AB_2684244"	"unprognostic (5.68e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.01e-1)"	"unprognostic (3.34e-1)"	"unprognostic (3.48e-1)"	"unprognostic (1.30e-3)"	"unprognostic (2.82e-1)"	"unprognostic (7.37e-2)"	"unprognostic (3.72e-2)"	"prognostic favorable (6.22e-5)"	"unprognostic (2.71e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.37e-1)"	"unprognostic (8.21e-2)"	"unprognostic (2.56e-2)"	24.2	24.0	43.7	21.0	42.6	25.4	23.7	38.5	47.9	23.7	38.5	32.4	21.2	26.7	27.4	25.4	25.9	19.3	25.2	42.6	39.8	34.1	20.5	28.6	26.5	40.4	42.2	26.8	26.4	38.1	26.4	22.5	41.1	23.0	25.4	24.7	24.8	26.0	33.5	28.6	25.2	28.9	39.5	28.3	27.0	29.0	44.0	33.8	23.9	30.9	31.2	29.7	21.8	42.0	76.4	90.8	52.7	82.5	58.6	42.8	54.8	54.8	56.0	93.4	87.2	54.9	32.5	90.3	52.6	72.7	62.3	72.0	114.4	85.8	78.0	63.7	105.0	46.7	74.8	56.9	79.1	44.0	57.9	55.1	86.5	107.1	103.5	53.3	76.0	102.1	61.5	24.7	73.0	51.4	107.9	33.6	64.2	70.9	54.5	97.1	48.8	52.4	62.9	44.0	52.5	67.6	55.3	52.7	60.0	66.6	44.1	28.5	40.5	53.0	45.9	51.3	119.0	36.3	40.4	57.3	53.9	45.7	80.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	43.7	42.6	38.5	47.9	42.6	39.8	40.4	42.2	41.1	39.5	44.0	42.0	4.5	3.2	5.4	0.0	4.9	8.5	6.4	1.6	10.2	6.1	6.7	11.0	7.1	7.2	3.6	1.8	22.9	3.0	4.8	2.6	0.0	2.3	1.4	4.0	4.2	4.7	6.6	1.3	0.0	2.4	2.3	3.8	3.6	4.7	1.3	5.2	8.2	2.7	1.5	6.7	0.0	3.0	2.0	6.0	6.4	0.7	4.1	4.9	3.6	0.0	4.7	5.5	4.1	0.0	0.0	2.1	0.8	2.2	6.4	6.1	4.0	1.1	2.1	7.3	0.0	5.2	4.4	3.7	4.0	7.4	11.6	4.1	4.9	3.0	3.7	6.4
SETDB1	"ESET, KG1T, KIAA0067, KMT1E, TDRD21"	ENSG00000143379	"SET domain bifurcated histone lysine methyltransferase 1"	Q15047	1	150926263-150964744	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Repressor, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	6	"U-698: 341.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018142, HPA058484"	Uncertain		Supported	Nucleoplasm,Vesicles		Yes	No			"Cluster 44: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	Vesicles	"HPA018142: AB_1856757, HPA058484: AB_2683731"	"unprognostic (1.07e-1)"	"unprognostic (4.08e-1)"	"unprognostic (8.02e-2)"	"unprognostic (2.24e-3)"	"unprognostic (1.65e-2)"	"unprognostic (9.57e-2)"	"prognostic unfavorable (8.88e-4)"	"unprognostic (6.03e-2)"	"unprognostic (9.94e-3)"	"unprognostic (7.13e-2)"	"unprognostic (1.21e-1)"	"unprognostic (6.65e-2)"	"prognostic unfavorable (4.25e-4)"	"unprognostic (1.59e-1)"	"unprognostic (3.93e-2)"	"unprognostic (3.14e-2)"	"unprognostic (1.14e-1)"	13.5	11.3	7.1	15.2	8.2	18.1	16.7	12.8	8.9	14.4	8.7	13.4	12.5	18.1	13.1	11.8	15.3	11.5	8.2	6.7	7.9	11.7	11.5	13.4	19.6	8.2	7.6	19.4	13.3	15.7	8.6	17.7	7.6	11.4	15.5	14.2	12.3	12.2	16.4	14.4	13.7	16.5	6.0	19.9	13.4	25.1	8.4	21.6	15.5	11.7	20.3	13.1	12.7	10.3	22.9	26.3	37.1	24.6	17.5	23.2	61.7	18.6	21.2	26.2	22.2	17.9	31.1	44.9	24.9	20.7	10.4	28.1	35.0	20.0	20.7	21.8	43.3	25.5	27.3	20.8	24.7	45.3	23.2	30.5	22.0	21.8	34.8	26.6	31.2	28.3	43.4	35.6	18.9	44.1	31.6	26.4	51.1	32.1	20.6	36.3	24.3	33.4	20.1	25.9	27.1	49.1	28.4	32.9	22.5	44.5	35.7	60.4	21.2	15.3	15.7	17.0	26.3	36.6	42.3	341.6	15.7	15.7	15.1	6.9	8.3	5.7	5.8	11.6	6.1	6.1	5.3	6.6	9.7	8.3	5.7	5.9	4.8	6.3	8.5	6.5	3.5	4.3	7.1	8.2	12.8	8.9	6.7	7.9	8.2	7.6	7.6	6.0	8.4	10.3	8.5	6.4	14.0	15.3	15.3	5.5	9.3	6.6	10.2	11.0	9.8	10.7	5.5	10.0	7.8	7.3	18.8	13.9	8.8	6.6	3.9	7.6	26.1	10.8	13.3	8.3	3.6	9.2	19.6	5.7	8.5	9.1	10.2	10.7	7.6	17.9	11.4	8.1	9.9	6.7	19.4	9.7	12.2	17.2	5.1	31.0	10.2	13.9	1.8	23.4	14.4	6.2	14.4	15.6	23.5	8.1	9.5	9.8	8.9	8.2	7.6	6.4	11.0	10.4	6.6	10.2	10.3	24.4	15.9	10.9	5.1	10.0	10.2	14.6	10.7	7.8
SFRP1	"FRP, FRP-1, SARP2"	ENSG00000104332	"Secreted frizzled related protein 1"	Q8N474	8	41261962-41309473	"Predicted intracellular proteins, Predicted secreted proteins"	"Differentiation, Wnt signaling pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"breast: 299.3;choroid plexus: 509.2"	"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 710.9;Breast myoepithelial cells: 1158.6;Cardiomyocytes: 266.3;Leydig cells: 578.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	5	"hTERT-RPE1: 3203.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008116, HPA064870"	Approved		Approved	Nucleoli,Cytosol	"Secreted in other tissues"	Yes	No		1300000		"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 35: Glandular cells - Unknown function"	Nucleoli	Cytosol	"CAB008116: AB_2187070, HPA064870: AB_2685376"	"unprognostic (1.23e-3)"	"unprognostic (7.01e-2)"	"unprognostic (2.14e-1)"	"unprognostic (3.59e-1)"	"unprognostic (7.13e-2)"	"prognostic favorable (1.55e-4)"	"unprognostic (1.79e-1)"	"unprognostic (2.69e-3)"	"unprognostic (2.15e-2)"	"unprognostic (4.67e-3)"	"unprognostic (3.52e-3)"	"unprognostic (4.74e-2)"	"unprognostic (1.72e-2)"	"unprognostic (1.75e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.57e-1)"	"prognostic unfavorable (3.12e-4)"	88.4	12.9	9.2	10.5	12.7	1.4	299.3	18.2	15.0	203.7	509.2	24.5	12.2	132.5	1.8	26.1	98.5	61.3	124.8	29.4	8.5	115.3	6.1	4.7	4.0	29.9	10.5	46.8	6.2	1.4	1.2	19.5	29.7	42.6	30.1	2.2	236.9	102.3	2.6	55.4	18.9	82.9	7.7	21.4	24.4	28.4	10.8	3.1	12.7	32.8	3.2	44.9	95.6	24.7	0.1	29.0	75.9	1.9	67.5	3.9	14.5	132.9	694.5	197.9	187.2	0.0	17.8	0.0	0.6	0.7	15.8	0.9	10.8	53.7	277.6	0.0	2.3	0.0	0.0	0.0	6.4	0.0	0.7	11.8	255.9	19.9	19.3	3203.5	6.2	0.2	0.0	0.0	3.7	0.0	0.0	0.2	205.8	0.1	0.3	0.0	15.7	0.0	422.6	0.0	4.1	18.5	5.5	0.0	41.5	264.7	0.1	2.1	1.9	0.1	19.6	0.2	18.3	0.0	0.0	0.0	0.2	0.0	279.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.2	12.7	18.2	15.0	29.4	8.5	29.9	10.5	29.7	7.7	10.8	24.7	8.4	0.0	0.0	2.0	1.2	11.2	134.0	1.4	147.4	1.8	710.9	1158.6	266.3	0.0	0.7	62.5	2.1	2.2	9.1	0.0	80.3	4.4	5.0	3.0	131.6	21.0	0.0	0.0	0.2	0.0	82.0	229.5	16.8	3.4	0.0	19.3	53.6	0.3	2.0	1.7	12.1	0.0	0.0	0.3	4.0	25.7	578.4	4.0	99.6	0.0	0.0	76.2	0.0	7.5	20.6	0.1	0.0	130.1	2.1	29.7	0.0	3.2	0.0	1.8	0.0	34.9	18.0	2.3	16.8	53.7	5.5	0.8	7.3	72.6	0.0	9.3
SGCE	DYT11	ENSG00000127990	"Sarcoglycan epsilon"	O43556	7	94524204-94656572	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"			"Disease variant, Dystonia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Fibroblasts: 116.6;Oligodendrocyte precursor cells: 133.2;Oligodendrocytes: 116.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"gdT-cell: 2.1;memory B-cell: 4.4;naive B-cell: 6.6"	"Group enriched"	"Detected in many"	4	"B-cells: 6.6;T-cells: 2.1"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA074790			Approved	"Nucleoplasm,Golgi apparatus,Vesicles,Plasma membrane"		Yes	No		170000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 50: Fibroblasts - ECM organization"	"Vesicles, Plasma membrane"	"Nucleoplasm, Golgi apparatus"	"HPA074790: AB_2686713"	"unprognostic (3.16e-3)"	"unprognostic (9.06e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.20e-3)"	"unprognostic (1.12e-1)"	"prognostic unfavorable (1.61e-5)"	"unprognostic (1.19e-2)"	"unprognostic (2.82e-2)"	"unprognostic (6.93e-2)"	"unprognostic (3.37e-1)"	"unprognostic (6.80e-3)"	"unprognostic (9.69e-2)"	"unprognostic (5.71e-2)"	"prognostic unfavorable (1.35e-4)"	"unprognostic (1.43e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.44e-2)"	43.2	63.4	19.9	9.4	21.6	0.4	36.5	22.1	31.6	45.1	20.9	51.6	8.0	43.2	27.1	13.3	40.7	27.6	38.9	19.6	21.0	19.5	14.4	30.5	16.7	23.2	20.6	92.2	21.5	10.9	30.9	52.7	22.4	18.0	12.8	16.8	21.1	31.6	8.5	8.2	19.2	41.8	21.9	25.1	23.8	18.5	20.4	12.8	23.9	19.8	7.2	35.6	34.6	26.7	13.5	42.5	39.6	61.8	63.7	110.8	7.1	51.3	92.3	40.7	60.4	24.9	78.0	12.8	70.4	86.5	83.7	9.4	60.0	21.6	49.1	2.2	32.7	1.4	36.9	28.3	44.0	4.3	0.0	95.5	31.1	64.8	79.3	104.9	30.8	0.0	0.1	93.7	43.5	42.6	0.0	0.0	32.8	8.0	29.0	19.8	51.0	25.8	78.6	13.6	26.2	20.8	0.0	52.2	65.1	44.2	17.6	0.8	0.0	131.1	45.1	11.8	81.7	50.8	67.9	14.8	51.4	0.2	74.2	0.7	0.0	0.1	2.1	0.0	0.8	4.4	0.6	1.0	0.0	6.6	0.2	0.7	0.3	1.0	0.1	0.2	0.2	0.3	19.9	21.6	22.1	31.6	19.6	21.0	23.2	20.6	22.4	21.9	20.4	26.7	39.2	70.5	33.3	66.9	6.1	5.0	18.4	16.8	1.8	18.6	9.7	44.4	18.6	30.0	28.3	20.2	4.2	90.2	1.4	0.0	5.9	42.5	1.6	4.0	17.1	18.8	1.2	0.4	85.2	4.3	26.1	116.6	1.5	6.6	2.5	37.3	58.2	11.2	6.3	20.2	68.5	0.1	12.2	2.5	7.3	3.7	75.5	1.4	51.6	15.9	0.0	31.5	0.0	133.2	116.3	2.1	0.0	58.3	2.6	5.5	0.0	14.1	13.7	30.3	85.5	68.0	60.7	17.1	13.0	0.9	4.0	82.8	2.7	44.0	0.0	2.2
SGF29	"CCDC101, FLJ32446, TDRD29"	ENSG00000176476	"SAGA complex associated factor 29"	Q96ES7	16	28553915-28591790	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"Early spermatids: 222.2;Late spermatids: 384.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052590, HPA053608"	Enhanced		Approved	Nucleoplasm,Nucleoli		Yes	No			"Cluster 26: Non-specific - Mitochondria"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 34: Spermatids - Unknown function"	Nucleoli	Nucleoplasm	"HPA052590: AB_2681875, HPA053608: AB_2682205"	"unprognostic (1.38e-2)"	"prognostic favorable (4.77e-4)"	"unprognostic (1.73e-1)"	"unprognostic (2.46e-3)"	"unprognostic (2.80e-2)"	"unprognostic (7.27e-3)"	"unprognostic (1.48e-1)"	"prognostic favorable (3.37e-4)"	"unprognostic (1.98e-1)"	"unprognostic (1.41e-1)"	"prognostic favorable (2.99e-4)"	"unprognostic (2.96e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.76e-1)"	"unprognostic (5.42e-3)"	16.8	16.1	13.6	11.2	15.6	12.4	16.5	16.7	14.6	26.8	13.8	28.0	12.8	29.1	9.5	12.0	27.6	9.1	15.3	13.4	14.9	11.1	19.9	14.0	16.9	15.2	14.4	33.3	25.6	10.7	10.3	7.1	15.4	16.4	7.2	7.8	16.6	16.7	51.1	16.0	18.8	12.0	14.9	16.2	19.8	43.0	14.6	14.1	17.6	19.8	10.2	23.5	16.4	16.8	13.1	21.3	16.3	10.5	10.6	10.9	29.5	8.5	9.6	21.7	20.2	24.6	11.5	39.1	21.1	6.7	13.2	15.0	12.4	15.4	6.1	12.8	24.0	24.3	12.9	33.7	27.1	22.1	26.1	11.5	20.0	13.1	13.2	11.7	8.3	24.5	20.8	19.4	7.9	43.4	25.5	43.2	22.7	9.6	20.5	38.9	10.6	34.2	11.3	19.5	26.3	12.2	13.3	25.3	15.0	5.8	20.7	18.4	5.9	15.4	12.9	9.2	15.3	22.4	35.7	22.7	10.9	36.9	12.5	20.6	47.0	50.0	53.6	41.8	65.2	57.9	74.2	65.8	47.6	65.9	84.1	66.3	13.4	55.1	33.7	71.4	78.3	58.7	13.6	15.6	16.7	14.6	13.4	14.9	15.2	14.4	15.4	14.9	14.6	16.8	11.2	16.0	16.7	0.0	20.0	0.0	18.1	0.0	32.5	5.5	12.5	21.1	0.0	12.8	7.4	18.4	14.6	17.3	27.1	7.9	9.8	12.6	222.2	8.5	10.1	8.7	3.6	17.1	0.0	12.9	11.8	12.7	10.2	7.7	6.3	16.9	11.0	17.3	14.2	0.0	0.0	8.8	0.0	12.9	0.0	384.4	30.7	13.5	0.0	0.0	17.1	11.8	22.6	0.0	0.0	10.1	15.7	21.8	16.7	9.5	40.1	23.7	6.6	14.1	19.7	18.3	13.0	10.5	30.9	17.0	0.0	21.1	21.0	14.8	11.9	12.0
SH3RF3	"FLJ00204, POSH2, SH3MD4"	ENSG00000172985	"SH3 domain containing ring finger 3"	Q8TEJ3	2	109129205-109504634	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"Astrocytes: 47.0;Excitatory neurons: 108.3;Inhibitory neurons: 160.9;Microglial cells: 164.9;Oligodendrocyte precursor cells: 42.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HHSteC: 19.8;RPMI-8226: 20.5;TIME: 23.2;U-266/84: 28.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA044822, HPA048444"	Approved		Supported	Nucleoplasm		Yes	No				"Cluster 47: Non-specific - Unknown function"	"Cluster 16: U-266 - Nucleosome"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"HPA044822: AB_2679103, HPA048444: AB_2680396"	"unprognostic (1.97e-1)"	"unprognostic (8.84e-3)"	"unprognostic (8.04e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.78e-1)"	"unprognostic (8.00e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.98e-2)"	"prognostic unfavorable (2.33e-4)"	"unprognostic (4.57e-2)"	"unprognostic (1.95e-1)"	"unprognostic (3.54e-2)"	"unprognostic (4.94e-2)"	"unprognostic (2.72e-1)"	"unprognostic (2.79e-2)"	"unprognostic (1.39e-2)"	6.1	6.7	4.7	3.0	6.1	0.8	4.3	1.3	6.5	5.5	1.6	5.6	1.1	3.7	0.7	2.8	4.8	4.4	6.0	6.3	3.2	6.8	1.1	7.2	2.1	3.0	4.5	3.2	2.0	0.5	1.9	5.2	2.8	4.7	1.4	0.6	1.6	4.4	5.7	3.1	3.3	3.8	3.1	2.1	2.9	4.2	3.9	3.2	2.5	7.3	1.2	5.5	4.2	3.5	0.0	0.1	0.1	2.2	9.0	6.9	0.0	4.2	12.2	3.1	1.1	1.1	0.0	0.0	3.1	3.1	0.7	0.0	0.2	1.8	1.3	0.0	4.2	0.0	0.2	0.0	19.8	0.1	0.0	12.0	2.9	14.1	6.3	1.8	11.4	2.2	0.0	11.7	7.3	0.0	0.0	6.5	1.1	0.0	12.0	2.6	0.0	20.5	0.0	0.0	0.7	2.5	0.0	0.0	0.4	0.1	0.2	0.0	23.2	4.0	12.0	11.5	5.5	4.0	28.6	0.0	0.0	6.3	5.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	4.7	6.1	1.3	6.5	6.3	3.2	3.0	4.5	2.8	3.1	3.9	3.5	5.3	0.0	0.0	47.0	0.2	1.9	0.4	0.2	1.8	0.5	0.6	0.5	10.7	0.0	0.7	0.0	0.0	0.0	1.5	0.1	0.0	1.1	2.6	9.4	9.6	6.7	1.8	0.0	108.3	0.2	0.2	4.8	0.0	1.1	0.0	0.2	7.5	0.0	4.7	10.1	160.9	0.8	0.0	2.5	1.5	5.2	2.1	1.2	5.4	164.9	0.0	1.7	0.0	42.3	1.9	0.1	0.0	3.0	1.6	0.2	0.0	0.6	2.1	0.0	13.1	3.2	6.8	0.7	9.6	0.8	0.9	0.1	0.5	2.3	0.1	0.0
SLBP	HBP	ENSG00000163950	"Stem-loop binding protein"	Q14493	4	1692731-1712344	"Predicted intracellular proteins"	"mRNA processing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 263.6;Spermatogonia: 294.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA019254, HPA061670"	Supported		Supported	Nucleoplasm,Nucleoli,Cytosol		Yes	Yes			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Nucleoli, Cytosol"	"HPA019254: AB_1856951, HPA061670: AB_2684581"	"unprognostic (1.81e-2)"	"unprognostic (6.80e-3)"	"unprognostic (2.05e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.94e-1)"	"unprognostic (7.09e-3)"	"prognostic unfavorable (2.29e-5)"	"unprognostic (5.53e-2)"	"unprognostic (1.94e-2)"	"unprognostic (1.13e-2)"	"unprognostic (9.81e-3)"	"unprognostic (9.55e-3)"	"unprognostic (4.58e-2)"	"unprognostic (7.31e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.44e-1)"	"unprognostic (7.07e-2)"	29.9	26.4	38.6	37.6	40.2	114.2	26.7	38.0	65.7	28.4	34.4	30.6	23.9	27.3	32.9	35.9	27.6	21.9	18.4	40.9	43.6	35.1	33.9	27.2	71.7	36.4	39.1	28.0	24.4	24.0	26.7	42.0	39.3	22.8	30.6	17.1	25.6	25.3	22.6	37.7	25.6	28.8	37.7	28.3	26.9	63.1	41.8	53.5	27.3	19.2	69.5	35.0	28.0	41.1	132.7	53.9	76.6	80.7	65.3	70.0	81.9	120.1	92.5	131.4	133.8	120.3	144.7	180.6	67.4	96.0	150.9	77.8	147.0	103.0	154.1	75.4	98.5	215.9	63.3	123.6	82.6	208.3	102.8	55.0	84.7	98.1	67.3	74.4	76.5	108.8	172.7	170.3	163.2	52.8	314.6	200.6	97.4	136.7	108.6	241.1	126.3	105.3	131.0	99.5	86.1	69.3	95.4	59.6	69.5	96.8	99.0	127.7	66.3	108.0	63.8	116.1	180.4	107.4	192.2	428.3	99.6	176.0	106.0	25.7	65.4	47.5	47.1	49.7	43.3	51.6	59.7	64.8	50.6	37.8	50.6	49.6	95.8	46.3	44.8	42.2	77.9	75.4	38.6	40.2	38.0	65.7	40.9	43.6	36.4	39.1	39.3	37.7	41.8	41.1	35.2	16.0	18.8	7.2	96.3	105.2	96.3	38.8	61.5	19.4	35.9	34.0	8.2	27.1	23.6	36.8	25.0	166.3	80.5	28.8	107.6	50.6	75.9	38.8	34.9	36.1	35.9	146.0	14.6	31.3	51.8	49.1	53.5	55.5	23.5	45.9	30.0	27.0	81.3	25.2	15.1	33.6	44.7	36.8	58.6	41.6	44.1	60.3	65.8	6.5	64.4	27.4	43.3	9.0	14.4	38.7	25.3	44.0	94.2	88.6	22.5	55.4	16.3	13.6	13.1	46.3	43.8	263.6	294.0	84.1	105.8	44.7	96.6	33.2	44.1	76.5
SLC25A42	MGC26694	ENSG00000181035	"Solute carrier family 25 member 42"	Q86VD7	19	19063994-19113030	"Disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 82.0"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 67.7;Hepatocytes: 52.1;Proximal tubular cells: 39.6;Rod photoreceptor cells: 41.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"gdT-cell: 2.7;MAIT T-cell: 1.4;memory B-cell: 3.3;memory CD4 T-cell: 1.5;memory CD8 T-cell: 2.4;naive B-cell: 3.2;naive CD4 T-cell: 1.0;naive CD8 T-cell: 1.4;NK-cell: 1.8;T-reg: 1.7"	"Group enriched"	"Detected in many"	6	"B-cells: 3.3;NK-cells: 1.8;T-cells: 2.7"	"Cell line enhanced"	"Detected in many"		"K-562: 20.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049449	Approved		Supported	Mitochondria		Yes	No			"Cluster 43: B-cells - Humoral immune response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 56: Bipolar cells - Visual perception"	Mitochondria		"HPA049449: AB_2680772"	"unprognostic (2.27e-1)"	"prognostic favorable (5.04e-4)"	"unprognostic (5.79e-2)"	"unprognostic (5.67e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.42e-3)"	"unprognostic (1.27e-3)"	"prognostic favorable (4.11e-4)"	"unprognostic (6.89e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.37e-3)"	"unprognostic (3.04e-2)"	"unprognostic (5.29e-3)"	"unprognostic (1.76e-1)"	"unprognostic (2.39e-2)"	"unprognostic (4.17e-2)"	"unprognostic (2.03e-2)"	8.5	7.5	17.2	4.3	16.9	8.3	7.9	14.5	18.3	13.1	16.7	8.4	5.1	10.1	3.7	5.2	12.5	3.5	15.8	17.9	16.9	34.1	82.0	6.6	9.0	14.9	15.2	16.9	11.3	6.0	14.4	2.6	14.7	9.9	2.4	8.4	9.2	5.2	46.5	6.7	9.3	4.9	13.9	12.7	8.3	7.0	18.0	8.1	25.6	32.6	7.5	9.6	9.1	13.9	7.3	1.0	1.8	3.2	6.8	5.6	2.8	3.5	5.2	5.3	6.0	1.4	14.3	5.2	8.0	3.3	5.3	1.3	3.7	2.9	3.0	1.3	7.0	1.8	2.0	11.8	5.4	0.8	3.6	5.6	2.0	4.0	2.4	4.3	2.4	16.8	20.9	9.2	2.8	6.6	9.0	8.4	1.0	2.0	7.4	6.8	3.2	10.2	2.1	1.3	2.0	1.5	3.7	0.1	1.6	2.4	6.5	4.1	2.2	3.9	2.2	8.2	3.4	10.7	6.2	4.1	4.1	11.2	2.0	0.0	0.1	0.1	2.7	0.3	1.4	3.3	1.5	2.4	0.2	3.2	1.0	1.4	0.0	1.8	0.3	0.4	1.7	0.9	17.2	16.9	14.5	18.3	17.9	16.9	14.9	15.2	14.7	13.9	18.0	13.9	4.6	0.0	13.1	12.4	14.2	3.2	2.8	3.3	2.8	67.7	5.9	6.6	9.7	5.7	4.1	9.2	18.8	7.7	16.5	3.1	13.7	1.5	1.2	2.5	5.4	4.1	8.4	13.7	18.6	3.1	3.8	5.1	4.1	3.6	3.8	8.3	5.3	52.1	1.8	3.3	25.0	3.8	6.1	0.6	1.9	1.6	5.0	1.4	3.6	6.5	1.3	12.5	32.0	16.1	8.6	2.5	4.6	6.4	16.4	2.4	9.2	39.6	3.0	41.4	6.6	9.6	5.8	10.6	7.6	0.9	2.8	4.7	10.9	8.0	3.1	1.7
SMC2	"CAP-E, hCAP-E, SMC2L1"	ENSG00000136824	"Structural maintenance of chromosomes 2"	O95347	9	104094260-104141419	"Predicted intracellular proteins"	"Cell cycle, Cell division, DNA condensation, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 25.7"	"Cell type enhanced"	"Detected in all"		"Endometrial ciliated cells: 114.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071309	Approved		Supported	Nucleoplasm,Nucleoli		Yes	No		26000	"Cluster 44: Non-specific - Transcription"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	Nucleoli	"HPA071309: AB_2686385"	"unprognostic (1.51e-1)"	"unprognostic (2.01e-3)"	"unprognostic (2.26e-2)"	"unprognostic (2.23e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.05e-1)"	"unprognostic (5.57e-3)"	"unprognostic (2.59e-3)"	"unprognostic (1.47e-2)"	"unprognostic (4.35e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.01e-1)"	"unprognostic (5.56e-3)"	"unprognostic (8.02e-3)"	"unprognostic (1.65e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.32e-2)"	5.2	4.1	2.8	11.3	4.0	18.4	6.6	4.4	3.3	7.5	1.3	8.2	7.5	6.0	2.6	7.3	4.7	4.0	7.9	2.2	4.0	6.3	4.7	4.5	16.0	4.9	3.7	4.7	3.5	5.7	1.5	6.9	4.1	4.2	8.8	5.6	3.1	4.7	2.2	7.4	7.6	5.4	3.5	7.2	6.1	12.0	3.5	25.7	7.6	5.4	15.9	4.9	3.2	5.0	59.3	45.0	49.4	45.9	10.3	14.9	46.2	53.5	25.4	46.9	39.4	39.3	44.9	112.6	25.2	27.7	40.5	97.6	72.3	34.8	63.2	71.6	30.3	67.9	68.8	25.5	2.7	41.5	65.6	9.8	7.0	63.7	25.7	15.9	33.7	71.2	55.8	89.8	43.0	28.9	109.1	21.3	42.9	47.6	34.8	72.0	141.3	42.2	20.1	21.1	46.5	35.9	63.8	29.6	15.5	20.5	59.5	28.0	27.1	56.8	59.1	79.3	67.9	32.6	118.2	64.6	36.8	59.8	70.3	15.0	2.2	2.5	4.8	5.9	5.4	7.3	4.4	4.8	2.6	7.9	5.0	5.8	0.3	7.0	7.4	4.4	6.0	2.4	2.8	4.0	4.4	3.3	2.2	4.0	4.9	3.7	4.1	3.5	3.5	5.0	19.6	25.6	11.9	6.5	19.9	27.3	16.4	27.6	11.4	39.7	16.6	19.3	45.1	7.2	17.8	16.5	8.4	54.3	15.2	13.7	35.2	18.9	40.0	114.6	21.6	21.4	4.9	95.3	10.2	20.4	93.8	20.2	13.3	16.0	22.2	40.4	21.0	7.6	44.3	28.6	15.5	14.6	26.4	19.8	19.8	24.7	18.6	22.9	7.2	7.5	19.8	15.6	22.6	5.5	18.4	15.6	6.3	12.4	40.9	7.3	10.3	15.0	12.0	19.1	13.1	25.1	37.7	84.5	93.5	27.4	23.2	25.9	18.1	28.1	35.0	14.2
SOX10	"DOM, WS2E, WS4"	ENSG00000100146	"SRY-box transcription factor 10"	P56693	22	37970686-37987422	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Deafness, Disease variant, Hirschsprung disease, Kallmann syndrome, Waardenburg syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 194.9;salivary gland: 114.3"	"Group enriched"	"Detected in some"	14	"Breast glandular cells: 32.3;Breast myoepithelial cells: 47.8;Melanocytes: 35.6;Oligodendrocyte precursor cells: 61.3;Oligodendrocytes: 59.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	510	"SK-MEL-30: 313.9;WM-115: 432.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003171, HPA068898"	Enhanced		Supported	Nucleoplasm		Yes	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 35: Glandular cells - Unknown function"	Nucleoplasm		"CAB003171: AB_2195374, HPA068898: AB_2686054"																		2.9	2.7	76.9	2.5	133.7	0.1	21.7	103.1	102.8	11.8	24.9	26.6	1.5	0.8	1.2	2.7	2.5	2.2	8.8	82.7	89.0	0.5	0.5	0.1	0.0	134.7	114.0	1.2	0.8	0.0	1.8	0.0	123.3	6.8	2.6	0.5	114.3	5.8	0.6	17.0	7.1	1.9	87.3	0.3	6.1	2.7	114.2	0.0	0.9	1.5	0.0	8.4	9.5	194.9	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	313.9	0.0	0.1	0.4	0.0	0.2	0.2	0.0	0.2	0.0	0.3	0.1	0.7	0.0	432.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	76.9	133.7	103.1	102.8	82.7	89.0	134.7	114.0	123.3	87.3	114.2	194.9	0.3	0.0	0.0	0.0	0.1	3.2	0.1	0.0	0.0	0.0	32.3	47.8	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.0	0.0	0.8	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.4	0.4	0.9	0.1	35.6	0.0	0.0	0.0	0.0	61.3	59.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.3	0.7	0.0	0.9	0.0	0.2	0.0	0.0	0.0
STK17A	DRAK1	ENSG00000164543	"Serine/threonine kinase 17a"	Q9UEE5	7	43582758-43650713	"Enzymes, Metabolic proteins, Plasma proteins, Predicted membrane proteins"	Apoptosis	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 644.6;T-cells: 273.7;Urothelial cells: 326.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA018138, HPA037979"	Uncertain		Supported	"Nuclear speckles,Plasma membrane"		Yes	No			"Cluster 48: NK-cells - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 22: Epithelial cell types - Mixed function"	"Nuclear speckles"	"Plasma membrane"	"HPA018138: AB_2669784, HPA037979: AB_10795247"	"unprognostic (1.81e-3)"	"unprognostic (1.08e-2)"	"unprognostic (2.67e-1)"	"unprognostic (5.41e-2)"	"unprognostic (5.11e-2)"	"unprognostic (3.35e-2)"	"unprognostic (1.03e-2)"	"unprognostic (9.15e-3)"	"unprognostic (2.07e-1)"	"unprognostic (6.34e-2)"	"unprognostic (1.36e-2)"	"unprognostic (6.61e-2)"	"unprognostic (2.99e-3)"	"unprognostic (3.76e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.97e-3)"	"unprognostic (3.66e-1)"	6.7	8.1	3.9	7.9	4.2	4.8	5.2	6.9	4.9	4.0	4.0	6.4	3.2	3.5	1.2	7.2	3.9	5.3	10.8	4.0	4.1	6.3	4.6	9.4	14.4	3.4	4.4	6.2	9.1	0.8	4.2	3.2	3.6	4.3	2.4	5.5	5.8	2.1	9.9	4.6	11.5	3.3	3.6	12.6	9.5	9.0	4.3	9.0	3.8	2.5	13.5	5.6	5.0	3.1	5.8	8.2	9.0	5.3	7.8	8.3	1.9	12.3	15.1	6.6	5.9	7.5	3.1	7.9	20.2	15.3	17.8	8.5	3.6	17.4	10.4	16.9	7.0	9.3	8.2	8.4	4.9	21.1	5.6	6.4	26.4	8.2	8.6	36.4	12.6	11.0	16.7	15.1	9.6	3.6	18.2	8.0	17.3	4.1	18.3	8.4	6.9	14.2	15.6	6.7	6.9	11.2	8.1	8.5	6.1	13.6	6.5	10.8	16.9	20.7	8.3	14.3	17.2	13.3	11.2	13.5	18.4	14.0	31.7	0.5	0.0	2.7	2.0	0.0	1.5	2.4	2.0	3.2	0.1	2.2	3.0	3.0	1.6	4.9	0.1	0.4	1.3	0.9	3.9	4.2	6.9	4.9	4.0	4.1	3.4	4.4	3.6	3.6	4.3	3.1	44.2	121.8	33.1	29.0	237.8	181.9	644.6	64.5	99.6	2.9	17.7	37.8	28.7	7.2	69.8	20.2	10.4	54.8	222.3	54.4	33.2	153.0	47.0	129.1	17.4	35.2	7.2	54.1	9.5	95.4	23.3	39.1	78.0	88.3	38.8	17.7	17.9	9.6	16.9	0.0	5.6	34.3	38.7	20.3	65.9	14.7	5.9	60.9	35.6	34.7	42.1	7.9	221.4	39.2	3.7	89.4	73.0	2.6	81.2	192.6	23.8	13.2	42.4	26.3	6.6	39.4	51.3	75.8	36.1	42.3	136.1	66.8	273.7	27.0	18.0	326.1
SUZ12	"CHET9, JJAZ1, KIAA0160"	ENSG00000178691	"SUZ12 polycomb repressive complex 2 subunit"	Q15022	17	31937007-32001038	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Repressor"	"Cancer-related genes, Disease variant, Mental retardation, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057436	Approved		Supported	"Nucleoplasm,Nucleoli,Nucleoli rim,Nuclear bodies"		Yes	No			"Cluster 15: NK-cells - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Nucleoli, Nucleoli rim, Nuclear bodies"		"HPA057436: AB_2683439"	"unprognostic (1.23e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.65e-3)"	"unprognostic (1.23e-1)"	"unprognostic (2.49e-1)"	"unprognostic (7.31e-2)"	"unprognostic (2.66e-3)"	"unprognostic (8.05e-2)"	"unprognostic (7.27e-2)"	"unprognostic (3.06e-2)"	"unprognostic (6.29e-2)"	"unprognostic (8.70e-2)"	"unprognostic (3.28e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.28e-1)"	"unprognostic (5.91e-2)"	"unprognostic (1.31e-1)"	12.3	11.8	6.3	18.8	6.3	45.4	15.0	11.1	8.5	11.6	6.8	14.9	16.0	15.2	12.0	14.0	11.0	12.0	10.3	5.4	5.8	16.4	18.1	12.6	33.0	5.4	5.9	11.4	11.5	19.8	6.6	18.7	5.6	13.3	16.4	26.5	10.5	12.2	8.1	13.0	15.3	14.7	5.2	18.4	15.2	27.4	6.1	38.5	18.3	11.0	30.0	15.6	9.0	7.1	46.5	40.4	37.2	42.9	21.1	26.8	38.2	44.2	38.8	53.0	63.7	30.9	25.5	100.7	33.2	27.7	45.4	40.1	56.0	25.5	85.7	35.8	54.0	69.9	32.9	22.3	24.8	111.5	68.7	18.7	28.1	53.1	40.4	32.1	33.1	47.3	68.8	135.6	46.2	16.2	133.3	64.4	21.3	32.4	24.4	78.5	95.3	81.9	31.1	44.6	47.5	37.1	71.3	22.7	43.3	25.8	66.0	91.5	24.7	41.9	38.0	50.8	69.3	73.5	98.4	122.5	30.7	67.4	38.7	0.6	0.7	1.6	1.4	1.1	1.1	2.4	1.6	1.6	0.6	1.8	1.5	2.1	1.6	1.8	0.7	1.9	1.8	0.4	6.3	6.3	11.1	8.5	5.4	5.8	5.4	5.9	5.6	5.2	6.1	7.1	44.5	41.7	45.8	43.1	50.1	58.5	50.2	21.8	31.9	77.6	54.2	36.8	32.3	27.1	32.6	35.0	108.4	61.5	65.2	24.0	17.6	28.3	16.2	52.8	55.8	45.1	29.4	93.6	71.6	21.9	53.1	35.1	31.1	54.2	15.8	41.4	38.2	42.3	32.9	62.2	69.5	31.8	10.2	42.1	58.2	13.9	26.8	47.3	24.9	45.0	73.1	45.7	38.1	75.4	71.3	27.8	15.4	25.6	66.2	62.8	21.5	26.6	29.6	80.9	13.1	47.2	38.4	121.7	128.9	48.6	71.7	69.5	52.5	52.8	35.6	66.7
TACC3	"ERIC-1, ERIC1, maskin, Tacc4"	ENSG00000013810	"Transforming acidic coiled-coil containing protein 3"	Q9Y6A5	4	1712891-1745171	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 58.9;lymphoid tissue: 52.4;testis: 50.6"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 70.4;Hofbauer cells: 43.9;Late spermatids: 69.9;Spermatocytes: 94.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005781, HPA006050, CAB010111, HPA022039"	Enhanced		Enhanced	"Vesicles,Mitotic spindle,Centriolar satellite,Cytosol"		Yes	Yes		11000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Mitotic spindle, Centriolar satellite, Cytosol"	Vesicles	"CAB010111: AB_628323, HPA005781: AB_1857724, HPA006050: AB_2667505, HPA022039: AB_1857725"	"unprognostic (2.95e-1)"	"unprognostic (1.18e-1)"	"unprognostic (7.71e-2)"	"unprognostic (4.35e-2)"	"unprognostic (6.58e-2)"	"unprognostic (1.84e-2)"	"prognostic unfavorable (3.30e-4)"	"unprognostic (1.10e-3)"	"unprognostic (4.61e-2)"	"unprognostic (9.12e-2)"	"unprognostic (2.91e-2)"	"unprognostic (2.26e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (4.66e-2)"	"unprognostic (2.09e-1)"	"unprognostic (4.44e-3)"	"unprognostic (9.75e-2)"	5.3	3.9	4.2	24.9	4.3	58.9	3.5	5.2	5.3	3.6	5.2	10.3	6.6	3.3	4.8	14.9	2.8	4.2	3.3	4.5	4.4	2.7	3.5	6.5	43.2	4.8	5.3	2.2	1.4	2.3	2.6	8.7	4.8	2.4	10.6	1.9	3.9	2.5	2.0	6.4	12.9	6.4	4.2	22.1	6.4	50.6	5.1	52.4	2.8	3.4	39.3	5.0	5.4	4.7	106.7	88.7	129.5	72.2	6.7	15.2	72.9	114.6	62.1	135.4	87.6	93.5	122.8	133.8	48.0	65.4	149.9	71.4	142.5	86.8	131.1	59.8	77.0	113.8	67.2	85.8	5.9	146.6	85.5	5.2	5.7	85.6	46.0	26.0	102.2	110.3	106.3	90.8	123.8	87.1	207.5	204.0	139.3	89.2	111.6	139.1	90.5	55.0	73.8	125.5	99.8	62.8	70.1	42.3	33.1	95.2	83.3	90.5	56.4	75.4	90.0	65.4	176.7	69.5	102.5	207.1	43.2	141.1	109.1	45.5	30.0	37.9	8.5	12.5	11.1	7.8	16.5	11.5	15.3	10.8	28.3	13.1	91.8	12.2	9.6	8.3	42.5	32.5	4.2	4.3	5.2	5.3	4.5	4.4	4.8	5.3	4.8	4.2	5.1	4.7	6.0	0.0	6.7	2.0	16.5	2.2	1.2	3.2	1.2	1.7	2.4	3.0	2.6	2.8	3.4	9.2	8.4	19.5	6.4	11.2	0.0	2.2	70.4	4.2	2.8	5.2	1.2	37.2	2.3	0.7	20.4	6.0	12.8	4.3	5.1	24.5	8.9	5.1	43.9	5.0	3.2	9.5	4.1	23.2	10.8	69.9	2.8	34.1	0.0	4.7	24.4	1.4	6.2	0.5	0.8	2.9	4.2	2.6	18.0	1.3	2.6	2.8	0.9	2.7	6.6	2.0	4.8	94.3	37.7	12.8	1.4	4.0	23.2	2.2	16.1	2.7
TAL1	"bHLHa17, SCL, TCL5"	ENSG00000162367	"TAL bHLH transcription factor 1, erythroid differentiation factor"	P17542	1	47216290-47232220	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 29.4"	"Cell type enriched"	"Detected in some"	4	"Erythroid cells: 151.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEL: 153.7;HMC-1: 70.6;HUVEC TERT2: 31.2;JURKAT: 60.0;K-562: 48.9;MOLT-4: 26.3;TIME: 34.4"	"Region enriched"	"Detected in many"	5	"midbrain: 14.3"	"Low region specificity"	"Detected in many"			"CAB017805, HPA047866, HPA073983"	Approved		Enhanced	Nucleoplasm		Yes	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 36: HEL - Hemostasis"	"Cluster 6: Erythroid cells - Oxygen transport"	Nucleoplasm		"CAB017805: , HPA047866: AB_2680192, HPA073983: AB_2732246"	"unprognostic (2.63e-1)"	"unprognostic (2.62e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.40e-2)"	"unprognostic (1.59e-1)"	"unprognostic (8.80e-3)"	"unprognostic (3.95e-3)"	"unprognostic (1.33e-1)"	"unprognostic (4.15e-2)"	"unprognostic (1.99e-2)"	"unprognostic (5.42e-3)"	"unprognostic (3.68e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.76e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.18e-2)"	7.5	2.5	4.9	1.0	4.5	29.4	6.3	4.7	4.4	2.9	3.0	2.1	0.8	2.9	0.6	1.8	3.5	2.3	5.9	4.6	4.6	4.4	1.5	13.0	1.4	6.5	7.1	1.2	0.9	0.9	1.7	6.9	6.8	2.1	1.3	0.2	1.1	0.8	2.1	1.7	3.1	2.7	6.9	7.1	1.8	0.9	6.4	0.4	5.4	2.5	0.7	2.4	2.5	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.3	0.0	0.1	0.0	0.0	0.0	0.0	10.6	0.0	0.0	0.2	0.1	153.7	0.0	0.0	0.0	0.0	70.6	0.0	0.0	0.0	0.0	0.0	31.2	60.0	48.9	0.1	0.0	0.0	26.3	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.1	0.0	0.1	34.4	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.5	4.9	4.5	4.7	4.4	4.6	4.6	6.5	7.1	6.8	6.9	6.4	6.8	23.9	0.0	0.0	0.0	0.5	0.9	0.0	0.0	0.0	0.0	0.1	0.1	3.7	1.5	1.3	1.8	0.0	0.1	0.0	0.0	0.0	0.1	5.3	0.0	0.1	18.1	0.0	151.5	0.0	0.0	0.3	0.6	0.0	0.0	36.8	0.0	26.7	0.1	10.6	0.0	0.1	0.0	0.0	1.6	1.5	18.2	0.0	4.8	1.8	29.0	0.8	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.4	1.3	0.4	0.1	1.0	0.0	2.0	0.0	0.0	0.0
TBC1D14	KIAA1322	ENSG00000132405	"TBC1 domain family member 14"	Q9P2M4	4	6909242-7033118	"Plasma proteins, Predicted intracellular proteins"	Autophagy	"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 68.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 197.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036930, HPA067398"	Approved		Supported	"Nucleoplasm,Golgi apparatus,Vesicles"		Yes	No			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 29: Early spermatids - Spermatogenesis"	"Golgi apparatus, Vesicles"	Nucleoplasm	"HPA036930: AB_10670155, HPA067398: AB_2685833"	"unprognostic (3.05e-2)"	"unprognostic (7.48e-3)"	"unprognostic (4.80e-3)"	"unprognostic (8.13e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.78e-3)"	"unprognostic (9.63e-2)"	"unprognostic (5.25e-2)"	"unprognostic (9.71e-2)"	"unprognostic (7.65e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.90e-1)"	"prognostic favorable (5.28e-10)"	"unprognostic (1.56e-1)"	"unprognostic (3.50e-1)"	"unprognostic (5.13e-3)"	"unprognostic (4.12e-2)"	26.3	42.1	42.7	31.5	41.9	15.9	27.6	38.7	43.9	19.4	50.2	26.4	22.8	20.9	22.9	34.0	23.5	17.0	30.4	42.9	44.9	44.5	27.4	24.4	29.8	49.3	45.6	28.7	19.5	41.9	27.1	23.8	44.8	24.5	26.3	18.5	31.7	20.2	51.6	49.5	26.0	22.9	45.7	34.9	58.5	30.0	48.7	40.1	19.2	41.3	26.9	19.8	22.2	44.2	34.5	36.8	40.4	45.5	32.8	27.4	24.5	27.0	29.3	24.7	21.1	38.3	69.8	54.9	15.6	32.5	62.8	24.5	68.4	61.7	30.0	15.5	22.2	91.8	23.8	40.4	22.7	42.0	197.9	21.3	85.8	23.4	38.3	31.5	23.5	51.2	88.6	19.3	30.2	22.3	64.9	42.5	54.9	41.1	40.8	80.2	53.2	59.9	36.8	23.9	61.6	44.0	22.4	24.1	84.3	31.2	33.3	39.4	23.7	27.2	20.5	24.0	40.3	36.7	91.6	55.7	25.4	53.2	26.6	2.6	13.2	5.6	8.6	8.2	13.1	8.1	9.3	9.3	10.7	8.3	6.9	6.6	40.6	8.6	3.9	11.5	11.9	10.8	42.7	41.9	38.7	43.9	42.9	44.9	49.3	45.6	44.8	45.7	48.7	44.2	8.4	6.4	17.7	22.5	15.5	9.1	7.0	15.8	15.9	10.2	21.1	16.3	4.6	10.0	14.8	14.7	14.6	12.5	16.3	17.7	19.6	11.5	68.0	12.3	10.3	7.8	6.6	7.2	25.6	10.2	7.1	9.5	14.8	11.9	7.6	18.9	8.2	24.4	26.0	25.2	25.1	15.7	10.2	33.6	8.7	41.0	7.2	27.8	19.6	27.2	24.4	13.4	16.5	51.8	27.0	11.8	14.2	8.6	15.4	12.9	12.8	19.8	10.7	6.6	0.0	12.7	7.1	17.7	18.0	19.8	11.9	16.4	16.3	12.5	19.9	10.1
TCF7L2	"TCF-4, TCF4"	ENSG00000148737	"Transcription factor 7 like 2"	Q9NQB0	10	112950247-113167678	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation, Wnt signaling pathway"	"Activator, DNA-binding, Repressor"	"Cancer-related genes, Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	9	"brain: 244.9"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 264.8;Distal enterocytes: 260.0;Extravillous trophoblasts: 231.4;Paneth cells: 211.1"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"thalamus: 244.9"	"Group enriched"	"Detected in many"	10	"intermediate monocyte: 28.9;non-classical monocyte: 86.6"	"Lineage enriched"	"Detected in many"	14	"monocytes: 86.6"	"Low cell line specificity"	"Detected in many"			"Group enriched"	"Detected in all"	9	"midbrain: 67.2;thalamus: 86.6"	"Group enriched"	"Detected in all"	5	"midbrain: 146.8;pons: 97.8;thalamus: 164.3"	"CAB013535, HPA038800"	Supported		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		Yes	No			"Cluster 51: Monocytes - Innate immune response"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	"Nuclear bodies, Cytosol"	"CAB013535: AB_2533167, HPA038800: "	"unprognostic (1.79e-2)"	"unprognostic (3.36e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.31e-2)"	"unprognostic (4.59e-3)"	"unprognostic (1.72e-1)"	"unprognostic (2.09e-1)"	"unprognostic (9.84e-2)"	"unprognostic (5.09e-1)"	"unprognostic (7.10e-2)"	"unprognostic (6.10e-3)"	"unprognostic (3.46e-2)"	"unprognostic (7.25e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.64e-1)"	"unprognostic (7.36e-3)"	28.1	9.4	47.4	8.6	6.3	7.6	25.0	0.2	12.1	18.9	1.0	22.9	20.4	25.1	6.7	9.9	18.1	9.4	11.3	4.3	46.9	9.9	22.4	13.9	5.4	5.1	98.0	22.9	12.4	11.1	9.6	17.7	1.7	12.3	21.3	4.6	14.5	13.1	8.4	17.2	19.3	16.4	1.6	22.2	23.3	7.6	244.9	5.8	12.9	6.9	3.7	13.8	14.3	3.2	15.0	37.8	40.7	39.6	20.8	13.7	48.5	10.3	20.0	7.1	8.5	24.9	45.3	0.1	11.3	19.4	9.6	10.5	14.0	17.6	9.1	1.7	13.1	10.4	25.2	23.6	22.0	4.2	3.7	24.4	6.3	11.0	18.2	29.7	12.0	8.8	11.0	0.7	8.2	28.0	6.7	2.5	29.2	16.6	21.6	19.0	29.8	6.9	15.2	20.4	0.8	12.4	15.7	15.4	17.0	31.5	10.0	2.2	27.9	6.8	18.7	16.9	21.3	2.6	0.3	0.4	6.5	8.7	14.9	0.4	4.5	0.4	1.5	28.9	0.9	0.0	0.4	1.2	4.1	0.0	0.4	0.6	6.0	0.0	86.6	0.2	0.0	3.5	47.4	6.3	0.2	12.1	4.3	46.9	5.1	98.0	1.7	1.6	244.9	3.2	62.0	22.4	26.5	264.8	3.3	42.6	27.3	35.8	64.9	2.8	53.0	54.9	13.6	52.9	35.5	40.5	6.2	44.2	9.1	260.0	11.7	39.3	8.8	40.1	140.6	46.1	19.8	4.8	35.1	43.6	231.4	90.8	90.2	64.2	0.0	37.6	52.8	74.2	17.5	5.0	16.6	87.7	16.2	99.9	20.6	5.0	59.0	54.6	32.0	107.7	22.4	34.4	5.2	192.5	34.9	59.0	211.1	48.5	6.0	38.4	75.3	16.2	26.8	6.1	92.1	37.3	51.3	9.4	28.9	61.1	39.8	28.5	6.7	13.1	73.9	49.0
TFAP2C	"AP2-GAMMA, ERF1, hAP-2g, TFAP2G"	ENSG00000087510	"Transcription factor AP-2 gamma"	Q92754	20	56629306-56639283	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 29.1;skin 1: 53.3"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 132.4;Basal squamous epithelial cells: 120.1;Breast glandular cells: 66.1;Breast myoepithelial cells: 79.6;Cytotrophoblasts: 91.7;Extravillous trophoblasts: 59.7;Squamous epithelial cells: 81.0;Suprabasal keratinocytes: 149.3;Syncytiotrophoblasts: 105.6"	"Cancer enhanced"	"Detected in many"		"testis cancer: 54.3"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"BEWO: 190.6;MCF7: 169.2;SK-BR-3: 308.9;T-47d: 86.8;WM-115: 114.7"	"Region enriched"	"Detected in single"	13	"olfactory bulb: 2.4"	"Region enhanced"	"Detected in single"		"olfactory bulb: 1.4"	"CAB016061, CAB016079, HPA055179, HPA057076"	Enhanced		Supported	Nucleoplasm		Yes	NA				"Cluster 31: Skin - Epidermis development"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm		"CAB016061: AB_667770, CAB016079: AB_2199447, HPA055179: AB_2682729, HPA057076: AB_2683329"	"unprognostic (1.74e-2)"	"prognostic favorable (6.90e-4)"	"unprognostic (2.24e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.52e-2)"	"unprognostic (6.75e-2)"	"unprognostic (2.54e-2)"	"unprognostic (8.26e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.14e-3)"	"unprognostic (2.63e-1)"	"unprognostic (9.04e-5)"	"unprognostic (2.31e-1)"	"unprognostic (1.85e-1)"	"unprognostic (6.71e-2)"	"unprognostic (3.28e-2)"	1.8	0.3	1.3	0.2	0.6	0.1	26.1	0.5	1.5	18.3	0.5	4.0	0.2	6.2	5.2	29.1	2.6	1.0	0.3	1.7	0.7	2.0	0.0	2.6	0.1	0.9	0.8	0.3	1.0	2.6	0.8	17.0	1.2	7.1	1.2	2.7	20.7	4.4	2.1	53.3	0.3	1.1	0.5	0.1	0.7	1.0	0.6	0.7	2.3	0.1	3.0	3.9	19.2	1.0	12.8	15.8	0.1	0.2	0.0	0.0	190.6	20.1	36.4	25.0	4.5	3.2	0.3	0.0	1.3	13.3	13.3	42.7	27.3	5.5	17.0	0.1	2.8	0.0	1.7	0.0	0.0	0.0	1.7	0.3	21.4	7.4	7.2	0.0	0.0	8.1	0.2	3.2	0.0	169.2	20.8	1.2	9.5	9.9	20.7	0.1	0.0	7.0	0.0	10.1	5.1	0.1	13.6	308.9	21.8	28.3	86.8	4.6	0.2	16.2	0.4	8.6	15.4	0.1	0.0	0.1	4.0	0.1	114.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.6	0.5	1.5	1.7	0.7	0.9	0.8	1.2	0.5	0.6	1.0	0.7	0.0	9.5	3.9	0.3	132.4	29.9	2.4	120.1	4.1	66.1	79.6	1.0	0.0	5.6	9.2	0.0	91.7	1.5	1.7	0.0	0.3	0.3	7.8	18.7	2.0	3.0	0.0	0.0	0.0	59.7	7.4	1.5	16.0	0.0	0.0	0.7	0.0	7.8	0.0	0.0	1.7	10.2	0.3	8.2	0.0	0.0	1.6	21.4	3.7	0.0	0.3	0.0	0.0	0.0	1.0	0.6	0.0	3.8	18.6	0.0	0.0	5.2	0.0	0.0	0.5	2.1	0.0	1.8	81.0	149.3	105.6	1.3	0.0	1.0	18.5
THUMPD2	"C2orf8, MGC2454"	ENSG00000138050	"THUMP domain containing 2"	Q9BTF0	2	39736060-39779267	"Predicted intracellular proteins"		"Methyltransferase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043042, HPA058025"	Approved		Uncertain	Nucleoplasm		Yes	No			"Cluster 30: Non-specific - Translation"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm		"HPA043042: AB_10964424, HPA058025: "	"unprognostic (6.30e-2)"	"unprognostic (9.12e-3)"	"unprognostic (2.48e-2)"	"unprognostic (4.62e-3)"	"unprognostic (2.16e-1)"	"unprognostic (1.39e-2)"	"prognostic unfavorable (6.05e-4)"	"unprognostic (1.22e-1)"	"unprognostic (2.31e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.72e-1)"	"unprognostic (2.54e-2)"	"prognostic unfavorable (7.27e-5)"	"unprognostic (2.17e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.14e-3)"	2.4	2.0	2.6	0.5	2.5	1.7	2.1	2.9	3.0	1.9	2.6	1.9	0.5	1.7	0.2	3.5	1.5	0.5	3.3	2.6	2.6	2.4	2.3	2.2	1.4	2.6	2.8	3.2	2.2	0.5	2.3	0.4	2.6	2.0	0.7	0.4	2.1	0.4	6.0	2.5	2.0	0.4	2.4	2.5	2.2	0.9	2.6	2.0	2.1	4.0	1.5	2.1	2.4	2.8	4.9	4.7	1.0	6.5	2.3	3.3	2.7	1.3	2.5	3.0	3.1	5.0	4.5	7.8	2.7	1.6	7.6	2.0	9.7	4.4	3.2	13.1	10.8	4.7	3.0	5.7	4.1	6.3	2.4	3.9	3.2	3.1	1.0	2.9	4.9	1.5	5.9	1.8	6.1	2.3	3.3	5.0	0.0	13.0	2.9	3.4	4.2	5.4	2.9	2.6	5.7	3.1	1.3	5.6	3.2	0.4	1.8	3.9	2.5	4.0	2.5	1.1	3.6	2.4	3.1	5.1	2.0	11.4	3.2	0.0	0.6	0.0	0.1	0.4	0.6	0.7	0.4	0.1	0.5	0.3	0.6	0.4	0.1	0.4	0.1	0.9	0.1	0.6	2.6	2.5	2.9	3.0	2.6	2.6	2.6	2.8	2.6	2.4	2.6	2.8	17.4	25.6	20.6	26.8	17.8	14.3	29.0	19.5	15.9	26.8	14.4	29.8	23.7	8.6	20.3	14.7	18.8	11.5	23.0	7.2	19.6	16.6	4.5	7.5	16.9	13.7	9.6	23.8	42.2	13.7	13.6	18.4	17.9	10.9	7.0	19.2	10.0	9.9	11.3	6.7	41.6	8.1	8.2	10.9	7.7	4.0	28.0	10.0	5.4	45.0	11.8	12.1	15.5	45.2	30.3	16.7	17.1	25.6	8.2	23.7	10.3	16.4	10.9	21.1	6.6	20.5	16.0	9.1	19.7	16.9	13.5	6.8	12.6	22.2	13.5	22.7
TM2D3	"BLP2, FLJ22604"	ENSG00000184277	"TM2 domain containing 3"	Q9BRN9	15	101621444-101652391	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054064	Uncertain		Approved	Nucleoplasm,Cytosol		Yes	No			"Cluster 5: Granulocytes - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Nucleoplasm	Cytosol	"HPA054064: AB_2682366"	"unprognostic (1.41e-1)"	"unprognostic (8.76e-2)"	"unprognostic (2.06e-2)"	"unprognostic (2.55e-3)"	"unprognostic (1.15e-1)"	"unprognostic (8.37e-2)"	"unprognostic (2.29e-1)"	"unprognostic (8.62e-2)"	"unprognostic (2.51e-2)"	"unprognostic (5.40e-2)"	"unprognostic (4.09e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.14e-2)"	"unprognostic (2.92e-2)"	"unprognostic (2.63e-1)"	"unprognostic (3.78e-2)"	"unprognostic (2.78e-2)"	32.2	38.3	58.9	23.5	62.8	28.2	33.9	57.0	74.7	36.7	51.4	31.1	24.6	40.8	43.5	23.9	34.2	29.6	47.8	62.0	70.1	32.2	58.1	28.1	30.5	54.9	58.7	55.7	30.3	40.6	35.7	31.7	58.5	32.7	24.2	32.3	34.4	35.3	44.5	27.0	26.2	32.1	55.9	29.2	29.1	28.0	61.1	29.5	45.2	55.7	31.7	32.8	28.5	58.0	20.1	48.9	25.6	46.6	71.9	53.1	31.3	25.9	42.6	30.0	33.4	26.4	55.5	32.5	34.9	35.5	50.7	45.9	40.3	33.3	23.7	31.2	88.4	48.7	39.9	45.4	47.2	38.4	55.8	44.2	66.3	18.1	37.4	42.1	42.1	41.5	40.6	47.8	47.9	40.8	28.3	40.2	39.5	90.4	16.2	33.9	32.3	51.0	61.5	52.0	34.3	31.3	35.8	37.4	54.3	43.7	35.5	49.8	33.7	31.6	32.5	21.2	28.9	45.0	71.2	35.3	26.9	47.5	26.7	36.4	40.6	81.9	41.2	41.9	46.4	30.6	33.6	31.6	29.1	44.8	44.1	41.4	69.6	52.4	32.4	24.6	38.4	41.3	58.9	62.8	57.0	74.7	62.0	70.1	54.9	58.7	58.5	55.9	61.1	58.0	52.4	25.6	28.7	22.2	55.8	66.3	58.5	142.3	32.5	47.1	42.6	45.8	35.7	35.8	67.9	42.3	33.3	73.7	51.9	23.0	19.6	61.0	8.0	28.1	38.2	48.8	27.0	30.3	41.5	42.3	64.7	53.7	23.0	44.8	25.3	37.6	60.3	56.6	32.3	69.0	55.3	23.2	91.6	42.1	36.4	10.8	73.7	39.2	26.6	37.5	44.4	60.6	56.7	29.1	45.8	27.8	20.7	62.8	41.3	66.6	32.6	39.5	47.2	46.8	72.3	40.1	67.0	89.3	84.2	25.0	55.4	91.0	55.1	21.5	27.8	40.0
TMA7	"CCDC72, HSPC016"	ENSG00000232112	"Translation machinery associated 7 homolog"	Q9Y2S6	3	48440257-48444208	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047397			Approved	"Nucleoplasm,Nucleoli,Nucleoli rim,Nuclear bodies"		Yes	No			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoli, Nucleoli rim"	"Nucleoplasm, Nuclear bodies"	"HPA047397: AB_2680029"	"unprognostic (1.26e-3)"	"unprognostic (1.21e-1)"	"unprognostic (9.10e-2)"	"unprognostic (1.18e-2)"	"unprognostic (2.06e-1)"	"unprognostic (5.02e-2)"	"unprognostic (3.55e-2)"	"prognostic favorable (8.33e-4)"	"unprognostic (1.14e-2)"	"unprognostic (3.85e-3)"	"unprognostic (1.92e-2)"	"unprognostic (2.55e-2)"	"unprognostic (1.14e-2)"	"unprognostic (9.31e-3)"	"unprognostic (3.13e-2)"	"unprognostic (1.14e-1)"	"unprognostic (8.64e-3)"	252.5	276.8	498.7	220.7	507.8	434.6	241.9	504.6	588.9	236.5	500.2	253.3	192.8	179.4	344.5	310.5	181.7	117.9	355.4	502.2	514.7	317.6	273.2	208.0	279.3	511.7	510.0	259.6	230.3	309.8	302.0	146.6	505.9	239.6	229.3	295.4	215.9	142.7	511.6	215.1	220.4	132.7	513.0	272.9	235.5	216.0	511.9	388.3	232.4	287.4	297.7	213.3	239.3	514.5	565.0	398.8	634.2	456.6	514.0	497.1	435.6	454.1	355.7	425.1	419.3	326.3	395.9	365.2	315.3	397.8	553.6	215.5	559.8	512.5	471.6	452.6	475.5	689.4	910.3	845.8	399.0	792.2	443.0	459.7	538.2	402.6	388.8	414.2	546.0	641.1	376.6	379.0	615.3	581.2	929.4	1071.2	847.1	607.0	637.3	262.2	397.0	620.4	746.0	748.7	207.8	526.1	511.0	369.3	736.1	583.6	356.7	1156.3	412.1	358.0	650.8	560.5	902.6	626.1	1001.6	902.8	459.1	754.2	379.9	1923.2	1058.7	2195.0	1127.1	1022.5	1237.6	1412.6	1486.0	1377.1	1150.8	1172.2	1464.7	1408.1	2036.5	943.8	1028.9	1521.6	1652.1	2663.7	498.7	507.8	504.6	588.9	502.2	514.7	511.7	510.0	505.9	513.0	511.9	514.5	518.8	240.4	370.4	20.9	615.0	716.3	534.0	1308.9	618.6	219.6	866.8	1111.2	633.4	513.3	616.2	901.2	106.3	785.4	797.4	948.2	1717.8	566.9	653.6	524.8	511.4	474.5	635.3	609.1	25.8	1032.9	830.9	443.7	356.3	646.1	454.4	376.5	574.7	1098.6	854.5	119.5	25.4	985.5	695.8	652.4	790.5	1123.9	646.8	544.3	777.3	18.7	850.3	522.8	1080.3	10.1	28.3	872.9	980.3	464.6	593.9	584.6	1211.0	1438.8	466.4	321.9	355.0	393.6	448.4	547.4	689.4	805.5	898.4	440.1	757.1	351.9	937.2	572.2
TMPPE	FLJ45032	ENSG00000188167	"Transmembrane protein with metallophosphoesterase domain"	Q6ZT21	3	33090421-33097146	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 5.5"	"Cell type enhanced"	"Detected in some"		"Rod photoreceptor cells: 2.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"intermediate monocyte: 2.4"	"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in many"	6	"BEWO: 27.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027019	Approved		Approved	Nucleoplasm,Mitochondria		Yes	No			"Cluster 7: Monocytes - Unknown function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Mitochondria"		"HPA027019: AB_1848942"	"unprognostic (1.14e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.37e-1)"	"unprognostic (5.03e-2)"	"unprognostic (2.96e-2)"	"unprognostic (6.34e-3)"	"unprognostic (8.14e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.25e-3)"	"unprognostic (9.58e-2)"	"unprognostic (1.60e-7)"	"unprognostic (1.61e-1)"	"unprognostic (5.40e-2)"	"unprognostic (2.13e-1)"	"unprognostic (4.33e-2)"	0.6	0.5	0.8	1.4	0.7	5.5	0.6	0.7	1.2	0.6	4.3	1.0	1.2	0.5	0.6	0.6	0.9	0.6	0.4	1.5	0.5	1.0	0.6	1.1	1.1	1.4	1.4	0.6	0.7	1.9	0.3	1.2	1.6	0.5	1.2	2.8	0.7	0.6	0.2	1.1	1.1	0.8	0.2	1.5	1.3	0.3	1.7	0.5	1.0	0.3	1.3	0.8	0.4	0.2	1.4	1.9	1.0	1.7	1.2	1.0	27.2	0.6	1.0	1.6	0.9	2.7	3.8	0.8	1.2	1.7	0.9	1.4	1.7	1.5	2.6	4.2	0.6	3.4	1.9	2.1	0.9	3.0	4.7	1.1	1.2	2.0	1.4	0.8	1.9	1.7	2.6	2.9	1.2	1.3	1.2	1.3	1.0	0.4	1.1	1.5	0.6	1.9	1.5	1.9	0.2	0.6	0.9	2.6	0.6	1.3	1.4	4.2	2.7	2.4	3.0	1.3	2.6	2.3	1.6	0.4	3.0	2.2	1.7	0.0	1.1	0.3	0.1	2.4	0.6	0.3	0.2	0.0	1.0	0.1	0.0	0.0	1.9	0.0	1.1	0.2	0.2	0.4	0.8	0.7	0.7	1.2	1.5	0.5	1.4	1.4	1.6	0.2	1.7	0.2	0.3	0.0	1.3	0.0	0.8	0.8	0.1	0.0	0.0	1.2	0.4	0.4	0.4	0.0	0.2	0.0	0.0	1.1	1.9	1.4	0.0	0.4	0.0	0.8	0.6	0.4	0.0	0.4	0.0	0.8	1.7	0.3	0.0	1.1	0.0	0.4	0.4	0.6	0.9	1.7	0.0	0.2	2.0	1.3	1.2	0.0	0.0	1.1	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.5	1.4	0.4	1.0	0.2	1.4	0.3	0.4	2.2	0.0	0.2	0.7	0.0	0.0	1.5	0.9	0.4	0.6	0.5	0.6	0.2
TOP2A	TOP2	ENSG00000131747	"DNA topoisomerase II alpha"	P11388	17	40388525-40417896	"Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms"	"DNA-binding, Isomerase, Topoisomerase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 127.8;testis: 65.7"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 216.8;Granulosa cells: 117.5;Spermatocytes: 621.2;Spermatogonia: 269.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Immune cell enhanced"	"Detected in some"		"T-reg: 2.4"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"basal ganglia: 4.2;white matter: 8.0"	"Low region specificity"	"Detected in some"			"CAB002448, HPA006458, HPA026773"	Enhanced	Approved	Supported	Nucleoplasm,Nucleoli		Yes	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	Nucleoli	"CAB002448: AB_564035, HPA006458: AB_1858189, HPA026773: AB_1858190"	"unprognostic (2.09e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.28e-3)"	"unprognostic (9.42e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.52e-1)"	"prognostic unfavorable (5.92e-6)"	"prognostic unfavorable (4.99e-4)"	"unprognostic (6.21e-3)"	"unprognostic (2.09e-1)"	"prognostic unfavorable (3.83e-5)"	"unprognostic (5.03e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (7.46e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.29e-1)"	2.2	2.5	0.2	20.0	0.2	42.0	5.4	0.1	0.7	5.0	1.1	17.8	18.1	3.9	0.3	29.0	1.5	2.6	1.2	0.2	0.2	1.2	2.8	4.1	40.3	0.2	0.8	1.0	0.9	0.3	0.3	15.9	0.5	1.4	19.8	0.1	4.3	0.5	0.3	15.3	17.0	7.6	0.2	9.9	8.9	65.7	1.1	127.8	1.9	0.2	42.5	6.0	9.6	0.4	212.6	275.6	343.1	158.0	16.8	33.9	76.3	283.3	151.5	255.0	224.2	130.5	157.6	339.4	140.1	96.7	152.7	326.5	266.8	113.5	339.5	182.7	177.8	224.8	167.9	216.7	1.6	318.4	228.6	7.4	9.2	179.8	181.4	55.1	136.3	216.5	247.5	225.8	279.2	72.6	372.3	209.6	143.0	152.4	108.3	310.7	531.9	141.3	61.6	133.3	201.6	144.6	229.3	281.4	89.4	198.2	236.9	143.2	90.3	167.0	233.2	195.5	276.7	128.4	154.9	290.7	94.3	214.9	285.0	0.2	0.0	0.0	0.2	0.0	0.0	0.6	0.3	0.3	0.1	0.1	0.0	0.0	0.1	1.4	0.1	0.0	2.4	0.4	0.2	0.2	0.1	0.7	0.2	0.2	0.2	0.8	0.5	0.2	1.1	0.4	1.0	0.0	2.0	0.3	17.4	11.7	3.7	15.0	2.2	0.0	18.7	17.1	1.3	2.8	5.8	0.0	0.0	72.9	6.1	19.8	0.0	0.8	20.3	12.7	15.8	9.3	0.0	216.8	0.2	0.0	92.4	23.3	23.0	10.0	0.0	117.5	20.7	5.4	83.5	0.0	0.1	34.2	18.3	33.9	13.2	19.1	4.7	14.1	1.8	0.0	2.6	0.0	3.1	0.0	0.1	0.3	3.5	1.9	31.3	3.1	3.4	0.1	1.8	0.0	72.3	0.5	19.5	621.2	269.6	45.1	6.1	8.9	14.8	4.3	61.0	6.9
TPX2	"C20orf1, C20orf2, DIL-2, p100"	ENSG00000088325	"TPX2 microtubule nucleation factor"	Q9ULW0	20	31739271-31801805	"Cancer-related genes, Predicted intracellular proteins"	"Apoptosis, Cell cycle, Cell division, Mitosis"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 48.0;lymphoid tissue: 70.3;testis: 30.7"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 90.7;Extravillous trophoblasts: 68.5;Granulosa cells: 46.6;Spermatocytes: 114.5;Spermatogonia: 63.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"T-reg: 8.1"	"Group enriched"	"Detected in many"	5	"granulocytes: 5.1;NK-cells: 3.6;T-cells: 8.1"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005487	Enhanced		Supported	"Nucleoplasm,Cytokinetic bridge,Mitotic spindle"		Yes	Yes			"Cluster 44: Non-specific - Transcription"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Cytokinetic bridge, Mitotic spindle"	"HPA005487: AB_1858223"	"unprognostic (2.18e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.97e-2)"	"prognostic unfavorable (2.43e-6)"	"unprognostic (2.99e-1)"	"unprognostic (7.56e-2)"	"prognostic unfavorable (8.07e-7)"	"prognostic unfavorable (6.46e-4)"	"unprognostic (3.70e-2)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (2.68e-5)"	"unprognostic (5.99e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (4.56e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.39e-1)"	1.9	1.4	0.9	13.0	0.9	48.0	2.7	0.8	1.0	2.3	0.5	11.6	9.4	2.4	0.2	13.2	0.9	1.8	0.8	1.1	0.6	0.7	4.2	1.9	26.6	0.6	1.0	0.5	0.4	0.4	0.2	8.3	0.7	0.7	14.2	0.5	2.0	0.5	1.4	9.8	9.4	6.8	0.6	5.2	6.2	30.7	1.3	70.3	1.0	0.8	32.3	3.4	4.1	0.9	455.1	149.1	176.4	139.1	13.8	25.2	169.8	186.1	104.5	264.0	197.7	319.1	190.4	212.4	106.7	104.5	196.8	232.7	203.7	169.0	298.8	92.3	78.8	416.3	139.7	219.6	4.2	161.9	102.8	8.7	9.1	166.0	120.0	37.9	144.6	157.1	313.8	187.8	209.7	186.2	272.2	125.3	197.1	174.0	159.3	152.5	475.5	128.2	71.2	72.8	127.5	85.7	284.6	106.3	82.0	120.9	185.1	97.3	98.3	294.1	179.7	136.5	290.0	74.4	138.6	187.3	92.2	565.1	195.8	5.1	0.0	0.4	0.4	0.0	0.2	0.6	1.4	1.7	0.5	0.2	0.3	0.5	0.2	3.6	0.1	1.0	8.1	1.0	0.9	0.9	0.8	1.0	1.1	0.6	0.6	1.0	0.7	0.6	1.3	0.9	1.0	0.0	4.2	0.0	5.9	6.9	1.5	4.3	1.2	0.9	3.0	3.4	0.9	4.3	3.8	0.0	0.0	23.3	3.8	6.4	0.0	1.2	9.3	7.3	6.6	3.9	1.2	90.7	2.9	0.4	68.5	9.2	16.3	8.4	0.0	46.6	8.9	3.0	19.5	1.7	0.9	9.8	10.2	8.0	5.5	13.1	0.9	7.6	0.0	1.0	2.1	0.4	3.1	0.5	0.5	1.8	1.4	0.0	30.8	2.5	0.9	0.0	0.7	0.4	0.0	1.1	15.4	114.5	63.1	31.2	6.1	4.7	8.2	4.2	18.4	2.9
TRMT11	"C6orf75, dJ187J11.2, MDS024, TRM11, TRMT11-1"	ENSG00000066651	"TRNA methyltransferase 11 homolog"	Q7Z4G4	6	125986479-126203817	"Metabolic proteins, Predicted intracellular proteins"	"tRNA processing"	"Methyltransferase, RNA-binding, Transferase, tRNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030473			Approved	"Nuclear bodies"		Yes	No			"Cluster 30: Non-specific - Translation"	"Cluster 85: Liver - Metabolism"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Nuclear bodies"		"HPA030473: AB_2673493"	"unprognostic (2.55e-1)"	"unprognostic (6.12e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.13e-2)"	"unprognostic (7.62e-2)"	"unprognostic (9.69e-2)"	"unprognostic (2.12e-1)"	"unprognostic (7.38e-2)"	"unprognostic (3.54e-2)"	"unprognostic (5.73e-2)"	"unprognostic (7.35e-2)"	"unprognostic (1.06e-2)"	"unprognostic (4.74e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.69e-1)"	"unprognostic (2.06e-1)"	8.4	10.2	7.3	8.1	7.5	2.9	11.7	12.9	9.9	9.5	6.6	8.8	12.8	13.5	9.9	8.0	9.7	9.0	10.9	7.3	7.8	13.3	19.8	7.9	10.5	6.7	7.4	12.5	6.4	12.6	13.3	9.4	7.2	9.1	9.4	16.9	8.8	8.5	7.6	6.6	10.7	10.7	5.8	6.8	8.8	7.7	7.2	8.7	12.9	8.8	10.4	9.6	8.9	9.0	17.4	11.0	24.2	11.4	12.9	13.7	16.6	13.1	21.7	15.6	24.3	30.8	19.8	26.0	24.2	8.3	29.1	20.7	26.1	14.3	26.4	19.5	37.6	17.8	20.1	46.2	21.9	29.0	5.4	14.3	15.5	15.9	25.6	22.4	7.6	9.1	44.5	5.3	17.7	22.0	15.3	34.6	20.4	15.4	15.1	9.1	16.3	17.6	22.3	9.8	32.4	16.9	13.9	18.0	36.3	18.0	13.1	28.3	5.4	9.7	10.7	27.3	25.8	13.9	1.3	6.6	23.2	24.5	17.7	1.0	1.6	0.0	5.6	1.3	11.0	7.0	7.9	6.5	3.5	6.0	9.5	8.6	0.5	7.7	0.7	4.3	6.0	3.2	7.3	7.5	12.9	9.9	7.3	7.8	6.7	7.4	7.2	5.8	7.2	9.0	11.0	6.4	22.0	24.8	17.4	13.4	27.8	29.4	23.3	59.5	11.2	13.7	12.2	21.5	26.1	7.3	73.0	18.7	14.9	8.5	19.6	19.2	10.1	13.1	25.5	10.4	9.1	8.4	56.1	16.3	13.7	27.3	27.0	12.3	18.4	20.0	6.8	22.5	7.2	20.2	63.8	11.1	18.3	6.0	3.7	4.7	25.7	7.1	3.6	23.4	11.8	21.1	9.2	31.7	48.5	13.2	15.5	24.5	12.3	22.6	22.6	30.2	24.3	74.7	6.6	21.0	17.2	15.6	9.2	14.3	10.1	14.9	14.7	27.2	13.7	17.9
TRNT1	"CCA1, CGI-47, MtCCA"	ENSG00000072756	"TRNA nucleotidyl transferase 1"	Q96Q11	3	3126933-3150879	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"tRNA processing"	"Nucleotidyltransferase, RNA-binding, Transferase"	"Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036938	Uncertain		Supported	Mitochondria		Yes	No			"Cluster 46: Basophils - DNA binding"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Mitochondria		"HPA036938: AB_10670566"	"unprognostic (6.39e-3)"	"unprognostic (1.58e-1)"	"unprognostic (2.38e-3)"	"unprognostic (4.69e-2)"	"unprognostic (4.92e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.39e-2)"	"unprognostic (2.68e-1)"	"unprognostic (6.22e-2)"	"unprognostic (5.65e-2)"	"unprognostic (4.62e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.24e-2)"	"unprognostic (6.50e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.78e-1)"	"unprognostic (1.02e-1)"	9.7	10.0	7.2	8.9	7.2	3.5	8.5	7.9	8.0	7.8	7.0	8.1	4.4	8.8	5.5	9.4	7.6	8.3	8.4	7.4	7.2	17.2	10.0	8.4	9.7	7.1	7.3	8.3	8.4	8.3	10.3	10.5	7.1	11.3	7.6	4.0	7.7	6.3	9.3	6.4	7.9	8.3	7.3	10.7	9.1	6.5	7.4	9.8	11.3	7.6	10.9	13.1	7.9	8.0	20.0	29.6	18.2	9.8	24.1	21.5	20.5	19.9	17.4	21.6	20.9	25.0	20.9	35.6	12.8	22.4	32.0	12.6	24.6	18.6	26.5	24.6	13.3	28.7	25.3	24.9	31.4	32.2	20.8	17.9	25.0	20.2	6.8	15.0	21.0	24.1	25.1	9.8	35.9	37.2	22.0	21.4	15.2	29.2	19.0	20.5	28.1	32.5	26.1	25.8	10.8	15.9	31.6	20.6	18.5	26.3	18.7	16.3	14.8	22.8	18.7	23.6	25.7	12.6	31.4	43.4	17.2	27.6	25.0	49.4	12.4	36.4	16.4	18.1	16.0	25.8	20.8	18.1	16.8	15.7	22.7	20.1	16.6	19.8	19.0	15.6	18.6	11.2	7.2	7.2	7.9	8.0	7.4	7.2	7.1	7.3	7.1	7.3	7.4	8.0	20.7	16.0	13.4	15.3	30.2	14.8	29.0	19.9	24.5	13.5	12.1	11.0	14.3	2.8	16.3	18.4	14.6	25.8	23.5	10.6	45.0	19.1	2.3	15.8	19.0	21.1	8.4	16.6	23.8	9.9	17.8	19.9	23.4	12.0	22.8	20.7	12.5	9.2	13.3	10.1	27.0	10.7	16.2	11.0	13.3	2.9	10.8	13.3	7.2	23.4	20.3	17.1	18.6	23.6	34.7	10.6	9.2	8.6	30.7	30.9	11.0	32.7	11.4	15.7	0.0	14.9	17.4	20.8	17.9	23.4	13.1	28.3	22.0	24.7	13.5	23.9
UBE2M	"hUbc12, UBC12"	ENSG00000130725	"Ubiquitin conjugating enzyme E2 M"	P61081	19	58555712-58558954	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEK 293: 1197.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004993, HPA054551, HPA057800"	Approved		Enhanced	"Nucleoplasm,Nucleoli,Nuclear bodies,Cytosol"		Yes	No		49000	"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	"Nucleoli, Nuclear bodies, Cytosol"	"CAB004993: AB_436983, HPA054551: AB_2682520, HPA057800: AB_2683531"	"unprognostic (1.42e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.39e-1)"	"unprognostic (8.35e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.17e-3)"	"unprognostic (3.90e-3)"	"unprognostic (4.86e-2)"	"unprognostic (1.09e-2)"	"unprognostic (3.05e-3)"	"unprognostic (1.96e-1)"	"unprognostic (1.81e-1)"	"unprognostic (8.63e-3)"	"unprognostic (1.76e-1)"	"unprognostic (5.85e-2)"	"unprognostic (8.42e-3)"	46.3	66.1	133.2	39.2	138.8	82.2	42.8	116.7	199.7	48.9	104.0	72.5	41.7	48.1	36.3	61.8	51.3	30.9	111.0	141.2	129.3	63.2	45.6	46.3	43.4	123.5	124.4	46.0	47.5	84.5	69.7	45.0	127.7	48.3	32.5	49.7	48.5	46.1	174.0	56.6	41.6	39.5	111.9	49.3	55.8	81.0	124.4	51.7	44.3	104.5	43.7	58.3	45.8	139.1	161.8	272.1	119.3	124.8	61.7	71.9	112.2	166.0	117.4	97.8	82.8	162.7	109.7	161.9	135.5	93.4	198.1	105.9	130.1	138.6	69.2	207.3	1197.4	235.5	163.7	113.7	154.4	197.3	192.9	82.1	107.1	145.9	167.3	102.6	117.8	146.3	119.6	179.4	127.3	158.2	177.2	223.7	87.1	155.1	306.5	171.7	106.7	204.5	111.6	166.8	239.5	205.5	133.1	149.7	163.3	41.6	94.4	188.4	105.2	333.4	80.5	110.6	281.3	262.3	411.9	169.6	206.0	177.6	220.5	6.7	3.6	4.2	3.0	2.6	2.2	2.8	3.2	3.2	2.8	3.8	3.3	2.2	10.1	1.7	2.7	6.7	2.9	1.9	133.2	138.8	116.7	199.7	141.2	129.3	123.5	124.4	127.7	111.9	124.4	139.1	75.1	6.4	13.0	14.7	32.7	40.4	36.3	15.9	6.2	100.0	74.5	81.3	38.5	20.0	11.6	18.4	20.9	21.0	72.9	63.9	7.9	17.3	25.7	89.6	68.0	40.1	41.2	39.8	22.9	30.6	22.4	38.9	21.9	63.3	19.7	103.3	28.5	38.0	35.4	109.4	20.8	43.8	20.3	27.0	33.5	34.0	17.4	42.5	35.6	15.9	21.1	142.3	14.4	8.5	17.9	41.8	21.4	13.9	35.4	59.1	37.9	33.9	18.6	81.1	26.3	41.5	55.4	27.1	7.9	17.0	56.8	52.5	41.0	156.1	41.6	56.2
UGDH		ENSG00000109814	"UDP-glucose 6-dehydrogenase"	O60701	4	39498755-39528311	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism"	"Allosteric enzyme, Oxidoreductase"	"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 137.7"	"Cell type enhanced"	"Detected in all"		"Exocrine glandular cells: 345.5;Hepatocytes: 231.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"A549: 509.6;Hep G2: 595.9;U-2197: 375.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034444, HPA036656, HPA036657"	Enhanced		Supported	Nucleoplasm		Yes	No		1300000	"Cluster 46: Basophils - DNA binding"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 1: Pancreatic cells - Digestion"	Nucleoplasm		"CAB034444: AB_2019602, HPA036656: AB_10671706, HPA036657: AB_10672360"	"unprognostic (1.22e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.73e-2)"	"unprognostic (3.96e-2)"	"unprognostic (5.54e-2)"	"unprognostic (1.63e-1)"	"unprognostic (8.78e-3)"	"unprognostic (6.07e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.41e-1)"	"unprognostic (9.81e-3)"	"unprognostic (6.86e-2)"	"prognostic unfavorable (5.51e-10)"	"unprognostic (2.48e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.97e-2)"	48.5	27.8	6.2	29.5	7.3	2.4	32.0	9.4	9.2	31.5	18.1	96.5	45.3	29.1	10.6	34.1	29.6	40.5	16.0	5.9	8.3	37.5	137.7	19.0	13.3	7.4	7.7	30.0	33.7	23.1	7.8	38.4	8.0	35.6	73.3	14.3	16.8	14.0	6.7	9.9	41.1	23.5	7.6	11.5	47.4	6.8	8.4	10.3	27.8	9.5	14.5	54.4	17.1	9.7	36.0	509.6	58.4	76.2	181.5	185.3	51.3	102.7	113.8	94.5	84.8	76.2	115.5	25.4	63.0	133.3	94.5	33.5	56.0	29.5	95.8	32.1	13.0	26.2	65.4	595.9	72.7	34.1	25.3	64.4	14.9	160.2	49.8	78.9	59.3	20.9	34.1	17.3	67.9	89.8	29.4	34.4	53.1	194.0	46.4	48.3	95.0	22.0	53.7	120.0	31.2	46.7	69.2	37.9	45.3	41.4	21.0	27.0	85.9	97.9	49.1	375.8	54.2	42.1	33.3	23.3	86.9	25.8	56.6	30.0	20.9	19.7	23.2	18.4	37.8	18.8	18.8	24.9	19.0	18.4	16.1	19.4	3.8	42.3	11.2	22.5	13.5	18.8	6.2	7.3	9.4	9.2	5.9	8.3	7.4	7.7	8.0	7.6	8.4	9.7	19.1	25.6	27.6	4.6	14.1	116.1	73.4	19.5	43.9	7.5	115.8	62.0	8.9	24.3	25.4	20.2	14.6	21.3	12.9	207.8	70.5	54.7	1.1	78.3	53.8	25.4	113.3	9.1	10.6	345.5	78.8	145.7	184.0	64.8	35.5	11.1	20.7	231.3	17.8	10.1	12.6	114.5	12.2	20.2	33.3	1.6	33.2	12.7	30.2	7.5	19.9	7.3	9.2	46.3	12.8	195.8	112.2	29.0	21.3	127.3	81.4	79.6	65.7	9.2	32.9	39.0	57.5	6.5	5.5	102.2	40.1	29.0	11.7	12.4	152.4	86.4
UGT3A2		ENSG00000168671	"UDP glycosyltransferase family 3 member A2"	Q3SY77	5	36035021-36071358	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 6.5;lymphoid tissue: 14.7;skin 1: 10.3"	"Group enriched"	"Detected in some"	4	"Collecting duct cells: 3.7;Early spermatids: 4.4;Late spermatids: 8.2;Proximal tubular cells: 3.8"	"Cancer enriched"	"Detected in some"	5	"testis cancer: 4.4"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 6.8;JURKAT: 6.3;MOLT-4: 12.4;REH: 29.9;SuSa: 11.8;T-47d: 7.2;THP-1: 18.0"	"Low region specificity"	"Detected in many"							HPA059475	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		Yes	NA				"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 14: REH - Unknown function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm	"Golgi apparatus, Cytosol"	"HPA059475: AB_2684031"	"unprognostic (1.83e-4)"	"unprognostic (9.94e-2)"	"unprognostic (8.87e-2)"	"unprognostic (4.82e-4)"	"unprognostic (3.18e-1)"	"unprognostic (3.52e-2)"	"unprognostic (1.56e-1)"	"unprognostic (6.08e-2)"	"unprognostic (2.04e-1)"	"unprognostic (8.13e-2)"	"unprognostic (7.49e-2)"	"unprognostic (4.17e-2)"	"unprognostic (1.36e-3)"	"unprognostic (6.65e-2)"	"unprognostic (7.52e-2)"	"unprognostic (7.38e-2)"	"unprognostic (4.52e-3)"	0.0	0.8	0.0	0.0	0.0	6.5	1.1	0.3	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.3	2.6	0.6	0.0	0.0	1.0	1.1	0.0	0.0	0.1	0.9	0.2	1.2	0.4	0.0	0.1	0.1	0.0	0.1	10.3	0.0	0.0	0.1	1.2	0.1	2.9	0.6	14.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.6	1.8	0.0	0.1	0.0	0.0	0.3	0.4	0.0	1.3	0.0	0.5	6.8	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	12.4	0.0	5.3	0.0	0.0	29.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.8	7.2	18.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.3	1.0	1.1	1.2	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	3.7	0.0	0.2	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.7	0.0	0.0	0.0	0.1	0.0	0.7	0.1	0.0	0.1	0.0	0.0	0.0	1.1	8.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.3	0.1	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.3	0.9	0.0	0.0	0.3	0.0	0.1	0.0	0.0
UNC13B	"hmunc13, Munc13-2, UNC13, Unc13h2"	ENSG00000198722	"Unc-13 homolog B"	O14795	9	35161992-35405338	"Predicted intracellular proteins"	Exocytosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 57.7;Alveolar cells type 2: 80.7;Cone photoreceptor cells: 95.9;Excitatory neurons: 60.4;Microglial cells: 73.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024493, HPA062300"	Approved		Approved	"Nucleoplasm,Golgi apparatus,Vesicles,Intermediate filaments"		Yes	No				"Cluster 77: Retina - Visual perception"	"Cluster 21: OE19 - Mitochondria"	"Cluster 9: Photoreceptor cells - Phototransduction"	Vesicles	"Nucleoplasm, Golgi apparatus, Intermediate filaments"	"HPA024493: AB_1858618, HPA062300: AB_2684742"	"unprognostic (9.73e-3)"	"unprognostic (2.33e-1)"	"prognostic favorable (4.96e-4)"	"unprognostic (6.56e-2)"	"unprognostic (9.93e-2)"	"prognostic favorable (8.51e-5)"	"unprognostic (7.64e-2)"	"prognostic favorable (6.59e-5)"	"unprognostic (3.80e-1)"	"unprognostic (1.64e-1)"	"prognostic favorable (3.71e-4)"	"unprognostic (1.74e-1)"	"prognostic favorable (4.34e-11)"	"unprognostic (2.40e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.80e-2)"	12.6	12.8	10.5	5.6	13.3	1.0	10.3	6.6	14.5	12.5	15.7	22.2	11.6	10.1	7.7	17.5	10.4	11.5	13.6	11.4	7.2	21.8	12.8	38.9	1.8	8.3	9.5	7.3	21.3	15.0	11.5	6.0	7.8	22.6	25.0	41.2	17.8	23.3	24.2	12.3	13.4	11.9	7.3	4.7	17.9	15.6	10.6	3.0	12.2	10.4	5.0	10.2	12.7	9.0	9.8	12.8	13.9	22.6	26.3	14.6	11.8	15.7	7.1	11.4	15.3	10.7	4.5	0.0	7.0	20.6	20.1	4.7	35.4	18.2	14.5	0.0	11.3	5.9	36.6	13.9	12.7	2.2	6.4	11.6	14.0	18.0	18.5	18.2	37.3	15.8	13.5	8.1	13.5	7.5	2.1	0.2	12.6	30.2	13.3	0.1	8.6	3.4	15.5	12.6	14.9	15.7	11.0	6.8	11.4	23.0	11.6	7.5	34.5	7.8	7.2	12.3	12.2	12.7	16.2	0.0	8.5	18.4	8.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.5	13.3	6.6	14.5	11.4	7.2	8.3	9.5	7.8	7.3	10.6	9.0	6.7	57.7	80.7	28.7	0.8	3.1	1.1	2.1	3.4	42.3	7.3	4.4	11.4	18.6	16.7	9.2	95.9	3.7	0.1	24.4	3.9	6.0	6.9	8.2	5.1	8.5	24.6	1.7	60.4	12.2	2.1	4.8	16.3	13.9	2.5	8.7	5.7	12.5	4.9	6.7	17.7	31.9	0.0	2.4	3.0	12.3	2.1	3.7	7.2	73.1	0.1	5.7	0.0	42.3	36.7	7.8	11.9	3.0	4.2	11.7	10.5	7.8	10.0	40.8	6.6	8.4	6.5	8.7	7.5	14.3	7.4	2.9	1.0	5.7	19.5	5.7
UXT	"ART-27, STAP1"	ENSG00000126756	"Ubiquitously expressed prefoldin like chaperone"	Q9UBK9	X	47651796-47659180	"Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Transcription, Transcription regulation"	"Activator, Chaperone, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050499, HPA058400"	Approved		Supported	"Nucleoplasm,Centriolar satellite"		Yes	No			"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 24: NB-4 - Immune response"	"Cluster 32: Non-specific - Translation"	Nucleoplasm	"Centriolar satellite"	"HPA050499: AB_2681146, HPA058400: AB_2683706"	"unprognostic (1.12e-1)"	"unprognostic (3.85e-3)"	"unprognostic (9.08e-2)"	"unprognostic (2.09e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.23e-1)"	"unprognostic (4.49e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.97e-1)"	"unprognostic (2.31e-3)"	"unprognostic (1.12e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.56e-2)"	"unprognostic (1.44e-1)"	"unprognostic (8.11e-2)"	"unprognostic (8.64e-2)"	"unprognostic (4.09e-3)"	124.7	148.6	82.1	78.8	84.9	212.0	127.1	85.6	111.7	121.8	86.5	112.3	77.2	93.6	123.6	116.6	103.3	66.7	144.6	80.1	85.1	134.2	135.1	97.8	148.7	87.1	82.5	184.6	182.3	90.5	107.0	65.3	88.4	119.7	99.7	42.8	121.6	65.9	130.7	143.6	113.8	68.2	87.7	139.5	131.7	46.3	83.7	166.9	96.3	95.2	143.0	109.6	111.9	91.1	192.0	208.6	87.4	116.0	194.3	233.4	152.3	119.2	178.5	203.6	191.7	182.1	178.1	217.3	86.4	173.5	188.0	151.8	123.5	163.8	145.3	143.7	240.8	111.6	220.8	182.4	224.2	246.6	208.1	162.9	207.5	168.6	183.8	142.2	165.9	185.6	122.2	205.1	174.8	211.5	170.7	342.1	125.4	174.7	231.2	149.5	177.2	300.9	168.1	141.4	82.1	107.1	133.1	146.7	197.8	157.7	170.4	227.2	122.4	140.7	153.2	196.2	136.7	161.7	154.5	200.7	179.8	270.1	145.1	110.1	159.7	123.4	169.5	166.1	229.8	262.7	242.6	184.2	213.3	245.2	303.2	255.4	100.7	172.1	156.9	270.3	248.2	247.9	82.1	84.9	85.6	111.7	80.1	85.1	87.1	82.5	88.4	87.7	83.7	91.1	108.3	73.7	79.5	5.5	276.8	214.9	274.3	247.9	212.3	27.3	242.1	239.6	100.7	165.8	141.4	97.5	16.7	189.4	207.2	212.1	315.0	161.2	73.5	122.3	125.2	129.6	187.2	170.0	4.0	318.9	212.6	127.6	78.0	114.0	154.1	161.4	193.5	242.4	246.5	10.1	4.3	331.9	126.1	248.0	277.4	185.2	210.3	179.8	197.5	1.9	316.0	108.2	212.1	3.5	7.7	189.3	338.0	196.0	198.3	256.4	297.8	466.1	138.0	28.6	144.7	224.3	145.2	78.7	85.6	183.3	203.7	213.7	240.5	185.5	328.5	286.0
VAX1		ENSG00000148704	"Ventral anterior homeobox 1"	Q5SQQ9	10	117128521-117138301	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Disease variant, Microphthalmia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	15	"brain: 8.4"	"Cell type enriched"	"Detected in some"	4	"Inhibitory neurons: 7.4"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"hypothalamus: 8.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"A-431: 3.1;WM-115: 2.3"	"Group enriched"	"Detected in some"	6	"basal ganglia: 5.6;hypothalamus: 3.2;olfactory bulb: 1.5"	"Low region specificity"	"Detected in some"			HPA028946	Uncertain		Approved	"Nucleoplasm,Nucleoli rim"		Yes	NA				"Cluster 65: Brain - Ion transport"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoli rim"	Nucleoplasm	"HPA028946: AB_10602679"		"unprognostic (1.08e-2)"		"unprognostic (1.92e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.96e-2)"		"unprognostic (5.77e-3)"	"unprognostic (2.19e-1)"			"unprognostic (1.17e-1)"		"unprognostic (5.72e-2)"	"unprognostic (2.09e-1)"		"unprognostic (2.99e-1)"	0.0	0.0	1.6	0.0	4.4	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	8.4	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	2.3	0.0	0.0	0.0	0.0	0.0	0.0	2.8	3.1	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	4.4	0.0	2.8	0.2	8.4	0.1	0.2	0.0	0.0	2.3	2.8	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.4	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0
VRK1		ENSG00000100749	"VRK serine/threonine kinase 1"	Q99986	14	96797304-96954846	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, Cell division, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"	Neurodegeneration	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 50.4;testis: 37.1"	"Cell type enhanced"	"Detected in all"		"Spermatocytes: 198.9;Spermatogonia: 110.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000660, HPA017929"	Enhanced		Supported	Nucleoplasm,Cytosol		Yes	No			"Cluster 15: NK-cells - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	Cytosol	"HPA000660: AB_1080579, HPA017929: AB_1858770"	"unprognostic (1.03e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.84e-2)"	"unprognostic (2.24e-3)"	"unprognostic (5.42e-2)"	"unprognostic (1.19e-2)"	"prognostic unfavorable (4.15e-4)"	"unprognostic (4.20e-2)"	"unprognostic (2.11e-2)"	"unprognostic (5.47e-2)"	"unprognostic (5.14e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.53e-2)"	"unprognostic (6.70e-2)"	"unprognostic (4.56e-2)"	"unprognostic (3.36e-2)"	"unprognostic (1.58e-1)"	5.9	5.2	5.9	12.8	7.1	50.4	11.5	6.0	7.9	5.2	4.3	10.8	6.5	6.5	6.9	8.9	9.2	4.4	5.2	5.9	5.1	4.9	5.5	4.9	27.1	5.3	5.5	6.0	3.2	5.4	3.1	7.6	5.4	5.0	12.3	4.4	4.3	5.0	4.7	7.4	7.2	6.7	4.8	11.3	6.5	37.1	5.9	35.5	5.9	4.6	27.9	7.7	5.4	7.0	52.4	27.0	78.5	30.2	9.2	14.9	44.8	42.8	34.4	67.1	65.4	36.0	54.7	139.2	22.4	24.3	39.2	56.5	75.5	54.4	90.5	73.4	36.4	90.5	18.7	39.3	10.2	168.5	49.2	8.5	9.7	50.4	32.6	12.8	47.0	104.8	76.6	79.0	56.9	65.5	137.1	76.5	47.8	39.9	59.3	124.5	134.2	48.6	32.3	59.3	53.2	28.0	34.2	36.4	30.8	36.0	39.3	66.6	24.4	27.9	22.8	47.7	37.3	37.7	53.5	124.8	44.7	74.6	34.8	42.7	12.3	26.2	21.5	15.5	29.0	31.3	24.9	26.4	15.7	32.7	27.1	27.3	6.5	45.6	15.2	21.4	34.9	19.4	5.9	7.1	6.0	7.9	5.9	5.1	5.3	5.5	5.4	4.8	5.9	7.0	15.3	3.2	4.6	6.8	30.6	16.8	13.8	23.3	6.2	12.4	9.3	11.3	11.8	12.8	16.7	14.7	8.4	34.8	24.8	6.3	11.7	13.5	21.3	21.1	8.3	12.4	3.0	76.2	42.0	19.4	48.3	11.4	14.8	10.8	28.5	20.0	7.1	3.3	19.2	10.1	36.2	10.4	20.3	11.8	14.9	11.5	5.6	12.0	12.4	19.7	14.2	6.2	27.8	12.1	19.8	10.3	2.2	9.8	25.4	6.1	3.0	11.2	37.6	9.6	19.7	14.3	15.1	198.9	110.9	14.1	13.9	15.1	26.8	9.2	18.1	10.4
WDPCP	"BBS15, C2orf86, CPLANE5, fritz, hFrtz"	ENSG00000143951	"WD repeat containing planar cell polarity effector"	O95876	2	63119559-63827843	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"		"Bardet-Biedl syndrome, Ciliopathy, Disease variant, Mental retardation, Obesity"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 18.6"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 169.9;Alveolar cells type 2: 128.0;Astrocytes: 124.7;Excitatory neurons: 261.4;Inhibitory neurons: 240.9;Oligodendrocyte precursor cells: 136.2;Oligodendrocytes: 296.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA044144	Uncertain		Approved	"Cell Junctions"		Yes	No			"Cluster 41: Basophils - Cellular respiration"	"Cluster 6: Brain - Smell perception"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Cell Junctions"		"HPA044144: AB_10969458"	"unprognostic (3.36e-1)"	"unprognostic (3.22e-2)"	"unprognostic (1.95e-1)"	"unprognostic (7.07e-2)"	"unprognostic (2.95e-1)"	"unprognostic (6.88e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.59e-3)"	"unprognostic (7.22e-2)"	"unprognostic (6.48e-2)"	"unprognostic (1.93e-1)"	"unprognostic (4.87e-2)"	"unprognostic (2.34e-3)"	"unprognostic (6.02e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.25e-3)"	"unprognostic (2.00e-1)"	4.7	3.5	11.3	2.5	11.7	8.2	3.2	17.7	15.7	2.5	6.5	1.6	1.8	3.9	4.0	2.0	4.2	2.8	4.9	10.4	6.9	3.6	2.4	2.5	3.3	6.4	5.4	4.6	1.5	2.9	1.9	2.6	8.4	2.6	1.8	12.2	2.2	2.1	5.3	3.4	1.7	3.0	3.2	3.3	3.3	5.1	6.3	3.6	3.5	2.9	2.7	1.8	1.1	18.6	5.2	4.6	3.3	4.0	3.7	4.6	3.0	4.3	2.2	2.8	2.3	3.3	2.6	5.8	3.5	2.9	3.3	3.4	2.3	2.8	3.3	5.7	3.8	6.1	3.5	2.8	2.5	5.0	4.1	2.3	1.9	2.9	1.9	3.7	2.9	6.7	2.3	5.7	2.9	5.3	5.8	5.1	3.9	2.7	1.7	6.2	4.3	5.0	1.9	2.5	5.2	5.2	3.7	4.4	5.3	4.7	3.8	3.9	4.7	4.6	7.2	4.0	3.6	5.3	3.6	10.3	5.2	5.3	5.3	6.6	2.8	1.5	1.9	1.5	3.7	1.8	1.7	2.6	2.3	3.1	2.3	3.6	1.9	3.8	1.3	2.7	1.5	1.1	11.3	11.7	17.7	15.7	10.4	6.9	6.4	5.4	8.4	3.2	6.3	18.6	6.0	169.9	128.0	124.7	8.0	4.1	3.2	4.3	2.8	16.1	4.4	3.2	10.1	7.2	59.6	1.8	22.9	2.5	5.5	0.8	1.9	2.6	46.7	17.9	6.2	14.4	0.0	7.8	261.4	2.2	2.6	13.5	6.6	3.7	65.0	7.4	5.0	1.8	4.0	11.8	240.9	1.3	4.1	3.0	4.4	17.5	4.4	8.4	5.4	103.0	3.8	7.5	6.2	136.2	296.3	1.8	1.6	3.8	5.1	1.5	0.5	4.5	98.8	27.4	0.0	8.6	5.7	16.1	9.5	2.3	3.4	1.9	9.4	4.0	1.1	1.7
XAF1	"BIRC4BP, HSXIAPAF1, XIAPAF1"	ENSG00000132530	"XIAP associated factor 1"	Q6GPH4	17	6755447-6775647	"Predicted intracellular proteins"	Apoptosis		"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 174.2;Endothelial cells: 90.4;Microglial cells: 103.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 81.8;BJ hTERT+ SV40 Large T+ RasG12V: 83.8;HHSteC: 35.3"	"Low region specificity"	"Detected in all"							HPA057302	Approved		Supported	Nucleoplasm,Mitochondria		Yes	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nucleoplasm, Mitochondria"		"HPA057302: AB_2683405"	"unprognostic (6.28e-2)"	"unprognostic (1.71e-1)"	"unprognostic (8.62e-3)"	"unprognostic (1.28e-2)"	"unprognostic (3.81e-1)"	"unprognostic (1.11e-2)"	"unprognostic (5.09e-3)"	"unprognostic (4.89e-2)"	"unprognostic (1.39e-1)"	"unprognostic (8.08e-3)"	"unprognostic (3.34e-3)"	"unprognostic (1.79e-1)"	"prognostic unfavorable (2.73e-7)"	"unprognostic (2.33e-1)"	"unprognostic (1.74e-2)"	"unprognostic (2.31e-1)"	"unprognostic (6.15e-3)"	31.9	12.8	28.3	29.7	29.8	33.4	24.2	27.7	39.6	42.3	23.8	17.5	26.8	26.5	13.0	17.0	22.5	34.0	30.9	27.5	29.2	23.5	63.6	35.8	29.7	37.5	28.4	52.9	2.9	2.9	14.3	25.9	30.8	24.9	16.8	4.8	47.6	11.2	14.1	18.4	25.4	24.3	31.9	63.4	23.6	9.2	31.5	23.8	18.2	13.5	15.5	17.3	22.1	27.5	5.2	0.3	0.7	1.4	6.7	15.1	0.7	7.1	26.3	81.8	83.8	0.7	7.5	1.3	2.0	10.2	28.9	3.1	0.0	1.3	9.3	11.4	0.3	1.9	0.9	1.0	35.3	1.2	8.0	6.9	0.0	11.3	0.3	0.4	6.9	25.5	0.7	26.1	2.6	0.4	6.3	22.1	0.6	0.2	2.2	11.3	0.4	0.5	0.2	4.9	0.5	0.6	3.6	0.5	14.3	0.6	0.8	30.4	0.7	1.1	0.8	2.3	0.5	3.9	1.4	0.5	2.6	18.4	2.2	17.4	9.6	4.3	7.8	12.7	5.7	3.6	6.0	5.6	8.0	4.6	3.8	4.0	10.6	8.0	12.5	0.8	9.9	5.6	28.3	29.8	27.7	39.6	27.5	29.2	37.5	28.4	30.8	31.9	31.5	27.5	174.2	60.9	29.9	14.0	25.7	5.2	5.7	5.5	13.1	0.5	4.1	10.3	2.7	8.6	30.0	0.0	0.0	0.4	37.1	12.4	0.0	1.3	4.0	18.9	68.4	90.4	1.8	10.7	0.3	1.9	5.1	29.8	27.5	10.4	48.7	44.4	33.5	20.1	15.9	0.0	0.3	9.2	0.0	21.3	11.2	2.6	36.4	54.4	5.4	103.0	44.5	1.1	70.0	1.5	0.6	10.1	2.7	27.4	11.4	2.5	11.4	0.3	24.3	0.4	19.7	27.3	19.0	0.2	0.8	11.8	2.7	0.4	35.1	47.3	9.2	5.6
Z82206.1		ENSG00000225528	"Novel protein similar to translation machinery associated 7 homolog (S. cerevisiae) TMA7"		22	39960397-39964718	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in some"		"bone marrow: 1.3;lymphoid tissue: 4.3"	"Cell type enhanced"	"Detected in some"		"Distal tubular cells: 7.9;granulocytes: 3.8;Proximal tubular cells: 3.2;T-cells: 1.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in some"	4	"K-562: 12.5"									HPA047397			Approved	"Nucleoplasm,Nucleoli,Nucleoli rim,Nuclear bodies"		Yes	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nucleoli, Nucleoli rim"	"Nucleoplasm, Nuclear bodies"	"HPA047397: AB_2680029"	"unprognostic (8.48e-4)"	"unprognostic (2.95e-6)"	"unprognostic (3.67e-1)"	"unprognostic (5.90e-2)"	"unprognostic (4.27e-1)"	"unprognostic (6.95e-3)"	"unprognostic (3.74e-1)"	"unprognostic (5.41e-4)"	"unprognostic (2.33e-1)"	"unprognostic (2.13e-2)"	"unprognostic (1.18e-3)"	"unprognostic (8.77e-2)"	"unprognostic (6.53e-5)"	"unprognostic (1.89e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.11e-1)"	"unprognostic (6.58e-3)"	0.1	0.0	0.0	0.2	0.0	1.3	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.2	0.9	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.1	0.0	1.1	0.1	0.1	0.0	4.3	0.1	0.0	0.3	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	3.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	2.4	12.5	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	1.1	2.7	2.9	1.3	2.5	2.3	3.5	3.2	1.6	2.0	3.6	4.4	2.4	1.3	1.2	1.7	2.6	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	7.9	0.1	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0
ZFHX2	"KIAA1056, KIAA1762, ZFH-5, ZNF409"	ENSG00000136367	"Zinc finger homeobox 2"	Q9C0A1	14	23520857-23556192	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 11.9;testis: 7.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 22.5;Early spermatids: 38.9;Excitatory neurons: 31.0;Inhibitory neurons: 20.0;Late spermatids: 19.1;Oligodendrocyte precursor cells: 27.2;Oligodendrocytes: 20.8;Spermatocytes: 16.5"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebellum: 11.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 4.8;SuSa: 3.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000720, HPA005146"	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center"		Yes	No			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 21: Non-specific - Transcription"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 49: Ciliated cells - Cilium organization"	"Nucleoli fibrillar center"	Nucleoplasm	"HPA000720: AB_10603462, HPA005146: AB_1859250"	"unprognostic (7.54e-3)"	"unprognostic (2.01e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.53e-1)"	"unprognostic (2.61e-1)"	"unprognostic (6.12e-3)"	"unprognostic (1.40e-1)"	"unprognostic (5.40e-2)"	"unprognostic (3.94e-2)"	"unprognostic (3.71e-2)"	"unprognostic (5.08e-4)"	"unprognostic (2.39e-1)"	"unprognostic (5.33e-3)"	"unprognostic (3.75e-1)"	"unprognostic (7.35e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.90e-2)"	0.5	0.7	1.8	0.5	6.3	0.1	0.4	11.9	5.3	0.4	0.0	0.7	0.1	0.7	0.4	0.2	2.2	0.4	0.3	3.2	0.0	1.3	0.2	0.5	0.3	1.5	0.1	0.5	0.4	1.7	3.4	0.2	0.2	0.6	0.2	3.1	0.4	1.2	0.7	0.5	0.3	0.6	0.0	0.2	0.4	7.3	0.9	0.2	0.7	0.5	0.2	0.3	0.2	2.3	0.1	3.1	2.4	4.8	1.6	0.2	0.1	0.7	0.2	0.3	1.2	0.3	0.2	0.2	0.3	0.0	0.3	0.1	1.2	0.1	0.5	2.2	0.8	2.5	0.0	0.6	0.2	0.4	1.7	0.3	0.1	0.5	0.1	1.3	0.3	2.1	0.4	0.4	0.1	0.8	0.3	0.3	2.9	0.3	0.7	1.4	0.0	0.0	1.3	1.2	2.7	1.7	0.4	0.6	0.1	3.6	1.0	0.6	0.1	0.0	1.2	0.7	0.3	0.3	1.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.8	6.3	11.9	5.3	3.2	0.0	1.5	0.1	0.2	0.0	0.9	2.3	0.5	0.0	1.1	22.5	0.7	0.1	0.6	1.1	0.0	9.0	2.2	2.3	2.5	0.0	2.4	1.8	0.0	0.3	0.1	0.6	1.9	2.8	38.9	12.2	0.6	1.1	6.7	0.0	31.0	2.4	0.0	1.4	2.0	2.5	0.0	3.2	0.7	0.2	1.0	8.4	20.0	0.7	2.0	1.0	1.9	19.1	0.6	0.8	0.0	4.7	1.0	2.7	0.0	27.2	20.8	1.2	1.2	0.4	0.1	1.4	0.4	1.4	9.8	3.8	0.0	2.5	1.3	16.5	1.2	0.7	0.0	0.3	0.4	0.2	0.6	0.3
ZFP37	ZNF906	ENSG00000136866	"ZFP37 zinc finger protein"	Q9Y6Q3	9	113038377-113056759	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Inhibitory neurons: 15.5;Oligodendrocyte precursor cells: 23.6;Oligodendrocytes: 29.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"T-reg: 2.4"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA049112	Uncertain		Approved	Nucleoplasm,Vesicles		Yes	No			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 21: Non-specific - Transcription"	"Cluster 18: U-2197 - ECM organization"	"Cluster 68: Oligodendrocytes - Mixed function"	"Nucleoplasm, Vesicles"		"HPA049112: AB_2680637"	"unprognostic (3.18e-1)"	"unprognostic (9.57e-2)"	"unprognostic (5.62e-2)"	"unprognostic (3.54e-3)"	"prognostic favorable (1.96e-4)"	"unprognostic (7.84e-2)"	"unprognostic (8.09e-2)"	"unprognostic (2.70e-3)"	"unprognostic (1.47e-1)"	"unprognostic (2.53e-2)"	"unprognostic (2.51e-2)"	"unprognostic (1.38e-3)"	"unprognostic (4.22e-2)"	"unprognostic (9.46e-2)"	"unprognostic (3.67e-1)"	"unprognostic (4.86e-1)"	"unprognostic (2.07e-1)"	1.6	1.7	2.2	1.3	2.9	0.2	2.8	4.4	2.5	3.0	0.5	1.6	0.8	4.5	1.8	1.2	2.5	1.3	1.5	1.9	2.7	2.3	0.6	1.3	1.2	2.3	2.2	7.1	1.3	2.9	3.8	1.3	2.5	2.5	1.0	6.3	0.9	1.8	1.4	1.2	1.1	2.5	2.5	2.0	1.2	2.2	3.3	1.2	2.9	1.9	1.3	1.8	1.6	4.0	0.6	1.7	7.2	6.0	3.9	7.5	3.7	2.3	3.4	2.5	2.1	0.0	1.7	4.2	1.8	2.4	3.3	1.5	0.0	0.9	3.9	5.2	0.8	0.2	3.5	1.9	2.1	0.0	0.8	2.1	0.7	3.0	5.8	6.1	1.4	0.0	0.4	3.6	5.2	0.0	0.0	0.0	7.4	4.4	0.0	0.0	10.0	0.6	1.9	0.0	6.1	5.8	7.1	1.5	1.4	3.5	6.0	0.0	0.6	5.8	2.5	6.9	3.5	1.4	2.9	0.0	4.5	0.1	3.6	0.1	0.0	0.0	0.9	0.2	0.7	0.9	0.8	0.9	0.3	0.4	0.6	0.9	0.1	0.7	0.0	0.0	2.4	0.3	2.2	2.9	4.4	2.5	1.9	2.7	2.3	2.2	2.5	2.5	3.3	4.0	3.4	0.0	0.5	5.5	2.1	0.3	0.9	1.3	2.2	10.3	1.4	2.8	8.0	0.0	0.5	0.0	6.2	0.8	1.6	0.1	3.9	1.6	1.0	0.6	4.9	3.2	1.2	0.0	9.2	0.9	1.6	3.8	2.6	0.6	5.7	2.5	2.5	1.3	0.5	6.7	15.5	0.6	4.1	0.3	0.3	0.2	2.1	0.8	0.0	3.7	0.5	3.4	3.1	23.6	29.7	0.4	1.3	2.2	1.1	0.5	0.1	3.1	0.4	6.0	6.6	6.4	4.2	5.6	3.2	2.7	0.0	0.1	1.3	2.6	0.3	0.4
ZKSCAN1	"KOX18, PHZ-37, ZNF139, ZNF36, ZSCAN33"	ENSG00000106261	"Zinc finger with KRAB and SCAN domains 1"	P17029	7	100015572-100041689	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 272.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006672	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Mitochondria"		Yes	No			"Cluster 18: Basophils - Vesicular transport"	"Cluster 15: Liver - Metabolism"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 17: Intestinal endocrine cells - Hormone signaling"	"Nuclear bodies"	"Nucleoplasm, Mitochondria"	"HPA006672: AB_1080707"	"unprognostic (2.58e-1)"	"unprognostic (1.59e-2)"	"unprognostic (3.57e-2)"	"unprognostic (4.62e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.24e-2)"	"unprognostic (1.47e-2)"	"unprognostic (4.76e-3)"	"unprognostic (3.24e-2)"	"unprognostic (1.86e-2)"	"unprognostic (6.34e-3)"	"unprognostic (8.59e-2)"	"unprognostic (1.27e-3)"	"unprognostic (7.75e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.70e-1)"	"unprognostic (9.09e-3)"	12.0	18.4	20.2	11.6	29.1	8.7	22.7	17.2	22.1	16.4	7.4	21.5	18.2	15.5	17.1	18.8	21.7	13.9	10.1	14.4	23.8	13.3	52.8	10.9	11.7	21.3	23.2	19.0	26.1	16.5	10.9	11.0	23.4	23.0	23.5	15.8	25.3	10.8	10.4	32.6	16.9	13.7	13.9	13.5	32.6	11.1	24.1	14.2	11.9	8.8	11.9	12.2	17.4	37.5	17.0	12.3	31.8	34.6	32.0	38.7	12.0	18.6	22.5	10.9	11.0	7.4	15.7	19.1	23.0	20.9	19.1	13.7	18.4	16.1	20.6	18.4	11.3	15.5	15.8	19.3	18.0	29.9	17.7	26.1	25.1	14.7	49.0	29.5	24.4	22.2	36.2	16.3	21.7	22.4	28.4	17.6	12.8	31.6	15.2	16.7	16.2	17.3	18.2	26.4	36.8	44.0	28.9	37.4	32.4	17.8	19.1	19.6	36.8	23.7	23.0	27.9	18.9	18.7	35.3	19.5	16.2	20.8	31.7	16.0	4.0	4.1	5.0	3.1	4.9	3.8	3.9	4.9	5.8	4.8	5.3	3.9	4.2	8.8	9.0	3.9	3.5	3.8	20.2	29.1	17.2	22.1	14.4	23.8	21.3	23.2	23.4	13.9	24.1	37.5	45.3	25.6	55.4	57.5	37.0	15.0	45.7	43.4	71.7	93.9	77.6	38.7	42.8	140.2	61.4	46.0	150.1	41.1	40.1	84.8	15.6	55.9	46.5	89.2	90.9	52.2	220.9	24.6	70.1	43.8	15.3	47.9	103.5	68.0	35.4	120.5	44.6	140.8	19.8	89.2	77.7	99.2	77.3	32.7	18.6	18.4	51.3	31.2	40.9	62.8	45.8	61.2	34.0	102.1	272.5	46.6	81.3	53.4	27.1	93.1	70.4	32.4	153.6	70.1	19.7	87.4	43.9	32.8	16.7	62.9	21.5	65.9	32.3	74.0	114.4	62.0
ZNF341	dJ553F4.3	ENSG00000131061	"Zinc finger protein 341"	Q9BYN7	20	33731657-33792269	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 11.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023240, HPA024607, HPA067108"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Vesicles"		Yes	No			"Cluster 34: Basophils - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Vesicles"	"Nuclear bodies"	"HPA023240: AB_1859207, HPA024607: AB_1859208, HPA067108: AB_2685780"	"unprognostic (1.74e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.73e-1)"	"unprognostic (2.10e-1)"	"unprognostic (9.31e-2)"	"prognostic favorable (3.93e-4)"	"prognostic unfavorable (1.87e-4)"	"unprognostic (2.44e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.80e-1)"	"unprognostic (7.38e-2)"	"unprognostic (9.31e-2)"	"unprognostic (8.17e-5)"	"unprognostic (4.84e-2)"	"unprognostic (2.90e-1)"	"unprognostic (8.67e-3)"	"unprognostic (3.68e-2)"	1.2	0.9	1.0	1.9	1.1	2.4	0.9	0.8	2.2	1.1	0.0	1.5	1.4	1.3	1.0	1.3	1.3	0.9	1.0	1.6	0.2	0.6	0.6	1.1	1.9	0.3	0.1	1.3	1.6	0.9	0.6	1.4	0.4	1.3	1.1	0.7	1.5	1.0	3.3	2.1	1.0	1.2	0.2	1.9	1.4	1.5	0.5	1.8	0.9	3.3	1.2	1.2	1.1	1.3	2.4	6.4	2.2	4.7	2.1	1.7	9.5	2.3	1.2	1.9	1.2	4.6	5.4	3.7	3.8	1.7	2.2	3.7	2.4	4.1	0.8	3.3	2.2	3.6	3.6	3.7	1.2	2.1	4.3	1.4	3.0	1.6	1.0	1.7	2.3	3.4	1.9	1.7	2.0	2.9	1.9	1.6	3.0	3.5	3.1	2.4	1.4	2.1	1.3	5.2	1.9	2.1	6.1	5.6	1.4	1.7	5.0	1.7	2.9	3.4	1.4	2.5	2.2	1.3	1.9	3.4	3.3	1.7	2.4	2.6	1.3	2.9	1.1	1.8	1.0	2.2	0.8	0.7	1.0	1.2	0.5	1.5	2.5	1.3	1.2	0.7	0.6	0.9	1.0	1.1	0.8	2.2	1.6	0.2	0.3	0.1	0.4	0.2	0.5	1.3	1.8	3.2	5.1	5.5	2.9	0.4	1.0	1.5	0.6	2.2	1.9	1.4	2.7	2.8	4.7	1.8	2.1	2.6	0.9	7.0	0.0	1.5	0.6	1.6	1.4	1.4	1.2	0.8	11.3	1.4	3.3	1.6	6.6	2.1	2.5	1.8	1.4	1.0	1.4	1.7	8.0	2.0	2.0	1.6	2.0	0.1	0.6	2.4	0.0	3.7	1.2	0.6	2.1	6.0	7.7	1.7	2.5	0.4	2.6	2.5	4.2	0.4	4.6	2.3	0.0	1.9	1.1	1.6	2.4	1.6	1.0	2.1	1.9	1.5	2.4	2.5
ZNF394	"FLJ12298, ZKSCAN14, ZSCAN46"	ENSG00000160908	"Zinc finger protein 394"	Q53GI3	7	99473877-99504857	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"bone marrow: 97.0"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051421, HPA054639"	Approved		Enhanced	Nucleoplasm,Cytosol		Yes	No			"Cluster 38: Basophils - Unknown function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	Cytosol	"HPA051421: AB_2681479, HPA054639: AB_2682553"	"prognostic favorable (3.56e-4)"	"unprognostic (1.62e-1)"	"unprognostic (2.83e-3)"	"unprognostic (2.60e-1)"	"unprognostic (2.09e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.54e-1)"	"prognostic favorable (2.11e-4)"	"unprognostic (3.62e-2)"	"unprognostic (4.14e-1)"	"unprognostic (6.28e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.59e-1)"	"unprognostic (4.70e-2)"	"unprognostic (7.47e-2)"	"unprognostic (3.42e-1)"	"prognostic favorable (1.09e-4)"	13.3	9.6	8.6	10.3	9.5	97.0	12.5	16.4	8.3	11.9	8.8	12.5	10.3	10.4	6.9	12.6	12.5	7.3	12.2	7.7	9.0	10.4	10.1	13.3	13.6	9.8	9.1	13.9	9.7	7.7	9.4	8.1	9.0	13.5	8.6	5.4	10.2	7.7	12.2	15.4	14.3	7.8	8.5	19.2	11.5	10.6	9.4	12.8	10.2	9.6	11.3	11.9	12.2	10.6	10.3	10.2	6.6	14.0	10.4	7.1	13.1	8.5	11.6	9.9	9.7	11.0	11.0	12.4	12.2	9.2	13.5	9.6	9.2	11.2	9.8	9.1	12.0	12.2	12.0	12.1	8.3	17.4	20.0	9.4	9.6	9.6	10.2	7.3	11.6	10.5	17.6	24.0	9.3	19.6	18.3	28.8	15.0	12.9	12.0	10.2	7.3	22.1	11.0	14.7	7.8	16.5	10.2	24.6	16.9	16.5	6.4	21.8	11.9	11.7	12.0	17.4	10.9	19.7	22.1	20.0	8.5	17.4	12.9	56.8	20.6	36.6	31.7	25.5	33.2	24.5	31.8	34.3	22.6	23.6	38.5	30.8	37.8	36.8	26.8	32.8	37.7	24.6	8.6	9.5	16.4	8.3	7.7	9.0	9.8	9.1	9.0	8.5	9.4	10.6	29.3	16.0	19.7	5.2	37.1	35.6	36.1	16.4	16.5	9.7	20.6	14.6	11.4	8.6	16.6	11.0	12.5	15.8	56.7	26.3	17.6	15.7	10.4	17.3	12.9	22.2	20.8	31.5	4.6	14.1	18.2	17.5	25.0	24.4	58.9	17.1	17.5	12.3	18.9	15.2	5.0	16.9	8.2	25.5	29.6	2.9	15.5	29.3	28.4	1.9	19.3	13.6	45.3	7.1	5.6	16.4	20.8	13.5	31.8	29.2	29.7	11.7	19.4	11.7	13.1	22.6	19.7	41.9	30.6	21.5	35.5	29.7	54.3	24.6	18.6	65.6
ZNF410	"APA-1, APA1"	ENSG00000119725	"Zinc finger protein 410"	Q86VK4	14	73886617-73932521	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 27.7;Excitatory neurons: 22.7;Inhibitory neurons: 23.8;Oligodendrocytes: 31.0"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002871			Approved	"Nuclear bodies"		Yes	No			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 59: Non-specific - Transcription"	"Nuclear bodies"		"HPA002871: AB_1080712"	"unprognostic (5.84e-2)"	"unprognostic (5.04e-2)"	"unprognostic (9.29e-2)"	"unprognostic (6.36e-3)"	"unprognostic (5.86e-4)"	"unprognostic (4.91e-2)"	"unprognostic (2.83e-3)"	"unprognostic (2.10e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.86e-3)"	"unprognostic (1.29e-2)"	"unprognostic (3.73e-2)"	"unprognostic (2.79e-2)"	"unprognostic (2.46e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.19e-1)"	29.0	33.0	26.8	18.7	30.4	57.7	29.4	30.9	33.9	30.0	28.9	30.6	19.0	27.5	43.7	33.4	28.1	22.6	21.0	26.3	28.0	33.0	28.8	27.6	25.6	29.1	27.5	38.7	20.6	27.1	27.0	32.2	29.6	29.5	24.4	22.8	24.4	27.3	21.1	37.6	25.2	28.4	26.7	26.1	25.7	44.7	28.3	29.9	24.6	18.3	30.7	29.1	28.7	37.0	46.7	35.8	42.4	45.2	44.8	39.8	52.4	51.4	56.9	88.2	82.0	37.6	40.1	38.4	21.7	65.7	28.2	42.1	42.9	52.8	83.2	56.2	26.9	36.2	31.6	29.9	67.4	30.6	45.6	37.0	72.4	44.5	83.1	39.5	47.5	43.9	38.2	33.0	43.3	88.6	45.8	51.2	15.5	56.3	41.7	40.7	48.5	24.7	57.0	43.7	39.0	50.3	57.2	52.5	54.6	35.5	48.3	52.2	30.7	62.7	59.0	37.1	47.2	45.2	83.4	48.0	40.1	34.1	53.7	65.9	45.3	74.8	47.5	43.1	51.9	37.7	49.0	49.0	45.6	43.0	42.3	43.5	34.4	60.5	50.1	30.8	46.7	55.9	26.8	30.4	30.9	33.9	26.3	28.0	29.1	27.5	29.6	26.7	28.3	37.0	4.3	0.0	3.1	27.7	10.8	0.6	1.5	1.0	10.8	1.5	2.2	1.7	1.1	0.0	2.9	0.0	4.2	1.8	5.0	1.7	0.0	1.0	3.8	4.7	5.6	2.6	0.0	5.9	22.7	0.9	1.5	5.3	10.7	6.7	10.8	2.9	1.8	0.4	1.2	1.7	23.8	1.1	0.0	2.2	3.1	1.1	1.2	5.4	1.8	18.7	1.1	2.4	2.1	18.1	31.0	1.3	1.4	0.4	13.4	1.0	2.4	0.7	0.2	4.7	0.0	4.0	5.1	3.3	1.9	10.1	1.1	2.6	10.5	4.1	0.8	1.4
ZNF426	MGC2663	ENSG00000130818	"Zinc finger protein 426"	Q9BUY5	19	9523223-9538645	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA029342	Approved		Approved	Nucleoplasm		Yes	No			"Cluster 44: Non-specific - Transcription"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 36: HEL - Hemostasis"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA029342: AB_10603007"	"unprognostic (3.64e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.65e-2)"	"unprognostic (6.62e-2)"	"prognostic favorable (3.74e-4)"	"unprognostic (4.34e-2)"	"unprognostic (1.77e-2)"	"unprognostic (4.75e-3)"	"unprognostic (1.05e-3)"	"unprognostic (8.89e-3)"	"unprognostic (7.41e-3)"	"prognostic favorable (2.57e-6)"	"unprognostic (1.05e-1)"	"unprognostic (3.17e-2)"	"unprognostic (2.49e-1)"	"prognostic favorable (1.81e-4)"	5.1	3.3	3.1	3.9	4.0	5.7	6.9	5.4	3.4	5.5	4.9	4.1	2.8	7.6	4.5	20.6	5.8	4.3	5.4	3.2	2.9	4.3	2.2	5.1	4.1	3.4	3.4	9.2	4.3	6.3	2.4	5.6	3.4	5.9	3.8	5.1	4.0	5.3	3.7	4.1	2.9	7.8	2.9	4.7	3.7	4.8	3.8	5.7	6.7	5.5	5.7	4.7	5.8	6.0	5.7	1.8	11.2	11.8	7.4	9.7	6.2	7.1	10.8	9.4	11.4	2.4	2.5	5.7	5.6	6.9	6.6	4.8	11.7	8.4	14.0	2.7	9.0	23.7	9.5	4.3	6.7	0.7	7.4	12.4	7.1	10.5	15.0	10.2	10.2	9.7	9.6	0.5	9.1	0.3	13.7	11.4	14.0	1.3	4.4	7.4	13.9	5.9	5.1	14.7	6.3	8.5	12.1	4.3	9.7	9.5	6.0	5.5	8.3	13.2	7.7	6.0	7.7	6.4	9.7	4.8	1.9	0.3	9.6	10.0	3.2	6.1	8.8	4.5	7.8	7.6	6.8	8.7	3.8	6.5	10.0	9.3	6.7	7.8	6.3	3.4	7.1	3.4	3.1	4.0	5.4	3.4	3.2	2.9	3.4	3.4	3.4	2.9	3.8	6.0	15.0	28.9	26.5	3.3	13.2	3.4	15.6	3.2	12.5	24.8	17.1	14.6	10.1	5.7	12.4	7.3	20.9	12.8	13.4	3.8	21.5	10.9	33.5	11.5	14.2	16.4	3.6	12.6	5.4	4.2	10.2	12.4	5.1	15.5	28.4	22.4	14.3	3.0	7.6	37.0	3.9	4.2	12.2	8.9	1.6	8.2	17.1	8.2	3.6	5.6	11.2	20.1	15.5	4.5	4.7	6.9	5.1	22.2	6.7	13.3	4.7	5.4	14.6	22.0	6.6	17.9	13.2	12.2	11.8	14.7	2.8	14.2	12.1	12.3	6.3	17.9
ZNF487	"KRBO1, ZNF487P"	ENSG00000243660	"Zinc finger protein 487"		10	43436841-43483181	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enhanced"	"Detected in all"		"testis: 28.2"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 191.2;Endometrial ciliated cells: 65.7;Late spermatids: 289.9;Respiratory ciliated cells: 73.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA037820			Approved	"Nucleoplasm,Nuclear membrane,Cytosol"		Yes	No			"Cluster 5: Granulocytes - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 49: Ciliated cells - Cilium organization"	"Nuclear membrane"	"Nucleoplasm, Cytosol"	"HPA037820: AB_10697083"	"unprognostic (1.97e-1)"	"unprognostic (1.69e-3)"	"unprognostic (1.49e-1)"	"unprognostic (3.42e-3)"	"unprognostic (7.40e-2)"	"unprognostic (1.42e-2)"	"unprognostic (7.10e-2)"	"unprognostic (4.84e-1)"	"unprognostic (4.00e-2)"	"unprognostic (1.05e-2)"	"unprognostic (6.97e-4)"	"unprognostic (5.85e-2)"	"unprognostic (3.97e-4)"	"unprognostic (2.91e-1)"	"unprognostic (4.42e-2)"	"unprognostic (2.52e-2)"	"unprognostic (5.92e-2)"	2.9	2.1	2.1	2.0	2.1	4.3	2.8	2.0	6.3	3.2	4.5	2.6	2.4	3.8	2.1	2.1	6.0	3.7	2.1	2.3	1.9	2.3	2.2	3.0	2.4	7.5	6.0	4.2	1.6	3.6	2.4	1.9	5.0	2.3	1.9	8.9	1.5	2.7	1.2	2.1	2.5	3.0	4.7	2.4	2.3	28.2	2.2	3.6	3.3	1.6	2.2	3.3	2.1	3.8	1.7	1.6	2.0	2.1	2.4	4.8	0.6	2.7	4.7	2.5	2.7	2.6	4.7	4.3	0.4	3.4	2.4	2.7	0.6	1.0	2.4	0.5	0.9	1.4	0.4	1.5	3.1	1.4	1.7	5.0	2.3	4.2	3.0	5.2	0.9	0.9	0.7	0.6	1.9	3.0	2.9	1.1	0.4	0.8	0.9	1.5	0.7	1.8	5.7	1.9	1.7	1.3	2.4	1.3	1.1	1.2	2.2	1.6	1.5	2.4	1.5	1.4	0.7	0.3	1.1	4.7	5.6	2.0	0.9	1.8	3.0	4.5	3.3	2.2	2.6	1.9	2.4	2.9	3.9	2.5	1.9	2.3	10.4	2.9	1.2	2.9	1.6	2.1	2.1	2.1	2.0	6.3	2.3	1.9	7.5	6.0	5.0	4.7	2.2	3.8	4.0	22.4	4.8	11.8	6.2	1.8	6.3	6.6	3.4	5.4	6.6	7.7	3.3	7.2	8.3	5.5	8.4	1.4	9.8	6.1	11.7	4.5	191.2	65.7	6.5	5.3	7.8	1.3	19.4	2.1	4.0	5.4	5.6	6.3	0.0	3.4	3.3	2.7	3.3	6.7	21.1	4.4	10.2	5.6	3.1	289.9	4.7	6.3	1.8	0.0	7.3	12.6	2.1	6.0	7.1	2.1	3.9	6.8	3.6	3.2	13.0	12.7	73.5	18.7	0.0	6.3	5.1	16.7	7.5	1.9	2.8	1.6	5.6	3.8	3.5	6.1
ZNF518A	"KIAA0335, ZNF518"	ENSG00000177853	"Zinc finger protein 518A"	Q6AHZ1	10	96129715-96205288	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 173.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029049			Approved	Nucleoplasm		Yes	No			"Cluster 18: Basophils - Vesicular transport"	"Cluster 34: Non-specific - Transcription"	"Cluster 32: U-937 - Innate immune response"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA029049: AB_2672885"	"unprognostic (1.48e-1)"	"unprognostic (5.24e-2)"	"unprognostic (1.70e-2)"	"unprognostic (4.66e-2)"	"unprognostic (7.61e-2)"	"unprognostic (3.38e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.73e-2)"	"unprognostic (6.02e-1)"	"unprognostic (2.97e-1)"	"unprognostic (1.09e-3)"	"unprognostic (8.38e-3)"	"unprognostic (1.43e-1)"	"unprognostic (3.06e-1)"	"unprognostic (3.09e-2)"	"unprognostic (1.16e-3)"	4.1	3.2	3.8	4.4	4.5	7.6	7.3	5.7	4.7	4.3	2.1	7.1	5.0	5.6	7.8	4.3	4.3	4.1	3.4	3.5	5.1	5.1	4.6	4.5	6.1	5.0	4.5	7.4	4.5	4.0	4.1	4.4	5.4	4.8	7.0	9.3	4.1	4.2	1.9	6.0	6.4	4.4	4.5	5.4	6.7	16.1	4.7	8.1	7.7	2.3	6.1	3.8	2.8	6.8	4.2	9.4	10.3	0.0	5.1	5.8	12.4	4.4	2.5	4.7	4.8	8.9	10.0	15.5	4.1	2.8	6.7	5.9	11.8	4.2	4.3	7.1	6.3	23.2	3.2	14.5	4.5	25.3	13.5	3.8	10.1	4.9	7.8	3.4	5.7	17.8	20.1	10.1	4.7	4.2	15.0	15.3	15.9	4.7	0.6	16.7	11.8	6.2	5.6	8.5	3.0	7.2	6.2	5.8	4.5	17.0	6.9	16.0	3.7	2.2	8.5	3.0	4.8	9.3	24.9	8.8	1.5	19.0	2.4	9.8	2.6	3.2	1.8	2.8	2.7	2.5	2.1	1.8	1.7	2.2	3.0	2.1	2.5	2.3	5.3	2.9	2.5	1.4	3.8	4.5	5.7	4.7	3.5	5.1	5.0	4.5	5.4	4.5	4.7	6.8	31.1	57.7	28.2	136.8	26.1	0.0	17.1	0.0	13.1	65.0	32.5	21.2	26.5	30.0	14.9	40.5	43.8	49.1	31.6	51.0	19.6	24.1	23.6	42.6	38.8	24.0	61.2	17.1	63.9	25.5	30.8	21.6	32.6	41.3	9.5	57.9	35.3	28.3	28.1	75.7	90.5	35.8	0.0	32.8	0.0	15.0	35.1	31.3	0.0	81.5	48.7	29.1	47.4	150.3	173.0	32.9	52.4	25.2	18.3	20.8	39.5	20.4	10.2	56.9	19.7	33.8	23.2	73.1	131.2	16.2	0.0	43.8	23.3	40.9	35.2	17.6
ZNF672	FLJ22301	ENSG00000171161	"Zinc finger protein 672"	Q499Z4	1	248838210-248849517	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 71.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055779, HPA062506"	Approved		Enhanced	Nucleoplasm		Yes	Yes			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Nucleoplasm		"HPA055779: AB_2682917, HPA062506: AB_2684786"	"unprognostic (1.64e-2)"	"unprognostic (3.45e-2)"	"unprognostic (8.96e-2)"	"unprognostic (2.92e-2)"	"unprognostic (2.50e-1)"	"unprognostic (9.54e-3)"	"unprognostic (7.42e-3)"	"unprognostic (1.08e-2)"	"unprognostic (2.50e-1)"	"unprognostic (2.40e-2)"	"prognostic favorable (7.51e-4)"	"unprognostic (9.03e-2)"	"unprognostic (1.16e-2)"	"unprognostic (1.99e-2)"	"unprognostic (2.69e-1)"	"unprognostic (8.35e-3)"	"prognostic favorable (1.79e-5)"	13.4	14.8	13.4	11.7	14.8	13.5	13.1	17.9	14.1	13.3	14.6	16.1	11.3	14.3	7.7	19.1	14.9	7.8	30.2	12.8	13.4	22.3	26.1	17.0	14.8	17.2	14.8	11.1	18.0	16.2	17.1	9.3	14.8	24.0	8.4	10.7	17.6	8.2	49.5	17.9	16.8	8.1	14.0	19.8	16.9	16.0	14.9	15.8	20.2	35.7	14.0	16.8	13.7	15.8	19.4	21.5	17.2	19.5	9.4	6.6	33.0	17.8	9.7	12.7	13.6	11.8	19.7	22.0	18.1	11.7	9.6	18.8	9.4	13.3	8.0	32.5	5.3	33.7	20.0	16.0	12.0	14.6	24.4	7.4	10.7	16.6	11.5	10.2	11.7	15.2	41.5	17.6	8.8	13.8	26.8	14.5	20.0	22.3	36.5	49.1	16.3	17.4	12.9	15.6	25.5	22.2	16.0	24.0	15.9	10.2	13.8	30.1	10.0	17.5	10.5	11.6	37.3	52.8	22.2	13.2	16.0	25.1	14.5	9.2	16.3	11.9	8.8	15.9	7.2	11.9	6.3	8.8	24.3	15.0	6.7	6.3	9.2	12.7	15.4	13.6	7.8	14.0	13.4	14.8	17.9	14.1	12.8	13.4	17.2	14.8	14.8	14.0	14.9	15.8	10.7	3.2	15.2	5.9	22.3	13.0	28.2	10.1	6.8	22.0	12.8	9.8	20.2	14.3	8.1	16.5	12.5	32.0	22.0	19.5	21.5	18.3	7.8	9.5	5.7	12.0	18.0	17.0	2.2	10.7	19.9	10.0	10.2	8.9	28.0	12.5	7.5	17.2	16.8	10.1	4.0	17.6	8.2	16.4	16.9	14.6	5.6	20.6	12.4	1.9	17.8	19.5	20.6	2.5	5.2	14.6	19.7	5.7	9.6	21.1	26.5	15.8	9.0	30.5	6.6	17.5	11.7	32.4	23.4	5.5	14.6	71.3	13.5	10.6	16.9	22.5
ZNF678	MGC42493	ENSG00000181450	"Zinc finger protein 678"	Q5SXM1	1	227563543-227677443	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocyte precursor cells: 38.2;Oligodendrocytes: 44.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"											HPA028507	Uncertain		Approved	Nucleoli,Mitochondria,Cytosol		Yes	No			"Cluster 41: Basophils - Cellular respiration"	"Cluster 34: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 68: Oligodendrocytes - Mixed function"	"Nucleoli, Mitochondria, Cytosol"		"HPA028507: AB_10603567"	"unprognostic (1.76e-2)"	"unprognostic (3.01e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.20e-2)"	"unprognostic (4.42e-3)"	"unprognostic (3.92e-2)"	"unprognostic (4.64e-2)"	"unprognostic (1.59e-2)"	"unprognostic (2.19e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.64e-1)"	"unprognostic (3.54e-6)"	"unprognostic (1.39e-1)"	"unprognostic (4.18e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.88e-4)"	2.5	3.1	2.2	3.0	3.3	3.4	3.7	3.6	2.8	3.6	1.1	2.9	2.3	3.8	2.4	2.1	3.1	3.1	1.9	2.3	4.3	2.6	2.2	3.2	4.4	3.1	2.8	4.0	3.3	2.3	1.5	4.2	2.8	4.0	4.1	5.7	2.7	2.4	1.5	1.4	2.1	2.4	2.3	3.6	3.3	3.9	3.4	4.4	5.4	2.7	4.0	2.1	2.3	5.6	2.5	4.0	13.6	15.5	1.6	3.7	8.3	3.3	3.2	4.8	4.9	3.3	2.9	9.7	8.3	1.5	2.5	4.6	8.3	2.2	7.6	4.2	15.8	4.5	2.9	2.0	3.0	8.0	12.0	3.3	3.8	2.8	6.0	3.5	4.5	10.9	12.4	15.1	5.2	2.0	11.3	2.8	12.1	3.6	6.3	8.4	8.9	3.9	3.4	7.7	5.8	11.2	4.8	5.6	2.3	6.6	7.9	9.2	3.3	5.9	5.5	5.2	6.6	4.8	11.8	10.5	2.3	1.4	6.2	5.4	0.6	0.8	1.3	0.1	1.6	3.7	1.3	0.8	1.2	2.6	1.2	1.7	0.1	1.4	0.4	1.8	1.7	0.8	2.2	3.3	3.6	2.8	2.3	4.3	3.1	2.8	2.8	2.3	3.4	5.6	10.9	3.2	7.3	21.2	7.8	2.3	4.0	2.9	2.2	12.2	5.5	2.9	4.2	4.3	4.5	3.7	4.2	2.1	8.2	6.8	1.9	4.0	0.9	4.6	6.0	6.5	9.6	10.3	11.7	5.2	2.4	6.5	7.1	4.8	3.8	9.4	5.3	3.0	1.8	1.7	17.2	4.8	4.1	3.1	3.7	0.6	7.5	3.3	0.0	17.8	3.3	4.7	5.2	38.2	44.7	3.3	7.3	2.6	5.8	5.4	1.3	1.4	5.5	7.3	0.0	12.3	4.9	7.6	10.5	3.1	0.6	1.4	5.8	4.2	3.8	3.8